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This thesis is concerned with approaches used by the Scottish Programme for
Clinical Effectiveness in Reproductive Health (SPCERH) to improve quality of care.
The work embraces two main themes: understanding factors that influence clinical
practice; and evaluating strategies to improve practice.
Many factors influence practice, such as the nature of targeted behaviours,
professionals and organisations (Chapter 1). An observational study, of practice
related to 42 audit recommendations in 16 gynaecology units, found that attributes of
recommendations independently modified the effects of a national audit and
feedback project (Chapter 2). Four evaluations of dissemination and implementation
strategies were conducted. The first, a telephone survey of 201 obstetricians and
midwives, highlighted gaps in awareness of national recommendations on the
prevention of maternal mortality (Chapter 3). The second, a before-and-after postal
survey of 92 obstetricians, found mixed changes in self-reported practice following
the dissemination of four national obstetric guidelines (Chapter 4). The third, an
interrupted time series analysis, evaluated trends in the care of 1263 women in four
maternity units related to of these guidelines, on mild, non-proteinuric hypertension
in pregnancy (Chapter 5). No improvements in the appropriateness of initial
investigations and subsequent clinical management were found. The fourth study, a
cluster randomised trial involving all 26 gynaecology units in Scotland, evaluated a
strategy to promote a guideline on induced abortion care. The strategy, delivered
under the auspices of SPCERH, comprised audit and feedback, educational meetings,
dissemination of a structured case record, and promotion of patient information. The
strategy was refined in the light of barriers identified following a pre-intervention
case record review, interviews with gynaecologists and a theoretically-derived
survey of 151 clinical staff (Chapter 6). Post-intervention compliance with guideline
recommendations was assessed by a review of 1474 case records and a survey of
1028 patients. No intervention effect was observed, possibly related to high pre-
intervention compliance with selected recommendations and the appropriateness of
the implementation strategy (Chapter 7).
The choices of study design were determined by SPCERHs' objectives, available
time and resources. More rigorous designs were judged to be less susceptible to bias
(Chapter 8). All studies were of moderate to high generalisability to secondary care
professionals targeted by SPCERH activities. Recommendations are made for future
evaluations of implementation activities (Chapter 9).
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Glossary
Adjustment. A summarizing procedure for a statistical measure in which the effects of
differences in composition of the populations being compared have been minimized by
statistical methods
After study. A study in which observations are only made following an intervention,
sometimes in more than one group of participants.
Association. Statistical dependence between two or more events, characteristics, or other
variables. An association may be fortuitous or may be produced by various other
circumstances; the presence of an association does not necessarily imply a causal
relationship
Audit and feedback. Any summary of clinical performance of health care over a specified
period of time. The summary may also include recommendations for clinical action. The
information may be given in a written, electronic or verbal format.
Bias. Systematic deviation of results or inferences from the truth, or processes leading to
such deviation.
Blind(ed) study. A study in which observer(s) and/or subjects are kept ignorant of the group
to which the subjects are assigned.
Case study. A description of the process of change in a single group (e.g. of health care
workers within a clinical team of unit).
Causality. The relating of causes to the effects they produce.
Clinical practice guideline. A systematically developed statement designed to assist
practitioner and patient make decisions about appropriate health care for specific clinical
circumstances.
Clinical governance. A system through which UK National Health Service (NHS)
organisations are accountable for continuously improving the quality of their services and
safeguarding high standards of care.
Co-interventions. Interventions other than the treatment under study that are applied
differently to the treatment and control groups.
Concealment of allocation. The process used to prevent foreknowledge of group
assignment in a randomised controlled trial. The allocation process should be impervious to
any influence by the individual making the allocation by having the randomisation process
administered by someone who is not responsible for recruiting participants.
Confidence interval (CI). The range of numerical values in which we can be confident (to a
computed probability, such as 90 or 95%) that the population value being estimated will be
found.
Confounding variable (confounder). A variable that can cause or prevent the outcome of
interest, is not an intermediate variable, and is associated with the factor under investigation.
A confounding variable may be due chance or bias.
xvii
Construct validity. The validity of inferences about the higher order constructs that
represent sampling variables.
Contamination. In randomised trials, the inadvertent application of the intervention being
evaluated to the control group.
Controlled before-and-after (CBA) study. Data are collected in non-randomised study
and control groups before and after the intervention is applied to study group. Differences in
performance between the study and control groups following the intervention are assumed to
be due to the intervention.
Cost-effectiveness analysis. An economic analysis that converts effects into health terms
and describes the costs for some additional health gain.
Cross-sectional study. The observation of a defined population at a single point in time or
time interval. Exposure and outcome are determined simultaneously.
Didactic educational meetings. Lectures or seminars without an interactive component.
Dissemination. Propagation of a message, e.g. by distribution of a clinical guideline.
Educational materials. Published or printed recommendations for clinical care, including
clinical practice guidelines, audio-visual materials and electronic publications
Educational outreach visits. Use of a trained person who meets with providers in their
practice settings to provide information with the intent of changing the provider's
performance. The information given may include feedback on the provider's performance
Effectiveness. A measure of the benefit resulting from an intervention for a given health
problem under usual conditions of clinical care for a particular group.
Efficacy. A measure of the benefit resulting from an intervention for a given health problem
under the ideal conditions of an investigation
Evidence-based medicine. The conscientious, explicit and judicious use of current best
evidence in making decisions about the care of individual patients. The practice of evidence-
based medicine means integrating individual clinical expertise with the best available
external clinical evidence from systematic research.
External validity. The extent to which a causal relationship holds over variations in
persons, settings, treatments, and outcomes.
Implementation. Execution of a plan, e.g. by taking actions to change clinical policy or
practice in line with a clinical guideline.
Implementation research. Research which aims to inform policy decisions about how best
to use resources to improve the uptake of research findings by testing approaches to change
professional and organisational behaviour.
Intention to treat analysis. A method for data analysis in a randomized clinical trial in
which individual outcomes are analyzed according to the group to which they have been
randomized, even if they never received the treatment they were assigned
xviii
Interactive educational meetings. Participation of health care workers in workshops that
include discussion or practice
Internal validity The validity of inferences made about whether an intervention causes an
outcome.
Intervention. A programme or treatment carried out, usually with the aim of improving
outcomes.
Intra-cluster correlation (ICC). A statistical measure of the degree of similarity' of
outcomes observed within any one group (e.g. a clinical team or hospital).
Local consensus process. Inclusion of participating health care workers in discussion to
ensure that they agreed that the chosen clinical problem was important and the approach to
managing the problem was appropriate
Local opinion leaders. Use of health care workers nominated by their colleagues as
'educationally influential'
Logistic regression. A statistical method used to investigate the relationship between an
event rate or proportion and a set of independent variables.
Meta-analysis. An overview which uses quantitative methods to summarise the results.
Multifaceted interventions. A combination two or more interventions
Null hypothesis. The null hypothesis states that the results observed in a study are no
different from what might have occurred as a result of the play of chance.
Number Needed to Treat (NNT). The number of patients who need to be treated to prevent
one bad outcome.
Odds ratio. The ratio of the odds of an event in the experimental (intervention) group to the
odds of an event in the control group.
Overview. A systematic review and summary of the health care literature.
Patient mediated interventions. Any intervention aimed at changing the performance of
health care providers where specific information was sought from or given to patients
Randomized controlled trial. A study design where treatments, interventions, or
enrollment into different study groups are assigned by random allocation. In cluster
randomised trials groups of participants are allocated to different interventions.
Recall bias. Systematic error due to the differences in accuracy or completeness of recall to
memory of past events or experiences.
Reminders. Any manual or computersied intervention that prompts the health care provider
to perform a patient specific clinical action
Reproducibility (repeatability, reliability). The degree to which results of a test or
measure are identical or closely similar each time it is conducted.
xix
Selection bias. A bias in assignment or a confounding variable that arises from study design
rather than by chance. These can occur when the study and control groups are chosen so that
they differ from each other by one or more factors that may affect the outcome of the study.
Statistical conclusion validity. Whether there is a true association between an intervention
and outcome and, if so, the strength of that association
Statistical power. The probability that the null hypothesis will be rejected if it is indeed
false.
Stratification. Division into groups. Stratification may also refer to a process to control for
differences in confounding variables, by making separate estimates for groups of individuals
who have the same values for the confounding variables.
Theory ofPlanned Behaviour (TPB). A motivational theory which proposes that
individual behaviour is primarily determined by the strength of an individual's intention to
perform that behaviour.
Time series analysis. The use ofmultiple observations before and after an intervention,
attempting to detect whether an intervention has had an effect greater than any underlying
trends in outcomes.
Uncontrolled before-and-after study. A study in which observations are made in one
group before and after an intervention and observed differences assumed to be due to the
intervention.
Unit of analysis error. The erroneous analysis of a study whereby individuals allocated by
groups are analysed as if they had been allocated individually. This can result in overly
narrow confidence intervals and false positive conclusions that an intervention has had an
effect.
Validity. The extent to which a variable or intervention measures what it is supposed to
measure or accomplishes what it is supposed to accomplish.
Variance. A measure of the variation shown by a set of observations, defined by the sum of




CEMD Confidential Enquiries into Maternal Deaths
CHI Commission for Health Improvement
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PPROM preterm pre-labour rupture of the membranes
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SD Standard Deviation
SEHD Scottish Executive Health Department
SHO Senior House Officer
SIGN Scottish Intercollegiate Guidelines Network
SOGAP Scottish Obstetric Guideline and Audit Project
SPCERH Scottish Programme for Clinical Effectiveness in Reproductive
Health
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The transfer of valid and relevant research findings into routine practice is unpredictable and
tends to be a slow and haphazard process. This problem occurs across different healthcare
settings, countries and specialities. Health care systems are under increasing pressure to
implement evidence-based care and reduce inappropriate care. Three broad approaches have
proposed to help achieve these goals: the dissemination of rigorously developed clinical
guidelines to inform health care practice and policy; the identification and use of effective
implementation strategies; and the creation of the right organisational conditions for change.
This chapter discusses the role of these approaches in promoting evidence-based care,
highlighting current knowledge and research needs.
Launched in 1997, the Scottish Programme for Clinical Effectiveness in Reproductive Health
(SPCERH) was given the over-arching goal: to improve health outcomes for women and their
families throughout Scotland by promoting more uniform standards of high quality, evidence-
based reproductive healthcare. SPCERH's work plan included a programme of research
evaluating the effectiveness of its dissemination and implementation strategies. This chapter
introduces that programme and sets out the related research objectives that form the basis of this
thesis.
This chapter is partly based upon the followingpapers
Foy R, Walker A, Penney GC. Barriers to clinical guidelines: the need for concerted action.
British Journal of Clinical Governance 2001;6:166-174.
Foy R, Eccles M, Grimshaw J. Why does primary care need more implementation research?
Family Practice 2001;18:353-5.
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1.2 The gap between evidence and practice
1.2.1 Inappropriate variations in health care
Clinical research continually produces new findings that can contribute to effective and efficient
patient care. However, such research cannot change patient outcomes unless health services and
health care professionals adopt them in practice. Pioneers of evidence based medicine
recognised frequent failures of the medical profession to base practice on scientific evidence (1).
Sometimes, this is represented by delays in compiling and appraising research findings in a
systematic fashion (2). More commonly, there are failures to act upon evidence.
The introduction of antenatal corticosteroids to prevent neonatal respiratory distress syndrome
illustrates a delay in uptake of valid research findings. A meta-analysis of randomised controlled
trials published in 1990 demonstrated a 70% relative reduction in mortality for infants born
before 31 weeks gestation when corticosteroids were administered for 24 hours or more before
delivery (3). A Scottish audit assessed care received by 1601 such infants among nine hospitals
over 1988-93 (4). Before publication of the meta-analysis, 16% of their mothers had received
antenatal steroids for 24 hours or more; only 29% received steroids within the four year period
following publication.
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Ineffective or inefficient clinical practices may continue despite evidence demonstrating lack of
benefit. Dilatation and curettage (D&C) was commonly used in the investigation of abnormal
endometrial bleeding. A report of a systematic review and a Royal College of Obstetricians and
Gynaecologists (RCOG) report recommended that: 'D&C should not be performed in women
aged under 40 and its use in older women could be replaced by cheaper and safer methods of
endometrial sampling' (5;6). A subsequent audit of practice across 12 hospitals in Scotland
found that D&Cs comprised 21% of endometrial sampling procedures and that 23% of women
undergoing endometrial sampling procedures were under 40 (7).
Inappropriate variations in care occur across different healthcare settings, countries and
specialities (8-14). Studies have been unable to explain this variation in terms of either patient or
resource factors. Accepting that variation alone does not necessarily represent inappropriate care
a small number of studies have gone on to assess appropriateness and conclude that inappropriate
care delivery was occurring (14). The UK NHS is under mounting pressure to reduce
inappropriate variations and improve the quality of care from successive governments impatient
for results.
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1.2.2 Factors that influence the implementation of evidence-based practice
Several frameworks have been used to describe factors that may promote or hinder the
implementation of evidence-based practice (15-20). One approach describes barriers under three
main categories related to the nature of the evidence or change itself, the characteristics of the
individuals who need to change, and the characteristics of the organisation or environment (21).
Tables 1.1 to 1.3 demonstrate the range of barriers to change, accompanied by illustrative
examples largely related to reproductive health care. The framework is not presented as a
theoretically-based taxonomy and some of the distinctions among barriers appear arbitrary.
Table 1.1. Barriers to change related to the nature of the evidence or change itself.
Barrier Example
Validity
Poor quality of evidence
Insufficient quality control in clinical guideline
development process
Poorer quality studies assessing diagnostic tests
may over-estimate their accuracy by up to three-
fold (22)
Failure to make explicit link between
recommendations and supporting evidence in 18%
ofmedical society guidelines published over 1988-
98 (23)
Relevance
Limited applicability to clinical practice related
to differences in or inadequate description of
population (24)
Use ofmagnesium sulphate to prevent fits in pre¬
eclampsia despite lack of clear evidence of benefit
(25)
Limited applicability to clinical practice related
to unavailability of or inadequate description of
interventions
Wider use of hysterosalpingography
(HSG) as first line in the investigation of infertility
limited by availability of appropriately trained
radiologists (26)
Uncertainty about the durability ('shelf-life') of
new research evidence (27)
Variation in the use of agents to prevent or delay
active preterm labour because of evolving evidence
about optimal choice of agent and regimen and
selection ofwomen most likely to benefit.
Unavailability of direct evidence to answer
clinically important questions
Lack of data indicating likelihood of myocardial
infarction for young, low-risk women using
combined oral contraception (28)
Practicality
Imprecise or ambiguous wording of guideline
recommendations (29)
Ambiguity of recommendations to investigate
'post-menopausal bleeding' because of varying
criteria to diagnose menopause
Disruption to routine practice (29) Need for changes in organisation of services to
introduce medical abortion service
Low awareness of information sources or
unavailability of evidence at point of need (30)
Limited or no access to Cochrane Reviews, (31 ;32)
Attainment of "ceiling effects," beyond which it
is difficult to change practice further
Lack of improvement in compliance with selected
recommendations from Cochrane Reviews (33)
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Lack of awareness that clinical practice ma)' be
inappropriate
Example
Prescribing of ineffective drug therapy for
endometriosis-related infertility (34)
Over-reliance on trusted or convenient sources of
information (35)
Seeking advice from colleagues or specialists
without questioning evidence base (36)
Over-estimation of self-reported performance,
(37) or perceived irrelevance to practice (38)
Over-estimation of actual use of corticosteroids to
prevent complications following preterm labour
(31)
Attitudes and beliefs
General hostility to guidelines (39) Fears that introduction of guidelines increases
susceptibility to litigation or reduces scope for
using clinical judgement (40)
Previous adverse experience of changing practice
(41)
Experience of fetal death following use of external
cephalic version in management of term breech
(42)
Doubts over credibility of source or change agent
(43-45)
Rejection of patient information leaflet by
midwives and ultrasonographers because of
disagreement with its assessment of costs and
benefits of routine ultrasound screening (43)
Hostility to challenges to established practices,
including those where research has been
outpaced by development (46)
Routine use of intra-partum cardiotocography
(CTG) despite doubts over the evidence base (47)
Low outcome expectation, i.e. belief that
following recommendation will not lead to
expected outcome (39)
Perceived low 'returns' on preventive measures
such encouraging smoking cessation in pregnancy
Avoidance of recommendations because of
perceived increased susceptibility to litigation
Over-investigation and management ofwomen
with mild hypertension in pregnancy because of
concern about missing severe hypertension (48)
Not sharing information with patients because of
perceived resistance or demands (30) or concern
about raising anxiety
Ultrasonographers' 'protection' ofwomen from
information about the potential harms of antenatal
ultrasound, e.g. abnormal scan result leading to
abortion ofnormal fetus (43)
Skills and capacity
Lack of skills and time to undertake brief
targeted searches for clinical evidence or
guidelines (49)
Undertaking apparently simple but time-
consuming Medline searches (30)
Lack of skills in critical appraisal (of clinical
guidelines as well as original research) (27;30)
Over-estimation of benefits or risks from
interventions when relative risk reduction is used
(50), e.g. 'risk of transfusion at time of abortion
doubles for every 2 week increment in gestation'
(51), fails to convey absolute risk of only 2/1000
and relative safety of abortion procedure
Lack of self-efficacy (i.e. ability or means to
perform a task) (39)
Limited capacity of professionals to process all
relevant information in clinical practice,
especially during high pressure situations (53)
Infrequent enquiry into domestic violence during
antenatal consultations by midwives or
obstetricians because of concerns about
counselling skills (52)
Complexity of and inherent uncertainty in
assessment of fetal distress during labour
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Table 1.3. Barriers to change related to characteristics of the organisation or environment.
Barrier
Established approaches to change
Example
Over-reliance on passive methods of dissemination
(54:55)
Passive dissemination of Report of Confidential Enquiries
into Maternal Deaths and resulting low awareness of key
recommendations among obstetricians and midwives (52)
Poor targeting of clinical guidelines Inability of professionals and organisations to cope with
proliferating quantities of clinical guidelines (56:57)
Clinical guidelines 'adopted' without consensus or
adaptation to local circumstances (58)
Imposition of national guidance without consultation -
such as the requirements for 'approval of independent
sector places for the termination of pregnancy' by the
Secretary of State for Health (51)
Competing priorities and organisational
inertia
Failure to prioritise implementation (59) Lack of resources for implementation relative to the
production of evidence (31)
Managing the complexity of adopting desired
practice (29:44)
Organisation ofmulti-disciplinary care and follow-up for
women with gynaecological cancer (60)
Culture
Little or no history ofmultidisciplinary working (38) Resistance to expanded role for gynaecology nurses
delaying the introduction ofmedical abortion services
Negative attitudes from colleagues or other
professionals towards challenging existing practices
or reinforcing new effective practices (30) (41)
Resistance to adoption of routine antibiotic prophylaxis at
Caesarean section despite Cochrane Review
demonstrating effectiveness (61)
Constraints of hierarchical relationships Midwives' support for Informed Choice patient
information leaflets compromised by obstetrician
preferences (62)
Constraints of normative values Range of choices in maternity care, highlighted by for
Informed Choice patient information leaflets, limited by
local availability and values (62)
Abdication or avoidance of organisational
responsibility
Tendency for internal reviews ofmedical errors to focus
on individual rather than organisational factors (63).
Resources
Lack of protected time and resources to plan changes
in practice (38:64) (39)
Continuing use of intensive schedules of antenatal care,
with duplications of care by obstetricians. GPs and
midwives, despite evidence that reduced-visit schedules
do not compromise safety and that many women can be
cared for by GPs and midwives alone (65:66)
Diluted or non-implementation of proven
interventions because of limited resources (67)
Rationing ofin-vitro fertilisation (68)
Opportunity costs of evaluating and changing
performance
Establishment of guideline initiatives without explicit link
to audit
Knowledge and assessment of organisational
performance
Marginalisation of clinical audit Concerns over perceived threats to professionals,
restriction of clinical freedom and increased workload
(69:70)
Absence or poor quality of clinical audit (44) Insufficient resources to support audit and lack of
expertise in its conduct (69)
Difficulty in measuring or interpreting outcomes
(71)
Unreliability of in-vitro fertilisation league tables in
assessment of units' performance because of year-on-year
random variation and biases in presentation of results
(72:73)
Short term outlook rather than appreciation of long
term nature of achieving and sustaining change (38)
Traditional short-term project funding of audit and
guideline exercises (74)
Patient preferences
Conflicting patient knowledge, expectations and
preference over choices in clinical management (43)
Demand for caesarean section in the absence of medical
indications (75)
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Some barriers are deeply entrenched whilst others are more amenable to change. Furthermore,
many factors categorised under barriers may also promote evidence-based practice. To date, the
knowledge and expectations of patients have mainly been identified in the research literature as a
barrier. However, informed patients may facilitate rather than impede more appropriate care in
some circumstances (76).
Professionals and policy-makers have responded to these barriers in a number of ways. These
responses have included the development and dissemination of clinical guidelines, the use of
effective implementation strategies, and the optimisation of organisational conditions for change.
The following sections (1.3 to 1.5) discuss the relevance of these three factors to evidence-based
care, highlighting current knowledge and research needs.
1.3 The need for rigorously developed clinical guidelines
Clinical guidelines are increasingly being used guide clinical practice and policy (77). Clinical
guidelines have been defined as "systematically developed statements to assist practitioner and
patient decisions about appropriate health care for specific clinical circumstances" (78). The
potential benefits of clinical guidelines need to be balanced against their potential costs and
limitations (79).
1.3.1 Potential benefits, costs and limitations of guidelines
Improving outcomes. Potential health benefits from following recommendations include reduced
mortality, improved health-related quality of life, reassurance and avoidance of unnecessary
procedures. The validity of guideline recommendations is critical, i.e. 'when followed they lead
to the health gains and costs predicted for them' (78). Clinical guidelines therefore need to be
developed using a rigorous methodology, including:
• The participation of professionals with expertise in the clinical topic, literature searching,
epidemiology, health services research, facilitating group processes and writing - as well as
other stake-holders, such as service user advocates (80)
• A comprehensive search to identify relevant research
• Linking of recommendations to reviewed evidence
• Explicit consideration of other factors in grading of recommendations, including the
relevance of the evidence to the target population, economic considerations, values of the
guideline developers and society, and practical issues concerning implementation (81).
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• Clearly defining where and when the guideline can be applied, e.g. according to the
availability of requisite skills or resources
An analysis of guidelines produced by specialty societies over 1988-98 demonstrated that the
majority failed to meet a range of criteria for good quality, such as explicit grading of evidence
(23). Guidelines are more likely to be valid if produced by national or regional guideline
development groups according to rigorous and explicit methods (82). Within the UK, the
Scottish Intercollegiate Guidelines Network (SIGN) has been developing expertise and
experience in guideline development (83). The National Institute for Clinical Excellence (NICE)
in England and Wales now also undertakes a similar role.
Coping with information. Health professionals work in an age of information overload and
increasing complexity of care. The production rate of new clinical evidence can overwhelm even
the most committed professional in any field (30;84). Given the burdens associated with
assimilating information from individual studies and the growing volume of systematic reviews,
guidelines can provide relevant and reliable summaries of clinical evidence.
Indiscriminate distribution of guidelines may cause alienation if clinicians are overwhelmed by
proliferating quantities of guidelines (56). In one survey, 45 different guidelines for the
management of depression in primary care were identified within the UK (85). There was a
considerable range in the quality of a subset of guidelines appraised in detail. Rather than
promoting uniform standards of care, the growth in the number of guidelines risks perpetuating
variations in practice.
Risk management. Guidelines can help professionals reduce or cope with clinical uncertainty by
explicitly balancing known benefits and risks. Whilst the avoidance of litigation is often
associated with taking additional actions (e.g. an investigation), it is often necessary to define
thresholds below which action is unlikely to produce clinical benefit. Defensive medicine has
been said to be rooted in the syndrome of "nominators looking for denominators" (86). Recent
clinical experience of a stillbirth may inappropriately but understandably lower the threshold at
which an obstetrician would advise caesarean section in subsequent deliveries. Guidelines can
help reduce inappropriate practice without compromising standards of care. For example, in a
high risk specialty such as obstetrics, guidelines may aim to reduce the caesarean section rate by
promoting a trial of labour in women with a previous caesarean section (87) or reduce
inappropriate investigations and hospital admissions associated with mild, non-proteinuric
hypertension (48).
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There is confusion as to whether the adoption of guidelines and pathways increases or decreases
vulnerability to litigation (88). On one hand, there is concern that clinicians who fail to follow
guidelines or pathways will be accused of falling short of acceptable standards. On the other, the
implementation of guidelines may lead to safer and more effective care, thereby reducing clinical
risk. There is no direct evidence that the introduction of guidelines has contributed to increased
rates of litigation, particularly from the United States where there is greater experience of
guidelines. Guidelines have been cited as evidence in 6% of a random sample of case in claims
opening over 1990-91, in roughly equal proportions for the plaintiff and defendant (89).
Resource allocation. There are two main costs associated with clinical guidelines. Firstly, there
are costs related to the development of the guideline and the measures (if any) taken to support
their dissemination and implementation (e.g. educational activities). Secondly, there are costs (or
savings) subsequent to putting recommendations into practice (e.g. increased or decreased
prescribing)(90). In some circumstances, the opportunity costs of guideline development,
dissemination and implementation may outweigh potential benefits.
Resources available for health care are limited. Policy makers, managers and clinicians need
relevant and reliable evidence to inform resource allocation. Ideally, the evaluation of new
health care technologies incorporates an assessment of cost-effectiveness. If cost-effectiveness
data are unavailable, guideline developers need to take account of approximate relative costs in
presenting their recommendations (81).
Rigorously developed guidelines can highlight under or over provision of certain services. Yet,
as well as encouraging fairer resource allocation, the adoption of guidelines may also promote the
inappropriate provision of health care interventions or facilities. Guideline developers therefore
need to consider the wider implications and possible unknown costs and consequences of their
recommendations (91 ;92).
Shared decision-making. There is a growing emphasis on enhanced patient involvement in
decisions relating to their care. Some guidelines are produced with 'lay' versions to promote
more consistent patient education, especially for chronic conditions which require a substantial
degree of self care. In addition, patients can use guidelines to prompt clinicians to reconsider or
change aspects of their care.
Guidelines tend to apply to a group of patients as a whole. There is a persistent perception that
guidelines restrict individual choice (39). Individuals may receive inappropriate care if
recommendations are poorly worded or interpreted without reference to individual clinical needs
8
and preferences. Patient clinical needs may be compromised, for example, if clinicians following
guidelines on the management of hypertension are unaware of their limitations and fail to take
into account pre-existing illnesses and risk factors that might complicate treatment and modify
outcomes (93). Patient preferences may bring them into conflict with the guidelines and
clinicians attempting to follow them, especially where a preference is expressed for ineffective or
less cost-effective options. As discussed above, health care resources are limited and guideline
development usually needs to favour more cost-effective treatment options. Setting limits within
guidelines to reflect what health care systems will pay for may reduce conflict between clinicians
and patients (94). Subsequently, the conflict may shift to one between patients (possibly with
their clinicians) and the health care system.
1.3.2 Determining the need for a guideline
Given the opportunity costs associated with developing or adopting guidelines, organisations
need criteria against which to judge the need for a guideline, such that the likely benefits of
implementation outweigh probable costs (95). The choice of topic is often determined by locally
or nationally set priorities. The criteria for selecting a topic may reflect evidence of inappropriate
clinical care, scope for preventing mortality or morbidity, or opportunities to improve the
efficiency of care.
Once a topic has been agreed, local clinicians and managers have the option of either developing
a new guideline themselves or adapting one already developed, usually at a national level. As
most health care organisations lack the resources (especially in terms of professional time)
required to develop new guidelines from scratch, it is usually expedient and probably more
efficient to draw upon pre-existing guidelines. Checklists are available for the critical appraisal
of guidelines not already reviewed by bodies such as SIGN or NICE (96). Local adaptation
usually requires input from a multidisciplinary team, similar in composition to that of the original
guideline development group. Guidelines can be adapted to reflect local circumstances, such as
the availability of services or patient characteristics. There is scope for changing
recommendations based upon weak evidence but changing those based on good evidence
requires explicit justification (95).
1.3.3 Guidelines and changing practice
Implementation of valid guidelines can improve clinical practice, especially if effective
dissemination and implementation strategies are used (58). Other factors, or effect modifiers, can
influence the effectiveness of such strategies (97). Until recently, most research has focused on
characteristics of clinicians or health care organisations, such as local attitudes or preparedness to
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change. However, the characteristics (or attributes) of clinical practice recommendations
themselves may also influence their rate of adoption (98). Higher or lower compliance may be
associated with certain attributes, e.g. those that are compatible with clinician norms and values
or disruptive to routine practice (29;99).
Previous work focused on the effects of various attributes on compliance with recommendations
(i.e. a one-off measure of performance). However, clinical guidelines are produced to promote
change in behaviour, which may be influenced by attributes different from those associated with
compliance. Less is known about whether various attributes of clinical practice
recommendations influence both compliance and change in clinical behaviour (Chapter 2).
1.4 The need for effective strategies to change professional practice
1.4.1 Existing strategies
A range of strategies exists to change professional behaviour and promote evidence-based health
care (Table 1.4, overleaf). These strategies are often designed to overcome barriers associated
with individual professional (Table 1.2) or organisational factors (Table 1.3). Strategies may
encompass professional interventions (e.g. continuing medical education, audit and feedback),
financial interventions (e.g. professional incentives), organisational interventions (e.g. the
expanded role of pharmacists) or regulatory interventions (e.g. professional accreditation). The
interventions are broadly based upon a range of theoretical approaches and assumptions about
how individuals and organisations behave. The challenge for those harnessing such interventions
to improve the quality of care is how to ensure their selection is based more upon evidence than
on belief (100).
1.4.2 Lessons from systematic reviews
As with clinical care, systematic reviews of rigorous studies have greatly contributed to
knowledge about what works in changing professional and organisational behaviour. An
overview of systematic reviews (101) suggested that it was possible to identify strategies that
were more, or less, effective. Strategies such as postal distribution of guidelines or didactic
educational sessions were suggested to be largely ineffective. Local consensus conferences, the
use of opinion leaders or audit and feedback were of variable effectiveness. Interactive
educational workshops, reminder systems, educational outreach and multi-faceted interventions
were suggested as largely effective.
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Table 1.4. Examples of interventions to promote professional behavioural change (102).
Educational outreach visits - Use of a trained person who meets with providers in their practice
settings to provide information with the intent of changing the provider's performance. The
information given may include feedback on the provider's performance
Reminders (manual or computerised) — Any intervention that prompts the health care provider to
perform a patient specific clinical action
Multifaceted interventions - A combination two or more interventions
Interactive educational meetings - Participation of health care providers in workshops that
include discussion or practice
Audit andfeedback - Any summary of clinical performance
Local opinion leaders - Use of providers nominated by their colleagues as 'educationally
influential'
Local consensus process - Inclusion of participating providers in discussion to ensure that they
agreed that the chosen clinical problem was important and the approach to managing the problem
was appropriate
Patient mediated interventions - Any intervention aimed at changing the performance of health
care providers where specific information was sought from or given to patients
Educational materials - Distribution of published or printed recommendations for clinical care,
including clinical practice guidelines, audio-visual materials and electronic publications
Didactic educational meetings - Lectures
Closer scrutiny of these findings by a recent systematic review highlights major weaknesses in
the evidence base (103). This review represents the most comprehensive systematic review to
date, including 235 studies comparing a total of 309 interventions. It challenges previous views
about the effectiveness and transferability of interventions to improve practice. For example,
there is no direct evidence that combinations of interventions are more effective than single
interventions, and simple dissemination of educational materials may be as effective as more
active methods. Effect sizes tend to be relatively small or modest and are sometimes of uncertain
clinical impact. However, interpretation was frequently hindered by the poor methodological
quality of primary studies.
The evidence for effective interventions may not stand up to the real world of local
implementation because of doubts over transferability. First, there is uncertainty over what
factors are important in the relative success or failure of reported strategies because of the lack of
an established theoretical framework. Second, studies do not measure or report potential effect
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modifiers. Systematic reviews indicate variable effectiveness within the same interventions, such
as audit and feedback or use of local opinion leaders (people identified as being educationally
influential by their peers). These variations might be attributable to the modifying effects of
context and content. The feasibility of identifying local opinion leaders and their potential
effectiveness are often compromised by the variability and idiosyncrasies of local professional
networks (104). Inconsistent findings might also be explained by variations in the intensity or
quality of the interventions tested. Third, interventions are often poorly described - thus posing a
problem for aggregation within systematic reviews and for subsequent interpretation in order to
reproduce successful interventions. Although prompts and reminders appear to be consistently
effective, their frequency and proximity to the point of clinical decision-making may influence
the size of their impact.
Interventions to overcome specific barriers should ideally be tailored to the nature of anticipated
local problems (100). There is a growing body of evidence to support the prior assessment of
barriers and needs (55). Theoretical models of change can be used both to understand the
behaviour of health professionals and organisations and to guide the development of
interventions to promote change (101; 105). These theories are derived from a range of
disciplines (e.g. applied psychology, management studies) and generally apply to different levels
of change, i.e. those of individual professionals, teams and organisations (18). Ultimately, the
aim is to develop an empirical basis for selecting interventions given specific barriers, and
circumstances.
Where effectiveness is consistently demonstrated, it is often difficult to judge whether benefits
are outweighed by costs. Few studies have assessed the direct costs of changing clinical
behaviour, not to mention the indirect effects on health services following implementation
strategies (103). Resources are limited and any implementation strategies that exhaust these
limited resources will not be sustainable in the long term. Those responsible for local
implementation need to know as much about the cost-effectiveness of behavioural interventions
as they do about that of clinical interventions.
1.5 Optimising organisational conditions for change
1.5.1 The influence of organisational factors
There is growing recognition of the influence of organisational culture upon the behaviour of
health care professionals and providers (106). Organisational culture has been defined as '"a set of
tacit assumptions about how the world is and ought to be that is shared by a set of people and
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determines their perceptions, thoughts, and feelings and. to some degree, their behaviour' (107).
Strategies to change or regulate an organisation's behaviour are complicated by and need to take
account of its established norms and values. Changing organisational culture requires substantial
political leadership and a marked shift in how members of an organisation perceive themselves
(18). The advent of clinical governance in the UK NHS represents an attempt to change
organisational culture and bring together a range of quality improvement methods to improve
health care.
1.5.2 Clinical governance
Clinical governance has been defined as "a system through which UK National Health Service
organisations are accountable for continuously improving the quality of their services and
safeguarding high standards of care by creating an environment in which excellence in clinical
care will flourish" (108).
Origins and scope. A series of events late in the 1990's undermined public confidence in the
NHS. Concern about 'rationing by postcode' highlighted the need to tackle inequity of health
care provision. More alarmingly, systematic failures in the organisation and provision of care
became apparent, notably during the inquin/ into paediatric cardiology at Bristol Royal Infirmary
(109). The specialty of obstetrics and gynaecology has also remained prone to adverse publicity,
e.g. following consultant suspensions for professional misconduct and discoveries of scientific
fraud (110-112). Against this background, the incoming Labour government was looking for a
'big idea' to spearhead its efforts to reform the NHS (113).
The 1997 White Paper, The new NHS, announced the establishment of new mechanisms and
structures to improve quality (114). The National Centre for Clinical Excellence (NICE) was
established to appraise and disseminate advice on new and existing treatments whilst National
Service Frameworks set out common standards for major clinical areas. Clinical governance
emphasised the local arrangements to ensure that national standards for clinical care were met; it
therefore united previous clinical audit (115) and effectiveness initiatives (116) with more
explicit procedures for managing and dealing with clinical risk and poor performance.
The impact of these earlier initiatives had been undermined by significant organisational
shortcomings. Firstly, clinical audit often appeared to be an ad hoc activity led by clinicians in
isolation from the rest of the organisation (and sometimes even from their peers) (70). There was
a lack of a broader framework to ensure that the emphasis of clinical audit shifted from
measuring performance and providing small amounts of feedback towards changing practice.
Secondly, the dissemination of clinical guidelines and rapid expansion in the availability of other
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paper and electronic sources of information were seldom accompanied by active local
implementation. Thirdly, management-led initiatives had mainly remained concerned with
resource use. The advent of the 'internal market' for health care had concentrated senior
management's attention on financial control and marginalised clinical issues from NHS board
agendas - unless provoked by adverse events or calls for more resources.
Critically, under clinical governance, chief executives ofNHS organisations were given ultimate
responsibility for assuring the quality of services, just as they were previously accountable for the
proper use of resources. Organisations appointed clinical governance boards with a central role
in monitoring and improving local standards of care. A designated senior clinician became
responsible for ensuring that the appropriate systems were in place. The Commission for Health
Improvement (CHI) was constituted to act as a watchdog over local clinical governance
arrangements and become involved in trouble-shooting if necessary.
The detail of arrangements differed in Scotland although the overall policy thrust remained
similar. Two key bodies were already in place. The Clinical Resource and Audit Group (CRAG)
initially led efforts to promote clinical effectiveness. The Scottish Intercollegiate Guidelines
Network (SIGN) represented a professionally led initiative for the development and
dissemination of clinical guidelines. The Scottish White Paper, Designed to Care, set up the
Health Technology Board for Scotland (HTBS) to appraise and provide guidance on new and
established health technologies, fulfilling an analogous role to NICE (117). The Clinical
Standards Board for Scotland (CSBS) was established to monitor and support local
implementation, albeit without the explicit watchdog function ofCHI.
Challenges to clinical governance. On top of professional cynicism at the prospect of another
quality initiative (118), getting the principles of clinical governance into practice posed major
challenges. Assessing clinical and organisational performance is problematic (119; 120) and
dissemination of such data may have unintended consequences (72;73; 121; 122). Much of the
focus and remedial actions to tackle poor performance have tended to focus on selected
individuals, teams or even hospitals (123). These occur at the expense of considering the wider
environments in which they exist (63) and despite recognition by the Department of Health of the
need to move away from a 'blame culture' (124). Cultural gaps remain between health care
management and health (most frequently, medical) professionals (18). Some of this gap has been
bridged by clinicians' greater adoption of managerial responsibilities - although the wider body
of clinicians may still perceive colleagues in management as relative outsiders.
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As well as representing a new template for NHS organisational culture, clinical governance
entails the integration of a variety of approaches to improving health care. e.g. clinical audit,
continuing professional development. Grol contends that the choice of interventions to promote
clinical effectiveness is currently as likely to be based on habit and belief rather than convincing
evidence of effectiveness (100). However, as highlighted above (section 1.4.2), better evidence
is needed to help identify effective and efficient strategies to promote good practice.
1.6 implementation research
Implementation research aims to inform policy decisions about how best to use resources to
improve the uptake of research findings by testing approaches to change professional and
organisational behaviour. Rigorous designs and methods are needed to allow valid and reliable
estimates of the likely effects of alternative interventions to be made (125). The validity and
relevance of research methods will be addressed throughout this thesis.
1.6.1 Measuring effectiveness
The validity and relevance of effectiveness data depend upon what is measured, the timing of
measurements and how measurements are taken. Measures of effectiveness can include changes
in health outcomes, such as complication rates or patient quality of life, or health care process
outcomes, such as compliance with guideline recommendations. Measuring health outcomes
generally results in the problems of prohibitive sample sizes, longer time scales and greater
expense associated with detecting clinically significant effects. Measures of process are more
sensitive than health outcome measures in detecting differences in the quality of care (126).
Implementation research tends to focus on tracer activities that reflect the overall quality of care
(127; 128). The key assumption is that the validity of the recommendations followed or changes
made is proven, thus negating any need to measure actual health outcomes.
The timing of measurements is relevant to the planning of studies and assessment of outcomes
(125). Measurements of baseline (or pre-intervention) performance inform sample size
calculations, allow comparisons to be made between intervention and control groups, and help
assess the magnitude of any changes in performance. The timing of measuring outcomes at
follow-up (post-intervention) requires careful consideration. If measured too soon, outcomes
associated with learning effects or more complex organisational changes may not be detected. It
is also possible that interventions may have significant but unsustained effects that later
measurements may fail to detect, e.g. improved compliance from raised awareness of a
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recommendation following an educational programme. Ideally, change over time should be
measured to identify such effects and quantify their influence.
How outcomes are measured influences their validity. Surveys of professionals may be useful
for testing by testing simple aspects of guideline dissemination, such as receipt by target users
and availability. However, compared with more objective measures, self-reports of activity tend
to overestimate actual performance (37;129). Other methods of data collection may also sensitise
professionals to desired practice. For example, the collection of structured data by professionals
participating in a study may improve performance by itself. Intrusive data collection may lead to
improved performance in both intervention and control groups, potentially underestimating the
effect of the intervention. Data collection should aim to be minimally intrusive. Where possible,
researchers should consider using routinely collected data, such as from case notes, in order to
reduce sensitisation.
1.6.2 Study designs
As with the testing of clinical interventions, randomised evaluations of interventions to change
professional and organisational behaviour produce the least biased estimates of effect. However,
well-designed non-randomised studies can still provide robust evidence where there are practical
and ethical barriers to conducting randomised studies (130). Following this brief outline, the
strengths and weaknesses associated with different methods of measuring outcomes and study
designs will be explored in detail under the separate studies contributing to this thesis.
Case studies describing the process of change in single groups can provide insights into factors
that influence change and generate hypotheses for further testing in rigorous evaluations,
especially if qualitative methods are applied. Some evaluations draw on a series of case studies
to explore factors that may promote successful organisational change (131). No causal
inferences can be made.
After studies. Observations are only made following an intervention, sometimes in more than
one group of professionals (132). Because observations are not made before the intervention, it
is not certain that the intervention has resulted in any change. The lack of a control group means
that no allowance can be made for secular trends.
Uncontrolled before-and-after studies. Observations are made in one group before and after an
intervention and observed differences assumed to be due to the intervention (133). The
advantage of this design is that many characteristics of the study population may be similar when
both measurements are taken. There are several problems in attributing any changes in outcome
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to the intervention. First, regression to the mean occurs when study units selected on the basis of
their extreme scores (e.g. low compliance with guideline recommendations) subsequently tend to
give scores closer to the average. Second, maturation occurs when the passage of time brings
about changes in the study units independent of the intervention. For example, clinicians may
become more familiar with a guideline and practising its recommendations over time and this
may be unrelated to the intervention. When measuring outcomes over time changes in the
definition or measurement of an outcome may change over time or (in questionnaire surveys)
professionals may become sensitised to the most appropriate responses.
Controlled before-and-after (CBA) studies. This design strengthens before-and-after studies by
incorporating a non-randomised control group that will experience trends and changes similar to
those of the study group. Data are collected in both groups before and after the intervention is
applied to study group. Differences in performance between the study and control groups
following the intervention are assumed to be due to the intervention. The need for similar
baseline characteristics and performance can make it difficult to find appropriate control groups,
e.g. with similar organisational characteristics and patient case mix. It is possible to assess
change from baseline performance where baselines differ but the very existence of baseline
imbalances suggests that a control group is not similar in other important respects (that can
modify effectiveness of any intervention tested). The non-randomised nature of CBAs therefore
risks residual selection bias. Regression to the mean may also complicate interpretation of
findings if participating study sites are (partly) selected on the basis of extreme scores.
Time series analyses entail the use of multiple observations before and after an intervention,
attempting to detect whether an intervention has had an effect greater than any underlying trends
in practice (134). Time series analyses may be used in estimating the effects of mass media
campaigns, legislation or dissemination of national guidelines. They therefore tend to be
opportunistic (135). Simple (uncontrolled) time series analyses allow for secular changes
resulting from maturation or regression to the mean to be estimated. Potential sources of bias
remain. External events, in addition to the intervention, may influence outcomes. Secular
changes in instrumentation, the way outcomes are measured, may occur. Controlled time series
analyses can enhance validity by including a control group to allow for more rigorous control of
external influences (76). As with other non-randomised studies, potential sources of bias may
stem from the selection of study units or regression to the mean.
Randomised trials aim to counter many of the aforementioned biases and represent the most
rigorous available design for evaluating interventions (125; 132;136;137). Randomisation by
individual is inappropriate for interventions taking place at an organisational or geographical
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level, largely because of contamination effects (138). In cluster randomised trials groups of
participants are allocated to different interventions. Cluster randomisation has major
implications for design and analysis (125; 132). Firstly, randomisation should occur at a level
that minimises potential contamination, e.g. at clinician, unit or hospital levels. Secondly,
patients within any one cluster are more likely to have similar outcomes - statistically measured
by the intra-cluster correlation (ICC). Hence standard statistical analyses assuming that the
outcome for one patient would be independent of another no longer hold. Subsequently, larger
sample sizes are required with analysis at or accounting for the cluster as the unit of
randomisation. Previous studies have often ignored important methodological issues, in
particular accounting for clustering effects (139).
The designs of cluster randomised trials can be strengthened. For example, in balanced
incomplete block designs, each participating professional experiences both the new intervention
and the status quo simultaneously for two or more clinical conditions (140). This design
equalises Hawthorne and other non-specific effects across both groups whilst maximising power
and efficiency. The main drawback concerns the complexity of design and subsequent conduct
and analysis.
In summary, methods of evaluating interventions to change professional and organisational
behaviour offer a range of strengths and weaknesses. Where feasible, the randomised trial is the
preferred design.
1.7 The Scottish Programme for Ciinicai Effectiveness in
Reproductive Health
The work for this thesis took place within the context of the Scottish Programme for Clinical
Effectiveness in Reproductive Health (SPCERH). The Programme was launched in 1997 (74).
Towards the end of the 1990's, the Scottish Executive Health Department (SEHD) reappraised
the conduct and funding of national clinical effectiveness activities. CRAG activities, such as
audit, had been mainly funded as fixed-term projects. The limitations of this approach in
addressing national priorities and establishing stable networks had been recognised. The
proposal for an integrated programme of work around reproductive healthcare was made during
discussions over 1996 to 1997 between the Scottish Executive Health Department (SEHD) and
representatives of key professional groups. The case for a programme was made by
representatives of the Scottish branches of the Royal Colleges of Obstetricians and
Gynaecologists (RCOG) and Midwives (RCM) and those leading existing national audits of
reproductive healthcare. Existing activities involving clinical audit (Gynaecology Audit Project
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in Scotland, GAPS) and clinical guideline development (Scottish Obstetric Guideline and Audit
Project, SOGAP) in reproductive health topics had demonstrated a high degree of support and
participation from professionals. However, such activities were largely being conducted in
isolation from one another. SPCERH provided the opportunity to unite and coordinate these
activities under the umbrella of a single programme.
1.7.1 Scope of the Programme
SPCERH was given the over-arching goal: to improve health outcomes for women and their
families throughout Scotland by promoting more uniform standards of high quality, evidence-
based reproductive healthcare. The Programme's work plan was based around four main roles.
Development of clinical guidelines and monitoring standards through clinical audit. Work
within this role includes the administration of two standing audits on behalf of the Chief Medical
Officer for Scotland: the Confidential Enquiry into Maternal Deaths; and the Scottish Stillbirth
and Infant Death Survey (SSBIDS, in partnership with the Information and Statistics Division of
the NHS in Scotland). SPCERH also initiates one national topic or criterion-based audit
annually. To date, these audits have covered the management of pregnancy in women with Type
I diabetes (141), the organisation of maternity services (142), and the prevention and
management of emergencies in labour (143). One of SPCERH's precursor projects (SOGAP)
was concerned with the development of four obstetric clinical guidelines. During its first year,
SPCERH completed the development and dissemination of these four guidelines. The
Programme emphasis later shifted from managing guideline development to nominating topics
and members for SIGN guideline development groups.
Education, training and facilitation of professionals providing reproductive healthcare. In
addition to disseminating reports of work and regular presentations at local units, SPCERH
publishes newsletters and organises an annual Reproductive Health Forum for professionals to
share and discuss experiences of approaches to improving practice.
Coordination and advice. SPCERH provides advice on other national and local audits within
Scotland, as well as several projects abroad. The Programme also has a core commitment to
providing professional and administrative support for Expert Advisory Groups on reproductive
health topics, e.g. the provision of infertility services (144), convened as required by the SEHD.
Implementation research. Although principally an implementation Programme, SPCERH is
committed to a programme of research evaluating the effectiveness of its dissemination and
implementation strategies. Much of this work forms the basis of this thesis.
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1.7.2 The value of clinical effectiveness programmes
At face value, programmes such as SPCERH offer a number of advantages over fixed term,
stand-alone projects. The first is the opportunity to integrate and coordinate a number of related
projects and build upon previous work. For example, the audit of pregnancy care in women with
diabetes was based upon criteria derived from recommendations in a previously published SIGN
guideline. Medium term funding is also more compatible with the time scales required for
clinical audit, allowing time for completion of the 'audit cycle' rather than an isolated assessment
of practice at one point in time. Hence, a re-audit of pregnancy care in women with diabetes was
scheduled for five years following the first audit.
The second advantage is the opportunity for a team of professional and support staff to build up
expertise and relevant networks and collaborations. This may facilitate longer term learning by
the Programme based upon continuing evaluation of its activities, as well as providing training in
and experience of clinical effectiveness activities for professionals temporarily employed by or
seconded to SPCERH. Much collaboration between SPCERH and reproductive healthcare
professionals in Scotland also depends upon mutual benefits realised and trust fostered over the
longer term by a professionally led programme.
The third advantage relates to the ability of SPCERH to directly link (implementation) research
to quality improvement activities. Proponents of an analogous programme in the United States
suggest iterative dialogues between researchers and clinicians can enhance the relevance of
research and improve the uptake of research findings (17).
Finally, reinforcement of guideline dissemination by a programme with professional credibility
may enhance implementation, at least partially through the social influence of professional
networks (15; 145).
The value of such programmes in improving healthcare and health outcomes has not been
formally evaluated. Controlled evaluations of, say, the impact of a programme compared with no
programme, are probably impractical. However, it is possible to evaluate the effectiveness of
strategies to improve healthcare within the context of a programme.
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1.8 Thesis aim and objectives
This thesis aims to evaluate strategies employed by national clinical audit and effectiveness
programmes in improving reproductive health care.
In order to meet this aim, this thesis will report work undertaken within a national clinical
effective programme, SPCERH. This work consists of two main strands: evaluating strategies to
change professional and organisational behaviour; and understanding factors that influence
behaviour. The objectives are set out linked to the issues identified in this introductory chapter in
Table 1.5. As this programme of work evolved over the course of a four year attachment to
SPCERH, Table 1.5 also sets out approximate timings of each project.
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Table 1.5. Thesis objectives.




To determine which attributes of
recommendations from a national
audit project best explain the extent
of their adoption into clinical
practice
Years 1 to 2
The potential effect modifying role of guidelines
in strategies to change clinical practice (1.3.3)
To survey Scottish obstetricians and
midwives to assess knowledge of
key clinical recommendations from
the Report on Confidential
Enquiries into Maternal Deaths in
the UK 1994-6
Year 1
The appropriateness of the strategy to disseminate
the findings of a national audit (1.4.2)
The role of a national audit as a core clinical
governance activity (1.5.2)
The strengths and weaknesses of an after (post-
intervention) study (1.6)
To survey Scottish obstetricians to
evaluate the impact on self-reported
practice of four national clinical
guidelines
Years 1 to 2
The effectiveness of a national guideline
dissemination and implementation strategy (1.4.2)
The strengths and weaknesses of an uncontrolled
before and after study (1.6)
The value of a national clinical effectiveness
programme (1.7.2)
To conduct a simple interrupted
time series analysis to evaluate the
impact of a national clinical
guideline on the management of
women with mild, non-proteinuric
hypertension
Years 2 to 4
The effectiveness of a national guideline
dissemination and implementation strategy (1.4.2)
The need for economic evaluations of
implementation strategies (1.4.2)
The strengths and weaknesses of a simple
interrupted time series design (1.6)
The value of a national clinical effectiveness
programme (1.7.2)
To identify barriers to the
implementation of a clinical
guideline on women requesting
induced abortion and tailor a
strategy to improve care
Years 2 to 4
Assessing the appropriateness of implementation
strategies (1.4.2)
Tailoring of implementation strategies according
to identified needs and circumstances (1.4.2)
To conduct a cluster randomised
trial of a strategy, delivered within a
national clinical effectiveness
programme, to improve
implementation of a clinical
guideline on women requesting
induced abortion
Years 2 to 4
The effectiveness of a guideline dissemination and
implementation strategy (1.4.2)
The need for economic evaluations of
implementation strategies (1.4.2)
The strengths and weaknesses of a cluster
randomised trial design (1.6)
The value of a national clinical effectiveness
programme (1.7.2)
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This programme of work involved the use of different research designs to evaluate the impact of
selected initiatives to promote good practice. The choices of design were related to SPCERH's
developing research agenda as well as available time and resources. Chapter 8 will provide an
over-arching critique of the strengths and limitations of the study designs employed. This
chapter will also draw more general lessons on the merits of various approaches to
implementation relevant to a national clinical effectiveness programme. Finally, Chapter 9 will
summarise lessons for SPCERH and implementation research.
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Chapter 2
Attributes of clinical recommendations that influence
change in practice following audit and feedback
2.1 Summary
A range of factors, or effect modifiers, can influence the effectiveness of interventions to
promote adherence to clinical guidelines. Previous work indicates that attributes of clinical
practice recommendations are independently associated with clinician compliance. This
observational study assessed which attributes of clinical practice recommendations influence
changes in clinical practice following audit and feedback.
Sixteen hospital gynaecology units in Scotland participated in a national audit project. Clinical
practice recommendations covering selected gynaecological topics were developed and data
collected to assess baseline (pre-intervention) compliance. Summaries of performance were fed
back to consultant gynaecologists in each hospital and follow-up (post-intervention) data were
collected. Compliance data were available at baseline and follow up for a total of 42 clinical
practice recommendations. Altogether, 4664 case notes contributed to baseline data and 4382 to
follow up data. Thirteen attributes describing clinical practice recommendations were developed,
based upon previous work, and pre-tested. A panel of seven consultant gynaecologists rated the
extent to which each of the 42 recommendations possessed each of the 13 attributes. Multi-level
modelling was used to examine the relationship between attributes of clinical practice
recommendations and compliance with the recommendations before and after audit and
feedback.
Recommendations judged to be compatible with clinician values and not requiring changes to
fixed routines were independently associated with greater compliance at baseline and follow-up.
However, recommendations judged to be incompatible with clinician values were independently
associated with greater change in practice following audit and feedback. Attributes of
recommendations may influence the effectiveness of audit and feedback in secondary care.
This chapter is based upon:
Foy R, MacLennan G, Grimshaw J, Penney G, Campbell M. Grol R. Attributes of clinical
recommendations that influence change in practice following audit and feedback. J Clin
Epidemiol 2002; 55: 717-22.
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2.2 Introduction
The implementation of valid clinical guidelines can improve the quality of health care (77).
Various factors, or effect modifiers, can influence the effectiveness of interventions to promote
adherence to clinical guidelines (97). Until recently, most research has focused on characteristics
of clinicians or health care organisations, such as local attitudes or preparedness to change.
Diffusion theory suggests that characteristics of clinical practice recommendations themselves
may also influence adherence (97). Rogers described five characteristics of an innovation that
could influence the diffusion process (98):
• Relative advantage - for the user(s)
• Compatibility - with personal and local norms
• Complexity
• Trialability - the extent to which an innovation can be tried temporarily and discarded if
found wanting
• Observability - whether the expected results can be seen to be achieved easily.
Grilli and Lomas first assessed the association between such characteristics and compliance with
clinical practice recomendations (99). They reviewed 23 published studies reporting compliance
rates with 143 different recommendations developed or endorsed by official organisations. These
studies covered a wide range of contexts and specialities. Insufficient data were available to
assess relative advantage and complexity. Where studies provided pre- and post-
recommendation data, only the latter were considered. Recommendations judged to be of high
complexity were associated with lower compliance rates (mean 42%) than those judged to be of
low complexity (56%). Recommendations judged to be of high trialability were associated with
higher compliance rates (mean 56%) than those of low trialability (39%). No differences in
compliance were found between high and low observability recommendations. However,
researchers rather than the targeted clinicians made judgements about the characteristics of each
recommendation. This undermines the validity of the study's conclusions as targeted clinicians
may have made different judgements because of greater familiarity with the recommendations
and their context.
Grol et al assessed the extent to which Dutch general practitioners' (GPs') compliance with
recommendations from ten different national guidelines was influenced by 12 characteristics (or
attributes) of the recommendations (29). A list of 16 attributes was developed following a
literature review and included modified versions of the aforementioned characteristics. Forty-
seven recommendations were selected from 10 different national guidelines for general
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practitioners developed by the Dutch College of General Practitioners. Four researchers
(including practicising GPs) independently assessed whether the attributes were present in the 47
recommendations. Three out of four researchers agreed on 87% of the ratings, whilst the
remaining ratings were determined by a structured consensus meeting. Post-dissemination
compliance with the guideline recommendations was assessed during a clinical audit using self-
recorded data from 61 GPs. Four attributes that the researcher panel did not agree upon or were
of low discriminatory value (i.e. present or not present in less than four of the recommendations)
were excluded, leaving a final set of 12 attributes.
The average compliance for all recommendations was 61%. On univariate analysis, all 12
attributes were associated with compliance. On stepwise regression analysis, three attributes
contributed most to explaining variance. Compliance was lower if recommendations were
vaguely worded, incompatible with clinician norms and values, and disruptive to routine practice.
These attributes explained 17% of the total variance.
This previous work focused on the effects of various attributes on compliance with
recommendations, i.e. a one-off measure of performance (29;99). However, clinical guidelines
are produced to promote change in behaviour, i.e. hereafter referring to a decrease or increase in
compliance, which may be influenced by attributes different from those associated with
compliance. This investigation determined whether various attributes of clinical practice
recommendations influenced both compliance and change in clinical behaviour among specialists
participating in a national audit programme.
2.3 Methods
Table 2.1 summarises the context and main steps of this study, now described in detail.
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Table 2.1. Summary of study methods.
Context. Following a multi-centre audit of gynaecological practice across 16 hospitals in Scotland,
case note data on compliance at baseline and follow-up were available for a total of 42 clinical
practice recommendations
Step 1. Development and pre-testing of 13 attributes describing clinical practice recommendations
Step 2. Panel of 7 gynaecologists, using a modified RAND consensus process, rates the extent to
which each of the 42 recommendations displays each of the 13 attributes
Step 3. Regression analysis to examine the influence of each attribute on compliance and change in
practice with the 42 recommendations. Multi-level modelling incorporated to account for potential
clustering effects of hospital data
2.3.1 Context: The Gynaecology Audit Project in Scotland (GAPS)
This study assessed change in clinical practice within the context of a national audit and feedback
programme. Audit and feedback is defined as: any summary of clinical performance of health
care over a specified period of time, which may include recommendations for clinical action
(146). Criteria for good quality care covering selected gynaecological topics were developed and
disseminated across Scotland between 1992 and 1997 (7;147-149). The criteria were developed
using an approach similar to that advocated for formal clinical guideline recommendations and
are hereafter referred to as 'clinical practice recommendations' (150). Their development was
based upon reviews of available evidence, panel discussions, questionnaire surveys of
gynaecologists and structured peer review.
Baseline compliance with the clinical practice recommendations was audited using data collected
from case notes. Trained audit assistants used standardised forms to abstract data from 16
hospitals across Scotland.
Following the baseline audit period for each topic, a feedback report summarising the agreed
clinical practice recommendations, the results of the audit exercise and suggestions for change in
practice was circulated to all consultant gynaecologists in Scotland. Gynaecologists working in
units contributing to data collection also received an individualised covering letter providing
information to allow their unit to be identified and highlighting the strengths and weaknesses of
the local results. The circulation of the reports was complemented by presentations of the audit
results at postgraduate meetings in individual hospitals and at national meetings. Follow up data
were then collected to help assess whether clinical behaviour had changed in line with the
recommendations. The cycle of audit and feedback lasted approximately 18 months for each
topic.
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Available clinical practice data. Baseline (hereafter referred to as 'pre-intervention') and follow
up ('post-intervention') data were available from case note audits for a total of 42 clinical
practice recommendations relating to four topics: induced abortion, endometrial sampling,
laparoscopic sterilisation and infertility. Altogether, 4664 case notes contributed to pre-
intervention data and 4382 to post-intervention data. The 42 clinical practice recommendations
and mean pre- and post-intervention compliance aggregated across all units are listed in
Appendix 2A.
2.3.2 Step 1: Selection of attributes
Thirteen attributes of recommendations (e.g. whether the recommendation was based on sound
evidence, whether it was compatible with clinician norms) were developed, based upon previous
work (29;99) and modified following pre-testing on a convenience sample of four consultant
gynaecologists. (See Table 2.2 for list and Table 2.3 for illustrative examples.)
2.3.3 Step 2: Rating of recommendations
A consensus panel was convened to rate the extent to which each of the 42 gynaecology
recommendations displayed each of the 13 attributes. A purposive sample of seven consultant
gynaecologists was recruited. Attempts were made to balance clinician age and their hospital
characteristics (teaching and non-teaching; urban and rural). Seven panellists were sufficient to
provide a reliable estimate of consensus and prevent 50:50 voting patterns (151).
A formal method of consensus development was required to enhance the validity of the rating
process (151). Using a modified RAND process, the panel rated the extent to which each of the
42 gynaecology recommendations displayed each of the 13 attributes. All panellists were visited
prior to the ratings (by RF) during which the study objectives, the meaning of the attributes, and
how to rate the recommendations on a questionnaire were explained. Initially, each panellist
rated the recommendations independently using an ordinal 1-9 scale. The median scores and
levels of agreement from this first round of rating were fed back at a panel meeting. Structured
discussion centred on the recommendation attributes over which there was maximal discordance,
defined as at least three panellists scoring 1-3 and at least three scoring 7-9. This was necessary
for 27 out of a total of 546 attribute ratings. Subsequent discussion was structured around
clarification of a recommendation or attribute followed by the case to support a high or low
rating of the recommendation. Much discussion concerned clarifying definitions of attributes or
recommendations and the degree to which certain recommendations displayed certain attributes.
Immediately after this discussion, panellists again independently rated the extent to which each
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recommendation possessed each attribute. A median score of seven or more was used as the cut
off point for categorising recommendations as possessing an attribute.
Clinician perceptions of the relative importance of each attribute were also explored. Following
the meeting, panellists were sent a supplementary questionnaire asking them to rank the attributes
in rank order (1 to 13) of what they believed would be their overall importance in predicting the
adoption of clinical guideline recommendations.
2.3.4 Step 3: Regression analysis
Regression analyses were undertaken to assess the strength of associations between adherence to
the recommendations and the extent to which each recommendation displayed each of the 13
attributes (as measured by the median panel rating). Initially the influences on compliance and
behaviour change were assessed for each attribute individually (univariate analyses).
Subsequently a multivariate analysis was undertaken to assess which attributes had the most
significant independent effect on compliance and behaviour change.
Analyses were performed relating to (a) pre-intervention compliance, (b) post-intervention
compliance and (c) change in compliance. The effect of each attribute on change in compliance
is presented as an interaction term, as recommended by Cook and Campbell (130).
There was marked variation in compliance among hospitals. Multi-level regression modelling
was, therefore, adopted for all analyses. Multilevel modelling is designed for the analysis of
hierarchical data, and thus allowed modelling of patient outcomes whilst adjusting for the
different hospital effects, e.g. hospitals might differ according to whether or not they were
teaching hospitals (152). A two-level hierarchical linear model was adopted for all the analyses
(patients within hospitals in this case) and a Normal error structure assumed. The multilevel
regression modelling was undertaken using the statistical package MLWin. The sub-clustering of
patients within clinicians was not incorporated in the model as it was assumed that clustering
would be most likely at the level of the hospital, as local management protocols, if any, would be
instituted at the organisational level rather than at the level of the individual clinician. In addition,
the intervention feedback was aggregated at the hospital level rather than the level of the
individual clinician.
The number of cases available for the assessment of compliance with each of the 42
recommendations varied widely (from 10 cases to 1510 cases). In order to avoid the possibility
of spurious correlation arising from analysis based upon rate ratios (in this case percentage
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compliance), the outcome variable in all regression analyses was the actual number of compliant
cases, with subsequent adjustment for the total number of cases in the regression model (153).
2.4 Results
2.4.1 Panel rating of clinical recommendations
The number of clinical recommendations displaying each attribute varied widely (Table 2.2). For
example. 40 (95%) of the 42 recommendations were judged to precisely describe recommended
clinical practice and 41(98%) as addressing a common clinical issue. None were judged as
requiring new knowledge or skills and only 3 (7%>) each as trialable or as complex.
Table 2.2. Number (percentage) of the 42 clinical practice recommendations judged by
consensus panel to possess each attribute.
Attribute Number (%) of
recommendations possessing
attribute
Addresses common issue: concerned with a common clinical issue or a 41 (97.6)
decision important in daily care
Precisely described: provides a sufficiently detailed and precise guide to 40 (95.2)
clinical practice
Compatibility: compatible with clinicians' current norms and values in 32 (76.2)
practice
Kev feature: essential to the whole set of recommendations and to the 29 (69.1)
ultimate goals
Based upon sound evidence: based upon sound scientific evidence 28 (66.7)
including, as appropriate, clinical trials or meta-analyses
Fits patient expectations: is likely to fit in with patient expectations 15 (35.7)
Observable: the benefits of using this practice or policy over existing 8 (19.0)
practices or policies can be seen quickly
Requires organisational change: requires changes in the way care is 6 (14.3)
organised or additional resources
Requires changed routines: requires changes to fixed routines or habits 6 (14.3)
High profile: has a high profile in educational programmes or the media 5(11.9)
Complex: is complex and requires many steps to do or organise 3(7.1)
Trialable: can be tried out and discarded easily 3(7.1)
Requires new knowledge or skills: requires the learning of new 0(0)
knowledge or skills
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2.4.2 influence of attributes on compliance
Overall mean compliance with the 42 recommendations was 58% pre-intervention and 61% post-
intervention although there were marked variations in compliance among hospitals (illustrated in
Table 2.3).
Many of the recommendation attributes were significantly correlated with one another (Table
2.4). The five attributes {precisely described, addresses common issue, requires new knowledge
or skills, complex and trialable) displayed by over 90%, or under 10%, of recommendations were
not included in further analysis, because of their lack of variation. Thus, only the modifying
effects of eight attributes on compliance and change were studied further. When considered
separately, all these eight attributes were significantly associated with compliance both before
and after feedback (Table 2.5). The regression coefficients were smaller for the post-intervention
compliance - primarily a reflection of the narrower range generally seen in compliance scores
post-intervention. As such, there was less potential for the attributes of the recommendation to
influence compliance in the post-intervention phase. The following six attributes had positive
effects on compliance both pre- and post-intervention: based upon sound evidence-, key feature-,
compatibility-, fits patient expectations', high profile; and observable. Negative effects were
associated with two attributes: requires organisational change and requires changed routines.
When the impact of all attributes were considered together on multivariate analysis, only two
attributes were found to be significantly and independently associated with compliance at both
pre- and post-intervention (Table 2.6). Compatibility was positively associated with compliance,
i.e. the more the recommendation was compatible with clinician values the higher the
compliance. Requires changed routines was negatively associated with compliance, i.e. the more
the recommendation required changes to routines, the lower the compliance. Compatibility was
significantly correlated with the other seven remaining attributes in the model and might
represent a general marker for a range of attributes that influence practice (Table 2.4).
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Table 2.3. Illustrative examples of clinical practice recommendations, compliance and ranges























Prior to sterilisation, women
should be given an
information leaflet
summarising the various
factors covered in the
counselling








Induced abortion: The follow
up appointment should be
within 14 days of the abortion









endometriosis in women with
this condition and infertility
do not improve conception
rates and should not be
prescribed for this purpose








woman's rhesus status should
be ascertained, and rhesus
prophylaxis given following
abortion, if indicated












































































































Table 2.5. Univariate analyses of the association between eight attributes and compliance
with recommendations.





Change pre- to post-
intervention <a)
Compatible 8.94 (7.42, 10.46) 5.79 (4.43,7.14) -3.34 (-5.37,-1.31)
Key feature 6.97 (5.27, 8.66) 4.96 (3.48,6.44) -2.32 (-4.56, -0.08)
Based upon sound
evidence
3.91 (1.84,5.98) 3.75 (2.00, 5.50) -0.30 (-3.00, 2.40)
Fits patient expectations 3.00 (1.07,4.93) 1.93 (0.03,3.57) 0.72(-1.79, 3.23)
Observable 5.06 (3.59,6.53) 3.42 (2.15,4.69) -1.68 (-3.62, 0.26)
Requires organisational
change
-5.63 (-6.99,-4.27) -3.66 (-4.84,-2.47) 2.19 (0.39,3.99)
Requires changed routines -6.04 (-7.26,-4.82) -4.00 (-5.07,-2.93) 2.18 (0.56, 3.80)
High profile 4.84 (2.14, 7.54) 4.29 (2.41,6.17) -0.63 (-2.12,3.38)
(a) Coefficient of interaction term
Table 2.6. Results of multivariate regression analysis of the association between the
attributes and compliance with recommendations.
Variable Regression coefficient (95% CI) Significance of
regression
Pre-intervention compliance
Compatible 6.76 (4.73,8.88) <0.001
Requires changed routines -2.52 (-4.10,-0.95)
Post-intervention compliance
Compatible 4.26 (2.44,6.08) <0.001
Required changed routines - 1.77 (-3.19,-0.35)
Change in compliance pre- to post-intervention
Compatible -3.34 (-5.37,-1.31)(aJ <0.001
(a) Coefficient of interaction term
2.4.3 Influence of attributes on behaviour change
Considered separately, four attributes were significantly associated with behaviour change.
However, the directions of these associations were reversed in comparison with those obtained
for compliance. The attributes positively associated with compliance (compatibility and key
feature) were negatively associated with behaviour change, and those negatively associated with
compliance (requires organisational change and requires changed routines) were positively
associated with behaviour change (Table 2.5).
When the impact of all attributes were considered together on multivariate analysis, only
compatibility was found to be significantly and independently associated with change in
compliance (Table 2.6). The more compatible the recommendation with clinician norms and
values the smaller the behaviour change pre- to post-intervention.
2.4.4 Panel perceptions of attributes
All 7 panellists responded to the supplementary questionnaire asking them to rank the attributes
in order (1 to 13) of what they believed would be their overall importance in predicting the
adoption of clinical guideline recommendations. The panel judged that clinical behaviour would
be best predicted by recommendations based upon sound evidence (Table 2.7).
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Table 2.7. Panellists' ranking of the overall importance of each of the 13 attributes in
predicting adoption of recommendations (1 = most important).
Attribute Panellists' ranking in
predicting adoption of
recommendations
Based upon sound evidence: based upon sound scientific evidence 1
including, as appropriate, clinical trials or meta-analyses
Precisely described: provides a sufficiently detailed and precise guide to 2
clinical practice
Addresses common issue: concerned with a common clinical issue or a 3
decision important in daily care
Compatibility: compatible with clinicians' current norms and values in 4
practice
Key feature: essential to the whole set of recommendations and to the 5
ultimate goals
Observable: the benefits of using this practice or policy over existing 6
practices or policies can be seen quickly
Requires organisational change: requires changes in the way care is 7
organised or additional resources
Requires changed routines: requires changes to fixed routines or habits 8
Complex: is complex and requires many steps to do or organise =9
Requires new knowledge or skills: requires the learning ofnew =9
knowledge or skills
High profile: has a high profile in educational programmes or the media 11
Trialable: can be tried out and discarded easily 12
Fits patient expectations: is likely to fit in with patient expectations 13
2.5 Discussion
2.5.1 Principal findings
Certain attributes of clinical practice recommendations were associated with variations in
compliance and behaviour change before and after an audit and feedback programme in
secondary' care. Consistent with previous work (29), recommendations compatible with clinician
norms and values and not requiring changed routines were independently associated with higher
compliance. However, clinical practice recommendations are intended to change behaviour, and
a different picture emerged when changes in compliance following audit and feedback were
examined.
Recommendations less compatible with clinician norms and values were associated with greater
improvements in clinical practice, probably because of a greater potential for change due to low
baseline compliance. Those recommendations more compatible with clinician norms and values
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thus may have been associated with potential ceiling effects, with limited scope for further
improvements in practice. Nevertheless, the multi-level model included an interaction term
which accounted for temporal changes (130). Therefore, the association between lower
compatibility and changes in practice cannot solely be attributed to greater scope for
improvement in the pre-intervention phase.
2.5.2 Strengths and weaknesses of the study
This is the first study to investigate whether attributes of recommendations independently
influence change in clinical behaviour as opposed to compliance. Much implementation
research is still based upon a 'black box' approach but it is important to explore the potential
impact of a range of effect modifiers (such as attributes of clinical practice recommendations) to
improve understanding of why interventions may or may not succeed in changing professional
behaviour.
Objective data from case notes were used to measure compliance in contrast to previous studies
which relied partially or completely on self-reports (29;99). Self-reports were associated with
higher levels of compliance in the study by Grilli and Lomas, suggesting observation bias (99).
Case notes may not contain all relevant information to assess whether recommendations are
followed in clinical practice. Although several clinical practice recommendations were
concerned with adequate recording of actions in the case notes, it is possible that the use of such
data might underestimate actual adherence to some recommendations. However, assuming such
a bias applies equally to the pre- and post-intervention data, it is unlikely to under-estimate
changes in behaviour.
A rigorous consensus process was used to assess the attributes of clinical practice
recommendations based upon the perceptions of the targeted clinicians. Structured processes are
associated with greater validity than informal methods (151). Given the retrospective nature of
this study, it is possible that panel ratings were biased by the gynaecologists' knowledge of how
widely certain recommendations were actually adopted into practice. However, given the large
variations in practice for many recommendations and the fact that current levels of compliance
were not explicitly raised during the panel meeting, this seems unlikely to be a major source of
bias. Furthermore, the attribute which clinicians predicted would have the greatest ability to
explain variation, based on sound scientific evidence, did not have a significant independent
effect.
The use of multi-level modelling, incorporating individual hospital effects, was justified given
the marked variation in practice observed among different hospitals. Analyses based on patient
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level data, which did not account for 'clustering' effects, might have over-emphasised the
significance of any results (152).
The explanatory power of certain attributes may have been reduced if panel members tended to
rate recommendation attributes according to their own pre-conceived ideas about the relative
importance of each attribute in influencing practice rather than the extent to each
recommendation displayed each attribute. Therefore, it is possible that trialability did not appear
to have any influence on practice, in contrast to earlier work (99) because of the panel members'
low expectations that such a factor might influence their own practice. However, in the study by
Grilli and Lomas, recommendation attributes were rated by researchers rather than by guideline
target users.
Grol et al found that precisely described recommendations were associated with higher
compliance (29). In this study, the precision of clinical practice recommendations explained no
variation because the vast majority of recommendations were rated as precisely described, thus
reducing this attribute's explanatory power. Further evidence for the overall importance of
precision comes from a randomised comparison of the effect of non-specific versus specific
guideline recommendations which demonstrated that the latter improved clinical decision-making
(154).
Two attributes, compatibility and requires changed routines, were associated with significant and
independent effects on compliance in both this and the primary care study (29). This finding
strengthens the likelihood that these two attributes have more generalisable influences on
compliance with recommendations within the context of national clinical audit projects.
However, in the stepwise regression analysis, compatibility was significantly correlated with a
number of other attributes. Compatibility might then operate as a general marker for other
attributes which influence practice.
2.5.3 Possible mechanisms and implications
Audit and feedback is variably effective as a strategy to improve professional practice (155); this
may be related to factors such as the method of feeding back performance data to clinicians, the
actual content of the recommendations, or the wider context.
In this study, audit and feedback appeared to be effective in promoting the implementation of
recommendations judged to be less compatible with clinician norms and values. For example, in
the care of women undergoing induced abortion, pre-intervention compliance was low (5%) for
one such recommendation, 'The follow-up appointment should be within 14 days of the
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abortion.' Following audit and feedback, compliance increased six-fold by 27% (to 32%).
Feedback permitting comparisons among hospitals during the audit programme may therefore
have prompted action on recommendations previously regarded as too disruptive or incompatible
to implement. In contrast, pre-intervention compliance was high (97%) for a recommendation
rated as compatible with clinician norms and values, 'The woman's rhesus status should be
ascertained, and rhesus prophylaxis given following abortion, if indicated'. Subsequently, there
was little scope for improvement in compliance with this recommendation following audit and
feedback.
Different attributes may have influenced change in clinical behaviour following an intervention
other than audit and feedback (e.g. interactive educational programmes). For example,
experience in the dissemination of four clinical guidelines within the context of a national clinical
effectiveness programme suggests that adherence to one guideline (albeit clinician reported) did
not improve because of the relatively complex nature of its recommendations (156) (Chapter 4).
One systematic review suggests that implementation strategies based upon a 'diagnostic analysis'
- identification of potential needs and barriers - are more likely to be effective (157). Attributes
of individual recommendations appear to influence both compliance and behaviour change and
need to be considered when planning implementation activities. It is likely that the effects of
different implementation strategies may be modified by the attributes of recommendations. At
present there is only limited information about how such attributes modify the effects of
implementation strategies. As further evidence becomes available consideration of the attributes
of practice recommendations may assist in the choice of implementation strategy.
2.5.4 Unanswered questions and future research
Further research is required to determine how attributes of recommendations modify the
effectiveness of different interventions in different contexts. These studies should focus on
behaviour change rather than compliance and use the most robust estimates of behaviour change,
preferably from randomised trials.
2.6 Conclusion
This observational study assessed which attributes of clinical practice recommendations
influence changes in clinical practice following audit and feedback. Recommendations judged to
be compatible with clinician values and not requiring changes to fixed routines were
independently associated with greater compliance at baseline and follow-up. However,
recommendations judged to be incompatible with clinician values were independently associated
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with greater change in practice following audit and feedback. Attributes of recommendations
may influence the effectiveness of audit and feedback in secondary care.
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Chapter 3
Survey of professionals' knowledge of key recommendatons
from a national confidential enquiry report
3.1 Summary
The Confidential Enquiries into Maternal Deaths aim to assess the main causes of maternal
deaths, identify substandard care and promulgate findings to all relevant health professionals.
Following publication of previous Reports, the organisation of maternity services has improved
but the impact on individual clinical staff is unknown.
Scottish obstetricians and midwives were surveyed by telephone interviews to assess knowledge
of key clinical recommendations from the Report on Confidential Enquiries into Maternal Deaths
in the UK 1994-6. The main outcomes were awareness of key recommendations from the Report
and participation in implementation activities. 201 out of 208 staff (97%) agreed to participate.
Two-thirds (131; 65%) stated they had read at least some of the Report. A median of 3 out of 18
key recommendations were recalled, with recall of newer issues being lower. Although reported
access to key clinical guidelines was high, other dissemination and implementation activities
were used inconsistently, if at all.
Publication of future Confidential Enquiry Reports should be accompanied by active
dissemination strategies, possibly emphasising newer or more important recommendations.
This chapter is based upon:
Foy R, Nelson F, Penney GC. Awareness of key recommendations from the Report on
Confidential Enquiries into Maternal Deaths 1994-6 among obstetric and midwifery staff in
Scotland. Journal ofClinical Excellence 2000;2:27-32.
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3.2 Introduction
3.2.1 The Confidential Enquiries into Maternal Deaths
The Confidential Enquiries into Maternal Deaths (CEMD) aim to draw generalisable lessons for
maternity care by scrutinising events preceding maternal deaths in the United Kingdom.
Participation in the Enquiries and implementation of subsequent recommendations represent core
functions within clinical governance (158). Many maternal deaths are associated with episodes
of sub-standard care. Furthermore, instances of sub-standard care related to mortality may
represent only the 'tip of the iceberg', with a large proportion of 'near miss' events likely.
Although maternal mortality has continued to fall, similar errors in clinical care tend to recur.
The implementation of the Reports' recommendations therefore continue to represent a major
challenge for maternity services, especially in light of the professional time and interest invested
in the conduct of the Enquiries and production of the Reports.
The 1994-6 Report, Why Mothers Die, additionally highlighted wider public health issues derived
from a more detailed assessment of deaths from domestic violence, car accidents and those
occurring as a result of psychiatric illness or substance abuse (159). The Report was also marked
by a change in style and emphasis, intended to make it more readable and have a greater impact
in improving care.
In general, the main causes of substandard care were attributed to:
• Failures of some junior medical, obstetric staff or accident and emergency (A&E) staff, GPs,
and midwives to diagnose or refer cases;
• Failure of consultants to attend in emergencies or to delegate appropriately;
• Inappropriate treatment;
• In some units, lack of protocols for the treatment or prevention of conditions such as massive
haemorrhage or pulmonary embolism; and
• Lack of team work.
The Report made a number of general recommendations, including the provision of guidelines
for key problems and the implementation of such guidelines subject to regular audit. Units were
also encouraged to organise regular "fire drills" for cases of massive haemorrhage so that all
members of staff became familiar with required action, such as the delivery of large quantities of
cross-matched blood to labour wards without delay.
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Specific recommendations were made regarding the recognition and management of obstetric
complications, such as ectopic pregnancy, pulmonary embolism and pre-eclampsia. The need for
close monitoring of medical conditions during pregnancy was emphasized. For example, for
women with epilepsy, it is important that staff check with relatives that they know what to do in
the case of a fit and provide instruction on how to place the patient in a recover}' position once
the fit is over.
The Report identified the need for staff training in the recognition and management of domestic
violence, the early identification and management of postnatal depression and the correct use of
seatbelts. For example, antenatal care provides an important opportunity to detect domestic
violence. Estimates of the prevalence of domestic violence within the current pregnancy among
women attending antenatal care vary, with ranges of 4 to 17% reported in the US (160).
Domestic violence is associated with poorer outcomes, including increased rates of miscarriage,
preterm birth, fetal injury and fetal death (161). Clinical practice recommendations highlight the
importance of enquiring about domestic violence as a routine component of antenatal care (162)
3.2.2 Dissemination of the Reports
Copies of the Report were sent to all consultant obstetricians and heads ofmidwifery in Scotland.
Given the multidisciplinary nature of maternity care, it is important that key clinical
recommendations are disseminated widely. The 1994-6 Report was supplemented by an
executive summary, listing key recommendations, intended for wider distribution among all staff
involved in maternity care.
An audit of all UK consultant-led maternity units in 1997 suggested that the vast majority had
made organisational changes in response to previous Reports (163). Compared with a previous
audit (164), more units had introduced clinical guidelines for the management of major
haemorrhage and eclampsia.
However, it is uncertain as to whether antenatal and labour ward staff knew of or had access to
guidelines or how aware they were of key recommendations from the Reports. Effective
dissemination represents a critical first step in implementation. This study therefore set out to
assess awareness of key recommendations from the 1994-6 Report among obstetricians and
midwives in Scotland and their participation in local dissemination activities.
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3.3 Methods
3.3.1 Development of interview schedule
An interview schedule for a telephone survey was developed to include: awareness of key
recommendations from the report and main causes of maternal mortality; reported clinical
practice; access to clinical guidelines highlighted by the Report; and participation in educational
activities relevant to the Report. Eighteen key recommendations were identified from the
summary Report. The interview schedule was piloted on a sample of doctors and midwives at
one hospital and modified (Appendix 3A).
3.3.2 Sampling frame
The sample consisted of obstetric (senior house officer, specialist registrar and consultant) and
midwifery (midwives in charge of labour wards and antenatal clinics) staff from all 23
consultant-led maternity units in Scotland. Prior permission to undertake the survey was
obtained from all clinical directors and heads ofmidwifery. A letter also went out to all clinical
staff forewarning them of the survey which would assess 'aspects of maternity care'. The precise
nature of the survey was not stated in advance to prevent staff from making special efforts to
consult the 1994-6 Report in advance.
The samples comprised medical and midwifery staff on duty on the day each hospital was called.
Midwives in charge of labour ward were asked to provide the names of medical staff providing
obstetric cover on the day they were telephoned. Medical staff were then telephoned and given
the choice of being interviewed that day or at a more convenient time later.
Most units were sampled twice with five staff members being approached on each occasion. In
the three smallest units, only three staffmembers were approached. In one larger unit, only four
staff members were eligible on the second occasion. Thus, 208 staff were approached for
interview.
3.3.3 Administration of interviews
The interviews took place 6 months after the Report was published. The precise topic of the
survey was only revealed at the time of interview. The confidential nature of this survey and the
fact that it was to assess dissemination of the Report rather than individual competence were
explained to all potential participants.
Enquiry was made into recall of key recommendations with minimal prompting by the
interviewers. The pilot suggested that interviewees would be unable to provide a comprehensive
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list of key recommendations. In order to provide a target to encourage responses, interviewees in
the definitive survey were asked if they could recall three or more key recommendations from the
Report.
Midwives were asked what aspects of social history, including domestic violence, they made
enquiry into at booking clinics. Obstetricians were asked whether they routinely covered the
same details when taking a history or checked midwives' booking notes for this information.
3.3.4 Analysis
In recall of key recommendations, respondents was rated as scoring a 'direct hit' if they recalled
all aspects of a recommendation or a 'near miss' if they could only recall one aspect. For this
analysis, mention of at least one aspect of a recommendation was counted as a positive response.
Data were entered into an Access database (165) and analysed using the Statistical Package for
Social Sciences (SPSS) version 8 (166). Median recall scores were compared using the Mann-
Whitney test with 2-sided P values.
3.4 Results
3.4.1 Response rate
Two hundred and one out of 208 staff agreed to be interviewed (response rate 97%). Three
refused to be interviewed and four could not be contacted after at least 6 attempts. Respondents
were evenly distributed by grade and discipline according to the sampling frame.
3.4.2 Awareness of Report
One hundred and eighty-five (92%) were aware of the 1994-6 Report (Table 3.1) and 131 (65%)
reported having read at least some of the Full Report or Executive Summary. Fewer had
participated in educational meetings or tests of emergency protocols ('fire drills'). Reported
access to clinical guidelines was high except for the management of women who declined blood
products and the management of ectopic pregnancy. The latter were mentioned as being more
frequently located in gynaecological units.
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Table 3.1. Reported participation in or access to dissemination activities.
Recognition, receipt and reading Number (%)
Awareness ofReport 185 (92)
Received or seen copy of Full Report 119(59)
Received or seen copy ofExecutive Summary 79 (39)
Read at least some of Full Report 104 (52)
Read at least some of Executive Summary 67(33)
Training activities
Lecture specifically on the most recent Report (didactic style) 19(10)
Group tutorial specifically on the most recent Report (interactive style) 40 (20)
Tests of emergency obstetric protocols ('fire drills') in preceding 6 mths 49 (25)
Access to local guidelines or policies
Management of pre-eclampsia and eclampsia 195 (97)
Management of obstetric haemorrhage 186 (93)
Use of thromboprophylaxis 179 (89)
Antibiotic cover for caesarean sections 169 (84)
Management ofwomen who decline blood products 102 (51)
Investigation and management of ectopic pregnancy 106 (53)
3.4.3 Recall of key recommendations
Respondents each recalled a median of three out of 18 key recommendations (range 0 to 10). At
least a third of responders recalled issues relating to the management of eclampsia and pre¬
eclampsia, protocols for emergencies, consultant attendance and delegation, and prophylaxis
against thromboembolism (Table 3.2). However, recall of certain preventive issues such as
seatbelt use, domestic violence, antibiotic prophylaxis in caesarean section and awareness of
puerperal sepsis was much lower. Forty-seven respondents (23%) were unable to recall any
recommendations.
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Table 3.2. Recall of key recommendations from the Report.
Kev recommendations Number (%) of respondents
Recognition ofmain direct causes of death 53 (26)
Importance of prompt diagnosis or referral of suspected 49 (24)
serious disease
Identification ofwomen at risk of postnatal mental illness 15 (7)
or self harm during antenatal care
Enquiry about domestic violence 8 (4)
Education ofwomen about the use of seatbelts 4 (2)
Education ofwomen about symptoms associated with pre-eclampsia 11 (6)
Education ofwomen about first aid of epileptic fits 12 (6)
Early attention to chest or leg symptoms to exclude presence 62 (31)
of thromboembolism
Management of eclampsia or pre-eclampsia by a single 88 (44)
senior clinician
Pregnancy testing considered in any woman with unexplained 11 (6)
abdominal pain
Prompt management of suspected ectopic pregnancy 33 (16)
Assessment of risk factors in considering prophylaxis against 66 (33)
thromboembolism in all women undergoing caesarean section
Use of prophylactic antibiotics in caesarean section 9 (5)
Awareness of puerperal sepsis 6 (3)
Participation in confidential enquiries 6 (3)
Consultant attendance or appropriate delegation in emergencies 77 (38)
Need for units to have protocols for massive haemorrhage 88 (44)
or pulmonary embolism
Unit "fire drills'' for emergencies 7 (4)
3.4.4 Awareness of causes of maternal mortality
Asked about direct causes of maternal mortality, most respondents ranked thromboembolism and
pregnancy induced hypertension within the top three but omitted amniotic fluid embolism (Table
3.3). Respondents were less aware that epilepsy and psychiatric illness represented major
indirect causes of maternal death. In response to a separate question about epilepsy, 120 out of
163 staff involved in antenatal care (74%) could recall neither of the specific recommendations
pertaining to personal safety (not bathing unsupervised and that friends or relatives know what to
do in the event of a fit).
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Table 3.3. Knowledge of main causes of direct and indirect maternal deaths.
Direct causes (in order of actual frequency) Number (%) ranked amongst top 3 causes
Thromboembolism 160 (80)
Pregnancy induced hypertension 173 (86)
Amniotic fluid embolus 19 (9)
Early pregnancy problems (e.g. ectopic) 11 (5)
Sepsis (or infection) 26 (13)
Haemorrhage 150 (75)
Uterine rupture 3 (1)
Fatty liver of pregnancy 1 (0)
Anaesthesia 16 (8)
Indirect causes
Cardiac disease 143 (71)
Epilepsy 48 (24)
Psychiatric illness (including suicide) 20 (10)
3.4.5 Social history taking
Enquiry about domestic violence was made least frequently of any aspect of social history taking
(Table 3.4). Out of 160 staff who provided antenatal care, 18 (11%) reported 'usually' enquiring
about domestic violence whilst a further 52 (32%) enquired if 'indicated' (Table 4). Out of 40
midwives working in antenatal clinics, 6 (15%) routinely enquired whilst 18 (45%) did so 'if
indicated'.
Table 3.4. Number of respondents (%) personally enquiring about or discussing issues
during antenatal care.
Enquiry made at antenatal booking Obstetricians (n=120) Clinic midwives (n=40)
'Usually' 'If indicated" 'Usually' 'If indicated'
Previous psychiatric disorders 49 (41) 48 (40) 34 (85) 5(13)
Episodes of self-harm 14(12) 53 (44) 7(18) 24 (60)
Domestic violence 12 (10) 32 (27) 6(15) 18 (45)
Substance abuse 71 (59) 34 (28) 31 (78) 8 (20)
Alcohol intake 87 (72) 21 (18) 37 (92) 3 (8)
3.4.6 Associations between participation in dissemination activities and recall of
key recommendations
Respondents who reported having read at least some of either report recalled a median of 3
recommendations compared with 0.5 for those who had not (Z=6.73, 2p<0.001). Respondents
who had attended any educational meeting recalled a median of 4 recommendations versus 2 for




Overall awareness of the content of Report was low, especially of those recommendations
included for the first time in the current report. Although most staff reported access to major
clinical guidelines, other educational efforts to disseminate key CEMD recommendations were
used inconsistently, if at all.
3.5.2 Strengths and weaknesses of design
The high response rate and quasi-random method of selecting participants improve the likelihood
that the sample was representative of obstetricians and senior midwives in Scotland. Attempts
were also made to minimise biases which might over-estimate awareness of the Report's content.
It is likely that the pressure of participating in telephone interviews led to an under-estimate of
respondents' actual knowledge. However, responses to a postal questionnaire might have over¬
estimated awareness of recommendations (because some respondents might have been prompted
to read the Report as they answered questions). Furthermore, information on the relative levels
of recall and recognition of recommendations indicates which recommendations appeared less
important to clinical staff or require reinforcement in future dissemination activities.
Participants recalled a median of three key recommendations, albeit often only in part. This
median may have been influenced by framing of the question (as discussed in 3.3.3) although
participants were encouraged to list more recommendations.
This study was not designed to assess the effectiveness of national or local dissemination
activities. Confounding may explain much of the apparent association between higher recall of
recommendations and reading of the reports or attendance at educational meetings. For example,
staff who received or read the reports may already have been more interested in the issues it
raised and so recalled more recommendations.
3.5.3 Policy implications
Knowledge of newer issues (e.g. the contribution of amniotic fluid embolism) appeared low
compared with those mentioned in previous reports (e.g. consultant attendance). The Report
incorporated a revised method for diagnosing deaths from amniotic fluid embolism (whereby the
clinical picture alone may fulfil diagnostic criteria without pathological evidence). It is possible
that the perceived contribution of postpartum haemorrhage to maternal deaths was raised
following the recent dissemination of a guideline on this topic in Scotland (167).
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The Report's public health messages appear to have been poorly assimilated, particularly those
pertaining to the correct use of seatbelts and domestic violence. Such recommendations may
have been given lower priority or seen as more problematic to implement.
There is clearly much scope for improvement, especially as self-reporting may over-estimate
actual practice (3 7; 129). These findings have implications for staff training and access to support
for women. Several midwifery respondents mentioned that they were currently exploring
acceptable ways to identify victims of domestic violence. Midwives frequently mentioned
difficulties either adopting an appropriate form of words to enquire about domestic violence or
being able to interview women in the absence of their partners. Brief screening questionnaires
appear to be more sensitive at detecting abuse than less structured enquiry (168). Appropriate
support is necessary following detection. A previous survey asked representatives of the same
maternity units what contact details for access to support agencies were given to women (169).
Women's Aid or another source of support for victims of domestic violence were spontaneously
mentioned in only four units.
The simple distribution of printed educational material is relatively ineffective at improving
clinical practice (170). An analysis of trends in perinatal mortality found no evidence to support
the effectiveness of a related activity, locally-based enquiries into perinatal death (171). The re-
audit of the implementation of the 1991-3 Report found improvements in the organisation of
maternity services and guideline availability (163). It is of concern that awareness of key
recommendations was so low, especially given the high profile of the Confidential Enquiry into
Maternal Deaths. Newer recommendations, such as enquiry about domestic violence, may
require greater emphasis in future reports and additional support to implement at a local level.
3.5.4 Unanswered questions and future research
Future work should address how the format of the Report can highlight key recommendations
more effectively and test the impact of additional interventions to support their implementation.
3.6 Conclusion
Participation in the Confidential Enquiries represents a core clinical governance task. However,
the time and effort expended in producing the Reports need to be matched by appropriate
dissemination activities. Among obstetric and midwifery staff in Scotland, knowledge of key
recommendations from the last Report (1994-6) was poor. Educational efforts to disseminate
recommendations were used inconsistently, if at all, at a local level. Publication of future
Reports should be accompanied by active dissemination and implementation strategies.
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Chapter 4
Before-and-after survey of professionals' knowledge of and
reported adherence to national clinical guidelines
4.1 Summary
Scottish obstetricians were surveyed to evaluate the impact of four Scottish Obstetric Guidelines
and Audit Project guidelines on self-reported practice. The guidelines comprised: The
Preparation of the Fetus for Preterm Delivery, The Management of Mild, Non-proteinuric
Hypertension in Pregnancy, The Management ofPregnancy in Women with Epilepsy and The
Management ofPostpartum Haemorrhage. The guidelines were disseminated by means of a
national meeting attended by medical and midwifery representatives from all Scottish maternity
units and by postal circulation to relevant medical and midwifery staff. Publication and
dissemination were undertaken under the auspices of the SPCERH.
Questionnaire surveys were administered before and after dissemination of the guidelines to 161
consultants and senior specialist registrars in Scotland. The response rates to the baseline and
follow-up surveys were 85% and 74% respectively. Over 90% of the responding obstetricians
kept the guidelines for reference and 85% had been prompted to change or reconsider their
practice. Reported compliance improved significantly for recommendations covering: the use of
tocolysis in women at risk of pre-term labour; the use of prophylactic antibiotics or entry to a
clinical trial for pre-term, pre-labour rupture of the membranes; the initiation of steroid therapy in
women with insulin-dependent diabetes mellitus; and the prescribing of periconceptual folic acid
and vitamin K to women with epilepsy. There were no significant improvements in relation to
mild, non-proteinuric hypertension or post-partum haemorrhage.
There were significant improvements in the reported management of women at risk of preterm
labour and those with epilepsy. However, reported practice in relation to mild, non-proteinuric
hypertension improved little. The guideline recommendations for this topic were relatively
complex and established patterns of practice perhaps more resistant to change. For the
management of postpartum haemorrhage, knowledge of relevant recommendations from the
1991-3 Report on the Confidential Enquiry into Maternal Deaths did not improve, partly because
baseline knowledge was already high for the majority of the recommendations.
This chapter is based upon:




4.2.1 Clinical guidelines and clinical audit
Clinical guidelines and clinical audit represent two fundamental components of the NHS clinical
effectiveness (172) and clinical governance (158) initiatives (Chapter 1). These initiatives
represent national efforts to promote more uniform standards of high quality, evidence-based
care. Within these recent, quality-promoting initiatives, attempts have been made to bring
together guideline, audit and related activities in a more concerted fashion. Previously, audit
(173) and guidelines (174) had been promoted as separate activities and were often undertaken in
isolation. (70)
4.2.2 The Scottish Obstetric Guideline and Audit Project (SOGAP)
SOGAP was a guideline development project initiated by the Scottish Executive Committee of
the Royal College of Obstetricians and Gynaecologists (RCOG) and funded by the Clinical
Resource and Audit Group (CRAG). Between 1995 and 1997, four obstetric guidelines were
developed in response to demand and concerns mainly raised by clinicians:
The Preparation ofthe Fetus for Preterm Delivery. Preterm delivery occurs in around 7% of all
pregnancies and is a major cause of infant mortality and morbidity (175). In Scotland in 1995,
there were 3228 singleton livebirths at gestations of under 37 weeks, ofwhom 111 (3.4%) died in
the neonatal period. Rigorous evidence exists that appropriate management (principally
administration of corticosteroids) prior to anticipated preterm delivery results in a large in
neonatal deaths due to respiratory distress syndrome, intraventricular haemorrhage and
necrotising enterocolitis. However, a Scottish audit over 1990-3 indicated that only 29% of
infants delivered before 31 weeks received a full course of steroids prior to deliver}' (176).
The Management ofMild, Non-proteinuric Hypertension in Pregnancy. Hypertensive disorders
of pregnancy comprise one of the major causes of maternal death in the UK and are associated
with increased risks of stillbirth and neonatal death (48). The reports of the Confidential Enquiry
into Maternal Deaths (CEMD) repeatedly highlight the need for clear guidelines for the
management of severe hypertensive disorders and suitable protocols should already be in place in
Scottish maternity units (159; 177). Less attention had been paid to the management of mild,
non-proteinuric hypertension in pregnancy. There was confusion about the relationships between
various categories ofmild disease and about their potential to progress to severe disease.
The Management of Pregnancy in Women with Epilepsy. Epilepsy affects around 1 in 200
women attending antenatal clinics (178). Epilepsy is associated with an increased risk of
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congenita] malformations, further raised if the mother is taking anti-epileptic drugs. The babies
of women born with epilepsy are at increased risk of neonatal problems, including haemorrhagic
disease of the newborn. For the mother, pregnancy may affect the progress of epilepsy, with
seizure frequency increasing by a third. An earlier survey of Scottish obstetricians had indicated
that one fifth were dissatisfied with the level of care then received by their patients with epilepsy
and that the majority considered guidelines necessary (179).
The Management ofPostpartum Haemorrhage. Obstetric haemorrhage remains one of the major
causes of maternal death (167). The CEMD Reports revealed no consistent fall in deaths related
to haemorrhage, the majority of which were judged to involve substandard care (177). An audit
of compliance with recommendations made in previous CEMD Reports revealed a number of
problems and deficiencies relating to obstetric units in Scotland (164). Only 62% of obstetric
units in Scotland reported having a protocol for the management of massive haemorrhage.
The guidelines were developed according to a methodology developed by the Scottish
Intercollegiate Guidelines Network (SIGN) (180; 181). Guideline development groups comprised
a range of professionals involved in the provision of care around each guideline topic and
relevant patient representatives. Relevant literature was identified via searches of Medline, the
Cochrane Library and secondary references, supplemented by material known to group members.
Individual recommendations within the guidelines were graded under the scheme then used by
SIGN (181):
• Grade A: requires at least one randomised controlled trial as part of the body of literature of
overall good quality and consistency addressing the specific recommendation;
• Grade B: requires availability of well-conducted clinical studies but no randomised clinical
trials on the topic of the recommendation;
• Grade C: requires evidence from expert committee reports or opinions and/or clinical
experience of respected authorities.
Advanced drafts of the guideline were peer reviewed and amended prior to submission to the
SIGN editorial board and the Scottish Executive Committee of the RCOG.
4.2.3 Dissemination strategy
The guidelines were disseminated by means of a national meeting attended by medical and
midwifery representatives from all Scottish maternity units and by postal circulation to relevant
medical and midwifery staff. Publication and dissemination were undertaken under the auspices
of SPCERH.
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In the spirit of an integrated clinical effectiveness programme, the development and
dissemination of these four guidelines was complemented by an audit exercise which aimed to
assess obstetricians' baseline compliance with the guideline recommendations and to assess any
changes in practice subsequent to dissemination. The findings of this survey of self-reported
practice are described here.
4.3 Methods
4.3.1 Questionnaire development
A questionnaire enquiring into aspects of practice related to each of the guidelines was
developed. This included a mix of direct questions about adoption of recommendations, a choice
of responses to vignettes related to recommendations and (for postpartum haemorrhage only) a
series of true/false questions. In addition to general questions about whether the guidelines had
been kept and influenced practice, the questionnaire also enquired into receipt, local adoption and
local clinical audit of the guidelines.
4.3.2 Sampling frame and administration of questionnaire
The questionnaire was posted to 161 senior obstetricians in 1997, comprising all consultants and
all identifiable senior registrar/ year 4 and 5 specialist registrars in Scotland. The findings of the
baseline audit questionnaire were disseminated at the time of distribution of the guidelines. A '
shorter questionnaire was posted to the same obstetricians two years later, containing a subset of
the original questions which mainly addressed those recommendations where there was some
potential for change in clinical practice (Appendix 4A). All initial non-responders to both
questionnaires received one reminder.
4.3.3 Analysis
Responses were entered into an Access database (165) and analysed using SPSS (166).
Responses were categorised as 'appropriate' if they were consistent with recommendations in the
guidelines and included in the analysis only when matched questions from both the baseline and
follow-up questionnaires had been answered. The exact matched pairs test was performed using
Arcus (182; 183) and 2-sided P values were used. To allow simpler presentation of results, the
overall proportion and direction of change in practice is presented in addition to baseline
compliance. As this way of presenting results could mask substantial shifts in opinion from
compliant to non-compliant responses, larger shifts (20% or more of respondents) in this





During the period between the two surveys, 19 of the original 161 obstetricians retired from
obstetric practice or moved outwith Scotland. Of the 142 obstetricians available for survey at
both time points. 121 (85%) returned the baseline questionnaire and 105 (74%) the follow-up
questionnaire. Ninety-two of these 142 obstetricians (65%) completed both questionnaires and
results are subsequently based upon this group.
4.4.2 Reported receipt and use of the guidelines
Eighty-four (91%) obstetricians reported that they had kept the guidelines for future reference
whilst the others were uncertain of their location or had thrown them away. Seventy-eight (85%)
reported that they had changed or reconsidered aspects of their practice in response to any of the
guidelines. Of these, 30 (33%) found the guidelines sufficiently relevant to prompt changes in
some aspects of practice, whilst 48 (52%) were prompted to reconsider their practice. The
remainder found them of general interest (12, 13%) or of no real interest (1, 1%). Approximately
half of all respondents reported local adoption of the guidelines but fewer reported their use in
clinical audit (Table 4.1). Of the four guidelines, that on mild, non-proteinuric hypertension was
least often adopted or used for audit locally.








The preparation of the fetus for pre-term delivery 79 (86) 46 (50) 18 (20)
The management ofmild, non-proteinuric
hypertension
85 (92) 40 (43) 6 (7)
The management ofpregnancy in women with
epilepsy
86 (93) 53 (58) 13 (14)
The management ofpostpartum haemorrhage 78 (85) 47 (51) 23 (25)
4.4.3 The Preparation of the Fetus for Preterm Delivery
In response to direct questioning, all respondents reported prescribing antenatal steroids for
women at risk of preterm delivery at baseline and follow up (Table 4.2). There was a statistically
significant increase from 93% to 100% in the proportion correctly responding to the vignette.
Most respondents suggested 24 weeks as the lowest gestation at which steroids would be
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considered. There was less agreement on the highest gestational age at which steroids could be
considered, reflected in responses to both direct questioning and the vignette. Compared with
seven respondents who (appropriately) changed response to the avoidance of steroid therapy in a
28 year old primigravida presenting at 35 weeks gestation with PPROM. 17 changed their
response to the prescribing of steroids.
Table 4.2. Guideline recommendations on the management of women at risk of preterm









Prescription of ante-natal steroids for women at risk of pre¬
term deliver)' (n=83) Grade A
83 (100) 0(0) 1
Lowest gestation of 24 weeks at which steroids would be
considered (n=84) A
69 (82) 4 (5) 0.39
Highest gestational range of 34 to 36 weeks at which
steroids would be considered (n=84) C
67 (80) 5 (6) 0.42
Use of tocolysis rarely to permit intra-uterine transfer to a
tertiary centre or to allow a course of steroids to be
administered and for a maximum period of 48 hours (n=83)
A
67 (81) 12 (14) 0.004
Use of prophylactic antibiotics or entry to ORACLE trial in
the management ofwomen presenting with preterm, pre-
labour rupture of the membranes (PPROM) (n=84) A
52 (62) 20 (24) <0.0001
Vignettes and appropriate choices
A 25 year oldprimigravida with insulin-dependent
diabetes (IDDM) and a twin pregnancy at 28 weeks
gestation at risk ofdelivery in the next 7 days.
Initiation of steroid therapy (n=83) C 77 (93) 6 (7) 0.03
Usual dosage if initiating steroid therapy (n=78) A 72 (92) 3 (4) 0.45
Use of tocolytic therapy to allow steroid therapy to have an
optimal effect, assuming that contractions are regular and
painful, and that vaginal examination has indicated the
cervix is 50% effaced and 3 cm dilated (n=84) A
55 (65) 10 (12) 0.07
Indomethacin as preferred drug for tocolysis in IDDM
(n=67)B
27 (40) 4 (6) 0.06
A 28 yr oldprimigravida with no relevant medical or
obstetric historypresenting at 35 weeks gestation with
PPROM
Avoidance of steroid therapy (n=83) C 62 (75) -10 (-12) 0.06
Use of prophylactic antibiotic therapy or entry to ORACLE 44 (52) 23 (28) <0.001
(n=84)A
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There was a significant reported increase in the appropriate use of tocolysis on direct questioning,
although responses to the vignette were more conservative.
There was a significant reported increase in the consideration of prophylactic antibiotic therapy
or entry to the MRC Preterm Antibiotic Uncertainty Study (ORACLE) in preterm pre-labour
rupture of the membranes (PPROM). This increase occurred for both the direct question and
vignette.
4.4.4 The Management of Mild, Non-proteinuric Hypertension in Pregnancy
There were no significant improvements in the management of mild, non-proteinuric
hypertension from variable levels of baseline compliance (Table 4.3). At follow up, nearly a
quarter of respondents (24%) did not report using Korotkoff phase IV (muffling of sounds) to
measure diastolic BP. There was a non-significant increase in the proportion of respondents who
would appropriately re-check a raised 'spot' diastolic BP. But over a quarter (26%) would
inappropriately initiate investigations.
The guideline recommends that mild, non-proteinuric hypertension does not require anti¬
hypertensive therapy after 32 weeks gestation. Under this gestation, less than a third (28% at
follow up) would consider treatment or refer to a colleague for advice. Over 32 weeks gestation,
the majority (90% at follow up) of respondents would either avoid treatment or seek advice.
There was little change from the low proportion preferring methyldopa as the first line agent for
treating gestational hypertension (from 15% to 21%).
Just over half (53% at follow up) would monitor mild, non-proteinuric hypertension
appropriately by checking BP and urinary protein twice weekly. A minority (20%> at follow up)
selected appropriate investigations for this condition. There was no change in the proportion of
obstetricians reporting performing at least 4 out of the 5 basic investigations recommended in
monitoring mild, non-proteinuric hypertension, with 50 (59%) doing so at baseline and 45 (53%)
at follow-up (P=0.46).
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Table 4.3. Guideline recommendations on the management of mild, non-proteinuric










Use of Korotkoff phase IV (muffling of sounds) in measuring
diastolic BP (n=84) Grade C
58 (69) 6 (7) 0.21
Methyldopa as preferred first line agent for treatment, where
appropriate, of gestational hypertension (n=85) B
13 (15) 5 (6) 0.23
Vignettes and appropriate choices
A patient attending for routine antenatal care is found to have a
"spot" diastolic BP of95 mmHg but no proteinuria.
Re-checking of BP within a short period and, if diastolic
remains elevated, make arrangements for a further check in the
hospital or community at least 4 hours later before initiating
further investigations, n=86) C
55 (64) 9 (10) 0.09
A 20 year oldprimigravida at 34 weeks gestation develops
gestational hypertension (diastolic BP consistently 95 mmHg)
but no proteinuria.
Avoidance of anti-hypertensive treatment or referral to a
colleague for advice (n=86) A
73 (86) 4 (4) 0.42
A 20 year oldprimigravida at 31 weeks gestation develops
gestational hypertension (diastolic BP consistently 95 mmHg)
but no proteinuria.
Consideration of anti-hypertensive treatment or referral to
colleague for advice (n=85) A
21 (25) 3 (3) 0.63
A 20 year oldprimigravida with a diastolic BP of95 mmHg but
noproteinuria at 34 weeks gestation.
Twice weekly (every 3-4 days) follow up for BP check and
urine testing for (n=85) C
40 (47) 5 (6) 0.49
Selection of investigationsfor intermittent assessment of the
above woman
No more than two deviations from a list of 14 appropriate and 16 (19) 1 (1) 1
inappropriate investigations. Appropriate tests are full blood
count, platelet count, 'dipstick' testing for proteinuria, urea and
electrolytes, and serum urate (n=85) C
4.4.5 The Management of Pregnancy in Women with Epilepsy
Seventy-nine respondents indicated that they provided care for pregnant women with epilepsy.
Improvements in reported practice were more pronounced, with significant increases in the use of
a higher dose of folic acid and combined administration of vitamin K (Table 4.4). Only 3 (4%)
of respondents would not encourage breast feeding as for any other mother. There was less
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consistency regarding the prescribing of oral contraception. Compared with 9 respondents who
changed (appropriately) to including combined oral contraception in options offered to women
on enzyme inducers, 20 subsequently would not.
Table 4.4. Guideline recommendations on the management of pregnancy in women with









Periconceptual folic acid supplements at 4-5 mg/day (as for
women with a previous history of neural tube defects) for
women with epilepsy (n=78) Grade C
52 (67) 18 (23) <0.0001
Use of vitamin K 1 mg at birth for babies and treatment of
mother with 20 mg orally daily from 36 weeks gestation
for the prevention of haemorrhagic disease of the newborn
(n=74) B
13 (18) 42 (57) <0.0001
Encouragement and support of breast feeding as for any
other mother (n=76) B
67 (88) 6 (8) 0.07
Inclusion of combined oral contraception (COC) among
the contraceptive options offered to women on enzyme
inducers whilst encouraging the use of non-hormonal
methods (n=79). B
42 (53) -11 (-14) 0.06
Use of regimens containing higher doses of oestrogen as a
first line when COC is chosen by a woman on an enzyme-
inducing anticonvulsant. (Any of: 50 ug pill, combination
of two lower dose pills or taking three or more packs of
pills in succession without a pill-free interval, n=79) B
58 (73) 6 (8) 0.38
4.4.6 The Management of Postpartum Haemorrhage
Knowledge of recommendations for major obstetric haemorrhage from the 1991-3 CEMD Report
did not consistently improve (177) (Table 4.5). Baseline knowledge was already high for 4 out
of the 6 recommendations. There was a non-significant increase in the proportion of respondents
who correctly recalled the need to order a minimum of two units of blood. But still only 50%
recalled this at follow up. Similarly, only 53% at follow up correctly recalled the
recommendation to set up central venous pressure (CVP) monitoring immediately. Compared
with 10 respondents who changed (appropriately) to setting up CVP monitoring, 21 would no
longer do so.
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Table 4.5. Guideline recommendations on the management of postpartum haemorrhage,
grade of recommendation and reported adherence.






Correct recall of recommendations made in the 1988-1990
Report on Confidential Enquiries into Maternal Deaths
provided guidelines for the management ofmassive obstetric
haemorrhage (n=86)
Alert all of the following: anaesthetist, haematologist, blood
transfusion and porters (true) Grade C
86 (100) -1 (-1) 1
A minimum of 2 units blood should be ordered (true) C 31 (36) 12 (14) 0.06
Dextrans are recommended for transfusion until blood arrives
(false) C
78 (91) 4 (4) 0.39
At least two intravenous lines should be set up using cannulae
ofnot less than 14 gauge (true) C
86 (100) -3 (-3) 0.58
Blood warming equipment is unnecessary (false) C 75 (87) -6 (-7) 0.29
Central venous pressure monitoring should immediately be
set up to ensure that therapy is safely controlled (true) C
57 (66) -11 (-13) 0.07
4.5 Discussion
4.5.1 Main findings
Most obstetricians recalled receipt of the guidelines and around half stated that they had been
adopted locally. Less than a quarter reported using each guideline for local clinical audit.
Feedback of results from a baseline audit and dissemination of guidelines under the auspices of a
national programme were followed by improvements in knowledge and self-reported obstetric
practice.
Reported adherence to the guidelines increased significantly for recommendations in the
guidelines concerning the management of anticipated preterm labour (despite relatively high
baseline compliance) and women with epilepsy. However, considerable uncertainty persists
regarding the optimal management of women with mild, non-proteinuric hypertension. There
were wide variations in the reported frequency of follow up, selected investigations and
therapeutic choices. For the management of postpartum haemorrhage, knowledge of relevant
recommendations from the 1991-3 CEMD Report did not improve, partly because baseline
knowledge was already high for majority of the recommendations.
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4.5.2 Strengths and weaknesses
This project represented one of the first attempts to complement national clinical guideline
development in Scotland with a related audit exercise. The results are consistent in direction and
magnitude with those observed in previous national audit projects (34). However, improvements
in practice cannot be directly attributed to the methods of audit and guideline dissemination for
several reasons.
Some significant changes may have occurred by chance. At a significance level of 5%. at least
one 'significant' change in practice will occur by chance following the multiple statistical tests
performed in this study. Nevertheless, the overall trend was consistent with improved knowledge
and practice and the limited number of obstetricians available for the survey probably constrained
the ability to detect further significant changes.
Compliance with the guideline recommendations may have been over-estimated for two reasons.
Firstly, 35% of the sample did not respond and obstetricians unaware of, or not following, the
guidelines may have been less likely to respond to the survey (response bias). Secondly, self-
reported practice may over-estimate actual clinical performance (37;129). Despite the
confidential nature of the survey, some obstetricians may have consulted the guidelines to find
the correct responses.
Other forms of bias related to the lack of a control group may have led to an over-estimation of
the impact of the guideline dissemination strategy. Firstly, for the follow-up survey, those
guideline recommendations with greatest scope for improvement in practice were selected.
Regression to the mean occurs when study recommendations selected on the basis of their more
extreme scores (low compliance with guideline recommendations) tend to give subsequent scores
closer to the average. Secondly, maturation bias occurs when the passage of time brings about
changes in clinical behaviour independent of the intervention. Clinicians may become more
familiar with certain clinical practices over time independently of knowledge of the guideline
recommendations (see 4.5.3 below). Thirdly, further problems may also occur in measuring
outcomes over time. Clinicians responding to the follow-up questionnaire may have become
sensitised to the most appropriate responses.
4.5.3 Meaning of the findings and possible mechanisms
Reported practice improved across most aspects of the management of anticipated preterm
labour, notably in the appropriate use of steroid therapy, tocolysis and prophylactic antibiotics in
PPROM. Significant improvements occurred despite high baseline compliance. This may have
61
reflected obstetricians' growing acceptance of a reliable evidence base (184) and, perhaps,
synergistic (or co-interventional) effects of educational activities undertaken by the ORACLE
study group around this time to promote the trial.
The reported improved management of pregnant women with epilepsy may reflect growing
awareness of the special risks and needs associated with this group of women (185). It is also
possible that characteristics of recommendations from this guideline influenced compliance
(chapter 2). The relatively precise nature of the recommendations to use combined vitamin K
regimens and the higher dose of folic acid supplement may have contributed to the observed
significant changes in reported practice. The instances where sizeable proportions of clinicians
shifted from compliant to non-compliant responses may be attributable to more ambiguous or
complex recommendations, e.g. the inclusion of combined oral contraception as an option for
women receiving enzyme inducers.
The 1994-6 CEMD Report indicated that pregnancy induced hypertension was the second most
common cause of maternal mortality (159). The aggressive management of women with mild
hypertension in pregnancy may reflect anxiety in missing or under-managing more serious
disease. The guideline set out to support obstetricians in minimising clinical risk by offering a
more structured, as well as efficient, approach to management. It is notable that 40 respondents
(47% of 85) did not report the use of at least 4 out of the 5 basic investigations recommended in
monitoring mild, non-proteinuric hypertension. One possible explanation for this is that the~~"-
guideline's structured approach to minimise clinical risk possibly represented some of the more
complex recommendations to follow, out of the four guidelines. Some established clinical
practices are difficult to phase out. Less appropriate choices of investigation (such as the use of
ultrasound) may have been influenced more by availability and women's preferences than by
guideline recommendations.
Approximately half of respondents did not correctly recall the CEMD Report recommendations
that a minimum of 2 units of blood should be ordered and that central venous pressure
monitoring should be employed in the management of massive obstetric haemorrhage. However,
responses to the baseline survey indicated that all Scottish maternity units had appropriate
protocols in place. Rapid access to such protocols during clinical emergencies may be more
important in improving standards of care than relying upon the limitations ofmemory (53).
4.5.4 implications for clinical practice and policy
All of the guidelines have been updated, with no major changes, since their original publication.
Given limited resources and the need to prioritise work within SPCERH's programme, these
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findings suggest that further dissemination activities are probably not warranted for the
guidelines on the preparation of the preterm fetus for deliver}'.
The reported improvements in the care of women with epilepsy contrast with the findings from a
population based, prospective study in the English Northern health region (186). This study
suggested that recommendations in the literature were still not being followed. Only 11% of
women reported taking folic acid appropriately and Vitamin K was given as recommended to
36% of infants. Although from a different region, these findings suggest the need for greater
scrutiny of the care of women with epilepsy based on a review of actual case note data rather
than clinician self-reports.
Given the lack of improvement in self-reported management of mild, non-proteinuric
hypertension and aspects of the management of post-partum haemorrhage, further dissemination
activities would seem justified for these topics. Since this work, SPCERH has undertaken a
national audit of the prevention and management of emergencies during labour (143). Of 411
cases of primary postpartum haemorrhage identified over 12 months (1999-2000), the care of
90% met at least 9 of 12 key criteria for good quality care based upon recommendations in the
SOGAP guideline. All 12 criteria were met in only 6% of cases. Common deficiencies included
the absence of'hands-on' management by a consultant obstetrician in 55% of cases, the failure to
site two or more intravenous lines in 44%, and cross-matching of blood for less than the (then)
recommended six units of blood 74%. Following the audit, a national feedback meeting attended
by representatives of Scottish maternity units made further recommendations to reinforce those
from the CEMD Reports and SOGAP guideline.
4.5.5 Further research questions
This evaluation demonstrated acceptable levels of professional participation in an audit of four
clinical practice guidelines. Nevertheless, the uncontrolled nature of this evaluation and the use
of self-reported practice as an outcome measure greatly limited the attribution of changes in
practice to the dissemination strategy. The next step therefore comprised a more rigorous
evaluation of the strategy, an interrupted time series analysis, using actual patient data related to
one of the guidelines (Chapter 5).
4.6 Conclusion
The dissemination and audit of clinical guidelines under a recognised national clinical
effectiveness programme may contribute to consistent improvements in reported clinical practice.
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Most obstetricians recalled receipt of the guidelines and around half stated that they had been
adopted locally. Less than a quarter reported using each guideline for local clinical audit. There
were significant improvements in the reported management of women at risk of preterm labour
and those with epilepsy. Reported practice in relation to mild, non-proteinuric hypertension has
improved little. This is possibly because this guideline was relatively complicated to understand
and apply,, and established patterns of practice are more resistant to change. More rigorous




Simple interrupted time series analysisof the impact of
national obstetric guidelines on clinical practice
5.1 Summary
The clinical guideline, The Management ofMild, Non-proteinuric Hypertension in Pregnancy,
was published in 1997 by the Scottish Programme for Clinical Effectiveness in Reproductive
Health (SPCERH). Identified as a priority by clinicians, hypertension affects up to 10% of all
women receiving antenatal care. The guideline encourages reductions in unnecessary hospital
admissions and investigations, improved efficiency of care, and minimisation of disruption to
women and their families. This study determined whether the dissemination of a clinical
guideline under the auspices of a national clinical effectiveness programme had any impact on
clinical practice and represented an efficient use of resources. It was planned and initiated prior
to the post-intervention survey of obstetrician self-reported practice described in Chapter 4.
The design was a simple interrupted time series analysis. The intervention comprised
distribution of the guideline under the auspices of SPCERH, supported by a national launch
meeting and distribution of results of a baseline audit of obstetricians' reported practice.
Data were collected from four representative Scottish maternity units over a total of thirty-six
months (24 months pre-intervention and 12 months post-intervention) between 1995 and 1998.
The main clinical outcomes were the appropriateness of (i) initial investigation and (ii)
subsequent clinical management, including the avoidance of unnecessary hospitalisation,
investigations and treatments. An economic evaluation was planned to measure the costs and
benefits of the guideline development, dissemination and implementation strategy.
The guideline was directly relevant to the 20.5% of women receiving antenatal care who
experience an episode of raised diastolic blood pressure, proteinuria or both after 20 weeks
gestation. The antenatal care of 1263 cases was assessed by a review of case notes. Care was
consistent with the recommendations on initial investigation for 757 (59.9%) of women. A time
series analysis indicated a non-significant increase of 10.6% in the compliance level (95%
confidence interval -0.1 to 19.3%), which decreased by 1.2% per month post intervention (95%
CI -2.5 to 0.1%).
Sufficient data were available on 1081 women to analyse clinical management, and 731 (67.6%)
were considered to have been managed appropriately. The appropriateness of management
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varied according to the required level of care. Compliance was highest (81.3%) for 739 women
categorised as requiring routine antenatal care and lowest for the 143 requiring enhanced
surveillance (4.9%). Women eligible for routine care tended to be over-investigated or seen at
clinics too frequently. Those with clinical problems requiring closer surveillance tended to be
under-investigated and attend clinics too infrequently. There was no evidence of a change in
level in the appropriateness of clinical management (-0.3%; 95% CI -8.7 to 11.2%).
A cost-effectiveness analysis was not justified given the lack of any significant effects. The
economic evaluation therefore focused on the costs of developing, disseminating and
implementing the guideline. The total cost of the strategy was estimated at £66,809. The cost of
guideline development accounted for 40% of the total costs whilst dissemination and
implementation accounted for 60%. The average cost of the dissemination and implementation
activities was estimated at £1695 per maternity unit in Scotland.
The most likely explanations for the lack of effect of the strategy are probably related to the
nature of the guideline topic, the complexity of the guideline recommendations and the low
intensity of the dissemination and implementation strategy.
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5.2 Introduction
5.2.1 Hypertension in pregnancy
Hypertensive disorders of pregnancy comprise one of the major causes of maternal death in the
UK, consistently ranking second to thrombo-embolism as a cause of direct maternal death (159).
Hypertensive disorders are also associated with increased risks of stillbirth and neonatal death.
Compared with normotensive women, proteinuric pre-eclampsia may carry a relative risk of 9.6
for stillbirth whilst diastolic hypertension alone is associated with a relative risk of 4.1 (187). Up
to 6% of perinatal mortality in Scotland has been attributed to hypertensive disease (188).
The reports of the Confidential Enquiry into Maternal Deaths have repeatedly highlighted the
need for clear guidelines for the management of severe hypertensive disorders and suitable
protocols should already be in place in Scottish maternity units (177). Less attention has been
paid to the management of mild, non-proteinuric hypertension in pregnancy. There is confusion
about the relationships between various categories of mild disease and about their potential to
progress to severe disease.
5.2.2 Development of the guideline
The guideline, The Management of Mild, Non-proteinuric Hypertension in Pregnancy, was
produced as part of the Scottish Obstetric Guidelines and Audit Project (SOGAP) in response to
these concerns. This guideline was systematically developed by a multidisciplinary group in
accordance with Scottish Intercollegiate Guidelines Network (SIGN) methods of appraising and
grading evidence (83). The guideline promoted the appropriate assessment and management of
women with non-proteinuric hypertension, experienced by approximately 10% of all antenatal
patients (i.e. 6,000 women per year in Scotland). The guideline addressed the following key
aspects of care:
• Definitions and classification of hypertensive disease in pregnancy
• Prevention of gestational hypertension
• Assessment and appropriate levels of surveillance
• Pharmacological and other treatment strategies
• Place ofmanagement
• Management after delivery
Specifically, the guideline recommended that levels of care should be tailored to clinical findings
(Table 5.1). Ideally, women should be able to move between levels of care according to their
clinical progress.
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Table 5.1. Recommended packages of care according to the guideline.
Care package Eligible women Components of care package
Routine antenatal care 'Spot' hypertension not
sustained on assessment
Basic surveillance Confirmed mild hypertension BP recording and urine 'dipstix"
twice weekly; clinical appraisal
of fetal size and well-being;
single estimate of serum urate,
urea and electrolytes, full blood
count, platelets
Enhanced surveillance Diastolic BP sustained at over
1 OOmmHg or with mild
hypertension and an incremental
rise more than 25 mmHg since
booking, clinical suspicion of
poor fetal or maternal well-
being or abnormal results on
basic surveillance blood tests
BP recording and urine dipstix
at least 3 times per week;
weekly serum urate, U&Es,
FBC, platelets, LFTs; scan
assessment of fetal size and
liquor volume; CTG assessment
of fetal well-being
Specialist management (outwith Severe hypertension,
guideline) proteinuria, or abnormal
findings during enhanced
surveillance
Referral for specialist obstetric
care
The guideline made other recommendations on clinical management. Neither inpatient
admission nor induction of labour is indicated by mild, non-proteinuric hypertension (Grades B
and C respectively). Anti-hypertensive drug treatment is not usually indicated for women with
non-proteinuric gestational hypertension. Consideration may be given to anti-hypertensive
therapy if hypertension has arisen before 32 weeks gestation or diastolic blood pressure rises to
100 mmHg or greater (Grade A recommendation). Ideally, drug treatment should comprise
either labetolol or methyldopa (Grade B).
Use of the guideline should reduce unnecessary hospital admissions and over-investigation,
improve the efficiency of care, and minimise disruption to women and their families.
Furthermore, a structured approach to management should also enhance clinical risk management
by (for example) improving detection ofmore severe hypertensive disease.
5.2.3 Dissemination and implementation of the guideline
The guideline was disseminated and implemented under the auspices of SPCERH (4.2.3). The
impact of support from such a programme was uncertain and had not been formally evaluated.
Furthermore, little work has previously assessed the cost-effectiveness of guideline development,
dissemination and implementation. Given the opportunity costs of such activities within a
clinical effectiveness programme, it is important to establish whether such costs are recouped by
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resources saved following any change in clinical practice. This is particularly relevant where
clinical guidelines may recommend reduced resource utilisation (such as the guideline on mild
hypertension).
5.2.4 Previous work and pilot studies
Surveys of Scottish obstetricians' reported practice in 1997 and 1999 suggested that obstetricians
appeared to investigate or admit women with mild, non-proteinuric hypertension at an
inappropriately low threshold (Chapter 4). The uncontrolled nature of this evaluation and the use
of self-reported practice as an outcome measure limited interpretation of these findings. The
results of the post-intervention survey were not known during the time that a more rigorous
evaluation of the dissemination and implementation strategy was being planned.
A preliminary survey of case notes was undertaken to pilot data collection for this study and
estimate the proportion of eligible cases. 100 consecutive maternity notes covering deliveries
during 1998 were assessed (40 from Aberdeen and 60 from Edinburgh). The guideline was
applicable to 35 out of 100 cases examined. Compliance with a limited number of
recommendations was assessed and revealed a mixed picture. For example, whilst blood
pressure was often checked appropriately, the use of supporting investigations was inconsistent
with evidence of excessive intervention in mild hypertension.
5.2.5 Research aim
This study aimed to determine whether dissemination of a clinical guideline on the management
of non-proteinuric hypertension in pregnancy under the auspices of a national clinical
effectiveness programme had any impact on clinical practice and represented an efficient use of
resources.
5.3 Methods
A Steering Group was established to advise on study design and conduct and to consider the
research findings (Appendix 5A).
5.3.1 Design
The research design was a simple interrupted time series analysis. Chapter 4 described the use of
an uncontrolled before-and-after design to assess the impact of four clinical guidelines.
Observations are made in one group before and after an intervention and observed differences
attributed to the intervention (133). As discussed earlier (1.6.2) and illustrated in Figures 5.1 and
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5.2. before-and-after studies may fail to account for underlying trends in practice. Therefore,
improvements in practice may be over- or under-estimated.









Interrupted time series analyses can detect whether an intervention had an effect significantly
greater than the underlying (secular) trend (Figure 5.3). Such designs are appropriate in
guideline implementation research for evaluating the effects of interventions when it is difficult
to randomise or identify an appropriate control group. Data are collected at multiple time points
before and after the intervention; the multiple time points before the intervention allow the
underlying trend to be estimated, the multiple time points after the intervention allow the
intervention effect to be estimated accounting for the underlying trend (189).
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Simple (uncontrolled) time series analyses allow for secular changes resulting from maturation or
regression to the mean to be estimated. The absence of a control group means that other sources
of bias can undermine validity. Hence, for simple time series analyses, it is important to identify
other factors that may influence outcomes in addition to the intervention, such as changes in
instrumentation or external events.
Figure 5.3. Change in compliance in an interrupted time series.
The analysis of time series can be complex. Firstly, autocorrelation can occur, whereby the value
of an observation at a given time point is related to the value of previous observations (190).
Therefore ordinary statistical tests that assume observations are independent of each other cannot
usually be used to compare (say) pre-intervention and post-intervention values. The effects of
autocorrelation can be investigated and, if absent, the use of ordinary tests may be justified.
Secondly, interventions may have immediate or delayed effects. Many interventions, such as the
dissemination of guidelines, may take time to diffuse and lead to a lag between intervention and
effect. There should be a strong theoretical basis to support the attribution of changes in values
to delayed effects of an intervention. The nature of the hypothesised effect should preferably be
stated in advance of analysis to reduce the risk of false positive conclusions.
5.3.2 Study setting and participants
The study participants comprised obstetric units in two teaching (Aberdeen Maternity Hospital
and Simpson Memorial Maternity Pavilion, Edinburgh) and two district general hospitals (Forth
Park, Kirkcaldy, and Ayrshire Central Hospital, Irvine) in Scotland. Earlier plans to recruit
Glasgow Royal Maternity Hospital as the fourth unit were abandoned because of problems
gaining access to case notes when the hospital moved to a new site. The hospitals were selected
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to balance geographical location and likelihood of compliance with the guideline (informed by
responses to the questionnaires of self-reported practice - Chapter 4). In this way. it was
intended to enhance the representativeness of the sampled hospitals.
The patient population consisted of women delivering a live or stillborn baby within each of the
above four obstetric units during the study time periods.
5.3.3 Intervention
The guideline, The Management ofMild, Non-proteinuric Hypertension in Pregnancy, was one
of four published and disseminated under the auspices of the Scottish Programme for Clinical
Effectiveness in Reproductive Health (4.2.3). Activities comprised:
• A national meeting to launch the guideline attended by senior clinical representatives of all
Scottish consultant-led obstetric units (March 1997). This meeting was also used to launch
three other national obstetric guidelines (4.2.2). Two didactic presentations focused on
hypertension in pregnancy; one on key points from the guideline; and the other on a profile
of current practice. Delegates were able to choose from four interactive sessions, one of
which covered the hypertension guideline.
• Distribution of results of a baseline audit of consultants' and specialist registrars' reported
practice (October 1997). Feedback therefore took place at a national level. The feedback
report highlighted what aspects of clinical care could be improved to comply with guideline
recommendations
• Distribution of the clinical guideline itself to 7,700 health care professionals in Scotland,
comprising all obstetric consultants and specialist registrars, all practising midwives, all
general practice principals, and all consultant neonatologists (October 1997).
5.3.4 Outcomes
Two primary outcomes were developed, based upon compliance with guideline
recommendations, to measure the appropriateness of diagnostic processes and subsequent clinical
management.
Appropriateness of initial investigation of mild, non-proteinuric hypertension or proteinuria was
to be judged according to the following criteria:
• Confirmation ofmild hypertension by checking two BP measurements 4-24 hours apart;
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• Investigation of proteinuria, including checking urine specific gravity for '+' proteinuria and
investigating for infection.
Following a later review of the raw data - before any analysis of time trends - it became clear
that applying the original criteria would leave a low proportion of cases categorised as
appropriately investigated. Of 392 women who had their diastolic BP re-checked, only 172
(44%) were documented as having had it re-checked 4-24 hours later. It is likely that many
women had their BP re-checked within 4 hours or did not have the timing of their assessments
recorded. Therefore the requirements to meet this criterion were relaxed so that any documented
re-checking was considered appropriate.
Similarly, of 635 women with documented proteinuria, only 2 (0.3%) were documented as
having had specific gravity checked. The criteria required to meet this recommendation were
also relaxed so that checking of specific gravity was no longer required to categorise care as
appropriate.
These criteria were relaxed to enhance the subsequent sensitivity of the analysis. In the most
extreme case, it would not be possible to detect any changes in the diagnosis of proteinuria if
documentation of specific gravity was retained as a criterion. However, excessive relaxation of
the criteria may undermine the validity of the compliance measures. The relaxation of the
diagnostic criteria was considered justified given that the relevant recommendations were graded
'C' (i.e. based upon evidence from expert committee reports or opinions and/or clinical
experience of respected authorities) and following discussions with the study's clinical advisors.
Appropriateness ofmanagement of women with a confirmed diagnosis of mild, non-proteinuric
hypertension was initially based on the following criteria:
• Allocation of women to the recommended package of follow up care: routine antenatal care,
basic surveillance, enhanced surveillance or specialist care (Table 5.1);
• Avoidance of hospitalisation (except for specialist care);
• Avoidance of interventions (anti-hypertensive therapy or induction of labour) after 32 weeks
gestation (except for specialist care).
The assessment of compliance with the recommended packages of follow up care proved to be
relatively complex. In particular, women could move between different levels of care over time,
depending upon clinical findings and the results of investigations. Subsequently, collecting data
to capture all relevant events over the complete course of a pregnancy would have been
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prohibitively time consuming and difficult to analyse. The assessment of compliance with
recommended packages of care therefore focused on the first seven days following the initial
detection of raised BP, proteinuria or both. This restriction had implications for the measurement
of other components of clinical management, namely the avoidance of inpatient admissions,
induction of labour and inappropriate anti-hypertensive therapy.
Firstly, it was possible that a proportion of women with diagnosed mild, non-proteinuric
hypertension developed more serious disease following the week of the initial diagnosis.
Therefore, only admissions within that week were recorded and categorised as inappropriate
unless specialist referral was indicated or the admission was for another stated indication.
Secondly, it was also originally planned to categorise induction of labour as inappropriate for all
levels bar specialist care. However, as it was not possible to determine the appropriateness of
subsequent induced labours, this criterion was removed.
Thirdly, the appropriateness of anti-hypertensive therapy was assessed using data collected
beyond the week of the initial problem. The initiation of drug treatment was considered
appropriate if hypertension was detected before 32 weeks gestation or DBP rose to 100 mmHg or
greater. However, the avoidance of drug treatment was also considered appropriate in these
circumstances. Therefore, inappropriate care comprised the use of drug therapy after 32 weeks
gestation ifDBP was less than 100 mmHg. Where drug therapy was considered justifiable, it had
to consist of either labetolol or methyldopa to achieve compliance with the guideline.
Following a review of the raw data, the criteria for appropriate clinical management were
modified - once again before the analysis of any time trends. When all of the criteria relating to
the number of contacts, avoidance of inpatient admissions, conduct of investigations, and use of
anti-hypertensive treatment were applied, compliance with the basic and enhanced surveillance
care packages was virtually zero. This represented a notable finding in itself but reduced the
ability of the planned time series to detect changes in practice.
For the definitive analysis, clinical management subsequent to the detection of raised blood
pressure or proteinuria was categorised for four patient groups and appropriateness measured as
in Table 5.2. The relaxation of these management criteria was justified on similar grounds to
those for appropriate initial investigation. In addition, one recorded check of platelet levels was
permitted for women receiving routine antenatal care. Platelet levels are frequently recorded as
part of the full blood count and commonly used to diagnose or monitor anaemia.
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Table 5.2. Appropriateness of care according to patient category.
Patient category Appropriate care
Routine antenatal care At least two out of three criteria to be met for the following areas of
care: number of contacts: investigations: and admissions
Basic surveillance At least three out of four criteria to be met for the following areas of
care: number of contacts; investigations; admissions; and anti-
hypertensive treatment
Enhanced surveillance At least three out of four criteria to be met for the following areas of
care: number of contacts; investigations; admissions; and hypertensive
treatment
Specialist care (outside Only documentation of being seen by an obstetrician required
scope of guideline)
5.3.5 Data collection
Identification ofeligible cases. The aim of case identification was to identify a quota of cases for
detailed review per month per maternity unit. The process is summarised in Figure 5.4. Data
collectors screened case notes using a standard form (appendix 5B) to identify women who met
at least one of the following criteria:
• Diastolic blood pressure (DBP) of 90 mmHg or greater recorded at any time after 20 weeks
gestation;
• Proteinuria of'+' or greater recorded antenatally on one or more occasions after 20 weeks;
• Referral from primary care for further assessment of blood pressure or other evidence that
the woman was managed for the assessment or treatment ofmild hypertension.
Figure 5.4. Identification of eligible cases for assessment of appropriateness of care.
Four maternity units
I
Pre-intervention (Mar 95 to Feb 97) and post-intervention (Nov 97 to Oct 98)
I
Total of 7200 randomly sampled records of women delivering a live or stillborn baby
(i.e. 50 case notes per unit per month)
I
Initial screening by data collectors to identify 1475 (20.5%) with episode of raised BP or proteinuria
1
Limit of up to first 10 cases per month per unit for detailed review
I
Total of 1263 cases (mean of 35.1 cases per month, range 26 - 39)
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Case note review. Women hold their own antenatal records, which are completed following each
visit for community or hospital care. Following delivery, these records are added to the hospital
maternity case notes. These completed records formed the basis for the case note review.
However, it was accepted that these records may not capture data from all contacts with relevant
professionals in the community.
Data were collected from eligible cases on baseline characteristics, the processes of care
occurring within the seven days of the detection of either raised diastolic blood pressure or
proteinuria, and other aspects ofmanagement from twenty weeks gestation onwards.
Baseline data included:
• Age of the women at first visit
• Gestation at first visit
• Parity
Data on management within the seven days of first detection of raised diastolic blood pressure or
proteinuria included:
• Initial and subsequent diastolic BP readings: urine dipstix testing, number of recorded
clinical contacts
• Admissions (including recorded indications)
• Documentation of review by an obstetrician
• Investigations conducted (including documentation of abnormal findings).
From 20 weeks gestation onwards, data were collected on: usage, timing and type of anti¬
hypertensive therapy; and mode and outcome of delivery.
Case identification and data collection were piloted on 100 consecutive case records in two of the
study hospitals. The final version of the data collection form is included in Appendix 5C.
Recruitment and training of data collectors. The recruitment of local data collectors was
necessary to satisfy requirements from ethical committees and the Privacy Advisory Committee
of the Information and Statistics Division (ISD) of the NHSiS. Data collectors consisted of
clerical or midwifery staff from each of the four maternity units. All data collectors were visited
and trained by the lead researcher (RF). These meetings covered the background to and
objectives of the study, case identification and data collection. After data collectors had
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extracted data from several case notes, their findings were compared with those of the lead
researcher. This allowed identification and correction of several ambiguous items in the data
collection form. All data collectors received an instruction booklet and a telephone number to
contact in case of coding queries.
Economic evaluation. Cost data were elicited and estimated for the development, dissemination
and dissemination of the guideline. The cost of development of the guideline included the costs
of literature search, development group meetings, travel, writing up, and peer review. Also
included in the development cost were the costs associated with organising the national launch
(i.e. planning, venue, catering, and participants travel expenses) and the costs of the audit and
feedback exercise which consisted of planning and performing the survey, and preparation and
distribution of feedback. The costs of dissemination were made up of the costs of printing and
postage incurred in the distribution of the guideline.
Cost estimates were derived from SPCERH records and local sources. Staffing costs of GPs,
doctors, and midwives were taken from standard sources (191-193). Average costs per woman
attending a maternity unit and per woman to whom the guideline directly applied (i.e. with an
episode of raised diastolic blood pressure or proteinuria) in Scotland were calculated. Estimates
of women attending maternity units were taken from ISD Scotland. Estimates of the women to
whom the guideline directly applied were taken from the study case identification data. Similar
average costs were also presented for the four maternity units that contributed data to the time
series analysis. Resource use and unit costs, expressed in 2001 values, are displayed in Appendix
5D.
The outcomes comprised the degree of behaviour change according to the two primary outcomes
outlined above (2.4). The cost-effectiveness of implementing this particular guideline depended
upon the cost-effectiveness of the interventions recommended by the guidelines. This approach
is recommended for evaluating the implementation of guidelines (90). To address this, it was
planned to ascertain NHS resource use from the case note review and estimate health benefits
from the literature review supporting the guideline.
5.3.6 Sample size
Given uncertainties in calculating sample sizes for time series analyses, it is acknowledged that
the number of time points and number of cases per time points were chosen largely on pragmatic
grounds (194; 195). Twenty-four monthly (2 years) pre-intervention data sampling points were
necessary to judge any preceding trends or seasonality (periodicity) in clinical management. By
considering 24 months, each calendar month was studied twice, thereby allowing seasonal effects
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to be investigated statistically. A further twelve monthly points were required post-intervention
to assess any changes in clinical management. Up to fort}' cases per month (10 per maternity
unit) were considered necessary to provide sufficiently reliable estimates of compliance per time
point. Forty cases per month gave the study 80% power at 5% significance to estimate the
proportion compliant at each time point to within 15%. This equated to a total planned sample
size of 1440 cases.
For each maternity unit to contribute 10 cases per month, it would be necessary for the data
collectors to screen an average of 33 case notes per month (based on the pilot study). To allow
for random sampling variability and missing case notes, 50 case notes per month were sought for
screening. The sampling frame was drawn from Scottish Maternity Record (SMR) 02 statistics
following permission from the Privacy Advisory Committee of the ISD. As the guideline was
disseminated between March and October 1997, eligible cases were sought with dates of
delivery:
• 1s" March 1995 to 28th February 1997
• 1st November 1997 to 31st October 1998
Fifty case numbers per hospital per month were randomly selected from the centrally held SMR
02 data. This equated to a total of 7200 case numbers. Only one delivery per patient was
extracted.
Where more than 10 eligible cases were identified within a month in an individual maternity unit,
the detailed case note review was limited to the first 10 cases. This limit was both based upon
the sample size calculation and the need for the costs of study to remain within given resources.
5.3.7 Data entry
Data were entered into an Access Database. The reliability of data entry was checked by re¬
entering data for ten variables for a 5% random sample of questionnaires (n=64). Three
miscoding errors were detected out of a total of 640 entries. As two of these comprised the same
miscoding error the whole database was searched for their occurrence. Eight further similar
errors were detected and the data entries corrected.
5.3.8 Analysis
Time trends. Compliance with recommendations was measured according to the criteria set out
in section 5.3.4 and detailed in the algorithms in Appendix 5E.
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Following visual inspection of time trends in compliance, a logistic regression model that
adjusted for the clustering per time point was fitted. Robust standard errors (SEs) were
calculated using time period as a clustering effect. The results of the logistic regressions were
given in terms of odds ratios. The odds ratios were also transformed to give estimates of level
and post-intervention slope in terms of percentage change using the predicted values from the
model fitting procedure (illustrated visually by Figure 5.5). Autocorrelation for the compliance
outcomes were investigated using the autocorrelation and partial autocorrelation functions.
Figure 5.5. Parameters assessed by the interrupted time series.
It would be naive to expect any change in clinical practice immediately following dissemination
and implementation of the guideline. However, it was anticipated that any observable effects
should start to occur within the first half of 1998 (the follow up year), by which time any relevant
educational activities and incorporation into local protocols should have occurred. The impact of
potentially confounding events was considered in the interpretation of the analysis. National or
local activities (e.g. local audit, publication of reports) that might influence clinical behaviour
were defined as confounding events. If prompted primarily by dissemination and implementation
of the guideline, such activities became in effect an extension of the whole intervention.
In addition to changing levels of compliance, it was also possible that dissemination and
implementation of the guideline reduced variability between time points, i.e. clinical practice
became more uniform. Therefore, a t-test was performed on the mean compliance per time point










Economic evaluation. Two phases of the economic evaluation were planned. Phase one would
compare the costs of implementation with the degree of behaviour change occurring. This would
help model the cost-effectiveness of national clinical effectiveness programmes to disseminate
other guidelines. For phase two, it was planned to present the data collected as a balance sheet if
the intervention demonstrated any effect. The balance sheet allows different health effects to be
weighed against each other and against net cost, thereby making explicit the choices and trade¬
offs implicit in a policy decision (196).
5.4 Results
5.4.1 Number of cases identified
Out of 7200 case notes screened, 1475 (20.5%) were identified as having had a raised DBP
reading, proteinuria or both over the study period (Table 5.3). The total number of cases
identified per maternity unit ranged from 299 to 464. The reasons for these differences are not
known but may reflect random sampling error or a combination of variations in data collectors'
abilities to detect eligible cases, availability of clinical data in the four formats of unit case
records and the true incidence of eligible cases.
When the limit of ten cases per hospital per month was applied, a total of 1263 cases were
available for detailed analysis, a mean of 35.1 cases per month with a range of 26 to 39. Table 3
shows the breakdown in the number of cases assessed by maternity unit.
Table 5.3. Number of cases identified for analysis by unit.






A 1800 379 334
B 1800 333 308
C 1800 299 281
D 1800 464 340
Total 7200 1475 1263
5.4.2 Characteristics of study sample
Table 5.4 shows the characteristics of the study sample. A total of 433 (34.3%) of women had
induced labours, ofwhich 183 (14.5%) were recorded to be indicated by hypertension. A total of
285 (22.6%) of women underwent caesarean section, of which 60 (4.8%) were recorded to be
indicated by hypertension.
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Table 5.4. Characteristics of study sample
Characteristic Number or proportion
Median age ofwomen at booking (Inter-quartile range, IQR) 28 (24-31)
Median number of previous completed pregnancies (IQR) 0(0-1)
Median number ofmiscarriages and induced abortions 0 (0-1)
Median gestation at delivery (IQR) 40 (38-40)
Proportion of induced labours (n=1263) 34.3%
- induced for hypertension 14.5%
- induced for other or unstated indications 19.8%
Proportion of caesarean sections (n=1263) 22.6%
- indicated by hypertension 4.8%
- other or unstated indications 17.8%
The study sample was assessed to detect any changes in basic demographic and clinical
characteristics over time. Appendix 5F presents tables of the number of cases, mean age at first
visit, mean parity (completed and uncompleted pregnancies), gestation, proportion with raised
diastolic episode and proportion with proteinuria episode broken down by month and maternity
unit. These data suggest no temporal trends in patient characteristics over the study period.
5.4.3 Appropriateness of initial investigation
5.4.3.1 Overall compliance
Out of a total of 1263, care was consistent with the recommendations on the initial investigation
for 757 (59.9%) of women (Table 5.5). Out of the 653 with an abnormal diastolic BP reading,
381 (58.3%) underwent appropriate initial investigation. Out of the 635 with proteinuria of + or
greater, 396 (62.4%) underwent appropriate initial investigation. Compliance ranged from 46 to
69% among the four maternity units (Table 5.6). This range may reflect true or random
variations in compliance, although it is possible that data were abstracted differently in unit D.
Table 5.5. Compliance with criteria for appropriate initial investigation.




Detection and initial investigation of 653 381 58.3
high diastolic blood pressure
Detection and initial investigation of 635 396 62.4
proteinuria
Overall compliance 1263* 757 59.9
*The total does not come to 1288 because 25 women experienced high diastolic BP
readings and proteinuria simultaneously.
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Table 5.6. Compliance with criteria for appropriate initial investigation by maternity unit.
Outcomes Number eligible Number compliant Percentage compliance
A 334 221 66.2
B 308 186 60.4
C 281 193 68.7
D 340 157 46.2
Overall compliance 1263 757 59.9
5.4.3.2 Time series analysis
Visual inspection. Figure 5.1 shows the graph of mean compliance with the diagnostic criteria,
with corresponding 95% confidence intervals broken down by month. Visually, there appears
little evidence that there was a change in level or slope for initial investigation but there is the
possibility of a downward trend in the last six months of the data. The percentage compliance
rates for initial investigation broken down by hospital and month are presented in Table 5.7.
Outliers were identified. Figure 5.6 shows that the level of compliance for initial investigation
was low for months 11 and 12. This was due to low compliance in two units (B and D) during
these months.










Table 5.7. Percentage compliance with criteria for appropriate initial investigation by month
and hospital
Month A (n=334) B (n=308) C (n=281) D(n=340) All hospitals (n=1263)
1 50 63 33 56 54
2 40 67 90 67 66
3 70 50 56 30 51
4 83 50 78 30 58
5 56 29 100 70 61
6 50 44 83 50 54
7 50 63 67 44 56
8 80 60 100 00 67
9 70 75 63 30 58
10 89 56 67 57 68
11 50 50 33 10 34
12 50 25 50 44 43
13 67 56 100 56 69
14 80 78 80 60 74
15 80 100 50 40 62
16 90 50 20 38 50
17 50 60 67 50 55
18 40 83 60 60 58
19 50 20 100 56 50
20 29 50 86 40 50
21 60 56 75 30 54
22 80 67 67 60 69
23 60 80 89 67 74
24 80 50 67 29 58
Intervention
25 90 86 71 40 71
26 70 80 60 50 66
27 50 70 67 60 62
28 80 40 89 80 72
29 80 56 56 20 53
30 78 80 100 80 83
31 60 70 100 50 68
32 70 78 70 40 64
33 56 60 67 45 54
34 80 67 30 40 53
35 90 100 67 40 71
36 56 50 56 20 45
Pre-post analysis (ignoring trend effects). The percentage compliance overall and by hospital is
shown in Table 5.8. There was a non-significant increase in the appropriateness of diagnostic
processes, with an overall increase of 5.3% (p=0.075). This analysis, however, did not take into
account possible trends in the data.
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Overall 58.1 63.4 +5.3 0.075
Unit
A 63.1 71.8 +8.7 0.140
B 56.2 68.2 + 12.0 0.054
C 68.8 68.4 -0.4 0.946
D 45.7 47.1 + 1.4 0.887
Changes in variability. To test for a possible change in the variability of the percentage
compliance point estimates per month (see visual inspection above), a t-test was performed and
Levene's test for equality of variances (pre to post) was used. There was no evidence that the
variability of the mean compliance with the diagnostic criteria changed (Levene's test: F = 0.351;
p = 0.558), i.e. clinical practice did not become more uniform following dissemination of the
guideline.
Logistic regression modelling. Table 5.9 presents the results of the logistic regression. This
indicates a non-significant increase of 10.6% in the compliance level (95% confidence interval -
0.1 to 19.3%), which decreased by 1.2% per month post intervention (95% CI -2.5 to 0.1%). The
autocorrelation and partial autocorrelation functions did not display any evidence of
autocorrelation in the series.
Table 5.9. Trends in appropriateness of initial investigation analysed by logistic regression
adjusted for the clustering per time point.
OR (95% CI) P % change (95% CI)
Slope 0.941 (0.883, 1.000) 0.058 - -
Level 1.587 (0.995,2.531) 0.053 10.6 (-0.1, 19.3)
Post slope 0.946 (0.891, 1.005) 0.073 -1.2 (-2.48,0.1)
5.4.4 Appropriateness of clinical management
5.4.4.1 Overall compliance
Sufficient data were available on 1081 cases to enable an analysis of the appropriateness of
clinical management. Overall, management was appropriate for 749 (69.3%) of cases (Table
5.10). The appropriateness of management varied according to the required level of care.
Compliance was highest (81.3%) for the 739 women categorised as requiring routine antenatal
care and lowest for the 143 requiring enhanced surveillance (17.5%). Compliance varied among
maternity units, ranging from 64.8 to 73.4% (Table 5.11).
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Table 5.10. Compliance with appropriate clinical management.




Routine care: at least two out of three 739 601 81.3
criteria met
Basic surveillance: at least three out of 43 20 46.5
four criteria met
Enhanced surveillance: at least three out 143 25 17.5
of four criteria met
Specialist care: criterion met 156 103 66
Overall compliance 1081 749 69.3
Table 5.11. Compliance with appropriate management by maternity unit.
Unit Number eligible Number compliant Percentage compliance
A 299 208 69.6
B 250 162 64.8
C 246 169 68.7
D 286 210 73.4
Overall compliance 1081 749 69.3
5.4.4.2 Explaining non-compliance
The data were explored to determine the main reasons for non-compliance with the guideline
recommendations on appropriate levels of care.
Routine care. Overall compliance with routine care was 81.3% based upon meeting at least two
out of three criteria (Table 5.12). Avoidance of unnecessary investigations was the criterion least
frequently met (69%). Serum urea and electrolytes was the most frequently conducted
inappropriate test, being carried out at least once in 91 (12.3%) women.
Table 5.12. Compliance with criteria for appropriate routine care (n=739)
Criteria and outcomes Number compliant Percentage
compliance
1 to 2 contacts within seven days 642 86.9
No in-patient admission or admission for labour 621 84.0
Avoidance of unnecessary investigations 510 69.0
All three criteria met 463 62.7
At least two out of three criteria met 601 81.3
Basic surveillance. Overall compliance with basic surveillance was 46.5% based upon meeting
at least three out of four criteria (Table 5.13). No cases met all four criteria. No women were
investigated appropriately. This was mainly because of failures to perform (or record) blood
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tests. Thirty-seven women (86%) had no serum urea and electrolytes performed, 36 (83.7%) no
serum urate, and 32 (74.4%) no platelet counts. Amongst other criteria. 9 women (20.9%) had
only one documented clinical contact within that week and eight women (18.6%) had over three
contacts.
Table 5.13. Compliance with criteria for basic surveillance (n=43).
Criteria and outcomes Number compliant Percentage
compliance
2 to 3 contacts within seven days 26 60.5
No in-patient admission or admission for labour 36 83.7
Appropriate investigations 0 0
Appropriate anti-hypertensive treatment 41 95.3
All four criteria met 0 0
At least three out of four criteria met 20 46.5
Enhanced surveillance. Overall compliance with enhanced surveillance was 17.5% based upon
meeting at least three out of four criteria (Table 5.14). No cases met all four criteria. Only one
woman (0.7%) was investigated appropriately. Again, this was mainly because of failures to
perform (or record) blood tests. Eighty-eight women (61.5%) had no serum urea and electrolytes
performed, 95 (66.4%) no serum urate, 71 (49.7%) no platelet counts, and 119 (83.2%) no liver
function tests.
Amongst other criteria, 93 women (65.1%) had less than three documented clinical contacts
within that week, and 53 (37.1%) were admitted for hypertension or another indication (except
labour). However, in 139 cases (97.2%), anti-hypertensive treatment was initiated or withheld
appropriately.
Table 5.14. Compliance with criteria for enhanced surveillance (n=143)
Criteria and outcomes Number compliant Percentage
compliance
3 to 4 contacts within seven days 41 28.7
No in-patient admission or admission for labour 90 62.9
Appropriate investigations 1 0.7
Appropriate anti-hypertensive treatment 139 97.2
All four criteria met 0 0
At least three out of four criteria met 25 17.5
Specialist care. As specialist care was outside the scope of the guideline, the only criterion to be
met was documented contact with an obstetrician. This was not met for 53 (34%) of relevant
cases.
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5.4.4.3 Time series analysis
Visual inspection. Figure 5.7 shows the graph of percentage compliance with the criteria for
appropriate management. Visually, there appears little evidence that there was a change in level
or slope. The graph does suggest a decrease in variability for management of cases as the
proportions appear closer together post- compared to pre-intervention). The compliance
percentages broken down by hospital and month are presented in Table 5.15.





13 15 17 19 21 23 25 27 29 31 33 35 37 39 41
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Table 5.15. Percentage compliance with criteria for appropriate management by month and
hospital.
Month A (n= 299) B (n= 250) C (n= 246) D (n= 286) All hospitals
(n=1081)
1 100 71 100 63 77
2 43 13 44 78 45
3 56 75 60 63 63
4 83 60 25 67 56
5 83 100 60 60 73
6 75 100 83 78 81
7 88 71 63 50 68
8 70 38 50 100 56
9 43 67 75 88 69
10 100 17 63 80 65
11 80 57 88 75 75
12 71 67 44 86 66
13 60 29 63 75 57
14 67 71 50 90 71
15 44 100 88 50 65
16 60 100 75 100 81
17 60 50 75 78 67
18 100 100 60 44 74
19 75 83 100 83 84
20 71 71 43 63 62
21 90 75 100 80 87
22 67 56 50 56 58
23 70 70 100 75 78
24 44 57 88 40 59
Intervention
25 70 71 86 33 -- 67
26 56 70 50 88 68
27 67 90 50 100 76
28 67 44 56 89 64
29 100 63 88 80 83
30 67 63 86 90 76
31 75 89 75 75 79
32 70 63 75 70 69
33 57 63 0 80 63
34 60 60 75 86 70
35 60 60 75 70 67
36 78 33 83 80 71
Pre-post analysis (ignoring trend effects). The percentage compliance overall and by hospital is
shown in Table 5.16. There was a small (3.7%) statistically non-significant change in
management, not accounting for possible trends in the data. Compliance fell by 2.3% in unit A
whilst compliance increased by 10.2% in unit D.
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Table 5.16. Pre- and post-intervention compliance with criteria for appropriate management.
Pre-intervention Post-intervention Difference P-value
compliance compliance
Overall 66.3 70.0 +3.7 0.235
Unit
A 68.4 66.1 -2.3 0.770
B 63.1 65.6 +2.5 0.789
C 66.3 71.1 +4.8 0.534
D 66.9 77.1 +10.2 0.088
Changes in variability. The variability of the mean compliance with the criteria for appropriate
management did not significantly change (Levene's test: F = 3.283; p = 0.08).
Logistic regression modelling. Table 5.17 presents the results of the logistic regression. There
was no evidence of a change in level in the appropriateness of clinical management (-0.3%; 95%
CI -8.7 to 11.2%). The autocorrelation and partial autocorrelation functions did not display any
evidence of autocorrelation in the series.
Table 5.17. Trends in appropriateness of management analysed by logistic regression
adjusted for the clustering per time point.
OR (95% CI) P % change (95% CI)
Slope 0.973 (0.926, 1.023) 0.28 - -
Level 0.968 (0.554, 1.692) 0.91 -0.3 (-8.7, 11.2)
Post slope 0.995 (0.995, 1.029) 0.65 -0.2 (-1.1,0.3)
5.4.5 Economic evaluation
5.4.5.1 Costs of the guideline strategy
The total guideline development, dissemination and implementation cost was estimated at
£66,809 (Table 5.18). The cost of guideline development was estimated at £26,142, accounting
for 40% of the total costs. The dissemination and implementation costs of £40,670 amounted to
60% of the total costs. Two-thirds (67%) of these costs were driven by the national launch
meeting.
Direct costs of staffing (time of research staff and health care professionals) and indirect costs of
staffing (costs of travel and catering) made up 85% of total costs. Other costs related to literature
search, printing and posting the questionnaire did not contribute substantially to the development,
dissemination and implementation of the guideline.
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Table 5.18. Costs of guideline development, dissemination and implementation (2001 values).
Component Resources Cost (£) Percentage of
total costs
Guideline development 26,142 40
Literature search 200 0
Development group meetings 6,416 10
Travel 1,080 2
Writing up 17,811 27
Peer review 635 1
Dissemination and
implementation













5.4.5.2 Mean costs of the guideline strategy
The guideline was valid for a period of three years and applied to all women attending a
maternity unit for antenatal care in Scotland. Alternatively, it could be argued that the guideline
was mainly relevant to women experiencing episodes of raised diastolic blood pressure or
proteinuria in Scotland. The proportion of women to whom the guideline directly applied was
taken as 20.5% (1,474 / 7,200), obtained from the case note review component of the study
reported earlier. The mean costs of the guideline strategy were estimated for these two
alternatives (i.e. all women and those to whom the guideline applied directly).
In the former case, it was assumed that approximately 155,800 women would attend a maternity
unit in Scotland over the next three years in Scotland. While in the latter situation it was
assumed that the guideline would be directly relevant to approximately 32,000 women during the
same time period. These data were combined with the total cost data presented in Table 5.19 to
provide mean costs. The mean cost of the dissemination and implementation activities was
£1695 per maternity unit in Scotland. The mean guideline strategy cost per maternity unit was
£2,784. The associated mean cost per woman attending for antenatal care was £0.43 whilst that
per woman with an episode of raised diastolic blood pressure or proteinuria was £2.09.
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Also shown in Table 5.19 is the mean cost per woman in each of the four hospitals that
contributed data to the time series analysis. It was assumed that the cost of the guideline was
evenly distributed across the 24 hospital maternity units in Scotland. The number of women in
each department was obtained from ISD Scotland. The mean cost per woman attending for
antenatal care ranged from £0.44 to £0.94. The mean cost per woman with an episode of raised
diastolic blood pressure or proteinuria ranged from £2.23 to £4.59.
Table 5.19. Mean costs of the guideline.
Guideline applies to Cost Number of
women
Cost of developing and
disseminating the guideline per
woman
All women £66809 155,800 £0.43
Women to whom the guideline £66809 32,000 £2.09
directly applied
All women (four recruiting hospitals A to D only)
A £2,784 4,208 £0.66
B £2,784 3,537 £0.79
C £2,784 6,099 £0.46
D £2,784 2,961 £0.94
Women to whom the guideline directly applied (four recruiting hospitals A to D only)
A £2,784 861 £3.23
B £2,784 724 £3.85
C £2,784 1249 £2.23
D £2,784 606 £4.59
5.5 Discussion
5.5.1 Main findings
This interrupted time series analysis assessed the impact of dissemination and implementation of
the clinical guideline, The Management ofMild, Non-proteinuric Hypertension in Pregnancy.
The guideline was directly applicable to 20.5% of women receiving antenatal care who
experience an episode of raised DBP or proteinuria after 20 weeks gestation.
The antenatal care of 1263 pregnant women experiencing an episode of raised DBP, proteinuria
or both was assessed by a review of case notes. Data were collected from four Scottish maternity
units over a total of thirty-six months (24 months pre-intervention and 12 months post-
intervention) between 1995 and 1998.
Care was consistent with the criteria for the initial investigation of raised DBP or proteinuria for
757 (59.9%) of women. Out of 653 with an abnormal diastolic BP reading, 381 (58.3%)
underwent appropriate initial investigation. Out of 635 with proteinuria, 396 (62.4%) underwent
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appropriate initial investigation. The time series analysis indicated a non-significant increase of
10.6% in the compliance level (95% confidence interval -0.1 to 19.3%), which decreased by
1.2% per month post intervention (95% CI -2.5 to 0.1%).
Sufficient data were available on 1081 women to analyse clinical management, assessed as
appropriate for 731 (67.6%). The appropriateness of management varied according to the
required level of care. Compliance was highest (81.3%) for 739 women categorised as requiring
routine antenatal care and lowest for the 143 requiring enhanced surveillance (17.5%). Women
eligible for routine care tended to be over-investigated or seen at clinics too frequently. Those
with clinical problems requiring closer surveillance tended to be under-investigated or attend
clinics too infrequently. However, in the majority of women requiring enhanced surveillance
(97.2%), anti-hypertensive treatment was initiated or withheld appropriately. There was no
evidence of a change in level in the appropriateness of clinical management (-0.3%; 95% CI -8.7
to 11.2%).
Given the lack of any significant effects, the economic evaluation focused on the costs of
guideline development, dissemination and implementation. The total cost was estimated at
£66,809. The cost of guideline development accounted for 40% of the total costs whilst
dissemination and implementation activities accounted for 60%. These costs were dominated by
the national launch meeting. The mean cost of dissemination and implementation was £1695 per
maternity unit in Scotland. For the guideline strategy, the mean cost per woman with an episode
of raised DBP or proteinuria ranged from £2.23 to £4.59 in the four study hospitals.
5.5.2 Strengths and weaknesses of study
This study design met all eight of the quality criteria for interrupted time series designs
recommended by Ramsay et al (134).
The intervention occurred independently of other changes over time. Potentially confounding
local and national events were investigated over the study period. Local clinical and audit staff
were contacted to identify relevant local activities. No relevant clinical audits were held or local
protocols introduced within the study period. An educational meeting for GPs, which covered
the mild hypertension guideline, was held in Aberdeen in November 1998. This was judged to
represent a local extension of the national dissemination strategy rather than a confounding event.
The newsletter of the RCOG was screened for relevant national meetings. Two were identified: a
meeting of the International Society for the Study of Hypertension in Pregnancy (Oxford.
September 1997); and an RCOG study day on pregnancy induced hypertension (Oxford, October
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1997). These both occurred within the intervention period. It was not possible reliably to
identify whether any clinicians from the study hospitals had attended either of these meetings. It
was judged highly unlikely that these meetings would have exerted any significant impact on
practice within the study hospitals, especially given the relatively small effects of educational
meetings (197).
The most relevant national publication over the study period was the Report of the Confidential
Enquiries into Maternal Deaths published in June 1996 - or month 16 of the time series (177).
The report highlighted the importance of detecting severe hypertensive disease and stressed the
need for early consultant involvement and local guidelines. According to Figure 1, compliance
with the criteria for initial investigation dropped slightly over month 16 and increased over the
subsequent two months. In contrast, Figure 2 shows that compliance with management criteria
peaked during month 16 and then declined. These changes could have represented random
variations and were considered unlikely to confound interpretation of any intervention effect. As
this identification was retrospective, it is possible that other events exerting significant
confounding effects were not detected.
In the absence of a control group the potential impact of trends in the management of
hypertension in pregnancy elsewhere in the UK could not be excluded. Given growing concerns
over litigation in antenatal care, it is possible that increased defensive medical practice could
have contributed to a rise (or fall) in the proportion of women managed appropriately. Any such
trends could still have been detected during the pre-intervention period but not if they occurred
afterwards.
The intervention was unlikely to affect data collection. Case identification and data collection
were retrospective. Therefore the intervention is unlikely to have affected data collection. It is
possible that documentation in case records improved following the intervention although no
improvements were detected refecting this. Such a change would have represented a benefit
from the intervention.
The primary outcomes were assessed blindly or were measured objectively. Data collection for
the case note review was not blinded but the outcomes comprised objective processes of care.
The detection of key clinical events or processes in the case notes might have varied according to
the vigilance of data collectors. Therefore, data collectors' awareness of the hypothesis that
clinical care was expected to improve following dissemination of the guideline could have
contributed to bias. However, given the complexity of interpreting such data in the assessment of
compliance, any such effects are unlikely.
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The primary outcomes were reliable or were measured objectively. As discussed above, the
outcomes comprised objective processes of care. Two problems were encountered in relation to
data collection. Firstly, clinical events and findings may have been inadequately documented in
case notes. For example, it is possible that women did receive appropriate investigations but
these were not documented or results were not adequately filed. However, given the importance
of sufficient documentation for both communication and medico-legal purposes, it was
appropriate to rely upon the presence of these data. The residual weakness lies in the possibility
that a proportion of clinical encounters in the community were not recorded or filed in the
completed case notes. Secondly, to meet with the requirement from ethical committees that only
locally employed NHS staff had access to case records, several data collectors were used. It is
possible that inter-observer variation significantly contributed to random error despite attempts to
minimise this by using objective outcome measures, and by training and offering continual
support to local data collectors.
A major problem concerned the measurement of compliance with the guideline
recommendations. It was not feasible to measure every aspect of care that potentially contributed
to the measurement of compliance. For example, much of the assessment of clinical
management was confined to the seven days following the initial detection of raised DBP or
proteinuria. In effect, the study used 'markers' or proxy measures of compliance. This was
justifiable given that the study aimed to measure professional behavioural change provided that
these measures were of sufficient sensitivity (see section 5.5.3).
The composition of the dataset at each time point covered at least 80% of the total number of
participants in the study. All sampled cases were included in the analysis of the appropriateness
of initial investigation. The analysis assessing the appropriateness of subsequent clinical
management included over 85% of the sample. The appropriateness of clinical management for
the remainder could not be judged given the lack of reliable diagnostic information. There was
no indication of any trend in the proportion of such cases missing at each time point that would
suggest case ascertainment bias.
The shape of the intervention effect was pre-specified. No data were collected over the
intervention period. Therefore, if the intervention had any effect, only an upward shift in the
intercept was expected.
A rationale for the number and spacing of data points was described. These were determined
largely on pragmatic grounds. Twenty-four monthly (2 years) pre-intervention data sampling
points were considered necessary to judge any preceding trends or seasonality in clinical
94
management. By considering 24 months, each calendar month was studied twice, thereby
allowing seasonal effects to be investigated statistically. A further twelve monthly points were
considered sufficient to assess post-intervention trends, including the decay of any intervention
effect. It seemed implausible that dissemination and implementation of the guideline would have
exerted a delayed effect 12 months or more post-intervention. Monthly data sampling points
were judged sufficiently sensitive to identify important changes in practice. Weekly or daily data
sampling points were avoided because they might have been associated with higher point-to-
point variability.
The study was analysed appropriately using time series techniques. Logistic regression
modelling, adjusted for the clustering per time point and hospital-level, was used. Although this
method does not account for auto-correlation (i.e. compliance levels between any two time points
may not be independent of one another), no evidence of auto-correlation was found when this
was investigated using the autocorrelation and partial autocorrelation functions.
5.5.3 Explanation of findings
There are several possible causes for the failure to demonstrate any significant effect of the
intervention: the study methods; the nature of the clinical guideline; and the effectiveness of the
intervention.
The study methods. Four aspects of the study methods, in addition to those highlighted above
(5.5.2), may account for the lack of effect.
Firstly, the outcome measures used may have been too insensitive to detect changes in practice.
This concern arose when the outcome measures for appropriate clinical management were
initially developed and tested. There were four broad criteria used to assess basic and enhanced
surveillance: number of clinical contacts; in-patient admissions; investigations; and anti¬
hypertensive therapy. Compliance was zero if all four criteria were applied, thereby diminishing
the ability of the time series to detect any changing trends. Therefore, 'relaxed' criteria were
applied to increase the sensitivity of the outcomes to detect change. Even when overall
compliance with appropriate management was 69.3%, no trends were detected. The lack of
effect is unlikely to be attributable to the outcome measures employed.
The second issue concerns precision of the estimates of compliance. In planning the study, it was
estimated that 40 cases per month would be sufficiently reliable. A mean of 35 cases per month
were available for the measurement of initial investigation whilst a mean of 30 cases per month
were available to measure the appropriateness of subsequent clinical management. Given the
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wide error around each data point in the time series, this study lacked sufficient precision to
detect any small to moderate changes in practice. Visual examination of the graph for
appropriate initial investigation suggests a small increase in the intercept, raising the possibility
that a small effect was not detected. However, there is little indication of any change in the
intercept or gradient for subsequent clinical management, suggesting that a larger study sample
would have been insufficient to detect a significant change.
The third issue concerns the number of data points. Following a non-significant post-
intervention increase in the appropriateness of initial investigation, there was evidence of a 1.2%
decay in compliance per month. Paradoxically, this decay could have caused an apparent
intervention effect. Decreasing compliance in the last five to six data points contributed to the
negative slope of the fitted line, hence increasing the level of effect at the intercept (start of the
post-intervention period). Hypothetically, had compliance subsequently risen again the negative
slope of the fitted line would have been reduced, thus diminishing the intervention effect.
Similar effects occurred earlier in the series; compliance decreased over months 13-19 and
increased over months 19-23. No statistical evidence was found of a seasonal pattern to explain
these trends. Without further data points (beyond 12 months post-intervention) it is not possible
to determine whether the increased post-intervention compliance for the appropriateness of initial
investigation was artefactual or real.
The final possible explanation related to study methods concerns the gap of eight months in data
collection between the pre- and post-intervention samples. This represented the intervention
period. Had data been collected over this period, it may have demonstrated a temporary increase
in compliance - related to raised awareness of the guideline. In planning this study, it was
decided to focus the limited resources available for data collection so as to detect any secular and
seasonal trends in the pre-intervention period and look for sustainable post-intervention effects.
Although temporary effects are beneficial from both clinical and economic perspectives, the
detection and monitoring of any more sustainable effects were given a higher priority.
The clinical guideline. The clinical guideline was introduced because of confusion amongst
professionals over the different categories of hypertension in pregnancy and uncertainty as to
what constituted optimal management. Whilst the guideline attempted to clarify these issues, the
management of hypertension in pregnancy remains relatively complex. For example, women can
move between different levels of care according to clinical findings and the results of
investigations. This became notably apparent during the design of the data collection instruments
and development and revisions of the outcome measures.
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The hypertension guideline was published as one of a set of four obstetric guidelines. In the
early stages of planning a time series analysis, it was intended to measure the impact of the
guideline. The Management ofPregnancy in Women with Epilepsy. This plan was abandoned
because of difficulty in obtaining relevant archive data (198). Clinician-reported practice
assessed before and after dissemination of the epilepsy guideline suggested significant
improvements in key aspects of care did occur (Chapter 4). Whilst self-reports over-estimate
actual compliance (37; 129) it is plausible that a time series, following an identical dissemination
and implementation strategy, could have detected a significant change in practice in relation to
the epilepsy guideline.
The intervention. Modest effects on care have been observed with the dissemination alone of
educational materials (197). There is evidence that the passive dissemination of national
guidelines can accelerate an existing trend in clinical practice if the overall context is hospitable,
e.g. if clinicians or patients are receptive to change (199). Although the dissemination and
implementation strategy for the hypertension guideline comprised other components, it was of a
relatively low intensity - at least as far as local activities were concerned. Its effectiveness
depended upon the actions of senior staff and existence of local mechanisms to promote
implementation. It is debatable whether the strategy would have had a greater impact in the
contemporary NHS given the advent of clinical governance and establishment of enhanced local
mechanisms to promote clinical effectiveness (70).
A further limitation of the intervention concerned the range of professionals targeted. The
guideline was intended for use by a range of professionals providing antenatal care, including
community midwives and general practitioners. The latter provide the majority of antenatal care.
However, the substantive part of the intervention targeted hospital obstetric and midwifery staff.
A wider ranging or different type of intervention might have been more appropriate (and also
more costly).
Despite some weaknesses in the study design, the most plausible explanations for the lack of
effect by the guideline strategy are probably related to the nature of the guideline topic, the
complexity of the guideline recommendations and the probable low intensity of local
implementation activities.
5.5.4 Implications for practice and policy
The guideline was directly relevant to the 20.5% of women receiving antenatal care. Confusion
over the optimal initial investigation and management of proteinuria and mild hypertension
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remained following the dissemination of the clinical guideline. It was anticipated that evidence
of inappropriate over-management would be found in women eligible for routine antenatal care.
Less expected was the extent of insufficient monitoring of women eligible for basic or enhanced
surveillance. However, anti-hypertensive treatment was initiated or withheld appropriately for
the majority of women requiring enhanced surveillance.
The clinical impact of these shortcomings in the process of care depends upon the validity of the
guideline recommendations. The guideline was developed in accordance with what was then
accepted to represent a rigorous methodology (83). Certain recommendations, such as the
avoidance of hospitalisation and the indications for anti-hypertensive therapy were allocated to
grade A: requiring at least one randomised controlled trial as part of the body of literature of
overall good quality and consistency (48). Yet little direct evidence of sufficient quality existed
to support the use and content of different levels of surveillance advocated by the guideline.
These recommendations were largely allocated as grade C: requiring evidence from expert
committee reports or opinions and/or clinical experience of respected authorities. The lack of
direct evidence presents a particular difficulty to health professionals who need to balance calls
for lower thresholds of clinical suspicion (159) against others advocating less intrusive antenatal
care (200). However, the type of focused, structured clinical care advocated by the guideline,
and optimal risk management need not be mutually exclusive.
There is a case, based upon the experience of collecting data and measuring outcomes for this
study, for re-appraising the recommendations within the guideline. This could address the
content of recommendations (e.g. the necessity of checking urine specific gravity) or their
presentation (e.g. the ease of following packages of care).
It would be premature to conclude that the method of disseminating and implementing guidelines
studied here, nationally via a clinical effectiveness programme, is ineffective. Firstly, further
evidence (e.g. from systematic reviews) is needed to judge the effects and consistency of such
approaches across a range of contexts. Secondly, the relatively low costs of more passive
methods of dissemination and implementation may justify their use. given the limited NHS
resources available to support guideline implementation and uncertainty over what constitute the
most effective strategies (197). Relatively modest effect sizes may still be sufficient to swing the
cost-benefit ratio in favour of less intensive and expensive strategies.
5.5.5 Unanswered questions and research needs
Given the growing emphasis placed upon National Service Frameworks and clinical guidelines
within the NHS, it is important to develop cost-effective means of their dissemination and
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implementation (114). National managed clinical networks or programmes focusing on specific
programmes (e.g. coronary heart disease, cancer) may provide the leadership and coordination
necessary to support local implementation (201). Time series analyses represent an appropriate
quasi-experimental method to evaluate the impact of these strategies, given the practical barriers
to randomised evaluations in such circumstances. As well as evaluating the effectiveness of
these strategies, further data are needed on their costs and on potential effect modifiers, such as
the nature of the guideline recommendations (Chapter 2).
5.6 Conclusion
This interrupted time series analysis assessed the impact of the clinical guideline, The
Management ofMild, Non-proteinuric Hypertension in Pregnancy. The intervention comprised
distribution of the guideline under the auspices of SPCERH, supported by a national launch
meeting and distribution of results of a pre-intervention audit of obstetricians' reported practice.
The appropriateness of antenatal care of 1263 pregnant women experiencing an episode of raised
DBP, proteinuria or both was assessed. Care was consistent with the recommendations on initial
investigation for 60% of women. Sufficient data were available on 1081 women to analyse
subsequent clinical management, considered appropriate for 69%. Women eligible for routine
care tended to be over-investigated or seen at clinics too frequently. Those with clinical
problems requiring closer surveillance tended to be under-managed.
A time series analysis indicated a non-significant but temporary increase in the appropriateness
of initial investigation after the intervention. No increase in the appropriateness of subsequent
management was detected. The cost of guideline development accounted for 40% of the total
costs whilst dissemination and implementation accounted for 60%. The mean cost of the
dissemination and implementation activities was £1695 per obstetric unit in Scotland.
Despite some weaknesses in the study design, the most plausible explanations for the lack of
effect by the guideline strategy were probably related to the nature of the guideline topic, the




The identification of barriers to change and tailoring of a
strategy to improve induced abortion care
6.1 Summary
Induced abortion is one of the most commonly performed gynaecological procedures. Major
variations in the quality of care among gynaecology units have been demonstrated in Scotland.
The Royal College of Obstetricians and Gynaecologists published the guideline, The Care of
Women Requesting InducedAbortion, in March 2000. This chapter describes the development of
a strategy to promote the implementation of this clinical guideline. Chapter 7 reports the cluster
randomised controlled trial undertaken to evaluate of the effectiveness of this strategy.
Compliance with guideline recommendations was measured by a review of case notes. Barriers
to and facilitators of guideline implementation were assessed as follows. Firstly, semi-structured
interviews with local lead gynaecologists identified a range of factors reported to influence the
implementation of five key guideline recommendations. Secondly, a survey, based upon
constructs from the Theory of Planned Behaviour (TPB), measured the behavioural intentions,
attitudes, subjective norms and perceived behavioural control (PBC) of staff providing abortion
care. Two key recommendations were selected for this: offer of an assessment appointment
within five days of referral; and supply of contraceptives at discharge if required. Correlations
between the psychological measures and unit compliance were assessed. Thirdly, open-ended
survey questions allowed staff to specify barriers.
Pre-intervention compliance data were available from 25 out of 26 gynaecology units for a total
of 1073 patients. These data demonstrated variations among units and scope for improvements in
care. A total of 507 case notes were reviewed for the 13 gynaecology units randomised to the
trial intervention arm and hence eligible for the assessment of barriers. Median unit compliance
was 46% for the assessment appointment and 59% for contraceptive supplies. Twelve units
participated in the identification of barriers, with 151 out of 205 questionnaires returned
completed (response rate 74%).
Lead gynaecologists reported the negative attitudes of staff in the wider organisation and limited
resources as obstacles to offering an assessment appointment within five days of referral.
According to the TPB survey, the mean behavioural intention of staff to follow this
recommendation was already high. Mean PBC was lower. Subjective norm emerged as the best
predictor of behavioural intentions (Adjusted R-squared = 0.27; p=0.001). Therefore, presenting
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the offer of an assessment appointment within five days of referral as consistent with professional
values and norms represented an appropriate approach to increasing behavioural intention. The
TPB model best explained unit compliance when PBC was added to behavioural intention
(Adjusted R-squared = 0.15; p=0.04).
Lead gynaecologists identified the availability and skills of clinical staff as important influences
on the provision of contraception at discharge. Behavioural intentions to follow this
recommendation were also high. PBC was the strongest predictor of behavioural intention
(Adjusted R-squared 0.34; p=0.03). Therefore, the most appropriate interventions may have been
those aimed at increasing PBC. The TPB model did not explain unit compliance.
This work informed the development of the strategy to promote guideline implementation. The
strategy comprised a package, deliverable by a national clinical effectiveness programme, that
included audit and feedback, educational meetings, the dissemination of a model structured case
record, and the promotion of patient information. However, clinical staff were already highly
motivated to implement the guideline recommendations but limited by organisational constraints.




6.2.1 Inappropriate variations in induced abortion care
Induced abortion is one of the most commonly performed gynaecological procedures, with over
12.000 annually in Scotland (202). Despite preventive measures, the number of abortions is
rising, with women aged under-20 accounting for 24% of the total in 1998. The Gynaecology-
Audit Project in Scotland (GAPS) previously demonstrated major deficiencies in the quality of
care among hospitals (203). For example, access to abortion services was inequitable, with
barely half of women requesting abortion receiving an assessment appointment within five days
of referral. The use of evidence-based interventions (e.g. screening for infections) to reduce the
risk of complications was low. Despite improvements following the GAPS audit and feedback
exercise, inappropriate variations in care persisted. Such variations became increasingly difficult
to justify given an evolving evidence base and clinical governance. For example, in 1999 the
proportion of abortions undertaken at less than 10 weeks gestation ranged across health boards
from 76% down to 37% (202).
The Royal College of Obstetricians and Gynaecologists (RCOG) guideline, The Care ofWomen
Requesting Induced Abortion, was published in March 2000 (51). It was developed in response
to such concerns. The guideline promoted equitable access to services, the use of more effective
interventions and improved communication with women. The guideline was developed by a
multidisciplinary group according to rigorous criteria, including explicit methods of appraising
and grading evidence (83). Recognising the importance of patient perspectives in judging the
relevance of research, the Guideline Development Group included service user representatives
from the Birth Control Trust and the RCOG Consumer Forum.
6.2.2 Selection of strategies to promote guideline implementation
The use of valid guidelines can improve clinical practice, especially if effective dissemination
and implementation strategies are used (58). Yet systematic reviews indicate that few
interventions to change professional and organisational practice work consistently across all
circumstances (Chapter 1.4.2) (197). It has been suggested that implementation strategies should
be based upon identified needs and barriers, allowing more rational selection or tailoring of
interventions (55; 100; 145; 170;204).
A systematic review of the effectiveness of continuing medical education found that 28 out of
160 comparisons evaluated targeted specific barriers or incorporated the use of a gap analysis
technique (such as audits to determine sub-optimal performance) to tailor interventions (55).
Such interventions were associated with higher rates of success. Although intuitively attractive,
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there is little empirical evidence on the most appropriate methods of identifying needs and
barriers (205) and the subsequent effectiveness of tailored strategies is uncertain (206).
6.2.3 Methods of identifying needs and barriers
It is often not known what factors are important in the relative success or failure of reported
implementation strategies because of the lack of a common conceptual framework.
Implementation studies require such a framework within which to describe common elements of
settings, individuals, targeted behaviours, and interventions (207). Hence, it should be possible
to identify what features influence the effectiveness of interventions. Various frameworks have
been used to describe factors that may promote or hinder the implementation of guidelines, thus
informing a 'diagnostic analysis' (15-18;39;100). In Chapter 1, barriers were considered (largely
on pragmatic grounds) under the headings of the guideline recommendations, the characteristics
of individual professionals, and the wider organisational context. A range of methods is
available to identify such factors, including surveys, interviews, group interviews and direct
observation. The combination of in-depth interviews with key informants to identify barriers and
facilitators followed by large scale surveys to measure the extent of these factors amongst (say)
clinical staff has been suggested as the most useful approach (205;208).
6.2.4 Identification of barriers within other intervention studies
A non-systematic sample of randomised trials of tailored interventions was identified from the
reference list of a recent study of a tailored intervention (209). These six studies and the recent
trial by Flottorp et al were appraised. Two of the seven studies provided no information on how
barriers were identified (Table 6.1, possibly because of journal restrictions on word counts)
(210;211). Methods described in other randomised evaluations include elucidation and
discussion at focus groups (212), consensus meetings for local opinion leaders (213), small group
educational meetings for targeted participants (214;215). Baker et al provide a more
comprehensive account of the investigation of barriers (216). In-depth interviews with study
participants were recorded and transcribed before analysis by researchers. The detail of
descriptions given within individual studies is highly variable, thereby hindering interpretation
and reproducibility.
Table 6.1 also summarises barriers identified in previous evaluations of tailored interventions.
Identified barriers were not described in two reports (210;211). The other reports demonstrate
the importance of organisational factors. The potential roles of individual clinician beliefs and
attitudes is highlighted in three of the primary care studies, possibly because the guidelines


















































































































































































































































































6.2.5 Application of behavioural change theories
Theoretical models of change can be used to understand the behaviour of both health
professionals and organisations (105; 170). It is uncertain as to what degree previous intervention
studies have explicitly and prospectively used behavioural change theory to assess barriers and
tailor interventions. This question is currently being addressed by a systematic review (P Davies.
personal communication).
Only one of the above studies explicitly drew upon behavioural theory to tailor the interventions
(216). A selection of theories was used to interpret observed performance and interviews of
general practitioners and guide the selection or tailoring of particular interventions. However, the
validity of these theories in predicting or explaining behaviour was not tested.
Elsewhere, a recent large-scale audit of compliance with evidence-based recommendations in
obstetrics assessed factors, albeit mainly retrospectively, that influenced their implementation
(217). Investigators interviewed managers and clinicians to measure to what degree they had
moved along the continuum of the 'theory of implementation intentions' (218). This theory
suggests that behaviour change is determined by the strength of intentions (or motivation) and to
what degree steps have been taken to plan or implement change. Marked changes in practice
were identified by the obstetric audit but these changes were not associated with the degree of
planning reported by clinicians and managers.
6.2.6 The Theory of Planned Behaviour (TPB)
Motivational theories propose that motivation is a key determinant of behaviour, and therefore
the best predictors of behaviour are factors that predict behavioural intention (or motivation).
Motivational theories have been widely used in health promotion research to understand
individual differences in health behaviours (e.g. exercise, condom use)(219). The theory of
planned behaviour (TPB) is a motivational theory which proposes that individual behaviour is
determined by intentions towards that behaviour (220) (Figure 6.1). The strength of a
behavioural intention is determined by three variables:
• Attitudes towards the behaviour, arising from a combination of beliefs about its
consequences and evaluations of those consequences
• Subjective norms based on the perceived views of other individuals or groups (i.e. perceived
social pressure)
• Perceived behavioural control, encompassing beliefs about self-efficacy (the ability to
perform an action) and wider environmental factors that facilitate or inhibit performance.
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Perceived behavioural control can also directly influence behaviour. The TPB model can be used
both to explain or understand behaviour and to plan interventions to change behaviour.
Interventions designed to strengthen or modify beliefs most strongly associated with behavioural
intentions are expected to be the most effective in changing behaviour. In this way, TPB can
inform the selection or tailoring of interventions to change clinical practice.
The application of TPB to understanding clinicians' adherence to evidence-based advice about
their practice has been limited. However, early studies suggest that it is a useful, systematic tool
to identify barriers to and facilitators of change and hence appropriate forms of intervention (221-
224).
6.2.7 Scope of this Chapter
A strategy to promote implementation of the RCOG guideline. The Care of Women Requesting
Induced Abortion, was developed and tested within a cluster randomised controlled trial: The
Improving Abortion Care Trial (ImpACT). This chapter describes the combination of pragmatic
and theoretically-based approaches used to identify factors that helped or hindered
implementation of the guideline, and thereby inform the development of the ImpACT strategy.
This process is set out largely in chronological order as follows:
• Early development of the strategy
• Measurement of pre-intervention compliance
• Methods used to identify potential barriers to and facilitators of implementation
• Factors identified as influencing compliance with the guideline
• Later development of the strategy
• Strengths and weaknesses of this work and implications for the implementation strategy
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6.3 Methods
6.3.1 Context and early development of the strategy
This study took place within the intervention arm of ImpACT, fully described in Chapter 7. In
brief, all RCOG fellows and members received identical printed guideline summaries. Half of
the 26 gynaecology units in Scotland were randomised to the intervention whilst the other half
acted as controls.
A provisional implementation strategy was developed for the original funding proposal to the
Chief Scientist Office (CSO) (Table 6.2). The use of a multi-faceted strategy was favoured for
two reasons. Firstly, available evidence then suggested that combinations of interventions were
more effective than single interventions (102). Secondly, combining interventions would permit
more than one barrier to be addressed (39;204). The content of the strategy was determined by
what could feasibly be delivered under the auspices of a national clinical effectiveness
programme (SPCERH). The methods of assessing factors that would influence guideline
implementation were considered as potential co-interventions and limited to the intervention arm.
Table 6.2. Provisionally identified components of the intervention strategy.
Component Rationale
Audit and feedback using pre-intervention data on Demonstration of any differences between
performance at unit level perceived and actual practice; stimulation of
discussion as to what further barriers exist and
means of overcoming them locally
Improved understanding of both the costs and
benefits associated with the guideline
recommendations (e.g. effectiveness and safety
issues); development of generic skills in
interpreting clinical evidence
Provision of structured case sheet for insertion Reduction of errors of omission by maintaining
into notes ofwomen undergoing abortion awareness of guidelines at time of patient contact
and prompting appropriate actions; detailing of
more complex recommendations (e.g. drug
regimens)
6.3.2 Pre-intervention compliance
A pre-intervention case note review was undertaken to assess compliance for three reasons.
Firstly, it provided baseline data on performance for an audit and feedback component of the
implementation strategy. Secondly, it provided measures of actual clinical behaviour to inform
the analysis of the TPB survey. Thirdly, these data enabled randomisation of pairs of
gynaecology units matched by pre-intervention performance. This third reason and the methods
of the case note review are fully described in Chapter 7.
Critical appraisal training focusing on evidence
relating to induced abortion
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In brief, women undergoing induced abortion over a three month period were identified from
ward admission books and fifty were randomly selected for a structured case note review to
measure compliance with the RCOG guideline recommendations. All cases were reviewed in
smaller units where 50 or fewer women underwent abortions during this period. Trained data
collectors used a structured form to extract relevant clinical details. Data were entered onto an
Access database (165) and analysed using SPSS (166).
6.3.3 Semi-structured interviews with lead gynaecologists
Semi-structured interviews were conducted with a lead gynaecologist in each intervention unit to
identify barriers to and facilitators of implementing the induced abortion guideline. Clinical
directors nominated the lead gynaecologists, usually selected because of their involvement in
organising abortion care. A framework comprising factors related to the recommendations, to the
health professionals and to the organisation was used, based upon an earlier literature review and
experiences from SPCERH work (21).
Questions were based around the guideline recommendations selected as five key outcomes for
ImpACT (see 7.3.6):
• Ideally, all women are offered an assessment appointment within five days of referral
• Assessment prior to induced abortion may be viewed as an opportunity to ascertain each
woman's cervical cytology history
• Abortion care should encompass a strategy for minimising the risk of post abortion infective
morbidity
• Misoprostol is a cost-effective alternative to gemeprost (early medical abortion, cervical
priming, mid-trimester medical abortion)
• Contraceptive supplies should have been offered if required. The chosen method of
contraception should be initiated immediately following abortion
A list of anticipated barriers and facilitators was drawn up for each recommendation, (illustrated
for the offer of an assessment appointment in Table 6.3). All lead consultants were sent a letter,
outlining the purpose of the interviews, what recommendations would be covered and general
examples of factors that might influence adherence to guideline recommendations. Preliminary
results of the pre-intervention case note review were fed back at the start of each interview.
Interviewees were asked what factors they thought influenced compliance with each
recommendation (see Appendix 6A for schedule). Otherwise, minimal prompting was used. The
interviewer (RF) used a checklist of specific anticipated barriers and facilitators - not seen by the
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interviewees - to minimise time spent writing notes. Following this, the planned trial
interventions were outlined and the format and content of the educational meetings negotiated.
Table 6.3. Illustration of anticipated barriers and facilitators.
Offer of appointment with a
gynaecologist within five days
of referral





Lack of evidence supporting
recommendation
Individualfactors Women seeking abortion seen
as high priority






Delay mainly caused by referrer




No limits on clinic
appointments; or sufficient
capacity
Coping with fluctuations in
demand or supply
6.3.4 Development of TPB questionnaire
6.3.4.1 Questionnaire design and procedure
The questionnaire (Appendix 6B) focused on two of the five key guideline recommendations:
• Ideally, all women requesting abortion are offered an assessment appointment within five
days of referral.
• Before she is discharged following abortion, contraceptive supplies should have been offered
if required. The chosen method of contraception should be initiated immediately following
abortion.
These recommendations were selected for two reasons. Firstly, the pre-intervention case note
review indicated the existence of variations in care and potential for improved compliance.
Secondly, individual professionals' control over following the recommendations was likely to
differ, and was anticipated to be greater for the offer of contraception supplies at discharge.
The number of guideline recommendations assessed was restricted to two because the
acceptability of the questionnaire to clinical staff was unknown. A draft questionnaire was
produced. It was anticipated that the response rate would be enhanced if professionals
understood the purpose and format of the questionnaire. Therefore, the questionnaire was
preceded by a brief explanatory note and headings used throughout to guide respondents. More
colloquial terms were used to describe psychological measures, i.e. 'motivation' was substituted
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for 'behavioural intentions', 'social pressure" for 'subjective norms', and 'ability' for "perceived
behaviour control". Wording of the items and the extreme labels were varied in direction to
reduce the likelihood of response set. All of the items measuring psychological variables were
rated on 7-point scales (1-7) with the extremes labelled according to the nature of each question.
Measures of the TPB constructs used scales and items recommended by Ajzen (220) and Connor
and Sparks (219).
It was recognised that staff had varying degrees of control over offering appointments or
contraception and that these factors could influence how much control they had over following
the recommendations. This was assessed by a closed question for each recommendation. The
first asked whether a centralised referral service existed for abortions. The second asked who
was responsible for providing contraception at discharge.
The draft questionnaire was piloted on three consultant gynaecologists, two specialist registrars
and two staff nurses. These respondents answered six additional questions on the acceptability of
the questionnaire. Following this, it became apparent that some respondents had become
confused by the variation in direction of the extreme labels. The wording of the items and the
extreme labels were varied less in the definitive version as some degree of response set was
judged less detrimental to the interpretation of findings than confusion caused by varying the
direction of the labels. Otherwise, the pre-tested respondents took 5 to 10 minutes to complete
the questionnaire, and found it easy to understand, relatively easy to complete and acceptable.
Some minor changes were made to the wording of items and the definitive questionnaire
contained 30 questions.
6.3.4.2 Dependent variables
Behavioural intention. Intentions to follow the recommendations were measured by responses to
a given scenario. For the first recommendation, it was: 'Next week, a woman is referred to your
clinical teams by her GP requesting abortion'. Three items measured intentions: 'I intend to offer
this woman an assessment appointment with five days of referral'; 'I want to offer this woman an
assessment appointment with five days of referral'; and T plan to offer this woman an assessment
appointment with five days of referral'. The response items consisted of 7-point scales labelled
'definitely do not - definitely do' with higher scores indicating stronger intentions.
For the second recommendation, the scenario was: 'Next week, a woman is being discharged
from your unit following suction termination of pregnancy. She has indicated her wish to use the
oral contraceptive pill but has not already been given supplies from any source.' The response
stems and items were worded similarly to the first recommendation.
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Behavioural intention was also analysed as an independent variable in the prediction of unit
compliance.
Compliance with the recommendations. Data on individual professional performance were not
available from the case note review. It was therefore planned to ask respondents about their own
behaviour, e.g. how many women they had supplied contraception for in the preceding month.
However, these questions were dropped following pre-testing as respondents found this difficult
to estimate. Therefore unit compliance - as measured by the pre-intervention case note review -
was used as a proxy measure for individual behaviour.
6.3.4.3 Independent variables
Attitude. Several of the beliefs underpinning attitudes towards both recommendations were
identified during the course of the interviews with lead gynaecologists. For example, it was
suggested that some professionals consider it is unfair that women requesting abortion should be
managed as a priority over other patient groups. The mean of four bipolar items assessing
attitudes towards the offer of an assessment appointment within five days was used as an attitude
measure for this recommendation. The stem read, 'Overall, I think that offering this woman an
assessment appointment within five days of referral would be...' The response items consisted
of four 7-point scales labelled 'bad practice - good practice', 'harmful to her - beneficial to her',
'the wrong thing to do - the right thing to do', and 'unfair to women awaiting appointments for
other reasons - fair'.
Similarly, the stem for the other recommendation read, 'Overall, I think that providing
contraceptive supplies to this woman prior to discharge would be...' The response items
consisted of four 7-point scales labelled as before except that the response on fairness was
substituted by, 'a waste of time - a good use of time'.
Subjective norm. The mean of three bipolar items was used to assess subjective norms towards
each recommendation. Different groups might be expected to approve or disapprove of
following the recommendations. These were professional colleagues, professional bodies (the
RCOG, the Royal College of Midwives, or the Royal College of Nursing) and other people
important to the professionals. For each of these three groups, respondents rated 7-point items
indicating the degree to which following the recommendation would be definitely approved or
disapproved.
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Perceived behavioural control fPBCj. Five control items were included for each
recommendation. Regarding the offer of an assessment appointment within 5 days of referral,
high scores on a 7-point scale indicated stronger perceived behavioural control for four items.
These comprised: offering this woman an assessment appointment is difficult / easy; the
likelihood of being able to offer an appointment is very unlikely / very likely; confident in ability
to offer assessment appointment (strongly disagree / strongly agree); and control over whether or
not to offer appointment (no control / complete control). Lower scores indicated stronger control
for the other item: factors outside control that prevent offer of appointment (strongly disagree /
strongly agree). Regarding contraception at discharge, the items were worded and scored
similarly except that lower scores also indicated stronger control for the item: control over
whether or not to offer contraceptive supplies (complete control / no control). For questionnaire
items where lower scores indicated stronger control, the scores were subsequently reversed on
analysis.
6.3.4.4 Specific influences on behaviour
Brief open-ended questions asked what factors helped or hindered following the
recommendations.
6.3.5 Survey sample and administration
The lead gynaecologists identified medical, midwifery and nursing staff involved in abortion care
at their units. The questionnaires were posted to these staff along with a brief explanation about
the purpose of the survey. A reminder was sent to non-responders three weeks later.
6.3.6 Analysis
Semi-structured interviews. Responses were collated and categorised under specific barriers and
facilitators listed in the interview schedule. New barriers and facilitators were added as required.
TPB survey. Survey data were entered into an Access database (165) and analysed using SPSS
(166). Summary measures for each of the four psychological variables (behavioural intention,
attitude, subjective norm, and PBC) were calculated from the means of the contributing items.
The correlations between behavioural intention and the other three psychological measures were
analysed using Pearson's correlation coefficient.
The analysis accounted for clustering effects, whereby individual professionals within
gynaecology units were more likely to respond in a similar manner. The intra-cluster correlation
(ICC) measures the degree of this intra-cluster dependence (125). Failure to account for
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clustering effects can lead to the over-estimation of the significance of results (152). Regression
analysis using robust standard errors to adjust for clustering within hospital respondents was used
to test for the strength of the relationship between behavioural intention, PBC and pre-
intervention compliance. As there was some evidence of skewness in the responses to some
behavioural measures, statistical analyses were repeated using non-parametric tests wherever
possible.
An interim analysis was undertaken when 116 questionnaires had been returned. This was
necessary if the TPB survey findings were to inform the later development of the intervention.
This analysis differed from the final analysis (reported here) in two ways. Firstly, it did not
account for clustering effects. Secondly, the interim analysis used categorical classifications of
pre-intervention compliance to assess associations with the psychological variables. This
approach substantially reduced statistical power to detect differences in levels of compliance.
In the analysis of the open-ended questions, more than one response was allowed for each
respondent. A content analysis of factors that helped or hindered following the recommendations
was undertaken (225). Two researchers (RF and GP) independently categorised the verbatim
open-ended responses according to which component of a framework of barriers and facilitators
they most closely fitted. The framework was piloted and modified. The final categories
comprised: attitudes; subjective norms; and perceived behavioural control (self-efficacy,
organisational and environmental). The responses were categorised blind to the gynaecology unit
and grade of respondent, in case knowledge of these variables biased categorisation. A third
researcher (AW) arbitrated where the first two disagreed over categorisations. Any
disagreements were resolved by consensus.
6.4 Results
6.4.1 Pre-intervention case note review
6.4.1.1 Number of cases identified
A total of 1073 cases was identified by 25 units (Table 6.4). No cases were identified by Unit Z,
based in a small, rural hospital. A total of 507 case notes (range 8 to 50) was reviewed for the 13
gynaecology units (A to M) randomly allocated to the intervention and hence to assessment of
barriers to guideline implementation.
113
Table 6.4. Number of cases identified by each unit for pre-intervention case note review.




























6.4.1.2 Compliance with guideline recommendations
Tables 6.5 to 6.9 summarise the results of the pre-intervention case note review. These findings
formed the basis of the baseline audit data fed back to the thirteen gynaecology units randomly
allocated to the intervention arm. The baseline audit report presented detailed findings (appendix
6C). Brief commentaries on the findings for the primary outcome recommendations which were
later discussed with the lead gynaecologists are included in section 6.4.2.2.
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Table 6.5. Compliance with recommendations on organisation of services.












Ideally, all women are offered an assessment
appointment within five days of referral
(primary outcome)
1041 403 45.8 19.5, 53.1
As a minimum standard, all women are
offered an assessment appointment within
two weeks of referral
1041 924 91.8 78.9,97.8
Ideally, all women can undergo the abortion
within seven days of the decision to proceed
being agreed
1054 889 87.5 76.3, 93.4
As a minimum standard, all women can
undergo the abortion within two weeks of the
decision to proceed being agreed
1054 1019 97.9 95.7, 100
As a minimum standard, no individual
woman need wait longer than three weeks
from her initial referral to the time of her
abortion
1042 949 91.7 84.7,97.0
In the absence of specific medical, social or
geographical contra-indications, induced
abortion may be managed on a day-case basis
1064 998 95.8 90.0, 100
Table 6.6. Compliance with recommendations on pre-abortion management.












Pre-abortion assessment should include
appropriate blood tests
1073 967 97.9 92.7, 100
It is not cost-effective routinely to cross¬
match women undergoing termination of
pregnancy
1073 1064 100 98.0, 100
Assessment prior to induced abortion may be
viewed as an opportunity to ascertain each
woman's cervical cytology history (primary
outcome)
776 413 57.9 20.2, 85.3
Women who have not had a smear within the
interval recommended in their local
programme may be offered a smear taken
opportunistically
413 304 75.0 61.4, 85.1
Ultrasound scanning is not considered to be
an essential prerequisite of abortion in all
cases
1073 385 11.1 2.1,76.5
Abortion care should encompass a strategy
for minimising the risk of post abortion
infective morbidity (primary outcome)
1073 1010 100 93.6, 100
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Table 6.7. Compliance with recommendations on abortion procedures.












Medical abortion is an appropriate method at
gestations of <7 weeks / Conventional
suction termination should be avoided at <7
weeks
132 111 89.2 45.8, 100
For early medical abortion, a dose of 200mg
ofmifepristone, in combination with a
prostaglandin is adequate
354 324 100 100, 100
Use of conventional suction termination at
gestations of 7-15 weeks if appropriate or
preferred
918 587 62.5 42.5, 89.4
For women presenting between 7-15 weeks'
gestation, suction termination may be safer
under local anaesthesia than under general
anaesthesia
587 2 0
Misoprostol is a cost-effective alternative for
gemeprost (early and mid-trimester medical
abortion, and cervical priming; primary
outcome)
1069 943 100 84.0, 100
Cervical preparation is beneficial prior to
suction termination and should be routine if
the woman is aged under 18 years or at a
gestation of > 10 weeks
164 158 100 100, 100
For mid-trimester medical abortion, a dose of
200mg ofmifepristone is adequate
65 65 100 100, 100
Surgical evacuation of the uterus is not
required routinely following mid-trimester
medical abortion
65 62 100 100, 100
Mid-trimester abortion by dilatation &
evacuation (D&E), preceded by cervical
preparation, is safe and effective when
undertaken by specialist practitioners*
0 0 0
For women presenting at greater than 15
weeks' gestation, as an alternative to D & E,
services may prefer to offer medical abortion
23 23 100 100, 100
"Denominator based upon surgical abortions.
Table 6.8. Compliance with recommendations on managing complications of abortion.
















In cases of suspected uterine perforation 2 2
laparoscopy is the investigation of choice
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Table 6.9. Compliance with recommendations on after care.









Anti-D IgG should be given to all non- 194 182 100 89.4, 100
sensitised RhD negative women following
abortion
A follow-up appointment (either within the
abortion service or with the referring
1073 255 10.2 2.5, 35.6
clinician) within two weeks of the procedure
should be offered to each patient following
abortion
Before she is discharged following abortion,
future contraception should have been
discussed with each patient
1073 979 96.0 82.5, 100
Contraceptive supplies should have been
offered if required. The chosen method of
contraception should be initiated immediately
following abortion (primary outcome)
1073 752 74.5 49.5,90.8
Sterilisation can safely be performed at the
time of induced abortion. However combined
1073 1057 100 97.0, 100
procedures are associated with higher rates of
failure and of regret
It is safe and effective to insert an IUCD for 1073 117 8.0 4.0, 16.3
contraceptive use immediately following
induced abortion
6.4.2 Semi-structured interviews with lead gynaecologists
6.4.2.1 Response rate
Twelve out of thirteen lead gynaecologists agreed to the semi-structured interviews. An
interview could not be arranged with the thirteenth consultant (from unit C) within the available
time frame. Consequently, no staffwere identified from this unit for the staff survey.
6.4.2.2 Barriers and facilitators identified
The following issues were identified by lead gynaecologists as influencing compliance with each
of five key recommendations (see Appendix 6D for detailed results).
Offer of an assessment appointment within five days. Median unit compliance with this
recommendation was 45.8% [Interquartile range (IQR) 19.5-53.1%]. Median unit compliance in
the intervention arm was 45.8% (IQR 19.3 - 56.9%). Most of the factors reported as influencing
compliance with this recommendation were of an organisational nature. Factors that hindered
implementation included problems coping with acute fluctuations in demand or supply (e.g.
colleagues on leave, theatre list spaces, raised by 9 interviewees), more chronic shortages of
space, facilities and staff (6) and insufficient resources to improve the referral system (3). In one
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health board area served by unit D and two other units, there were historical problems in
managing demand. Despite the existence of a centralised referral service, some GPs could get
patients seen earlier if they by-passed this system. In other units, such as F, there was a
reluctance to increase throughput within dedicated clinics because reduced appointment times
might compromise proper counselling and other aspects of care.
Factors mentioned that facilitated implementation included the existence of a telephone referral
system (raised by 9 interviewees), one person having responsibility for coordinating clinic
appointments (5), and maintaining sufficient clinic capacity to manage fluctuations in demand
(4). In two units, reminder letters were routinely sent to GPs who referred by letter rather than by
telephone.
Individual factors also influenced service delivery. In six units, women seeking induced abortion
care were seen as a high priority - usually by the lead consultant. However, five interviewees
reported that other colleagues partially or not involved in providing abortion care assigned a
lower priority to this client group compared with (say) women requiring investigation for
potential malignancy. Three interviewees suggested that an increasing proportion of junior
medical staff were opting out of providing abortion care, thus placing a greater amount of
workload on the remainder.
Ascertainment of cervical cytology history. Median unit compliance was 57.9% (IQR 20.2 -
85.3%). More factors reported as influencing compliance centred around the recommendation
itself. Doubts were expressed about the appropriateness of gynaecology units 'interfering' with a
primary care-led screening programme (3), especially given the increased uptake of the
programme in the community (2). However, two interviewees reported that a high priority was
given to this aspect of care. Checking cervical smear status was easier to follow if it fitted in
with routines, e.g. performing vaginal examinations in the clinic (2).
Individual factors appeared to act predominantly as barriers. Reasons suggested for low
compliance included accidental omission from history taking (4) and failure to record history
taking (4). Organisational factors mainly promoted adherence, especially where cervical
cytology history taking was an established norm (4) or structured case notes were available (3).
Antibiotic prophylaxis or screening for lower genital tract organisms. Median unit compliance
was 100% (IQR 93.6 - 100%). This recommendation had become the expected local norm in ten
units, with seven leads reporting the availability of local guidelines or protocols. These
organisational factors were supported by views about the recommendation itself, which was
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perceived as being supported by convincing evidence (3). disseminated by credible bodies such
as the RCOG or SIGN (3) and effective in reducing post-abortion complications (2) in a high risk
population (2). A minority of colleagues was reported as having more negative attitudes because
of concerns over acceptability of screening to patients (2) and disruption to routine care (2). One
lead gynaecologist directly mentioned (and others alluded to) the increased costs associated with
using more effective regimens.
Misoprostol as a cost-effective alternative to gemeprost. Median unit compliance was 100%
(IQR 84 - 100%). This recommendation was widely supported by a range of recommendation-
specific, individual and organisational factors. A convincing evidence base (4) was supported by
a credible professional body, such as the RCOG (3). Using misoprostol offered distinct
advantages over gemeprost, including fewer side-effects (3) and greater ease of storage (2).
Cost-effectiveness was acknowledged as a priority by ten interviewees. The recommendation
had often become an expected local norm (5), and was covered by local protocols or structured
case sheets.
Four interviewees reported that several colleagues and pharmacists objected to the use of
misoprostol tablets for abortion procedures by the vaginal route as this constitutes an unlicensed
indication and an unlicensed route of administration. The guideline, however, states that the 'EC
Pharmaceutical Directive 65/65/EEC specifically permits doctors to use licensed medicines for
indications or in doses or by routes of administration outside the recommendations given in the
licence.'(51) In unit G, the lead gynaecologist remained sceptical over purported benefits and
planned to audit the introduction of misoprostol. Misoprostol was also unsuitable for cervical
priming within the unit's 'fast track' abortion service.
Offer of contraceptive supplies if required at discharge. Median unit compliance was 74.5%
(IQR 49.5 - 90.8%). Median unit compliance in the intervention arm was 58.6% (IQR 49.5 -
93.9%). Compliance was reported as being largely related to individual or organisational factors.
Seven interviewees assigned a high priority to the provision of contraception at discharge.
Whilst low compliance was sometimes explained by inconsistent recording in the case notes (3)
or accidental omission (1), others saw provision as more of a priority for community services (1)
or expressed uncertainty about the purported benefits of an active policy (1).
Organisational factors promoting the provision of contraception included the availability of a
range of methods to offer women (7), its inclusion in unit guidelines or protocols (6), the
availability of nursing staff trained in family planning (4), and a shared perception amongst staff
that contraception was a priority (4). Good relations with or a close proximity to pharmacy
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departments also helped (2). The absence of these factors reportedly had a detrimental effect, e.g.
lack of choice of methods (4), shortages of appropriately trained staff (3). delays in obtaining
supplies from pharmacies (2). or lack of a unit protocol (1). In unit E. there was an on-going
dialogue with the pharmacy department over the legality of providing unlabelled supplies for
storage on the ward.
6.4.3 Survey of clinical staff
Findings from the final analysis are presented below. Any major differences from the interim
analysis are highlighted.
6.4.3.1 Response rate
Of 205 questionnaires sent, 116 (56%) questionnaires were returned in time for the interim
analysis (Appendix 6E). Later, 151 (74%) had been returned for the definitive analysis (Tables
6.10 & 6.11). Two respondents had removed the gynaecology unit code from their
questionnaires; their data could not be used in the subsequent analyses related to unit compliance.
Response rates varied among grades of staff and disciplines, ranging from 100% for staff grade
gynaecologists to 51% for senior house officers.
Table 6.10. Response rates to staff survey by discipline and grade.






Consultants 43 38 88
Staff Grades 5 5 100
Specialist Registrars 31 21 65
SHOs 45 23 51
Nursing and midwifery sisters 23 17 74
Staff midwives and nurses 58 43 74
Total 205 147 72
*Excludes four responses where grade unknown
120
Table 6.11. Response rates to staff survey by gynaecology unit.
Gynaecology unit Number of recipients Number completing Response rate (%)
questionnaires
A 6 6 100
B 18 16 89
C - - -
D 15 12 80
E 8 8 89
F 31 25 81
G 22 14 64
H 14 11 79
I 14 11 79
J 18 12 67
K 23 14 56
L 8 4 50
M 28 16 60
Total 205 149 73
6.4.3.2 Reported organisation of services
Offer of an assessment appointment. Staff were asked whether patients were referred to their
units via a centralised referral system. The presence or absence of such a system might influence
their ability to offer an assessment appointment within five days. There was uncertainty about
the existence of local referral systems in the majority of gynaecology units (Table 6.12).
Table 6.12. Staff awareness of a centralised referral system (n=144).
Gynaecology unit Patients referred via a centralised referral system
No Not sure Yes
A 3 2 1
B 2 1 12
C - - -
D 0 1 10
E 2 0 6
F 4 8 11
G 6 3 4
H 4 2 5
1 1 *>5 7
J 6 i 5
K 0 i 12
L 3 0 1
M 6 2 7
Not stated 0 0 2
Total 37 24 83
Total % 26 17 58
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Provision of contraception. Similarly, staff were asked who usually provided contraception at
discharge in their units. The responses to this question also varied among staff from the same
hospital, suggesting confusion over responsibility for the provision of contraception (Table 6.13).
Table 6.13. Staff awareness of who usually provides contraception at discharge (n=144).











A 0 4 1 0 1
B 0 0 0 12 4
C - - - - -
D 0 0 0 7 4
E 0 2 0 0 5
F 1 o 0 7 11
G 0 1 0 6 6
H 1 0 0 1 9
I 0 0 1 3 7
J 0 0 3 7 2
K 0 0 4 4 5
L 0 1 2 0 1
M 1 0 0 6 9
Not stated 0 0 0 0 2
Total oJ 11 11 53 66
Total % 2 8 8 37 46
6.4.3.3 Pre-intervention compliance by unit
Pre-intervention data were used to measure compliance for the two key recommendations.
Gynaecology units were initially divided into three groups: lower compliance within the lowest
quartile; moderate compliance within the second or third quartile; and higher compliance within
in the fourth quartile (Tables 6.14 & 6.15). Whilst this illustrates the spread of compliance
among gynaecology units, there are problems with this categorical division of data. There is
substantially reduced statistical power to detect differences across these groups and there is no
evidence that there are three distinct groups, rather there is a continuum of compliance (i.e. it is a
continuous measure)(226). The final analysis therefore evaluated the correlation between unit
pre-intervention compliance and psychological variables.
Table 6.14. Pre-intervention unit compliance with assessment appointment within five days
of referral.
Compliance Units Respondents
Lower (= or < 21%) OJ 49
Moderate (21 - 53%) 6 64
Higher (>53%) 3 36
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Table 6.15. Pre-intervention unit compliance with offer of contraceptive supplies at
discharge.
Compliance Units Respondents
Lower (< 49%) 3 42
Moderate (49 - 94%) 6 76
Higher (>94%) 3 31
6.4.3.4 Psychological variables
Psychological variables. Scores on the four measures calculated for each of the two
recommendations (behavioural intention; attitude; subjective norm; and PBC) are shown in Table
6.16. Respondent agreement with each of the four psychological variables was measured on a
scale of 1 to 7. Higher scores indicate a stronger intention to perform the behaviour, a more
positive attitude towards the behaviour, stronger subjective norm to perform the behaviour, and
stronger perception of control over the behaviour. Six of these measures achieved acceptable
internal reliability (Cronbach's alpha > 0.7). The two measures of subjective norm were
relatively unreliable (assessment appointment alpha = 0.46, contraceptive provision alpha =
0.63).
Table 6.16 also illustrates a degree of skewness in the data. However, the results of the
subsequent analyses were reproducible by non-parametric statistics with one exception (section
6.4.3.6).
Assessment appointment. The mean behavioural intention to comply with this recommendation
was high. Mean perceived behavioural control was lower (3.95; SD 1.37). The ICC of 0.29 for
perceived behavioural control was high, suggesting that staff within the same gynaecology unit
were more likely to have similar levels of perceived control. The ICCs for the other variables
were much smaller, suggesting that responses to behavioural intentions, attitude and subjective
norms were more related to individual staff rather than a 'unit' effect.
Contraceptive supplies. The mean behavioural intention to comply with this recommendation
was high. However, mean perceived behavioural control was higher (6.03, SD 1.13) compared
with that for the offer of an assessment appointment. The ICCs followed a broadly similar
pattern to the first recommendation, suggesting a common effect of gynaecology units on
perceived behavioural control.
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Table 6.16. Psychological measures on assessment of appointment within five days of
referral and offer of contraceptive supplies at discharge.
Mean SD Median ICC
Assessment appointment
Behavioural intentions 6.16 1.12 6.67 0.0007
Attitude 6.37 0.99 7.00 0.098
Subjective norms 5.93 0.89 6.00 0
PBC 3.95 1.37 4.00 0.29
Contraceptive supplies
Behavioural intentions 6.69 0.87 7.00 0.048
Attitude 6.78 0.72 7.00 0
Subjective norms 6.49 0.67 6.67 0.075
PBC 6.03 1.17 6.60 0.22
6.4.3.5 Prediction of behavioural intention
Relationships between behavioural intention and the other psychological variables were
examined for each recommendation.
Assessment appointment. All psychological variables were significantly correlated with one
another (Table 6.17). After regression adjusting for the clustering in the data, subjective norm
emerged as the best predictor of intentions to offer an assessment appointment within 5 days
(attitude Beta =0.05, p=0.58; subjective norm Beta =0.52, p=0.001; and PBC Beta =0.13,
p=0.10). Overall, the TPB measures accounted for 27% of the variance in behavioural intention
(Adjusted R-squared = 0.27; p=0.001).
Contraceptive supplies. All psychological variables were also significantly correlated with one
another (Table 6.17). In the interim analysis, attitude appeared to be the measure most highly
correlated with behavioural intention. Following the final regression analysis, PBC was the
strongest predictor of behavioural intention (attitude Beta =0.37, p=0.27; subjective norm Beta
=0.37, p=0.16; and PBC Beta =0.15, p=0.03). Overall, the TPB measures accounted for 34% of
the variance in behavioural intention (Adjusted R-squared 0.34; p=0.034).
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Table 6.17. Correlations (Pearson's r) among psychological variables.





Subjective norms 0.51** 0.44** -




Subjective norms 0.50** 0.49** -
PBC 0.32** 0.07* 0.37**
"Correlation significant at the 0.05 level (2-tailed).
""Correlation significant at the 0.01 level (2-tailed).
6.4.3.6 Psychological measures and prediction of pre-intervention compliance
Scores on questionnaire measures were compared across the unit levels of compliance for both
recommendations.
Assessment appointment. Attitudes and perceived behavioural control were positively and
significantly associated with unit pre-intervention compliance (p=0.03 and p<0.001 respectively,
Table 6.18). The non-significant correlation between pre-intervention unit compliance and
behavioural intentions (p=0.06) suggested that higher behavioural intentions were associated with
working in higher complying units. Both the interim analysis and non-parametric testing did not
detect a significant association.
On regression analysis, behavioural intention alone significantly predicted unit compliance
(Adjusted R-squared = 0.04; p=0.008). The predictive power of the model increased when PBC
was added to behavioural intention (Adjusted R-squared change = 0.11; p=0.04).
Contraceptive supplies. Both subjective norms and perceived control were positively and
significantly associated with unit pre-intervention compliance (p=0.04 and p<0.001 respectively,
Table 6.18). On regression analysis, there was no evidence that behavioural intention predicted
unit compliance with the offer of contraception at discharge (Adjusted R-squared = 0.004;
p=0.48). The addition of PBC had no statistically significant impact (Adjusted R-squared change
= 0.10; p=0.16).
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Table 6.18. Correlation between psychological variables and unit compliance for
assessment appointment within five days of referral and contraceptive supplies at discharge.
Correlation with pre-intervention compliance P value
Assessment appointment
Behavioural intentions 0.165 0.06
Attitude 0.186 0.03*
Subjective norms 0.158 0.07
PBC 0.371 <0.001
Contraceptive supplies
Behavioural intentions 0.053 0.52
Attitude 0.003 0.97
Subjective norms 0.178 0.04
PBC 0.306 <0.001
*Non-significant on non-parametric testing
6.4.3.7 Barriers and facilitators identified by respondents
Assessment appointment. One hundred and thirty-eight open-ended responses were categorised
regarding the offer of an assessment appointment (Table 6.19). For these 138 comments, RF and
GP initially agreed on 129 (93%) categorisations. All remaining disagreements were resolved by
consensus. The majority of responses (126, 91%) related to perceived behavioural control. Out
of these, most factors perceived to help or hinder implementation were of an organisational
nature. Overall, respondents reported more factors that acted as barriers than as facilitators.
Contraceptive supplies. One hundred and twenty-five open-ended responses were categorised
regarding the offer of contraception at discharge (Table 6.19). For these 125 comments, RF and
GP initially agreed on 96 (76%) categorisations. All remaining disagreements were resolved by
consensus. Once again, the majority of comments (114, 91%) concerned perceived behavioural
control, and specifically organisational factors. However, environmental factors (such as patient
characteristics) accounted for a greater proportion of reported barriers (20, 28%). Factors
reported as barriers and those as facilitators were more evenly divided.
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6.5 Later development of the strategy
6.5.1 The process of linking barriers to strategy development
The strategy to promote implementation of the guideline was further developed following
analysis of pre-intervention compliance, semi-structured interviews with the lead gynaecologists
and the interim analysis of TPB questions from the staff survey. Information from these three
components contributed to tailoring of the intervention as follows:
• Pre-intervention unit compliance: demonstration of local scope for improvement;
prioritisation of feedback to each gynaecology unit
• Semi-structured interviews: provision of information on what factors helped or hindered
implementation of recommendations, including which barriers were specific to individual
units or more generally related to each recommendation
• TPB survey: information on which individual factors were associated with compliance and
might be amenable to change
Pre-intervention unit compliance was presented to and discussed at a meeting of the ImpACT
Steering Group (Appendix 7A). Interpretation of the interim TPB analysis was undertaken in
conjunction with the behavioural scientist (AW). Summaries of the semi-structured interviews
and the TPB analysis were discussed with other members of the Steering Group. The content of
the implementation strategy was subsequently modified. It is worth noting that most of these
discussions were relatively informal and took place within the short time available (two weeks)
between the analysis of data on barriers and the first gynaecology unit outreach meeting.
Therefore, the scope for both reflecting on the overall findings and systematically linking them to
the content of the strategy were limited.
The final, multi-faceted strategy was intended to represent a range of activities that could feasibly
be carried out by a clinical effectiveness programme. Table 6.20 summarises the content of each
intervention component and the rationale for its inclusion.
Table 6.20. Summary of interventions used and rationale.
Intervention Refinements made in later
development
Rationale
Audit andfeedback Feedback to each unit focused
on five main outcome
recommendations and those
where local compliance was in
the lowest and highest quartiles
Represents an intervention
frequently used by SPCERH
Local strengths and weaknesses
highlighted by selective
feedback
Educational meetings Most units opted for a one hour
meeting rather than a half-day
workshop
Key messages refined in light of












Copies were not printed for
inclusion in local unit notes
Potential of prompts and
reminders to reduce errors of
omission
Structured case records already
used by majority of units






from website, became available
during development of strategy
Units able to amend or add local
patient information
Potential of changed patient
expectations to influence
subsequent provision of care
6.5.2 Audit and feedback
Audit and feedback comprises any summary of clinical performance fed back to health
professionals (155). Within ImpACT, this intervention was designed to demonstrate differences
between perceived and actual practice, thereby highlighting poorer than expected compliance
with the guideline, or reinforce good performance (227). Presenting performance data from all
gynaecology units in Scotland made indirect use of peer pressure.
All lead gynaecologists were sent several copies of a feedback report for circulation to relevant
clinical staff within each intervention unit (Appendix 6C). Data from the pre-intervention case
note review, measuring compliance with each of 27 guideline recommendations, was used in the
compilation of audit results for each unit. For each recommendation, the feedback document
presented:
• Grade of recommendation
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• Rationale or supporting evidence
• How the case note data were analysed to measure compliance
• The total number of cases assessed for each recommendation
• Bar charts detailing median compliance with the upper and lower quartiles
• A brief commentary' on the findings, including comments from lead gynaecologists on
factors that helped or hindered implementation
The report emphasised the limitations of the audit data. Firstly, the sample size of up to fifty
cases per unit was relatively small and therefore some of the variation among units may have
been caused by random variation. Secondly, case note reviews underestimate actual compliance
with guideline recommendations when patients receive care which is not recorded in the case
notes. However, clear recording in case notes was important for the majority of the
recommendations, least of all for medico-legal purposes. Feedback was anonymised so that
gynaecology units on the bar charts were only identifiable by an alphabetical letter sent out with
each report. The feedback documents were sent out as soon as possible following data analysis
to be available before the next stage of the intervention package.
6.5.3 Educational meetings
Educational outreach visits entail the use of a trained person who meets with professionals in
their practice settings to provide information with the intent of changing their performance (228).
The information given can include feedback on performance. Within ImpACT, educational
meetings were intended to provide convincing evidence or reasons to justify changes in practice
where guideline recommendations were not being followed.
The meetings took place at gynaecology units over May and June 2001 (with one taking place
later in July). Each unit was offered the option of a one hour educational meeting (largely to fit
in with existing continuing medical education programmes) or a longer three hour workshop.
Twelve units opted for the short meeting and one for a two hour meeting (unit B).
Each meeting contained the following components (presented by RF):
• A briefoutline of the IMPACT study
• Background to the RCOG guideline
• Feedback of baseline audit results - focusing on five key recommendations and those
recommendations where local unit compliance was in the lowest and highest quartiles
• The rationale for and evidence supporting key recommendations
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• Feedback of barriers identified from the staff survey and interviews with lead gynaecologists
• Discussion of barriers and potential solutions
All meetings were accredited for continuing medical education. All staff involved in the
provision of abortion care, including nursing and clerical staff, were encouraged to attend.
Immediately following each meeting, a shorter meeting took place with lead consultants and
other key individuals to formulate a local action plan. Two days later, the lead gynaecologists
were sent a follow-up letter summarising the main action points agreed.
6.5.4 Review of structured case records
Structured case records act as prompts or reminders, prompting health professionals to perform a
patient specific clinical action (229;230). Discussions with gynaecologists highlighted the
potential benefits of structured records in reducing errors of omission (e.g. checking cervical
smear status) or detailing more complex recommendations (e.g. drug regimens).
The original application to the CSO suggested the use of structured case records to help improve
care. When contacted later, the majority of units (at least fourteen) reported that they already
used structured case records. There were variations in the content of these case records,
especially regarding follow up arrangements and contraception. Therefore, copies were obtained
of all structured case records in use across Scotland. These were reviewed and a suggested
'model' case record was developed and finalised after pre-testing on a small convenience sample
of gynaecologists and nurses. Paper and electronic format copies of the model case record were
circulated to all intervention units (Appendix 6F). This package included a structured discharge
letter modified from a version already used by one unit.
6.5.5 Promotion of patient information booklet
Patient mediated interventions comprise any intervention aimed at changing the performance of
health professionals where specific information was sought from or given to a patient (231). In
2001, the RCOG published an information booklet for women having an induced abortion. The
booklet was available as a downloadable A4 version via the College website. The content and
availability of this booklet were highlighted to intervention units. It was suggested that the
booklet, or a local modification of it, could be distributed to women attending clinics.
6.5.6 Tailoring of educational messages
Educational messages for two key recommendations presented at meetings were refined in light
of findings from the interim analysis of the TPB survey. As all of the points raised at each
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meeting could not then be dealt with in detail, a summary of responses to 'Frequently Asked
Questions' (FAQs) was circulated to all intervention units four to six weeks after each meeting
(Appendix 6G). This sheet included a summary of what action other gynaecology units had
taken to improve implementation of key recommendations.
For the offer of an assessment appointment within five days of referral, behavioural intention was
most strongly associated with subjective norms. Meeting this recommendation was presented as
the professional norm. In an earlier survey, 81% of Scottish gynaecologists agreed or strongly
agreed that 'referral to appointment' interval should be five days or less (232). In addition to this,
the FAQ sheet highlighted other potential benefits of offering assessment appointments earlier.
For example, the earlier in pregnancy an abortion is performed, the lower the risk of
complications (233;234).
For the offer of contraceptive supplies at discharge, behavioural intention was most strongly
correlated with attitudes - according to the interim analysis. The educational message regarding
this recommendation therefore focused on changing outcome beliefs, i.e. the benefits of ensuring
women had received contraceptive supplies by discharge were discussed. The FAQ sheet
provided a worked example. This suggested that if in an average sized gynaecology unit an
additional 10-20% of women were prescribed contraception immediately following abortion,
between 5 and 25 unwanted pregnancies could be prevented in the following year. Across
Scotland, this would translate into the prevention of between 120 and 600 unwanted pregnancies.
Hence, considered in the context of other 'numbers needed to treat' (e.g. use of antenatal
steroids)(3), provision of contraception at discharge could be relatively effective.
6.6 Discussion
6.6.1 Main findings
A multi-faceted strategy, based upon what could be delivered within a national clinical
effectiveness programme, was developed to promote the implementation of the induced abortion
guideline. The baseline (pre-intervention) audit indicated variations in compliance with
guideline recommendations across recommendations and among gynaecology units. Barriers and
facilitators were assessed systematically among gynaecology units in the intervention arm of the
trial by three methods. Semi-structured interviews with local lead gynaecologists identified a
range of barriers to the implementation of five key recommendations. The postal survey of
clinical staff assessed behavioural intentions and beliefs in relation to two of these
recommendations: assessment appointment within five days of referral; and provision of
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contraception at discharge. This information was complemented by open-ended responses to the
staff survey.
In the intervention arm, less than half of all women (46%) referred for induced abortion care
were offered an assessment appointment with five days. Limited resources and underlying
attitudes of staff in the wider organisation were reported as major barriers to the implementation
of this recommendation. There was uncertainty among individual staff about the existence of
local referral systems in most gynaecology units. Staff generally had strong behavioural
intentions to offer an assessment appointment within five days but perceived control over this
action was low. As subjective norm explained 27% of behavioural intention, it was considered
appropriate to tailor educational messages to suggest that this recommendation was consistent
with professional norms and values. Behavioural intention alone explained 4% of unit
compliance compared to 15% when PBC was also considered. In other words, compliance was
higher in units where staff believed they had more influence over the offer of an assessment
appointment.
In the intervention arm, 59% ofwomen received contraceptive supplies, as required, at discharge.
The availability and skills of clinical staff were reported as the most important barriers. In
addition, there was some confusion in several units as to who was responsible for the provision of
contraception at discharge. Staff expressed strong behavioural intentions to offer contraception
at discharge, with PBC explaining 34% of intention. Therefore, actions that could increase
perceived behavioural control represented the most appropriate intervention. However, it appears
that staff experienced substantial problems in putting these intentions into practice as the TPB
model did not explain variation in unit compliance.
The final strategy consisted of audit and feedback, outreach educational meetings, dissemination
of a model structured case record and promotion of patient information. The format of the
interventions was negotiated with local lead gynaecologists and the educational content refined
according to identified barriers and predictors of behavioural intention.
6.6.2 Comparison of methods used to identify barriers and facilitators
The main findings from the interviews with lead gynaecologists, and the TPB and open-ended
questions from the staff survey were compared (Tables 6.21 & 6.22). These comparisons give
some indication of the ability of the various methods to identify barriers and facilitators but
should be interpreted with caution. Firstly, the semi-structured interviews and open-ended
questions identified factors perceived by respondents to influence compliance whereas the TPB
questions identified factors associated with actual compliance (using unit performance as a
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marker for individual practice). Secondly, the method used to compare findings draws upon the
categorisation system used for the analysis of open-ended questions. As such, factors identified
in the semi-structured interviews were re-assigned to these categories post-hoc, e.g.
recommendation-specific factors were considered under attitudes whilst individual factors were
usually placed within attitudes, subjective norms or self-efficacy. For example, the need for
family planning training of nursing staff to enable improved provision of contraception at
discharge was categorised under self-efficacy (as a belief contributing to PBC, section 6.2.6)
although it is also an organisational issue. Insufficient data were available from the TPB analysis
to permit a further sub-categorisation of PBC into self-efficacy, organisational and environmental
factors. Thirdly, the impact of each factor has been judged qualitatively as low, moderate or
high.
Table 6.21. Comparison of findings from different methods used to identify factors that
influenced the offer of an assessment appointment within five days.











Attitudes Moderate Moderate Low




Self-efficacy Low n/a Moderate
Organisational High n/a High
Environmental Moderate n/a Low
Assessment appointment. All three methods identified perceived behavioural control as having a
major influence on the ability to follow this recommendation. Findings from the semi-structured
interviews and open-ended questions suggested that specific organisational factors represented
the predominant influence. However, the open-ended questions from the staff questionnaire
appeared to be less sensitive in identifying attitudinal factors, possibly because the respondents
were reluctant to report negative attitudes.
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Table 6.22. Comparison of findings from different methods used to identify factors that
influenced the offer of contraception at discharge.











Attitudes Low Low Low




Self-efficacy Moderate n/a Moderate
Organisational High n/a High
Environmental Moderate n/a Moderate
Conti-aceptive supplies. Once more, all three methods identified PBC as a major influence on
compliance. However, PBC added to behavioural intention did not significantly explain
compliance following regression analysis. The semi-structured interviews and open-ended
questions specified the effects of organisational factors and further suggested that both self-
efficacy and environmental factors exerted moderate influences on practice. Environmental
factors included the refusal of some women to accept contraception at discharge.
The findings from the three approaches need to be considered within their specific contexts. The
staff survey mainly comprised members of staff providing abortion care. Behavioural intentions
and positive attitudes towards abortion care were already high in this group of staff - and
therefore these factors did not represent barriers. However, the interviews with lead
gynaecologists suggested that attitudes to abortion care among other colleagues or in the wider
organisation were less supportive.
6.6.3 Strengths and weaknesses of methods used to identify barriers and
facilitators
Pragmatic and theory-based approaches were combined to identify local needs and barriers to
implementation of the guideline. The systematic approach increased the likelihood of identifying
most factors that significantly influenced adherence to the guideline.
The use of a behavioural theory (TPB) offered three advantages. Firstly, it contributed to the
diagnostic analysis by measuring the extent of potentially remediable factors, such as beliefs and
intentions. This diagnosis informed the development of an implementation strategy. Secondly,
the use of theory enhances the transferability of findings from intervention studies. It is often not
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known what factors are important in the relative success or failure of reported strategies because
of the lack of an established conceptual framework. Thirdly, psychometric methods may be
more valid and reliable in the identification of individually-mediated barriers and facilitators.
Many studies have investigated why clinicians follow clinical guidelines or not (212-216). Most
of these studies describe clinicians' reported reasons for their actions but these reasons are not
necessarily the same as the causes of their behaviour. A sceptical view is that reasons such as
organisational constraints are actually rationalisations of negative individual attitudes to changing
practice. However, the use of TPB in this case provided empirical evidence that highly
motivated individuals were constrained by organisational factors.
The major limitation is that TPB did not represent the most appropriate approach to identifying
wider factors that influence behaviour, such as the organisation and wider environment (235).
The interviews with lead gynaecologists did provide such information. Yet this complementary
approach was not based upon a theory-derived framework, thus limiting its transferability.
Another limitation is that it was not possible to obtain data on the performance of individual
professionals. Unit compliance was used as a proxy measure for individual behaviour. This
might have compromised the ability to identify statistically significant relationships between
individual intentions and behaviour.
Response bias represents a potential threat to external validity. The absence of any interview or
questionnaire survey data from one gynaecology unit is noteworthy; this unit's levels of
compliance with both guideline recommendations assessed by the TPB survey were in the lowest
quartiles. Therefore, information about poorer performing units was lost.
The overall response rate from the other twelve units participating in the staff survey was
satisfactory, notably with a high response rate from consultants (88%). The lower response rates
from junior medical staff may have reflected greater mobility or perceived irrelevance of the
survey. Whilst the survey responses are likely to be representative of staff directly involved in
the provision of abortion care, the beliefs and intentions of staff in the wider organisation were
not ascertained. Several lead gynaecologists suggested that other members of staff can have
indirect but important influences on the provision of abortion care through, for example,
competition for limited resources.
At a practical level, the process of identifying barriers was time-consuming both for the
researchers and to a lesser degree for local clinical staff. This had consequences for the study
itself and has implications for their more general application. Firstly, within the limited time
frame of the research project, the intervals between identification of barriers, their analysis and
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delivery of the intervention were both short. Indeed, these processes over-lapped to some degree.
This allowed little opportunity to reflect on the findings and modify the interventions more
systematically. The need to undertake an interim analysis of the TPB survey - initially ignoring
clustering effects - led to the over-estimation of the influence of attitudes on individuals'
intentions to offer contraception at discharge. Secondly, outwith research contexts, methods used
to identify barriers can be prohibitively time-consuming and too complex to justify their routine
use in the development of guideline implementation strategies.
6.6.4 Implications for the implementation strategy
The strategy to promote the guideline was tailored in the light of barriers and locally identified
needs. The content and format of the strategy were negotiated with local lead gynaecologists.
Low and high levels of compliance with recommendations relative to other gynaecology units
were highlighted during feedback. The interactive nature of the educational meetings encouraged
staff to link feedback on unit performance to their own experiences and identify ways of
improving service delivery (15). The ImpACT strategy was relatively novel because its
development was refined according to empirical data that attempted to explain behaviour. The
educational messages subsequently targeted factors initially considered most strongly associated
with intentions to follow two key recommendations.
Refinement of the strategy. Subjective norms best explained behavioural intentions to offer an
assessment appointment. Therefore, this recommendation was presented as consistent with
professional norms, albeit with some difficulty since the pre-intervention case note review clearly
indicated it was not the norm throughout Scotland. However, participants in meetings were
reminded that in response to an earlier survey, 81% of Scottish gynaecologists agreed or strongly
agreed that 'referral to appointment' interval should be five days or less (232). On later
reflection, there were three limitations to this approach. Firstly, the measure of subjective norm
was unreliable (Cronbach's alpha = 0.46). A subsequent sub-analysis indicated that subjective
norm item, 'Most professional colleagues would offer this woman an assessment appointment
within five days of referral' was the best predictor of behavioural intention (Beta=0.16, p=0.05).
Secondly, the mean behavioural intention of staff involved in the provision of abortion care to
follow this recommendation was already generally high. Any interventions that aim to improve
performance by increasing behavioural intentions alone were likely to encounter 'ceiling effects'
or even become counter-productive. Thirdly, PBC was the strongest predictor of unit
compliance. Reconfiguring appointment systems to improve their reliability and give
professionals greater control over the offer of assessment appointments may have represented a
more appropriate approach to improving compliance.
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Lead gynaecologists reported the negative attitudes of staff in the wider organisation and limited
resources as major obstacles to offering an assessment appointment within five days of referral.
Therefore, interventions targeting both the attitudes and beliefs of those with greater power and
the wider organisation may have been more promising.
For the offer of contraceptive supplies, behavioural intention was most strongly correlated with
attitudes - according to the interim analysis. The educational message regarding this
recommendation therefore focused on changing outcome beliefs, i.e. the benefits of ensuring
women had received contraceptive supplies by discharge were discussed. The final analysis
indicated that PBC was the strongest predictor, explaining 34% of behavioural intention.
However, behavioural intention and PBC did not explain unit compliance. This was unexpected,
as it had been anticipated and demonstrated that individual staff perceived greater control over
the offer of contraception compared with the assessment appointment. Yet the interviews with
lead gynaecologists had suggested that the availability of contraception and skills of clinical staff
substantially influenced compliance with the recommendation. The practical implication is that
enhancing the PBC of individual staff by providing training should be accompanied by
organisational changes (such as increasing the range of contraception available) to increase the
proportion ofwomen discharged with contraception supplied.
The focus of interventions. The need to specify the main components of the strategy in advance
limited the scope to alter planned interventions or select new interventions. This was partly
related to the need to specify provisional interventions as part of the project funding application
to the CSO. However, interventions such as the educational meetings had to be planned at least
several weeks in advance to fit in with local postgraduate programmes. The project also
addressed what range of interventions a national clinical effectiveness programme could feasibly
deliver. It was important to retain and test this intervention as much of SPCERH's work
programme is based upon audit and feedback.
The final interventions selected largely focused on individuals and teams of clinical staff
involved in the provision of abortion care. According to the TPB survey, most staff involved in
providing abortion care already had strong intentions to follow the guideline recommendations.
This 'ceiling effect' reduced the potential for interventions targeted at health professionals to
improve guideline adherence by increasing behavioural intentions.
Relatively high levels of pre-intervention compliance were measured for range of
recommendations (e.g. antibiotic prophylaxis or screening for lower genital tract organisms)
previously associated with low compliance in an earlier national audit (203). It is possible that,
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once accepted by gynaecologists, such recommendations were less difficult to implement
compared with chronic, complex organisational problems, e.g. reduction of waiting times for
assessment appointments.
Certain aspects of the strategy were relevant to organisational barriers. For example, during
delivery of the intervention lead gynaecologists were reminded that they could share audit data
with other clinical colleagues and managers to highlight the need for change. Suggestions on
how to address factors external to the units were also shared, e.g. the introduction of routine
reminders to practices contributing to delays in referrals by failing to use telephone referral
systems.
Had more time and flexibility been available, it is uncertain what interventions could have been
designed and delivered to tackle such recommendations associated with lower compliance.
Given that barriers ranged from individual through to team and organisational levels, a multi¬
level approach might have been more appropriate. However, little rigorous evidence is available
on the effectiveness of interventions, such as Continuous Quality Improvement (CQI), targeting
the organisational end of this spectrum (236;237). More importantly, the necessary time,
resources and expertise were not available to test such approaches within the context of this trial.
Strengthening interventions. There could have been a greater emphasis on strengthening
promising aspects of interventions to tackle more remediable barriers. For example, compliance
with the recommendation to record cervical smear history was generally low. This was mainly
attributed to errors of omission, from poor recording or failing to take the history during
assessment appointments. In this case the use of structured case records represents an
appropriate intervention to prompt improved recording. The introduction or amendment of local
structured records was (necessarily) left to the discretion of local gynaecologists. The extent to
which changes were actually made to this process of care is reported in Chapter 7.
6.6.5 Unanswered questions and research needs
A behavioural theory was used in developing the content of the intervention and provided a
greater understanding of the underlying barriers to change. Theories from behavioural sciences
are increasingly being used to investigate professional and organisational practice. Theoretical
approaches to implementation research may focus on factors within individual health care
professionals that are associated with adherence to evidence-based health care, or organisational
factors. Process Modelling in ImplEmentation research (PRIME), an MRC-funded collaborative
programme of work, aims to develop an understanding of individual professional behaviour in
order to identify what processes should be targeted in interventions to change behaviour (A
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Walker, personal communication). Experience from developing the ImpACT strategy underlines
the need to extend similar work towards team and organisational levels. The long term aim is to
develop diagnostic tools that can provide an empirical basis for the most appropriate selection of
interventions and level to target (e.g. individual, team or organisational) given specific barriers
and circumstances.
6.7 Conclusion
Experience from the development of the ImpACT strategy highlights lessons relevant to the
development of other implementation strategies. More than one approach may be required to
identify potential barriers and needs, especially if both individual and organisational factors are
important. Yet, this can be relatively resource-intensive. A range of barriers to the
implementation of the induced abortion guideline was identified. The key issues were to what
degree these different barriers were remediable to interventions and at what level such
interventions should take place. Approaches solely aiming to influence individual staff to follow
the guideline recommendations were likely to be ineffective or counter-productive because of a
'ceiling' effect around behavioural intention. In selected units, there may have been scope for
increasing staff behavioural intentions by presenting the offer of an assessment appointment
within five days of referral as the professional norm and increasing staff control over the
provision of contraception at discharge. However, such actions were unlikely to be effective if
wider organisational barriers were not addressed.
Sufficient time needs to be integrated within project plans to allow reflection upon findings and
planning of the definitive intervention components. The final strategy consisted of audit and
feedback, educational meetings, dissemination of a model structured case record and promotion
of patient information. The format of the interventions was negotiated with local lead
gynaecologists and the educational content refined in the light of identified barriers and
predictors of intention. Ideally, the range of available interventions should be sufficient to allow
the selection of those most relevant to identified remediable barriers. However, even where




A randomised evaluation of a strategy, delivered within a
national clinical effectiveness programme, to improve
implementation of a clinical guideline on women requesting
induced abortion
7.1 Summary
Chapter 6 described the development of a strategy to promote implementation of the Royal
College of Obstetricians and Gynaecologists guideline, The Care ofWomen Requesting Induced
Abortion. This chapter reports an evaluation of the effectiveness and efficiency of the strategy,
the Improving Abortion Care Trial (ImpACT).
The study design was a two-arm cluster randomised controlled trial. Pairs of gynaecology units
matched by pre-intervention performance were randomly allocated to the intervention or control
arms. All fellows and members of the RCOG in the control units received printed summaries of
the guidelines alone. The intervention units received a tailored package, deliverable by a national
clinical effectiveness programme, comprising audit and feedback, educational meetings,
dissemination of structured case records, and promotion of a patient information booklet.
Twenty-six gynaecology units in Scotland participated. The primary outcomes were compliance
with five guideline recommendations representing key aspects of quality of care. Outcome data
were collected from a review of case notes and a patient survey. Process and cost data were also
collected from interviews and documented notes.
1474 case notes from 25 gynaecology units were reviewed. No post-intervention differences
between intervention and control units were observed with respect to any of the primary or
secondary outcomes. There was no evidence that the ImpACT strategy reduced variations in
compliance among intervention units compared with controls.
1028 / 2109 patient questionnaires were returned completed, a response rate of 49%.
Significantly fewer women in the intervention group recalled having been counselled about the
complications and possible sequelae of abortion (OR 0.45, 95% CI 0.25 to 0.80). No other
significant differences between the intervention and control groups were observed with respect to
compliance with recommendations or satisfaction with care received.
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The average cost of the intervention per gynaecology unit was £2067, with the audit and
feedback component accounting for half this cost. No significant differences in primary
outcomes meant that a cost-effectiveness analysis was not justified. There was no evidence that
intervention units planned or made more changes to service provision than control units.
This tailored multi-faceted package to promote implementation of a clinical guideline had no
effect on the quality of induced abortion care. The most plausible explanations for the lack of
effect include the timing of the study in relation to publication of the guideline (with limited
scope for improvement in relation to several recommendations), and the intensity and
appropriateness of the intervention.
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7.2 Introduction
7.2.1 The design and evaluation of implementation strategies
A range of interventions exists to promote improved clinical practice and reduce inappropriate
variations. The interpretation of the substantial body of literature on implementation strategies is
hindered by the poor methodological quality and limited generalisability of primary studies.
Chapter 1 highlighted lessons from systematic reviews for the design of implementation
strategies and their evaluation. Several features of the Improving Abortion Care Trial (ImpACT)
were designed to address such shortcomings.
Validity of change. In previous primary studies, the clinical benefits or relevance of
improvements in practice have sometimes been of uncertain or doubtful value. Proposed changes
in clinical and organisational practice should ideally be based upon robust evidence. Guideline
recommendations are more likely to be valid if produced by national or regional guideline
development groups according to rigorous and explicit methods (238). The RCOG guideline,
The Care of Women Requesting Induced Abortion, was developed by a multidisciplinary group
according to rigorous criteria, including explicit methods of appraising and grading evidence
(239). The guideline recommendations were graded as follows:
A Requires at least one randomised controlled trial as part of a body of literature of
overall good quality and consistency addressing the specific recommendation.
B Requires the availability of well conducted clinical studies, but no randomised clinical
trials on the topic of the recommendation.
C Requires evidence obtained from expert committee reports or opinions and/or clinical
experience of respected authorities. Indicates an absence of directly applicable clinical
studies of good quality.
Good practice points. Recommended best practice based on the clinical experience of
the Guideline Development Group.
Combining intei-ventions. Earlier reviews suggested that combining interventions increased the
likelihood of successful implementation, perhaps because of their ability to overcome more than
one barrier to change (20). However, there is little evidence that increasing combinations of
interventions augments effect sizes (103). It is also questionable whether any additional potential
benefits associated with combinations of interventions outweigh their greater costs.
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Tailoring of implementation strategy. It has been suggested that implementation strategies
should be based upon identified needs and barriers, allowing more rational selection or tailoring
of interventions (19;101;208;240;241). Although intuitively attractive, there is little empirical
evidence on the effectiveness of this approach. The design of the ImpACT strategy was based
upon the application of a behavioural theory to understand barriers to change (Chapter 6).
Generalisability. Much previous research is of limited generalisability: out of 239 guideline
implementation studies identified in the review of guideline implementation strategies, only 8
(3%) took place in UK secondary care (103). Eight studies were identified that evaluated
combinations of educational materials, educational meetings and audit and feedback against no
control interventions. The observed effects were small - with a median absolute improvement in
outcomes across three cluster randomised controlled trials of 3%. Only two of these eight
studies, both time series analyses, took place UK secondary care settings. One US cluster RCT,
set in primary care, evaluated a combination of educational materials, educational outreach,
educational meetings, and audit and feedback against no control and found an absolute
improvement in outcomes of 6% (242). ImpACT represented the first cluster randomised
evaluation of a similar combination of interventions in UK secondary care.
Rigorous study design. Cluster randomised trials generally represent the most rigorous design
available to test interventions to change professional and organisational behaviour. Previous
studies have been associated with a number of weaknesses, particularly failures to account for
clustering effects in design and analysis (243). Other improvements in design, such as the
collection of baseline data on performance and the use of minimally intrusive methods of data
collection, can also strengthen the design of randomised evaluations (244). The design of
ImpACT met these criteria.
Economic evaluation. Only 29% of comparisons assessed in the aforementioned review reported
any economic data (103). Overall the methods of the economic evaluations and cost analyses
were poor. As well as the direct costs of changing clinical behaviour, little work has been done
on the wider effects on health services following implementation - which may be affected by the
choice of the guideline topic or recommendations (245). The design of ImpACT incorporated an
economic evaluation.
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7.2.2 Aim and research questions
ImpACT aimed to evaluate the effectiveness and efficiency of a multi-faceted intervention
delivered by SPCERH to improve implementation of the RCOG guideline, The Care ofWomen
Requesting InducedAbortion. The study set out to address the following questions:
• How effective is a package of clinical guidelines and a tailored intervention delivered within
the context of a national clinical effectiveness programme, compared with the guidelines
alone, in improving the care ofwomen requesting induced abortion?
• What are the costs of supporting the dissemination and implementation of a guideline with
such a package ofmeasures?
• What are the cost implications of different levels of adherence to the guideline and do these
offset the costs of the intervention package?
Figure 7.1. Timing of main components of ImpACT study.
Recruitment of 26 gynaecology units
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Assessment of barriers: interviews with
lead gynaecologists; staff survey
Final refinement of intervention
Feedback of pre-intervention (audit) data
Local educational meetings and other local action
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The study design was a two-arm cluster randomised controlled trial. The main components of
the study are summarised in Figure 7.1. The design and planning of the trial were supervised by
a multidisciplinary steering group (Appendix 7A).
7.3.2 Study setting and population
The study population comprised all gynaecology units in Scotland responsible for providing
induced abortion care.
7.3.3 Randomisation
Randomisation occurred at the level of gynaecology units. Units were initially stratified by
throughput and then matched by baseline performance with three of the guideline
recommendations used to assess the main outcomes (see 7.3.6). This method of randomisation
attempted to reduce pre-existing variations in practice between intervention and control units
(246;247). The three recommendations were used in the following order to match randomised
units: provision of an assessment appointment with five days of referral (matching correlation
0.99), antibiotic prophylaxis and/or genital tract screening (0.72), and cervical cytology history
(0.56). The units in each matched pair were randomised to either intervention or control by an
independent statistician.
During the planning of the study, NHS reforms in Scotland led to several mergers of the
management of acute hospitals to form one acute NHS trust within each Health Board (248;249).
This gave rise to a risk of contamination of the intervention if two or more gynaecology units
within one NHS trust were allocated to intervention and control units. Contamination might have
arisen, for example, from the establishment of joint protocols or educational meetings. Relevant
clinical directors were telephoned to assess the potential for contamination. They indicated that
the mergers would be in the early stages of developing joint management systems and that shared
activities to improve clinical care were likely to be non-existent or minimal during the
intervention and follow-up periods. Nevertheless, in implementing the intervention measures
were taken to avoid contamination, e.g. avoidance of any joint educational meetings between
gynaecology units in the same trust.
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7.3.4 Intervention arm
All fellows and members of the RCOG received identical printed guideline summaries. The
implementation strategy was described earlier (Chapter 6.5) and comprised audit and feedback,
educational meetings, review of structured case records and promotion of a patient information
booklet. The format and content of the interventions were refined according to identified barriers
and local needs.
7.3.5 Control arm
In gynaecology units randomised to the control arm. all fellows and members of the RCOG
received identical printed guideline summaries. Following the collection of pre-intervention data
and randomisation, no further contact was made with these units until post-intervention data
collection started.
7.3.6 Primary outcomes
The primary outcomes were determined in advance of pre-intervention data collection. As far as
possible, each outcome was selected to fulfil the following criteria: clinical importance; easily
definable; potential for improvement; sufficiently common to provide reliable data; and
responsive to the planned intervention (250;251). Five guideline recommendations
encompassing different aspects of care were subsequently selected. Data measuring compliance
with each of these recommendations were available from case notes.
Ideally, all women are offered an assessment appointment within five days of referral. This
Grade C recommendation related to the organisation of services. The earlier in pregnancy an
abortion is performed, the lower the risk of complications. The absolute risk of complications at
the time of abortion is low (0.7%)(233). The risk of serious complications increases 1.4 times for
every 2 week increment in gestation beyond 12 weeks (234). The Birth Control Trust suggested
five days as an appropriate target between referral and assessment, a target endorsed by a
consensus survey of Scottish gynaecologists (232). The last known measure of pre-study
compliance (as opposed to pre-intervention compliance described in Chapter 6) was 49% across
ten Scottish gynaecology units in 1992 (149).
Assessment prior to induced abortion may be viewed as an opportunity to ascertain each
woman's cervical cytology history. This Good Practice Point related to pre-abortion
management. Ideally, abortion care should provide holistic sexual health care. Checking
cervical smear status offers an opportunity to discuss the value of screening and explore any
concerns with women whose smears are overdue. Women requiring a smear can be reminded to
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attend their own general practices following the abortion. A sub-group of women attending for
abortion care may make poor use of preventative services and subsequently represent a high risk
group for cervical cancer. Pre-study compliance with this recommendation was 61% (149).
Abortion care should encompass a strategy for minimising the risk ofpost abortion infective
morbidity. Appropriate strategies include antibiotic prophylaxis (Grade A) or screening for lower
genital tract organisms with treatment of positive cases (Grade B). This recommendation also
related to pre-abortion management. Genital tract infection is a recognised complication of
abortion, occurring in up to 10% of women not receiving antibiotic prophylaxis. Long term
sequelae of post-abortion infection include tubal infertility and ectopic pregnancy. Universal
antibiotic prophylaxis halves the risk of infective morbidity (252) and, by itself, is the most cost-
effective strategy for minimising short term infective sequelae of abortion (253). Universal
prophylaxis with screening allows an opportunity for contact tracing (254). Pre-study
compliance with this recommendation was 31% (149).
Misoprostol given vaginally is a cost-effective alternative to gemeprost (in early and mid-
trimester medical abortions and cervical priming). This Grade A recommendation related to
abortion procedures. Misoprostol is as effective as gemeprost (255-261). Gemeprost costs
approximately £20 per dose compared with around £1 for misoprostol. No data were available
on pre-study compliance.
Contraceptive supplies should have been offered if required. The chosen method of
contraception should be initiated immediately following abortion. This Grade B
recommendation related to after care. Ovulation occurs within a month of first trimester abortion
in over 90% of women (262). In 1999, 24% of 12,167 women undergoing induced abortion in
Scotland had experienced at least previous one abortion (ISD data). The provision of
contraception is an essential component of preventive care following abortion. Pre-study
compliance with this recommendation was 54% (149).
7.3.7 Secondary outcomes
The secondary outcomes mainly comprised compliance with 30 of the remaining guideline
recommendations (Table 7.1). In approving funding for the original proposal, the CSO Health
Services Research Committee requested an assessment of women's views as part of the
outcomes. For several recommendations (e.g. relating to provision of information), a patient
survey represented the most appropriate, if not the only, way to ascertain compliance.
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The patient survey also assessed six other secondary outcomes not directly related to the
guideline recommendations. Four of these outcomes were taken from a North American survey
of women following abortion: staff competency; the counselling process; staff sensitivity; and a
global rating of satisfaction (263). The other two outcomes were derived from a previous survey
of Scottish women: the sufficiency of time and help from staff to make decisions: and whether
women now felt that the decision made was right for them (264).
7.3.8 Data collection
Primary and secondary outcome data were available from the case note review, the patient
survey, or both (Table 7.1). Altogether, 20 recommendations were assessed by the case note
review only, 5 by the patient survey only, and 10 by both.






Ideally, all women are offered an assessment appointment within five days of referral
(primary outcome)
X X
As a minimum standard, all women are offered an assessment appointment within two
weeks of referral
X X
Ideally, all women can undergo the abortion within seven days of the decision to
proceed being agreed
X X
As a minimum standard, all women can undergo the abortion within two weeks of the
decision to proceed being agreed
X X
As a minimum standard, no individual woman need wait longer than three weeks from
her initial referral to the time of her abortion
X X
In the absence of specific medical, social or geographical contra-indications, induced
abortion may be managed on a day-case basis
X
Information for women
Verbal advice must be supported by accurate, impartial printed information which the
woman considering abortion can understand and may take away and read before the
procedure
X
Information for women and professionals should emphasise the duty of confidentiality
by which, as for any form of health care, all concerned with the provision of induced
abortion are bound
X
Professionals providing abortion services should possess accurate knowledge about
possible complications and sequelae of abortion. This will permit them to provide
women with the information they need in order to give genuinely informed consent
X
Pre abortion management
Pre-abortion assessment should include appropriate blood tests X
It is not cost-effective routinely to cross-match women undergoing termination of
pregnancy
X
Assessment prior to induced abortion may be viewed as an opportunity to ascertain
each woman's cervical cytology history (primary outcome)
X
Women who have not had a smear within the interval recommended in their local
programme may be offered a smear taken opportunistically
X
Ultrasound scanning is not considered to be an essential prerequisite of abortion in all
cases
X
Abortion care should encompass a strategy for minimising the risk of post abortion
infective morbidity (primary outcome)
X
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Ideally, abortion services must be able to offer a choice of recommended procedures
for relevant gestation bands
X
Medical abortion is an appropriate method at gestations of <7 weeks / Conventional
suction termination should be avoided at <7 weeks
X
For early medical abortion, a dose of 200mg ofmifepristone, in combination with a
prostaglandin is adequate
X
Use of conventional suction termination at gestations of 7-15 weeks if appropriate or
preferred
X
For women presenting between 7-15 weeks' gestation, suction termination mat' be safer
under local anaesthesia than under general anaesthesia
X
Misoprostol is a cost-effective alternative for gemeprost (early and mid-trimester
medical abortion, and cervical priming; primary outcome)
X
Cervical preparation is beneficial prior to suction termination and should be routine if
the woman is aged under 18 years or at a gestation of >10 weeks
X
For mid-trimester medical abortion, a dose of 200mg of mifepristone is adequate X
Surgical evacuation of the uterus is not required routinely following mid-trimester
medical abortion
X
Mid-trimester abortion by dilatation & evacuation (D&E), preceded by cervical
preparation, is safe and effective when undertaken by specialist practitioners
X
For women presenting at greater than 15 weeks' gestation, as an alternative to D & E,
services may prefer to offer medical abortion
X
Managing complications of abortion
Oxytocics are effective in reducing intra-operative blood loss X
In cases of suspected uterine perforation laparoscopy is the investigation of choice X
After care
Anti-D IgG should be given to all non-sensitised RhD negative women following
abortion
X
After an abortion, women must be given a written account of the symptoms they may
experience and a list of those that would make an urgent medical consultation
necessary. They should be given a 24 hour help-line telephone number to use if they
feel worried about pain, bleeding or high temperature
X
A follow-up appointment (either within the abortion service or with the referring
clinician) within two weeks of the procedure should be offered to each patient
following abortion
X X
Before she is discharged following abortion, future contraception should have been
discussed with each patient
X X
Contraceptive supplies should have been offered if required. The chosen method of
contraception should be initiated immediately following abortion (primary outcome)
X X
Sterilisation can safely be performed at the time of induced abortion. However
combined procedures are associated with higher rates of failure and of regret
X X
It is safe and effective to insert an IUCD for contraceptive use immediately following
induced abortion
X X
7.3.8.1 Case note review
Case identification. Data collection from women's case notes took place over two phases: a pre-
intervention sample of up to 50 abortion cases per gynaecology unit; and a post-intervention
sample of up to 75 per unit. Cases were identified for two periods: 1st September to 30th
November 2000 pre-intervention; and 1st September to 30th November 2001 post-intervention.
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Cases were identified retrospectively from ward admission diaries. Women admitted for
spontaneous miscarriage or for induced abortion because of fetal anomalies were excluded. All
consecutive cases were included from smaller units, where no more than 50 and 75 cases were
available over the two phases. Random quota sampling was necessary for units with greater
throughputs.
Data collector training. Locally employed hospital nursing or clerical staff extracted clinical
information from case notes. The majority of these staff attended one of two training days.
Training included small group work during which participants jointly abstracted data from case
notes from their own gynaecology units. The remaining data collectors received a standard
training package during visits (by the author) to gynaecology units. The data collection form was
developed and modified following pre-testing with the data collectors (Appendix 7B). All data
collectors received a booklet detailing key aspects of case note retrieval, data abstraction and a
research office telephone number to contact with queries.
The feedback of pre-intervention results to intervention units provided an opportunity to verity
data from the case note reviews. The main error detected was the failure of data collectors in
three units to identify all women who had received antibiotic prophylaxis. This primarily
occurred because treatments were sometimes written up on day case sheets rather than
prescription sheets. Subsequently, prescribing policies in control units with low levels of
compliance were checked and the database amended as required. More explicit instructions on
the abstraction of such data from case notes were included in the post-intervention data collection
form.
Protection ofconfidentiality. Recognising the sensitivity of this clinical issue, the data collection
form contained no items (e.g. name, address, hospital number or date of birth) that could have
enabled the identification of individual cases. Within each hospital, local data collectors assigned
a unique study number to each case, based upon numbers listed on the case identification forms
(Appendix 7C). The data collectors held a master list of patient case note numbers and the data
abstraction form numbers. This helped to avoid retrieval of duplicate case notes and facilitated
later checks of any anomalous or erroneous data. Thus data returned to the project team were
anonymised. Data received for analysis were held within a secure database in the SPCERH
office.
As in other trials requiring organisational level recruitment, written consent for access to patient
case notes was obtained from appropriate 'guardians', namely the clinical directors and
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consultant gynaecologists responsible for the care of women undergoing abortions (265). Only
one consultant refused permission for access to patient case notes.
7.3.8.2 Patient survey
Questionnaire development. The questionnaire was primarily developed to assess gynaecology
units' compliance with guideline recommendations from the patient perspective (Appendix 7D).
The patient survey assessed patient recall of information provided. For one recommendation,
concerning the provision of accurate information about possible complications and sequelae of
abortion, a summary variable was derived from the following items:
• Whether doctors or nurses talked to women about possible problems or complications after
the abortion
• Which of the following possible complications had been mentioned: excessive bleeding
following the abortion (haemorrhage); damage to the uterus, or womb, requiring a more
major operation (uterine perforation); failure of the abortion method (and need for another
abortion procedure); and pelvic infection.
For women who had undergone surgical abortions, compliance with the recommendation was
met if all five questions were answered 'yes'. For medical abortions, compliance was met if four
questions (having excluded uterine perforation which is only relevant to surgical abortions) were
answered 'yes'.
Questions assessing other aspects of care were drawn from previous surveys (263;264). The
following summary variables and items, each rated on a five-point Likert scale assessing
agreement with statements, from Zapka et al were incorporated:
• Staff competency, comprising four items assessing agreement on a five-point scale with the
following statements: the clinical care I received was excellent; my confidentiality was
protected; the staff treated me with respect; the staffwere professional and thorough.
• The counselling process: there was too much emotional talk; there was too much medical
talk; the staff asked too many questions.
• Staff sensitivity: the staff treated me as a whole person; the staff weren't afraid to discuss
emotional issues.
These items have been demonstrated to have good internal consistency, with Cronbach's alpha
coefficients ranging from 0.73 to 0.99 (263). As in the study by Zapka et al, global satisfaction
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was rated on a five-point scale according to whether respondents agreed with the statement.
"There are some things about the medical care I received that could be better."
Following this initial development, the content of the questionnaire was pre-tested on medical,
nursing and midwifery staff involved in abortion care and a representative from the Family
Planning Association. Minor modifications were subsequently made. The resulting draft was
then pre-tested during one-to-one interviews with a convenience sample of women undergoing
medical and surgical abortions. Women were invited to state whether any aspect of the
questionnaire required clarification or seemed insensitive or inappropriate. Changes were
required to clarify some of the questions.
To protect anonymity, the survey form only allowed identification of the gynaecology unit
attended. To allow comparison of baseline characteristics, women were asked to provide
information about their age, gestation of pregnancy at the time of the abortion procedure and
postcode sector (the postcode minus the last two letters). The latter data were to be used to
derive Carstairs Deprivation indices.
Sampling frame. All women attending Scottish gynaecology units for an induced abortion were
eligible except for those unable to read and understand English. The survey commenced six
months following the intervention activities and took place over four months. The first month
effectively represented a 'run-in' phase because of postal delays affecting the receipt of
questionnaire packs by several units.
Survey administration and consent. Conducting a survey of this client group presented a range of
methodological and ethical problems. Some women undergoing induced abortion may
experience anxiety and distress. The conduct of the survey was designed to minimise any
additional burden imposed by participation in research.
The first issue concerned timing. Women may have been able to provide more considered (and
possibly valid) views about their care later after discharge. However, there was a risk that
surveying women a month following discharge from abortion care would have led to a reduced
response rate. It was also considered inappropriate to contact women by post because of the risk
of breaching confidentiality. The survey was therefore administered at the point of discharge
following the abortion procedure.
The second issue concerned consent. There was a risk that selection bias might have occurred
had clinical staff been responsible for consenting women. For instance, clinicians in the
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intervention group could have recruited a different group of women from those clinicians in the
control group (e.g. those more satisfied with care received). Use of a consent form was also
considered inappropriate because it might facilitate later identification of individual women.
Therefore, by choosing whether or not to complete the questionnaires, women were able to give
implied consent.
The patient survey form only allowed identification of the gynaecology unit attended. All
women received a sealed envelope, containing a questionnaire stapled to an SAE, as part of the
administrative procedure during discharge. Women who opted to participate in the survey
retained the option of handing (sealed) it to staff or posting it themselves. In this way, women's
responses could be kept confidential from clinical staff. Clinical staff were informed about the
study in case women required further information.
The conduct of the survey was piloted in two gynaecology units (one intervention and one
control) to test the feasibility and acceptability of administration to both staff and the women.
Out of 120 questionnaires administered, 48 (40%) were returned, an acceptable response rate in
comparison with similar surveys (149;263). No administration problems were reported.
7.3.8.3 Economic evaluation
Costs. Data on costs of the strategy were elicited and categorised in relation to its development,
dissemination and implementation (196). Development costs included those costs that would not
necessarily need to be replicated in future use of the strategy in gynaecology units. These costs
consisted of centrally incurred costs in designing aspects of the intervention such as the audit and
feedback process. The costs were apportioned equally to each unit. Such costs conceivably
could be incurred in the replication of the intervention strategy by a national clinical
effectiveness programme, or equivalent.
The intervention costs were estimated separately for each of the five components of the
implementation strategy:
• Audit and feedback
• Identification of barriers
• Educational meetings
• Dissemination of a model structured case record
• Promotion of a patient information booklet
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For the intervention arm, data were collected during each significant contact, namely the
meetings with lead gynaecologists and local educational meetings. Structured notes were taken
to record the length of each contact and the number and grade of local staff involved (Appendix
7E). Action plans agreed with each unit following the educational meetings were recorded.
Some of the centrally incurred costs (e.g. time taken to plan the audit) were estimated
retrospectively following discussions among project team staff. The amounts of staff time,
including travelling time, at each grade for the personnel involved in each stage of the
intervention were estimated and combined with figures for per hour salary rates. The rates used
were the mid-point on the salary scale for each grade with the addition of on-costs for
superannuation and national insurance. Other costs included catering at the various meetings and
any travel expenses incurred by intervention staff to visit the units, and administration costs such
as printing, postage and photocopying of data collection forms audit reports.
Primary outcomes. These comprised differences in the level of compliance with each of the five
key recommendations (section 7.3.6).
Secondary outcomes. These comprised differences in the level of compliance with each of the
other recommendations as measured by the case note review and patient survey (section 7.3.7).
Post-intervention, a semi-structured telephone survey took place with lead gynaecologists in both
control and intervention units. This survey ascertained what efforts had been made to change
local services in the six months since the start of the intervention phase. The interview schedule
covered action taken specifically in relation to the five key recommendations (Appendix 7F).
The collection of this data also enabled an exploration of differences in compliance with
recommendations among control and intervention units that might be related to reported local
activity following the implementation strategy.
7.3.9 Sample size
Case note review. The original sample size calculations were based upon the anticipated
recruitment of twenty gynaecology units. The sample size for the case note review was based
upon a cluster level analysis that matched gynaecology units by pre-intervention performance
and randomised each of the matched pairs of units to intervention or control (266). Using data
from the Gynaecology Audit Project in Scotland (GAPS), the average compliance across 10
hospitals with a key RCOG guideline recommendation (assessment appointment within 5 days of
referral) was 49%. Based upon this outcome, it was expected that the hospitals could be matched
so that the correlation between the matched pairs exceeded 0.7. Using these characteristics, a
study with 20 hospitals and 75 cases per hospital at follow up would have had 80% power at 5%
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significance level to detect a difference of 20% in average compliance between intervention and
control hospitals. Two developments led to the modification of this approach. Firstly, 26 units
were recruited. Secondly, for the five primary outcomes, none of the correlations within the
matched pairs were sufficiently strong (over 0.7) to warrant a matched analysis (Table 7.2). Such
an analysis would have had 55% power to detect a 20% difference. Therefore, the matching was
broken and the study analysed as two independent groups (267), resulting in 82% power to detect
a difference of 20% in the definitive analysis.
Table 7.2. Pre- to post-intervention correlations within matched pairs for key outcomes.
Recommendation Pearson correlation Significance
(2 tailed)
Appointment with a gynaecologist within five days of
referral
0.53 0.08
Ascertainment of cervical cytology history 0.40 0.20
Antibiotic prophylaxis or screening for lower genital tract 0.20 0.54
organisms
Misoprostol cost-effective alternative to gemeprost -0.10 0.76
Offer of contraceptive supplies if required prior to
discharge
0.39 0.21
Patient survey. The sample size for the patient survey was based upon a patient level analysis
correcting for clustering using multilevel modelling. This required 1000 patients (i.e. 50 patients
from each of 20 hospitals) to detect a difference between units of 20% (44% versus 64%), with
80% power and a 5% significance level. This assumed an intra-cluster correlation (ICC) of less
than 0.1. There were no previous ICC estimates relating to patients' experiences of and
satisfaction with secondary care. However a primary care study of patients' satisfaction with out-
of-hours primary care observed ICCs of the order of 0.05 (268) which were similar to the order
of ICCs observed in outcome surveys (269).
7.3.10 Data entry
All data were entered onto an Access Database. For the case note review, the reliability of data
entry was checked by re-entering 10 selected items for a 5% random sample of records. No
miscoded entries were found out of 72 records and 720 entries. For the patient survey, data were
also re-entered for a 5% random sample of records. Based upon 48 records and 32 items per
questionnaire, one entry was miscoded out of 1536, an agreement of 99.9%.
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7.3.11 Analysis
Case note review. The primary analysis of the data was planned to estimate the effect of the
multi-faceted strategy on clinical practice. The case note data were analysed as described in
Appendix 7G.
Generalised estimating equations (GEE) represented the principal analysis technique adopted.
This is a technique for use with hierarchical data sets (patients within gynaecology units in this
case) and allowed variation to be modelled separately at each level (270). Given the difficulties
in interpreting and adjusting for baseline in cluster trials with cross sectional binary
measurements (271), the a priori analysis strategy (272) was to compare the difference between
the compliant proportions in the post intervention data only. It was noted that, in this case,
adjusting for baseline using the log odds of the pre-intervention compliance scores as a covariate
made no difference to the size of effects.
Where compliance rates were high (>90%) or low (<10%), differences between the groups were
tested for on the log-odds scale using the Mann-Whitney test. The exponential of the difference
between the medians was then taken to give an odds ratio, as recommended by Ukoumunne and
Thompson (271). All results are presented as odds ratios.
It was possible that the ImpACT strategy might have reduced variations among intervention units
compared with control units, i.e. clinical care became more uniform. Levene's test was therefore
used to compare equality of variances between the intervention and control units (273).
Analysis was by 'intention to treat', in that all women managed by gynaecology units allocated to
the intervention were analysed as study patients, irrespective of whether or not the gynaecology
unit utilised the intervention fully. Information on the uptake of the intervention was used to
explore the impact on any changes in clinical practice.
Patient survey. The analysis was similar to that for the case note study in that it allowed for
clustering effects and was based upon intention to treat. The patient survey outcomes were
analysed as described in Appendix 7H. The survey also collected data about age and gestation at
the time of abortion, permitting two comparisons to assess bias and generalisability. Firstly,
comparison between the intervention and control groups allowed the detection of systematic
differences that might be related to selective recruitment. Secondly, the characteristics of the
patient survey respondents were compared with those ofwomen in the case note review.
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The number of patient survey packs sent to each gynaecology unit was recorded. The
denominator used to calculate the survey response rate was derived by subtracting the number of
packs remaining at the end of the survey period from the number sent out to each unit.
Economic evaluation. The evaluation was planned to address the costs and benefits of guideline
dissemination. This was appropriate on the assumption that implementation of the guideline is
beneficial (since the recommendations were derived using a rigorous methodology) and that
findings on the costs and benefits of the intervention should be generalisable to the
implementation of other clinical guidelines (274;275). In addition to the cost-effectiveness
analysis, a balance sheet approach was planned to identify the costs and benefits of the
intervention if the intervention was found to result in statistically significant improvements in the
primary outcome measures (276).
7.3.12 Ethical approval
The study was approved by the Multi-centre Research Ethics Committee for Scotland and
accepted by ten individual local research ethics committees (LRECs).
7.4 Results
7.4.1 Recruitment of gynaecology units
Figure 7.1 shows the recommended flow chart to facilitate reporting of cluster randomised trials
(277).
Figure 7.1. Flow chart for cluster randomised trial.
Assessed for
eligibility (26 gynaecology units)
Randomised (26)








Mean cluster size 58.7
Range 12-77








Mean cluster size 59.7
Range 0-76
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Twenty-six gynaecology units were identified and recruited, comprising eight teaching and 18
non-teaching hospitals. Eighteen mainly served urban populations and eight semi-rural or rural
populations. The number of abortions performed annually varied among units, with the majority
of units (16) providing abortion care for between 101 and 500 women each year (Table 7.3).
Table 7.3. Annual number of induced abortions for 12 months over 1998-9 in Scottish
hospitals (Source: Scottish Abortion Statistics, ISD).
Annual number of induced abortions Number of hospitals




1001 - 1250 2
Over 2000 1
Total 26
7.4.2 Case note review
7.4.2.1 Number of cases identified
A total of 1474 eligible cases were assessed by the post-intervention case note review, 763 from
the intervention arm and 711 from the control arm (Table 7.4). A mean of 56.7 cases was
assessed per unit. No cases were identified in unit Z.
Table 7.4. Number of cases assessed for each gynaecology unit (presented in matched
pairs as originally planned for the analysis).
Intervention units Number of cases assessed per unit Control units
A 12 0 Z
B 75 75 W
C 23 76 X
D 50 51 o
E 53 38 Q
F 75 75 s
G 58 59 u
H 75 56 R
1 67 75 N
J 75 48 V
K 75 52 T
L 48 31 P
M 77 75 Y
Total 763 711 Total
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7.4.2.2 Patient and unit characteristics
Overall, intervention and control units were balanced with respect to patient and unit
characteristics, except for a higher proportion of medical abortions in the intervention arm (Table
7.5). Pre-intervention unit compliance was compared between intervention and control units
(Table 7.6). There were no statistically significant differences except for one outcome, antibiotic
prophylaxis and screening, where the 95% confidence interval for the 1.5% difference between
the medians was 0 to 8.3%.
Table 7.5. Post-intervention patient and unit characteristics.






Patient age at time of referral (years) 24.9 (0.8) 25.5 (0.8)
Number of live and still births per patient 0.9 (1.1) 0.9 (1.2)
Number ofmiscarriages and previous induced abortions
per patient
0.4 (0.8) 0.4 (0.7)
Estimated gestation at date of assessment appointment
(weeks)
7.8 (0.6) 8.1 (0.7)
Method of abortion (proportion medical abortion) 49.8 (31.8) 44.3 (25.9)
Number of cases per cluster (SD) 58.7 (21.1) 59.7 (15.6)
Table 7.6. Pre-intervention unit compliance with five key outcome recommendations.














Appointment with a gynaecologist within five days
of referral (1041)
40.1 (19.5) 37.5 (17.3) 2.6 (-12.6 to
17.9)
Ascertainment of cervical cytology history (776) 50.5 (34.8) 55.6 (32) -5.1 (-32.9 to
22.7)
Antibiotic prophylaxis or screening for lower 100 (98 to 97 (90.3 to 1.5 (0 to 8.3)
genital tract organisms (1073) 100)* 100)*






0 (-2 to 18)
Offer of contraceptive supplies if required prior to
discharge (1073)
69.2 (22.0) 70.8 (24.7 -1.6 (20.9 to
17.7)
*The medians (inter-quartile range) and median differences for skewed data
7.4.2.3 Primary outcomes
There were no significant differences between intervention and control units for any of the five
primary outcomes (Table 7.7). There was one non-significant trend favouring the intervention
160
group for one recommendation (antibiotic prophylaxis or screening for lower genital tract
organisms, OR 1.70; 95% CIs 0.71 to 5.99). Mean unit compliance remained low for the offer of
an assessment appointment within five days of referral. However, it was near optimal for two
recommendations: antibiotic prophylaxis or screening for lower genital tract organisms; and the
use ofmisoprostol as a cost-effective alternative to gemeprost.
The variances in post-intervention compliance were tested for equality using Levene's Test.
There were significant results for two of the outcomes. For antibiotic prophylaxis or screening,
there was significantly less variation within the intervention arm (SD 3.34) compared to the
control arm (SD 11.31, p=0.02). This was principally related to low compliance in one control
unit. For the use of misopostol, there was greater variation within the intervention arm (SD
14.39) compared to the control arm (SD 4.67, p=0.005). This was mainly related to lower
compliance in three intervention units. Taken together, these findings suggest that the ImpACT
strategy had no consistent effect on inter-unit variation for the primary outcomes.
Table 7.7. Primary outcomes based on case note review.











Appointment with a gynaecologist within
five days of referral (n=1430)
35.5 (17.1) 40.5 (18.3) 0.89 (0.50, 1.58)
Ascertainment of cervical cytology
history (n=1074)
58.5 (29.2) 60.2 (32.1) 0.93 (0.36, 2.40)
Antibiotic prophylaxis or screening for













Offer of contraceptive supplies if required
prior to discharge (n=1474)
72.1 (17.7) 73.0 (24.9) 1.11 (0.48, 2.53)
*The medians (inter-quartile range) and median differences for skewed data
7.4.2.4 Secondary outcomes
No significant differences between intervention and control were observed with respect to any of
the secondary outcomes measured from the case note review (Tables 7.8 to 7.12).
For pre-abortion management, there were two non-significant trends favouring the control group
(Table 7.9). Firstly, the mean proportion of women appropriately undergoing opportunistic
cervical smears was 12% lower in the intervention group (OR 0.79, 95% CI 0.26 to 2.44).
Secondly, the mean proportion of women appropriately undergoing ultrasound scanning was
27.6% lower (OR 0.28, 95% CI 0.07 to 1.07).
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For abortion procedures, there was one non-significant trend in favour of the intervention group
(Table 7.10). The use of conventional suction termination at gestations of 7-15 weeks if
appropriate or preferred was 4.8% higher (OR 1.34. 95% CI 0.55 to 3.25).
The numbers of eligible cases were too small to detect any differences between control and
intervention units for the management of complications (Table 7.11).
The variances in post-intervention compliance were tested for equality using Levene's Test.
There were two significant results for two of the 25 outcomes assessed. For the recommended
dose of 200 mg mifepristone in early medical abortion, a dose of 200mg of mifepristone, there
was significantly less variation within the intervention arm (SD = 0) compared to the control arm
(SD 31.37, p = 0.03). This was principally related to low compliance in one control unit.
Similarly, for the avoidance of routine surgical evacuation of the uterus following mid-trimester
medical abortion, there was significantly less variation within the intervention arm (SD = 0)
compared to the control arm (SD 11.11, p = 0.03), also related to low compliance in one control
unit. For other recommendations, no consistent non-significant trends were found in favour of
reduced variation among the intervention units. Overall, these findings provide little evidence
that the ImpACT strategy influenced inter-unit variation for the secondary outcomes.
Table 7.8. Secondary outcomes on organisation of services based on case note review.











As a minimum standard, all women are 89.7(11.4) 88.5 (15.9) 1.15 (0.71, 1.89)
offered an assessment appointment within
two weeks of referral (n=1430)
Ideally, all women can undergo the
abortion within seven days of the decision
79.8 (7.8) 78.7(13.5) 1.00 (0.59, 1.70)
to proceed being agreed (n=1459)
As a minimum standard, all women can 96.0 96.0 0.96 (0.65, 1.92)
undergo the abortion within two weeks of
the decision to proceed being agreed
(n=1459)
(94.8,98.1)* (94.6, 98.1)*
As a minimum standard, no individual 89.5 93.6 0.87 (0.37,2.29)
woman need wait longer than three weeks
from her initial referral to the time of her
(83.1, 94.9)* (83.6, 94.8)*
abortion (n=1432)
In the absence of specific medical, social 93.1 95.3 0.86 (0.44, 1.60)
or geographical contra-indications,
induced abortion may be managed on a
day-case basis (1428)
(89.3, 96.1)* (90.7, 96.3)*
*The medians (inter-quartile range) and median differences for skewed data
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Table 7.9. Secondary outcomes on pre-abortion management based on case note review.
Recommendation (total number of Percentage Percentage Odds ratio
eligible cases) intervention mean control mean unit (95% CIs)
unit compliance compliance (SD)
(SD)
Pre-abortion assessment should include 97.9 98.3 0.77 (0.22, 1.99)
appropriate blood tests (n=1474) (86.5, 100)* (96.2, 99.7)*
It is not cost-effective routinely to cross¬ 100 100 1.31 (0.85,2.59)
match women undergoing termination of (98.4, 100)* (98.0, 100)*
pregnancy (n=1474)
Women who have not had a smear within 63.4 (24.3) 75.5 (11.9) 0.79 (0.26, 2.44)
the interval recommended in their local
programme may be offered a smear taken
opportunistically (n=637)
Ultrasound scanning is not considered to 21.1 (32.4) 48.7 (40.7) 0.28 (0.07, 1.07)
be an essential prerequisite of abortion in
all cases (n=1474)
The medians (inter-quartile range) and median differences for skewed data
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Table 7.10. Secondary outcomes on abortion procedures based on case note review.











Medical abortion is an appropriate
method at gestations of <7 weeks /






be avoided at <7 weeks (n=233)
For early medical abortion, a dose of 100** 100 1.22 (0.77, 3.67)
200mg of mifepristone, in combination
with a prostaglandin is adequate (n=567)
(96.2, 100)*
Use of conventional suction termination 62.2 (23.0) 57.3 (33.3) 1.34 (0.55, 3.25)
at gestations of 7-15 weeks if appropriate
or preferred (n=1212)
For women presenting between 7-15 0* Q* * * n/a
weeks' gestation, suction termination may
be safer under local anaesthesia than
under general anaesthesia (n=725)
Cervical preparation is beneficial prior to






if the woman is aged under 18 years or at
a gestation of >10 weeks (n=207)
For mid-trimester medical abortion, a 100** 100** n/a
dose of 200mg of mifepristone is
adequate (n=92)
Surgical evacuation of the uterus is not 100** 100**** n/a
required routinely following mid-
trimester medical abortion (n=92)
Mid-trimester abortion by dilatation & - - n/a
evacuation (D&E), preceded by cervical
preparation, is safe and effective when
undertaken by specialist practitioners (no
cases)
For women presenting at greater than 15 100** 100** n/a
weeks' gestation, as an alternative to D &
E, services may prefer to offer medical
abortion (n=29)
The medians (inter-quartile range) and median differences for skewed data
**AII units 100% compliant
***AII units 0% compliant except for one case in one unit
****AII units 100% compliant except for one case in one unit
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Table 7.11. Secondary outcomes on managing complications of abortion based on case note
review.







control mean unit (95% CIs)
compliance (SD)
Oxytocics are effective in reducing intra¬
operative blood loss (no cases)
- - n/a
In cases of suspected uterine perforation
laparoscopy is the investigation of choice
(n=3)
oo* 0** n/a
*Based upon two clusters of n=1; **Based upon one cluster of n=1.
Table 7.12. Secondary outcomes on after care based on case note review. (NB.
proportions expressed are medians because of skewed data.)
All















Anti-D IgG should be given to all non-







A follow-up appointment (either within
the abortion service or with the referring
clinician) within two weeks of the
procedure should be offered to each






Before she is discharged following
abortion, future contraception should







Sterilisation can safely be performed at
the time of induced abortion. However
combined procedures are associated with







It is safe and effective to insert an IUCD
for contraceptive use immediately








A total of 1028 questionnaires were returned completed out of 2109 distributed, a response rate
of 48.7%. The response rate was lower in the intervention arm (45.1%; 482 / 1069) than in the
control arm (52.5%; 546 / 1040). Response rates varied markedly among units, ranging from 3%
to 98% (Table 7.13).
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Table 7.13. Response rates to patient questionnaire by gynaecology unit (based upon
original matched pairs).





A 4/8 50 - 0/0 Z
B 122/138 88 88 76/86 W
C 13/32 41 22 13/60 X
D 99/101 98 81 117/144 0
E 28/52 54 40 4/ 10 Q
F 32/64 50 61 118/194 s
G 27/50 54 30 15/50 u
H 33 / 64 52 11 5/47 R
I 37/59 63 77 174/227 N
J 23 /109 21 10 5/52 V
K 55/182 30 12 6/50 T
L 3/38 8 10 2/20 P
M 6/172 3 11 11/100 Y
Total 482/ 1069 48.7 52.5 546 / 1040 Total
7.4.3.2 Patient characteristics
Overall, intervention and control units were balanced with respect to patient characteristics
except for, as in the case note review, a higher proportion of medical abortions in the intervention
arm (Table 7.14). It had been intended to compare Carstairs indices using responses to an item
about postcode sector in the questionnaire. However, this was not possible as responses to,.this
item were frequently found to be unsuitable for analysis.
Table 7.14. Baseline characteristics of questionnaire respondents.






Patient age at time of referral 24.4 (7.63) 24.4 (7.67)
Estimated gestation at date of abortion 8.4 (3.22) 9.1 (3.04)
Method of abortion (proportion having medical abortions) 53.5 48.5
Mean number of cases per cluster 37.1 (36.1) 45 (59.9)
7.4.3.3 Compliance with guideline recommendations
No significant differences between the intervention and control groups were observed with
respect to the organisation of services, abortion procedures or aftercare (Table 7.15). However,
significantly fewer women in the intervention group recalled having been counselled adequately
about the complications and possible sequelae of abortion (OR for summary score 0.45, 95% CI
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0.25 to 0.80). Out of the possible complications, intervention group women recalled failure of
the abortion method (OR 0.59, 95% CI 0.33 to 0.95) and pelvic infection (OR 0.53. 95% CI 0.34
to 0.82) significantly less often.
Table 7.15. Compliance with recommendations as measured by patient survey.
Recommendation (total number of eligible cases) Percentage Percentage Odds ratio
intervention control (95% CIs)
median (IQR) median (IQR)
compliance compliance
Organisation of services
Ideally, all women are offered an assessment appointment within 25.0 25.0 1.0
five days of referral (n=965) (13.5.34.7) (11.8,38.2) (0.49. 2.05)
As a minimum standard, all women are offered an assessment 96.0 99.1 1.06
appointment within two weeks of referral (n=965) (89.3, 99.1) (82.6, 100) (0.40. 3.00)
Ideally, all women can undergo the abortion within seven days of 85.0 78.5 1.73
the decision to proceed being agreed (n=959) (72.1, 84.7) (71.4, 97.7) (0.81,3.67)
As a minimum standard, all women can undergo the abortion within 100 95.9 1.85
two weeks of the decision to proceed being agreed (n=959) (96.0, 100) (92.3. 100) (1.01, 3.56)
As a minimum standard, no individual woman need wait longer 84.0 85.2 1.60
than three weeks from initial referral to the time of abortion (n=912) (78.1,95.0) (75.3, 98.1) (0.63.4.15)
Information for women
Verbal advice must be supported by accurate, impartial printed 78.8 64.6 1.45
information which the woman considering abortion can understand (58.3, 84.9) (42.3, 90.5) (0.64, 3.32)
and may take away and read before the procedure (n=1012)
Information for women and professionals should emphasise duty of 92.4 96.1 1.11
confidentiality (n=1012) (88.9, 100) (87.7, 100) (0.44. 1.99)
Professionals providing abortion services should possess accurate
knowledge about possible complications and sequelae of abortion
Possible complications mentioned to women (n=T006) 85.2 89.0 0.46
(69.5, 96.4) (80.8 . 92.8) (0.3, 0.69)
Excessive bleeding following the abortion (haemorrhage, n=972) 69.9 75.5 0.76
(61.5, 74.5) (62.5, 83.2) (0.52. 1.12)
Damage to the uterus, or womb, requiring a more major operation 55.0 68.2 0.55
(uterine perforation: only relevant to surgical abortions: n=438) (25.1,66.7) (18.8. 88.8) (0.24. 1.25)
Failure of the abortion method (and need for another abortion 50.0 63.6 0.59
procedure; n=977) (32.1. 59.0) (42.3, 76.5) (0.33, 0.95)
Pelvic infection (n=978) 51.4 68.5 0.53
(36.0, 66.2) (45.9, 80.1) (0.34, 0.82)
Summary score (for above five questions; n=906) 22.7 45.7 0.45
(8.7,35.4) (9.8, 59.0) (0.25, 0.80)
Abortion procedures
Ideally, abortion services must be able to offer a choice of 53.8 50.0 1.13
recommended procedures for relevant gestation bands (n=826) (23.6, 69.5) (21.8, 75.9) (0.47, 2.69)
After care
After an abortion, women must be given a written account of the 67.5 77.2 0.67
symptoms they may experience and a list of those that would make (46.8, 82.5) (52.9. 80.0) (0.36, 1.25)
an urgent medical consultation necessary (n=973)
A follow-up appointment (either within the abortion service or with 18.2 14.3 1.36
the referring clinician) within two weeks of the procedure should be (15.8,30.3) (1.9,25.5) (0.77, 2.85)
offered to each patient following abortion (n=1029)
Before she is discharged following abortion, future contraception 98.3 100 1.09
should have been discussed with each patient (n=981) (94.3, 100) (99.0, 100) (0.39. 2.34)
Offer of contraceptive supplies if required; chosen method of 88.2 93.8 0.94
contraception initiated immediately following abortion (n=972) (79.2, 100) (80.0. 100) (0.29, 2.48)
Sterilisation can safely be performed at time of induced abortion. 100 100 1.53
However combined procedures are associated with higher rates of (98.7, 100) (100, 100) (0.35, 5.53)
failure and regret (n=1029)
It is safe and effective to insert an IUCD for contraceptive use 12.5 6.5 0.66
immediately following induced abortion (n=l 029) (1.8. 15.9) (0. 34.5) (0.27, 1.57)
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7.4.3.4 Satisfaction with care received
There were no significant differences with respect to satisfaction received (Table 7.16) or other
outcomes of counselling (Table 7.17) between the intervention and control groups.
Table 7.16. Satisfaction with care received (lower scores indicate stronger agreement with
statements on a 1 to 5 scale)
Recommendation (total number of Weighted Weighted control Difference*
eligible cases) intervention mean
(SD)
mean (SD) (95% CIs)
Staffcompetency
The clinical care I received was 1.6 (0.7) 1.7(0.7) -0.44 (-0.16, 0.07)
excellent (n=l013)
My confidentiality was protected
(n=1012)
1.6 (0.7) 1.6(0.7) 0.02 (-0.08, 0.13)
The staff treated me with respect
(n=1020)
1.5 (0.6) 1.5 (0.6) -0.04 (-0.14, 0.07)
The staffwere professional and thorough
(n=1020)
1.5 (0.6) 1.5 (0.5) 0.02 (-0.08,0.11)
Summary score (n=1005) 1.5 (0.5) 1.6 (0.5) -0.01 (-0.09, 0.08)
The counselling process
There was too much emotional talk 3.8 (0.8) 3.8 (0.8) -0.01 (-0.19, 0.18)
(n=968)
There was too much medical talk 3.8 (0.7) 3.8 (0.7) -0.01 (-0.14, 1.29)
(n=969)
The staff asked too many questions
(n=975)
4.0 (0.7) 4.0 (0.7) 0.01 (-0.12,0.14)
Summary score (n=963) 3.9 (0.6) 3.9(0.6) 0.13 (-0.49. 0.76)
Staffsensitivity
The staff treated me as a whole person
(n=1016)
1.5 (0.6) 1.5 (0.6) -0.05 (-0.16, 0.06)
The staffweren't afraid to discuss 2.1 (0.9) 2.2 (0.8) -0.10 (-0.16, 0.14)
emotional issues (n=1010)
Summary score (n=1008) 1.8 (0.6) 1.8 (0.6) -0.03 (-0.15, 0.08)
Global satisfaction
There are some things about the medical 3.7(1.0) 3.6 (1.0) 0.01 (-0.13,0.16)
care I received that could be better
(n=1004)
'Differences may differ slightly from those between intervention and control means in
preceding columns because of adjustment for clustering in GEE
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Table 7.17. Other outcomes following counselling.
Percentage Percentage Odds ratio
intervention Control median (95% CIs)
median (IQR) (IQR)
compliance Compliance
During your clinic appointments, did you 96.8 96.3 0.72 (0.33, 1.24)
have enough time and help in reaching (92.5, 100) (93.7, 100)
your decision to have an abortion?
(n=984)
Do you feel now that your decision was 100 100 1.13 (0.59,2.56)
right for you? (n=976) (95.9, 100) (97.6, 100)
7.4.4 Economic evaluation
Costs. The total cost of the intervention was £26,875 for 13 units, an average (mean) cost per
unit of £2067. Table 7.18 presents a summary of these costs whilst Appendix 71 details the full
costing. The largest component of this cost was incurred at the audit and feedback stage,
estimated at £1026 per unit.
Since the ImpACT implementation strategy involved numerous meetings for training, data
collection and action planning, staff time costs were anticipated to comprise the largest
component of costs. All grades of staff involved in the provision of the abortion service in each
of the intervention units were involved at each stage. Over half of the total cost for the outreach
educational meetings was related to staff attendance at the meetings (£4228 out of a total of
£8041).
Table 7.18. Estimated costs of intervention.
Component Total cost (£) Mean cost per gynaecology
unit (£)
Audit and feedback 13341 1026
Identification of barriers 4579 352
Educational meetings 8041 619
Review of structured case records 881 68
Promotion of patient information booklet 31 2
Total 26,875 2067
Primary outcomes. The lack of statistically significant differences in primary outcomes
attributable to the intervention meant that a cost effectiveness analysis was not justified.
Although the study was limited by the relatively small total number of hospitals, the magnitude
of any differences was small from a substantive point.
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Secondary outcomes. Similarly, the insignificant differences in secondary outcomes (from both
statistical and substantive perspectives) meant that cost effectiveness analysis of these outcomes
was not warranted.
The numbers of control and intervention units reporting any action taken on the key
recommendations, along with a description of these changes (when stated by the unit) is
presented in Table 7.19. In total, the intervention and control units reported similar rates of
action for the key guideline recommendations, though the types of actions varied.
Table 7.19. Action taken on key recommendations: number of units reporting changes and
description of change.
Recommendation Control Examples of changes /
comments




2 Referral system modified to
routinely faxed abortion
requests; all women now seen
by one consultant
4 Overflow clinic established.
Reminder to practices of 'hotline'
for referrals; extra patient per




1 Standard proforma designed
and introduced for all patients
2 Now routinely record smear status
if over 20 years
Antibiotic
prophylaxis and / or
screening
2 Routine antibiotic use since
October 2001; standardised
prescription chart now used.
3 Standardisation of local policy -
all women now screened and all
offered antibiotic prophylaxis;
Standardisation of protocol - all
patients now receive doxycycline
(plus azithromycin if positive for
chlamydia); change of antibiotic
to universal use of azithromycin.
Use ofmisoprostol 2 Misoprostol introduced as part
of a clinical study; misoprostol
used in medical abortions as
standard; with similar change
planned for surgical abortions.
2 Standardisation of policy towards
more consistent use of
misoprostol; now use misoprostol




2 Proforma sets out explicit plan. 2 Routine recording in nursing and
medical notes of contraception
offer and provision; oral
contraception now prescribed at
assessment clinic (named patient
basis).
Other 9 Better written information for
patients; increased use of
medical abortions; integrated
care pathway introduced; early
medical abortion service about
to be introduced; medical
abortion now offered at 9-12
weeks gestation
6 Reduction in senior nursing input
Development of patient leaflet
Development of Integrated Care
Pathway.
Several units provided details of staff time in changing clinical policy and implications for
resource use as a consequence of a change in policy (e.g. use of antibiotics or contraceptives).
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Unfortunately, the information was not always sufficiently detailed or specific to enable a
reliable estimate of the costs of these changes to be made. However, in order to illustrate the
nature and extent of any effects on resource use, quoted estimates of staff time and other
resources involved in policy changes are listed in Table 7.20. Some changes in resource use
could have occurred. Where units changed their policy on antibiotic prescribing there would be
corresponding changes in drug costs. Similarly, extra provision of contraceptives would have
incurred additional prescribing costs. The use of misoprostol in place of gemeprost would have
reduced costs since the latter is more expensive.
Table 7.20. Reported details of the staff time to effect any policy change and any
implications for resource use as a consequence of changes in policy.






Additional session of Trust grade doctor
time to operate an extra overflow clinic.
One hour for 2 consultants in agreeing
changes to policies for recording smear
status, antibiotic prophylaxis policy,
misoprostol use, and policy on the provision
of contraceptives.
Meetings about change to prostaglandin use
with pharmacists and consultants plus
briefing of nursing staff estimated at 2
hours for one consultant and 1 hour for a
senior pharmacist.
48 hours of consultant time (and
unspecified head pharmacists time)
negotiating change in contraception
prescribing policy with pharmacist.
3 hours of staff nurse time to develop a
patient leaflet.
5 hours for both a consultant and staff nurse
for development of integrated care pathway.
Development of standard proforma for
cervical smear status required 10 hours of
consultant time.
Negotiation for change to use ofmisoprostol
took 6 hours of consultant grade time.
Audit project on discharge documentation for
contraception provision required 4 hours of
senior house officer grade time.
Improvements in written patient information
required 1 hours of consultant time plus 4
hours of staff nurse time.
Higher proportion ofmedical abortions
increased demand on nursing time.
Change to misoprostol required 8 hours of
consultant time to negotiate.
Change to routine antibiotic use required 4
hours of consultant grade time for paper
submitted to clinical governance committee.
Integrated care pathway involved a wide
range of staff in a steering group for monthly






Perception of reduced delays in referrals
from some practices as a result of reminder
about hotline for referrals.
Increased awareness of recording issues and
increased confidence of day care staff.
Routinely faxed referrals made appointments
easier to arrange.
Earlier discharge freed up bed space and
helped to increase throughput.
Big reduction in waiting times as a result of
additional clinic session and use of a single
lead consultant on one afternoon with all
women now seen within 5 days.
Standardised prescription chart saves time
writing up prescriptions.





A tailored, multi-faceted strategy, delivered under the auspices of a national clinical effectiveness
programme, to promote implementation of a clinical guideline had no effect on the quality of
induced abortion care. Moreover, there was no evidence that the strategy reduced variations in
compliance among intervention units compared with controls.
According to the post-intervention case note review, overall median compliance was 100% for
two of the key recommendations (antibiotic prophylaxis or screening for lower genital tract
organisms and misoprostol as a cost-effective alternative to gemeprost), indicating little scope for
improvement ('ceiling effects'). Compliance remained poorest for the provision of an
appointment with a gynaecologist within five days of referral (intervention 35.5%; control
40.5%). The lack of effects for the other two key outcomes (ascertainment of cervical cytology
history and the offer of contraceptive supplies prior to discharge) were also disappointing.
The patient survey produced a satisfactoiy overall response rate, although unexpectedly lower in
the intervention arm (45.1%) than in the control arm (52.5%). Significantly fewer women in the
intervention group recalled having been counselled about the complications and possible
sequelae of abortion (OR 0.45, 95% CI 0.25 to 0.80). No other significant differences between
the intervention and control groups were observed with respect to compliance with
recommendations or satisfaction with care received.
The average cost of the intervention per gynaecology unit was £2067, with the audit and
feedback component accounting for half of this cost. The lack of any significant differences in
primary outcomes meant that a cost-effectiveness analysis was not justified. Both the
intervention units and the control units reported some changes in abortion policy. It was not
possible, given the information available, to readily identify whether any changes in the
intervention units occurred as a direct result of the intervention. It is conceivable that there were
some changes in efficiency of provision of abortion services that were not reflected in the
primary or secondary outcome measures. There was no other evidence that any efficiency gains
were necessarily greater in intervention units than in control units.
7.5.2 Strengths and weaknesses of study design
The ImpACT implementation strategy and its evaluation had several important strengths. Firstly,
the guideline recommendations disseminated were developed using a rigorous methodology,
benefiting from a major input from groups representing patient interests. Secondly, the study
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employed a strategy tailored according to systematically identified needs and barriers. The
design and content of the interventions were based upon a theory of behavioural change, thereby
enhancing the generalisability of findings. Thirdly, ImpACT used a rigorous design achieving
both greater validity than much previous implementation research and greater generalisability to
UK secondary care settings. Fourthly, an economic evaluation was included, frequently absent
from previous research despite the major opportunity costs of clinical effectiveness initiatives.
The quality of the study design can be assessed according to the Methodological Quality Criteria
for randomised evaluations set out by the Cochrane Collaboration Effective Practice and
Organisation ofCare (EPOC) Group (278).
Concealment of allocation. For cluster randomised trials, the unit of allocation and the
randomisation process should be explicitly described. Gynaecology units comprised the unit of
allocation and randomisation was performed using a computer programme.
Follow up ofprofessionals. To protect against exclusion bias, outcome measures should be
available for at least 80% of professionals randomised. No cases were identified nor patient
questionnaires returned for one small unit allocated to the control arm. One consultant in the
intervention arm refused permission for access to patient case notes. Post-intervention data were
available for the patients of all consultant gynaecologists providing abortion care in Scotland
during the study period (except one from an intervention unit who refused permission to access
case notes).
Follow up ofpatients or episodes ofcare. A follow up of at least 80% of patients randomised is
judged necessary to protect against exclusion bias. For the larger units, random quota sampling
was used to derive a representative sample of patients. In the smaller units, all cases were
included if 75 or less eligible cases were identified for the post-intervention period. The cases
were identified using ward and day care diaries as this was considered the most comprehensive
method of case identification. A small number of case notes were missing in some units,
requiring replacement by other randomly selected cases to make up the quota of 75. The
proportion of missing case notes did not approach 20% in any unit.
The overall response rate to the patient survey was 49%. Although considerably below the 80%
threshold, this represents a satisfactory response rate compared with other surveys of this client
group (263;264). However, the overall response rate masks marked variations in response rates
among individual gynaecology units, ranging from 3 to 98%. Therefore, women responding in
units with lower response rates may have systematically differed from those in other units (e.g.
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feel more satisfied with care received). Assuming that the case note review was generally
representative of all women receiving abortion care in Scotland, there was evidence that
respondents to the questionnaire were similarly representative. The mean age of the women was
similar to that of the case note review. The mean gestation at the time of abortion was also
consistent with the overall mean for the case note review (8.8 weeks). It remains possible that
women responding to the questionnaire were more, or less, satisfied with their care than those in
the reference population.
Whilst the external validity of the survey may be acceptable, the other key issue within the
context of a randomised trial concerns internal validity and the possibility of response bias, i.e.
differences in the characteristics of respondents between the intervention and control arms. The
response rate was 7% higher in the control arm. This was unexpected because greater awareness
of the trial, and hence improved distribution of the questionnaire, was anticipated in the
intervention arm. Yet there were no differences in the baseline characteristics between the
intervention and control arms, except for the proportion undergoing medical abortions. This
suggests that the women in the two arms were broadly similar, reducing the likelihood of
significant response bias.
Blinded assessment of primary outcomes. The assessment of primary outcomes should be
blinded or outcome measures are objective (e.g. length of stay, drug levels). Data collection for
the case note review was not blinded but the outcomes were objective processes of care. During
data checking, unexpected low levels of compliance were queried (e.g. use of antibiotic
prophylaxis or screening). It is conceivable that feedback from the intervention units during the
educational meetings improved ascertainment of outcomes when some data items were
subsequently reviewed and corrected. However, efforts were also made to validate low
compliance for key recommendations in the control units. Furthermore, clinical policies were
confirmed during the interviews with both intervention and control lead gynaecologists at the end
of the follow up period.
Baseline measurement. Performance or patient outcomes should be measured prior to the
intervention, and no substantial differences should be present across study groups. Pre-
intervention performance was measured, mainly to inform the matched randomisation and
provide data for the audit and feedback component. The numbers of cases in individual clusters
were insufficient to allow reliable comparisons to be made before and after the intervention.
Several minor pre-intervention imbalances were present. Notably, the use of antibiotic
prophylaxis or screening was higher in the intervention arm review (Table 6). However,
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regression modelling which accounted for pre-intervention compliance levels demonstrated little
impact on the final outcomes compared with an unadjusted analysis.
Reliable primary outcome measures. There should be good inter-rater agreement or the outcome
assessment should be objective. This was also met as discussed above.
Compliance with ten recommendations was assessed by both the (post-intervention) case note
review and patient survey. This provided an opportunity to compare findings related to the use of
either method (Table 7.21). The overall medians were similar for seven out of ten
recommendations. This comparison suggests that the case note review over-estimated
compliance for the offer of an assessment appointment. The differences in the other two
recommendations related to after care probably demonstrate lack of documentation in the case
notes (although actual documentation itself represents a valid outcome). These differences are
unlikely to reduce the internal validity of the study.
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Ideally, all women are offered an
assessment appointment within five days of
referral
39.1 25.0 Case note review relied upon documented
date on referral letter - may under-estimate
interval and hence over-estimate compliance.
Survey asked women to recall time interval
between first contact (for referral) and first
hospital or specialist appointment - may
represent imprecise estimate
As a minimum standard, all women are
offered an assessment appointment within
two weeks of referral
94.6 96.6
Ideally, all women can undergo the
abortion within seven days of the decision
to proceed being agreed
80.0 80.0
As a minimum standard, all women can
undergo the abortion within two weeks of
the decision to proceed being agreed
96.0 97.4
As a minimum standard, no individual
woman need wait longer than three weeks




A follow-up appointment (either within the
abortion service or with the referring
clinician) within two weeks of the
procedure should be offered to each patient
following abortion
8.0 17.4 Case note review assessed actual
documentation of an appointment date -
hence under-estimating offers —
Patient survey asked whether follow-up
appointment had been arranged. Refusal to
accept a further appointment was counted as
non-compliance to enhance comparability
Before she is discharged following
abortion, future contraception should have
been discussed with each patient
98.0 100
Contraceptive supplies should have been
offered if required. The chosen method of
contraception should be initiated
immediately following abortion
73.9 91.8 Case note review and patient survey asked
similar questions - with former relying upon
documented evidence of availability or
supply.
Sterilisation can safely be performed at the
time of induced abortion. However
combined procedures are associated with
higher rates of failure and of regret
100 100
It is safe and effective to insert an IUCD
for contraceptive use immediately
following induced abortion
9.3 8.1
Protection against contamination. Allocation to study group should be by community,
institution or practice and it should be unlikely that the control group received the intervention.
The risk of contamination among units was recognised, especially in view of the concomitant
NHS Trust mergers. Discussions with relevant clinical directors had suggested that shared
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clinical effectiveness activities were minimal during the intervention and follow-up periods.
Furthermore, during the intervention phase, measures were taken to avoid contamination, e.g.
avoidance of any joint educational meetings between Trusts.
The study took place within the broader context of a national clinical effectiveness programme.
The existence of the programme and knowledge of the trial among clinicians may have exerted
non-specific Hawthorne effects that improved performance in the control units. However, there
were no consistent trends towards improved median compliance pre- to post-intervention across
the recommendations in the control arm, most notably for the main outcomes (Table 7.22). The
ascertainment of cervical cytology status did improve across both intervention and control arms
but was most likely to be related to the growing use of structured case records. The larger
increase in compliance for the offer of contraceptive supplies probably represents a case of
regression to the mean, especially given that the median intervention unit compliance actually
fell from 80.5% to 73.9%.
Table 7.22. Median unit pre- and post-intervention compliance with five key outcome
recommendations in the control arm.







Appointment with a gynaecologist
within five days of referral
41.1 36.0 -5.1
Ascertainment of cervical cytology 61.4 69.6 8.2
history
Antibiotic prophylaxis or screening
for lower genital tract organisms
97 96.5 -0.5
Misoprostol cost-effective 98.6 100 1.4
alternative to gemeprost
Offer of contraceptive supplies if
required prior to discharge
58.6 78.3 19.7
In conclusion, the study design satisfied most of the Methodological Quality Criteria for
randomised evaluations. Nevertheless, as discussed below (7.5.5), the power of the study could
have been enhanced by attaining more precise estimates of pre-intervention compliance.
7.5.3 Possible explanations for the main findings
This study indicated that the multi-faceted strategy to improve abortion care had no beneficial
effect. Possible explanations for this result relate to the study methodology and timing, and the
uptake, ownership and selection of the interventions.
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Methodology. Other studies evaluating multi-faceted strategies that have included educational
outreach and audit and feedback have found modest to moderate effects (103). Some of these
evaluations involved the use of non-randomised designs or poorer quality methods, often
associated with larger effect sizes (279;280). The use of a robust methodology could simply
suggest that such a multi-faceted strategy was ineffective but other reasons for this negative
finding, including other aspects of the study methods, merit consideration.
Two factors related to the outcomes may have contributed to the failure to demonstrate any
effect. Firstly, the relatively small number of clusters and the coincident failure of the matched
randomisation resulted in reduced statistical power. However, no trends were observed in favour
of the intervention, suggesting that a more highly powered study would not have detected any
consistent and significant differences. Secondly, the post-intervention outcomes measured
performance within three months of the completion of the main intervention (the outreach
educational meetings). As some of the key recommendations required changes in clinical policy
or organisation of services, it is possible that there was insufficient time for such changes to work
through to the actual delivery of care.
Two findings make this latter explanation less likely. There was little difference between the
control and intervention arms in the numbers of lead gynaecologists reporting any actions taken
over the key recommendations. And no differences were observed for recommendations where
greater awareness might have led, at least in part, to changes in practice (such as documenting the
history of cervical cytology). There was limited evidence of an intervention effect related to one
of the secondary outcomes: a follow-up appointment within two weeks of the procedure should
be offered to each patient following abortion. There was resistance to the universal routine offer
of an appointment within this time period. But most participants in the outreach educational
meetings agreed that documenting follow-up arrangements offered within any time scale
represented good medico-legal practice and enhanced communications with other sectors (e.g.
primary care). Weighted mean intervention compliance with documentation of follow-up
arrangements over any period of time was 75.8% (SD 24.8) versus 48.4% (SD 25.2) in the
control group, a difference of 27.4% (95% CI 6.5 to 48.2; OR 3.4, 95% CI 1.4 to 8.5). This
suggests that participants made changes that were relatively straightforward to implement and
(perhaps) more readily accepted as representing good professional practice.
Overall, insufficient power and timing of the outcome measurements are unlikely to explain the
absence of an intervention effect.
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Timing ofstudy. The study took place approximately ten years following the Gynaecology Audit
Project in Scotland (GAPS) (149). Despite improvements following GAPS, inappropriate
variations in care had remained. The RCOG guideline was developed in response to such
problems and was published a year before the trial intervention started. The pre-intervention case
note review demonstrated that compliance for one of the key recommendations, antibiotic
prophylaxis and screening, had substantially improved since GAPS. Pre-intervention compliance
was also high for another key recommendation, the use of misoprostol as a cost-effective
alternative to gemeprost. Such 'ceiling effects' may explain the lack of effect demonstrated in
relation to these two recommendations. Similar problems have been encountered with
evaluations elsewhere (247;281). Indeed, an audit of the implementation of clinical practices
supported by Cochrane Reviews in maternity care demonstrated a marked improvement, leading
the authors to suggest that the dissemination of high quality research does change practice,
providing time is allowed for the necessary accumulation of consensus (282).
Pre-intervention measures of compliance suggested that scope for improvement still existed in
relation to other recommendations (e.g. offer of an appointment within five days). However, the
implementation of such recommendations may have been more difficult as they required more
complex organisational changes or wider attitudinal shifts.
Uptake of intervention. All intervention units accepted the intervention package. However, the
intervention and control units reported similar rates of action for the key guideline
recommendations, though the types of actions varied. Actions reported by the intervention units
were subjectively perceived to have a greater degree of focus than the actions undertaken by
control units, though any differences were not ultimately reflected in the primary or secondary
outcomes.
Ownership. The trial intervention comprised a multi-faceted strategy deliverable within the
context of a national clinical effectiveness programme. This approach offered the potential
advantages of standardisation of the intervention and enhanced credibility of its association with
a credible professional network. However, as most of the planning and organisation of the
intervention were centralised, ownership by clinicians might have been lower compared with
locally led efforts to improve care. The average amount of time lead gynaecologists spent
directly on delivery of the intervention - although not insignificant - amounted to an average of
less than four hours. Therefore, the intervention might not have been sufficiently focused nor
locally owned to promote change. Elsewhere, the relatively small impact of a tailored complex
intervention has also been attributed to its relatively passive nature (209).
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The lead researcher (i.e. the author) was experienced in teaching evidence-based medicine using
interactive styles and mainly led the outreach educational meetings. Presentations delivered by a
peer (i.e. a gynaecologist) could have been perceived as being more credible although such an
approach did not work elsewhere (247). An alternative approach would be to ask local clinicians
to present audit findings themselves. This would possibly engender greater ownership of and
responsibility for the audit findings and is planned for future SPCERH audit work of this nature.
Gynaecology units were asked to set at least two or three targets following the feedback
meetings, preferably including action on one of the five key recommendations. The guideline
itself contains 57 recommendations. The potential advantage of such a wide ranging audit is that
it allows units to identify local priorities requiring further action. It is possible that action taken
locally in response to the guideline was 'diluted' across this range of recommendations - and
therefore not detected among any of the outcome measures. Specifying and focusing
implementation on a smaller number of recommendations might have provided gynaecology
units and the study with a more realistic target.
Appropriateness of intervention to identified barriers. The use of a systematic and combined
approach to identifying barriers makes it unlikely that the ImpACT strategy failed because of a
wrong diagnostic analysis. The main weaknesses probably concerned the selection or tailoring of
interventions (Chapter 6.6.4). Work on developing the intervention strategy suggested that a
'ceiling' had been reached on motivating most staff involved in the delivery of abortion care to
follow the recommendations. Therefore, components of the strategy that aimed to increase
motivation were unlikely to be effective. Interventions targeting wider aspects of the
organisation might have been more appropriate and effective.
In summary, there are several plausible explanations for the lack of an intervention effect. Those
considered most likely to have contributed include the timing of the study (and associated
'ceiling effects'), and the intensity and appropriateness of the intervention.
7.5.4 Other findings
Information on complications and sequelae. Significantly fewer women in the intervention
group recalled having been counselled about the complications and sequelae of abortion. There
are three possible explanations for this apparently harmful effect of the intervention. The first is
that it represents a chance finding, partly related to multiple significance testing. This seems
unlikely given the magnitudes of the differences between the intervention and control groups
and, more importantly, the finding that outcomes were significantly worse for three out of the
five items contributing to the summary score. The second explanation is that this finding
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represents a real (side) effect of the intervention. However, the likely mechanism is not certain.
Clinicians in intervention units may have paid greater attention to other aspects of abortion care
(e.g. the five main outcome recommendations) at the cost of improving information for women.
Yet, there were no reports from control units of specific efforts to improve information and,
overall, there were no differences in reported actions taken to implement the guideline between
intervention and control units. The third explanation relates to potential pre-intervention
imbalances. There are no data on patient information prior to the intervention but this remains
the most likely explanation given pre-intervention imbalances with respect to other outcomes and
the lack of evidence to support the alternative causes.
Potential sub-group effects. No effect of the ImpACT strategy was found across gynaecology
units exhibiting a range of compliance. It could be hypothesized that the strategy could have
exerted an intervention effect among units with lower pre-intervention compliance. An a priori
sub-group analysis of this nature was not considered in the design of the trial but might be of
value in future studies.
There are three reasons why the detection of any sub-group effect would have been unlikely in
ImpACT. Firstly, on exploration of the process and outcome data, there was no clear link
between gynaecology units' reported actions to implement the recommendations and
improvement in compliance. Secondly, there was no indication of consistently improved
compliance pre- to post-intervention across the primary and the secondary outcomes. Thirdly,
the analysis of changes in compliance pre- to post-intervention would be hindered by the
unreliability of the pre-intervention estimates of compliance and the small number of
gynaecology units available for such an analysis. These factors reduce the probability of finding
a sub-group effect but do not in themselves disprove the hypothesis of a sub-group effect.
A small post-hoc exploration of the data was undertaken for one of the key recommendations for
which there was evidence of an overall improvement in pre-post compliance: the offer of
contraception at discharge. Eight intervention units had pre-intervention compliance below 70%
compared with four control units. Compliance improved by 15% or more for four out of eight
intervention units compared with one out of four controls. This could be interpreted as a chance
effect or result of selection bias (since these gynaecology units may have differed systematically
from the whole study sample). Regression to the mean is likely to have occurred but such effects
should have been evenly distributed between intervention and control units. This post-hoc
exploration provides insufficient evidence to support a sub-group effect. Furthermore, an
alternative post-hoc analysis exploring detrimental effects (i.e. reductions in unit compliance
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greater than 20%) would have demonstrated reductions in two intervention units compared to
none of the controls.
7.5.5 Implications for clinical practice and policy
This study indicated that a tailored, multi-faceted strategy to promote adherence to the RCOG
clinical guideline on induced abortion care, delivered within the context of a national clinical
effectiveness, had no impact on the quality of care. This finding is context specific. It would be
erroneous to conclude that tailored, multi-faceted interventions (involving educational outreach
and audit and feedback) will be universally ineffective. Contextual modifiers, such as timing of
the study, may have reduced the potential for the ImpACT strategy to have any effect.
There is evidence that the interventions selected were inappropriately targeted. In the case of
ImpACT, the interventions were tailored in the light of known barriers, but the time scale to
modify the interventions was short and the choice of interventions was limited. Those
developing other initiatives to promote adherence to clinical guidelines should consider
protecting more time for the development of implementation strategies and build a broader
armoury of interventions. The continuing dilemma, given the limitations of the current evidence
base, is what interventions are most likely to be effective (103)? There are no universal answers
to this; no one intervention will be consistently effective across all contexts. The selection of any
intervention should be based upon rigorous evidence of its effectiveness, cost considerations,
feasibility and the nature of identified barriers and facilitators.
The costs of the strategy at national and local levels are of interest to policy-makers. The average
cost of the intervention per gynaecology unit was £2067, with the audit and feedback component
accounting for half of this cost. The organisation of activities, such as the audit, at a national
level centralised costs and probably would have been less expensive compared with the
organisation of similar activities locally across 26 gynaecology units. Data collected on local
activities outside of the main interventions (Table 7.20) illustrated the hidden but not
insubstantial costs ofmaking even modest changes in clinical policy, e.g. time spent negotiating
changes in drug regimens or availability (283). The hypothetical trade-off is that locally-led and
owned activities might have been more effective in changing practice.
7.5.6 Recommendations for further research
ImpACT has highlighted lessons on the statistical design and analysis of cluster randomised
trials, the selection of clinical topics, and the use of theory in designing interventions.
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Statistical design and analysis. The importance of statistical issues in the design of cluster
randomised trials was highlighted in the design and analysis of this study. In ImpACT. the
patients identified at each time pre- and post-intervention period were different; hence this trial
used a repeated cross-sectional design. This differs from a cohort design whereby the same
patients are assessed both pre- and post-intervention. Pre-intervention data were collected to
inform matched randomisation and thus increase power. In the event, the cluster sizes (of up to
50 cases) in the pre-intervention period were too small to allow sufficiently precise estimates of
compliance. The imprecise estimates of pre-intervention performance led to low correlation
between pre- and post-intervention performance. Hence, incorporation of pre-intervention
performance may not improve the precision of the intervention effect (J Mollison, personal
communication)(271). Given several pre-intervention imbalances in ImpACT outcomes, a
secondary analysis was performed incorporating pre-intervention compliance. This approach
subsequently had a negligible impact on the results compared with the analysis of post-
intervention outcomes alone. Therefore, the latter analysis was used.
'Careful stratification' of clusters prior to randomisation represents one option to prevent such
difficulties in the interpretation of repeated cross-sectional designs (271). Given the failure of
this approach within ImpACT, it is recommended that stratification is based upon sufficiently
large pre-intervention samples to allow precise estimation of pre-intervention performance or that
larger post-intervention samples are obtained.
The other factors with important influences on statistical power were the number of clusters and
levels of compliance. Firstly, the number of gynaecology units in Scotland was limited but,
given the national boundaries of SPCERH, it was not feasible to recruit further units from
elsewhere. Had more units been available, recruiting more units would have represented a more
efficient means of increasing statistical power than sampling more patients per cluster (269).
Secondly, high levels of compliance with several recommendations made the analysis more
problematic. Lessons learned from this are discussed next.
The selection of clinical topics. The development of clinical guidelines is usually prompted or
justified by demonstrated inappropriate variations in the quality of care. The RCOG guideline
had been developed in response to such problems in abortion care, in part demonstrated by a
previous Scottish audit (149). Although the ImpACT analysis showed continuing deficits in
access to services and after-care, quality of care had already markedly improved for
recommendations probably more amenable to change. Greater scrutiny of the scope for
improving practice is needed when selecting guideline topics for evaluation and appropriate
interventions. Unfortunately, costly pre-study data collection may be required to assess the
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extent of inappropriate care. This barrier can potentially be circumnavigated by using a range of
other data sources, such as routine NHS data and surveys of professional practice, whilst
allowing for their limited validity.
The use of behavioural theory. Strategies that aim to change professional and organisational
behaviour represent complex interventions. The MRC framework for the development and
evaluation of complex interventions recognises the need to establish the theoretical bases of
interventions and undertake exploratoiy studies to choose and refine interventions (207). This
enables interventions to be optimised for evaluation in definitive trials and can improve
understanding of the generalisability of subsequent findings. As in ImpACT, theories from
behavioural sciences are now being used to investigate professional and organisational practice.
Greater use of theory may help explain why interventions work in some contexts but not others.
The overall aim of such work is to develop a scientific basis for selecting and evaluating an
approach to improve professional and organisational practice given specific barriers and
circumstances.
7.6 Conclusion
This cluster randomised trial tested the effectiveness of a tailored package delivered under the
auspices of a national clinical effectiveness programme comprising audit and feedback,
educational meetings, dissemination of structured case records, and promotion of a patient
information booklet. The strategy produced no significant improvements in the quality of care
with respect to the primary and secondary outcomes. There was no evidence that the ImpACT
strategy reduced variations in compliance among intervention units compared with controls. The
lack of significant differences in primary outcomes meant that a cost-effectiveness analysis was
not justified. The mean cost of the intervention per gynaecology unit was £2067, with the audit
and feedback component accounting for half of this cost. There was no evidence that
intervention units planned or made more changes to service provision than control units.
The most likely explanations for the lack of an intervention effect include the timing of the study
in relation to publication of the guideline (with associated 'ceiling effects'), and the intensity and
appropriateness of the intervention.
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Chapter 8
Application of a framework to appraise the validity of the
study designs
8.1 Summary
This chapter sets out an assessment of the strengths and weaknesses of the six different studies
presented within this thesis with respect to their validity, cost and relevance to the needs of the
SPCERH programme. Four different types of validity were considered: statistical conclusion;
internal; construct; and external.
The main threat to statistical conclusion validity comprised low statistical power in the
interrupted time series analysis and cluster randomised trial, increasing the potential for type II
error. In contrast, multiple hypothesis testing in the uncontrolled before and after survey of
obstetrician reported practice increased the likelihood of type I error. The analyses of four
studies appropriately adjusted for clustering effects, thereby reducing the likelihood of type I
errors.
Adding or improving control groups improved internal validity, progressively countering the
potential biases of history, maturation, regression and selection effects. Although the cluster
randomised trial emerged with the fewest threats to internal validity, the interpretation of the time
series was only limited by the possibility (but not probability) of history and instrumentation
effects.
The definition of study constructs and recognition of confounding represented key issues in
determining construct validity and, hence, transferability of the research findings. The study
constructs became more complex with increasing sophistication of both study designs and
interventions. The failure to describe studies according to a common taxonomy contributes to
confusion and uncertainty over the effectiveness of interventions to improve professional
practice.
The studies were ofmoderate to high generalisability to secondary care professionals targeted by
SPCERH activities. However, the absence of any observed effects in the time series analysis and
cluster randomised trial does not necessarily mean that that none would be observed in different
settings of if the interventions were to be varied.
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The cost of the studies increased with growing complexity of design. All studies met the needs
of SPCERH's work programme, particularly the development of clinical guidelines and
monitoring standards through clinical audit, and the development of ways of implementing
effective practice through research.
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8.2 Introduction
The work described in this thesis drew upon a range of study designs, briefly described in
Chapter 1.8.2 and summarised in Table 8.1. Each study design and its methods are associated
with different factors that may strengthen or threaten validity. This section will consider the
meaning of validity and threats to different types of validity, using the framework and definitions
put forward by Shadish. Cook and Campbell (284;285).
Table 8.1. Summary of study objectives and designs.
Study objective (chapter) Design
To determine which attributes of Observational: Observations made before and
recommendations from a national audit project after an intervention
best explain the extent of their adoption into
clinical practice (2)
To survey Scottish obstetricians and midwives to
assess knowledge of key clinical
recommendations from the Report on
Confidential Enquiries into Maternal Deaths in
the UK 1994-6 (3)
To survey Scottish obstetricians to evaluate the Uncontrolled before and after: Observations are
impact of four national clinical guidelines on self- made in one group before and after an
reported practice (4) intervention
To conduct a simple interrupted time series Simple interrupted time series analysis: Multiple
analysis to evaluate the impact of a national observations made before and after an
clinical guideline on the management ofwomen intervention
with mild, non-proteinuric hypertension (5)
To identify barriers to the implementation of a Cross-sectional: Observations made at one point
clinical guideline on women requesting induced in time
abortion and tailor a strategy to improve care (6)
To evaluate the effectiveness of a strategy, Two-arm cluster randomised controlled trial:
delivered within a national clinical effectiveness Groups of participants randomly allocated to
programme, to improve implementation of a different interventions
clinical guideline on women requesting induced
abortion (7)
Uncontrolled after: Observations only made
following an intervention
8.3 Validity
Validity refers to the truth of an inference. The determination of validity entails judging to what
extent relevant evidence supports that inference as being true or correct. Evidence is judged on
the basis of both empirical research findings and the consistency of these findings with other
sources of knowledge, including previous research findings and theories. The determination of
validity is seldom absolute, especially in relation to a single study, and judgements are
fundamentally subjective. Furthermore, as Shadish et al highlight, validity is a property of
inferences and not of study designs or methods (284). For example, critical appraisals of
randomised trials frequently reveal flaws in their conduct, such as differential loss to follow up.
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In such circumstances, it may be erroneously concluded that an intervention is effective despite
probable biased estimates of effect.
There are four types of validity: statistical conclusion; internal; construct; and external. The
following sections provide definitions and descriptions of associated threats to validity (i.e.
biases). This scheme will later be used as a framework to appraise the studies described in this
thesis.
8.3.1 Statistical conclusion validity
Statistical conclusion validity refers to whether there is a true association between an intervention
and outcome and, if so, the strength of that association. The inference may be incorrect in one of
two ways. Firstly, it may be incorrectly concluded that there is an association where none exists
(Type I error). Secondly, it may be incorrectly concluded there is no association where one does
exist (Type II error). Table 8.2 summarises the main threats to statistical conclusion validity.




An insufficiently powered experiment may incorrectly
conclude that the relationship between an intervention and
outcome is not significant
Violated assumptions ofstatistical
tests
Violations of statistical test assumptions can lead to either
overestimating or underestimating the size and significance of
an effect
Fishing and the error rate problem Repeated tests for significant relationships, if uncorrected for
the number of tests, can artifactually inflate statistical
significance
Unreliability ofmeasures Measurement error weakens the relationship between two
variables and strengthens or weakens the relationships among
three or more variables
Restriction ofrange Reduced range on a variable usually weakens the relationship
between it and another variable
Unreliability of intervention
implementation
If an intervention that is intended to be implemented in a
standardised manner is implemented only partially for some
respondents, effects may be underestimated compared with full
implementation
Extraneous variance in the
experimental setting
Some features of an experimental setting may inflate error,
making detection of an effect more difficult
Heterogeneity ofunits Increased variability on the outcome variable within conditions
increases error variance, making detection of a relationship
more difficult
Inaccurate effect size estimation Some statistics systematically overestimate or underestimate
the size of an effect
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8.3.2 Internal validity
Internal validity refers to the validity of inferences made about whether an intervention causes an
outcome. Such inferences are supported if the intervention clearly precedes the outcome, if a
statistical association has been demonstrated, and if no other plausible explanations for the
relationship exist. Table 8.3 summarises the main threats to internal validity.
Table 8.3. Threats to internal validity (based on reference (284)).
Threat Description
Ambiguous temporal precedence Lack of clarity about which variable occurred first may yield
confusion about which variable is the cause and which is the
effect
Selection Systematic differences in types of units recruited to
intervention and control groups
History External events occurring between pre- and post-intervention
measurements which also influence outcome
Maturation Naturally occurring changes over time could be confused with
an intervention effect
Regression Experimental units selected on basis of extreme scores tend to
give subsequent scores closer to the average, an occurrence
that could be confused with an intervention effect
Attrition Loss of experimental units to the intervention or to
measurement which can produce artifactual effects if loss is
systematic
Testing Administration of baseline measurement may alter response to
subsequent measures, an occurrence that could be confused
with an intervention effect
Instrumentation Measurement of outcomes changes over time in a way that
could be confused with an intervention effect
Selection maturation interaction Time-dependent changes vary systematically in different types
of experimental units
8.3.3 Construct validity
Construct validity refers to the validity of inferences about the higher order constructs that
represent sampling variables. Construct validity requires an adequate elucidation (or explication)
of the constructs and an adequate assessment of the variables sampled. Within implementation
research, the constructs include features of interventions, settings or outcomes. For example, the
term 'audit' describes any process of feeding back performance data within a specified period of
time (155). Several attributes of this intervention may vary, such as the content, source,
recipient, timing or format of the feedback data. Sufficient knowledge of and agreement upon
the main attributes of an audit and feedback intervention demonstrated to be effective are
necessary to ensure its replication.
The constructs of the variables sampled within implementation research also require sufficient
elucidation. For example, the self-reported practice of consultant gynaecologists is insufficient
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as a measure of gynaecology unit performance partly because the practice of individual
consultants may not reflect that of all other staff who contribute to the performance of a
gynaecology unit. Table 8.4 summarises the main threats to construct validity.





Failure to adequately define a construct may lead to incorrect
inferences about the relationship between operation and construct
Construct confounding Operations usually involve more than one construct, and failure to
describe all the constructs may result in incomplete construct
inferences
Mono-operation bias Any one operationalisation of a construct both under-represents
the construct of interest and measures irrelevant constructs,
complicating inference
Mono-method bias When all operationalisations use the same method (e.g. self-
report), that method is part of the construct actually studied
Confounding constructs with
levels ofconstructs
Inferences about the constructs that best represent study
operations may fail to describe the limited levels of the construct
that were actuallv studied
Intervention sensitive factorial
structure
The structure of a measure may change as a result of an
intervention, change that may be hidden if the same scoring is
always used
Reactive self-report changes Self-reports can be affected by participant motivation to receive
an intervention, motivation that can change after assignment is
made
Reactivity to the experimental
situation
Participant responses reflect not just interventions and measures
but also participants' perceptions of the experimental situation,
and those perceptions are part of the intervention construct
actually tested
Experimenter expectancies The experimenter can influence participant responses by
conveying expectations about desirable responses, and those
expectations are part of the intervention construct as actually
tested
Novelty and disruption effects Participants may respond unusually well to a novel innovation or
unusually poorly to one that disrupts their routine, a response that
must then be included as part of the intervention construct
description
Compensatory equalisation When the intervention provides desirable goods or services,
administrators, staff, or constituents may provide compensator)'
goods or services to those not receiving the intervention, and this
action must then be included as part of the intervention construct
description
Compensatory rivalry Participants not receiving the intervention may be motivated to
show they can do as well as those receiving the intervention, and
this compensatory rivalry must then be included as part of the
intervention construct description
Resentful demoralisation Participants not receiving a desirable intervention may be so
resentful or demoralised that they may respond more negatively
than otherwise, and this resentful demoralisation must then be
included as part of the intervention construct description
Intervention diffusion
(contamination)
Participants may receive services from an intervention to which




External validity refers to the extent to which a causal relationship holds over variations in
persons, settings, treatments, and outcomes. This involves inferring whether a causal relationship
established within an experiment can be generalised beyond that experiment. Table 8.5 lists the
main threats to external validity.
Targets of generalisation can be diverse:
• Narrow to broad, e.g. whether results of implementation studies including gynaecologists can
be generalised to all secondary care clinicians
• Broad to narrow, e.g. whether results of studies involving a wide range of secondary care
clinicians can be generalised to gynaecologists
• At a similar level, e.g. whether results of studies including Scottish gynaecologists can be
generalised to gynaecologists in the North ofEngland
• To a different kind, e.g. whether results of studies involving general surgeons can be
generalised to gynaecologists
• Random sample to population members, e.g. to what degree results from a random sample of
gynaecologists can be generalised to the whole population of gynaecologists
Generalising from single studies is problematic. The design of experimental studies often
requires specification of the range or heterogeneity of persons, treatments, or outcomes
considered. If one or more of these variables is too heterogeneous, real associations may be
missed within a combined analysis. However, narrower specifications can substantially limit
generalisability. Systematic reviews are useful because they can provide information about
whether a causal effect holds over a wider (more heterogeneous) range of contexts.
Table 8.5. Threats to external validity (based on reference (285)).
Threat Description
Interaction ofthe causal relationship An effect found with certain kinds of units might not hold if
with units other kinds of units had been studied
Interaction of the causal relationship An effect found with one intervention variation might not hold
over intervention variations with other variations of that intervention, or when that
intervention is combined with other treatments, or when only
part of that intervention is used
Interaction of the causal relationship An effect found on one kind of outcome observation may not
with outcomes hold if other outcome observations were used
Interactions ofthe causal An effect found in one kind of setting may not hold if other
relationship with settings kinds of settings were to be used
Context-dependent mediation An explanatory mediator of a causal relationship in one context
may not mediate in another context
191
8.4 Appropriateness of study designs
Factors other than validity influence the choice of study design. These factors primarily include
resources available and relevance to the needs of research programmes. Experimental and some
quasi-experimental studies are relatively expensive and time-consuming to plan and conduct.
Less rigorous opportunistic studies can still usefully contribute to the knowledge base built up
within a programme of research if their associated limitations are acknowledged. The designs
and methods of the studies described in this thesis therefore need to be appraised in the context of
SPCERH's work plan:
• Development of clinical guidelines and monitoring standards through clinical audit
• Education, training and facilitation of professionals providing reproductive healthcare
• Provision of coordination and advice
• Developing ways of implementing effective practice through research
The strengths and weaknesses of individual studies within this thesis have been discussed in
previous chapters, applying criteria for methodological quality in two (Chapters 5 and
7)(134;231). The main objective of this chapter is to apply a more generic framework to appraise
the strengths and weaknesses of the studies with respect to their validity, cost and relevance to
the needs of the SPCERH programme. The framework best fits the appraisal of intervention
studies; hence the defined threats to validity do not always appear relevant to the descriptive and
observational studies described below. However, the framework has been applied pragmatically
to highlight key lessons learned from each study and the overall critique is intended to be
illustrative rather than comprehensive.
8.5 Appraisal of studies
8.5.1 Attributes of clinical recommendations that influence change in practice
following audit and feedback
This observational study measured pre- and post-intervention compliance in gynaecology units,
assessed by a case note review, following an intervention consisting of an audit and feedback
programme (Table 8.6). Multi-level modelling was used to examine the relationship between
thirteen attributes of clinical practice recommendations and compliance with the
recommendations before and after the intervention.
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Table 8.6. Appraisal of the validity of the observational study.
Study objective: To determine which attributes of recommendations from a national audit project best
explain the extent of their adoption into clinical practice (Chapter 2)
Relevant threats to validity Strengths Limitations
Statistical conclusion validity









Regression Regression effects controlled for
in model
Construct validity
Construct confounding Elucidation of intervention,
measures of clinical practice,
and rating of recommendation
attributes
Association between attributes
and change in practice
controlled for in model
Confounding related to
observational study design
Changes in practice also
possibly related to residual
confounders
External validity




Generalisable to other study
settings uncertain
Interaction of association with
intervention variations
Association may not hold for
variations of audit and feedback
methods or other types of
intervention
Interaction of association with
study context
External evidence of convergent
findings in primary care
Statistical conclusion validity. The use of multi-level modelling, incorporating individual
hospital effects, was justified given the marked variation in practice observed among different
hospitals. Analyses based on patient level data, which do not account for 'clustering' effects,
might have over-emphasised the significance of any results (152).
Internal validity. As changes in clinical practice were measured before and after the intervention,
ambiguous temporal precedence is not a threat. Recommendations less compatible with clinician
norms and values were associated with greater improvements in clinical practice, possibly
because of greater potential for change due to low pre-intervention compliance. The multi-level
model included an interaction term that accounted for temporal changes (130). Therefore, the
association between lower compatibility and changes in practice cannot solely be attributed to
improvements upon more extreme low levels of pre-intervention compliance (regression effects).
Construct validity. The constructs comprised the following:
193
• Participants: gynaecology units
• Intervention: attributes of recommendations
• Outcomes: compliance and changes in compliance
• Setting: national audit and feedback project in secondary care in Scotland
The attributes of the guideline recommendations are categorised as the intervention in this
instance - although conventionally they represent effect modifiers and the audit and feedback
project represents the intervention.
The attributes were rated by end-point users, i.e. a consensus panel of gynaecologists. Different
results might have been obtained had the attributes been rated in another way, such as by a panel
of researchers or using a different style of consensus development.
Construct confounding related to study design can hinder the interpretation of outcomes. There
were no control groups of gynaecology units. The effect estimates of audit and feedback may
have been biased (inflated) by a combination of self-selection by participating units (16 out of 26
units in Scotland participated), and history and maturation effects. If the association between
recommendation attributes and changes in compliance were to be assessed in a different
experimental context, such as a randomised trial of audit and feedback, the effect estimates might
be reduced. Hence, the association between attributes and changes in compliance might be
weaker if tested within studies of greater internal validity.
Construct confounding may also present difficulties in interpretation of the associations between
changes in practice and the recommendation attributes. In crude terms, for each attribute changes
in practice were compared between one group of recommendations possessing that attribute and
another group without. Changes were attributed to effects of the attributes, controlled for the
potential confounders of other attribute effects and pre-intervention compliance. Residual
confounding effects may have confused the real strength and/or direction of the associations.
Compatibility with clinician norms and values was significantly correlated with the seven other
attributes and might represent a general marker for a range of attributes that influence practice,
including unknown attributes that remained unadjusted for in the final model.
External validity. The study findings are directly generalisable to gynaecologists participating in
national audit projects in Scotland. The observed association may be modified or may not hold
over other contexts. For example, different attributes may have influenced change in clinical
behaviour following an intervention other than audit and feedback (e.g. interactive educational
programmes). But with regard to setting, two attributes, compatibility and requires changed
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routines, had significant and independent effects on compliance in both this and a similar study
of audit and feedback in primary care (29). This finding strengthens the likelihood that these two
attributes have more generalisable associations with compliance (but not necessarily changes in
compliance).
Appropriateness of study. This was an opportunistic study conducted at relatively low cost. It
addressed SPCERH's role in developing interventions to support guideline implementation.
8.5.2 Survey of Scottish obstetricians and midwives to assess knowledge of key
clinical recommendations from the Report on Confidential Enquiries into
Maternal Deaths in the UK 1994-6
It is worth noting that this survey was primarily intended as a descriptive study. In order to
illustrate the limitations of using such designs in intervention studies, it will be appraised as an
uncontrolled after (post-intervention) study (Table 8.7). Observations, consisting of knowledge
and self-reported behaviour, were only made following the intervention, dissemination of the
Report (132).
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Table 8.7. Appraisal of the validity of the uncontrolled after study.
Study objective: To survey Scottish obstetricians and midwives to assess knowledge of key clinical
recommendations from the Report on Confidential Enquiries into Maternal Deaths in the UK 1994-6
(Chapter 3).
Relevant threats to validity Strengths Limitations
Statistical conclusion validity
Fishing and the error rate
problem






Historv Lack of control group




Response to interviews may
under-represent extent of
knowledge prompted in vivo by
clinical events
Mono-method bias Only one type of outcome
measured
Reactivity to the experimental
situation
Efforts made to conceal nature
of survey before interviews and
to ensure anonymity
Interviewees may have given
socially desirable responses







Interaction of the causal
relationship with units
High response rate and quasi-
random sampling of staff
Findings may not be
generalisable or relevant to
other professional groups
Interaction of the causal
relationship over intervention
variations
Findings may not be
transferable to other types of
confidential enquiries
Context-dependent mediation Potential effect modification of
SPCERH
Statistical conclusion validity. Minimal inferential statistical analysis was performed given the
descriptive nature of the study. The only reported statistical test compared median recall of key
recommendations among groups exposed in varying degrees to the Report. There was risk of
type I error as this hypothesis was tested post-hoc.
Internal validity. As no observations were made before the intervention, it was not possible to
determine whether the intervention resulted in any change. Respondents who reported having
read at least some of the Report or had attended a relevant educational meeting recalled more
recommendations compared with those who had not. Yet the timing of the relationship between
knowledge and exposure to the Report is unclear (ambiguous temporal precedence). For
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example, staff who received or read the Report may already have been more interested in the
issues it raised and hence recalled more recommendations.
The absence of a control group meant that no allowance was made for secular trends, including
history and maturation. To illustrate the latter, obstetric units conducting their own enquiries
may have reached similar conclusions to the Report and might have independently disseminated
recommendations to local staff.
Construct validity. The main constructs evaluated initially appear to be clear:
• Participants: junior and senior obstetric medical and midwifery staff
• Intervention: postal dissemination of educational materials
• Outcomes: professional knowledge; self-reported behaviour
• Setting: secondary care in Scotland
On closer scrutiny, the intervention and outcomes merit further elucidation. The dissemination of
the Report was supported by SPCERH, via national meetings and its newsletter. Therefore,
SPCERH may have represented a co-intervention. One outcome, awareness of key
recommendations, may be context-specific. For example, a midwife may not be able to recall
recommendations concerning pre-eclampsia when questioned 'out of the blue'. Confronted with
a patient at high risk of pre-eclampsia, she might be prompted to recognise the need for senior
medical input and warn the patient to be vigilant about possible warning signs. Therefore, the
survey method may have under-estimated the true prevalence of professional awareness.
Only one type of outcome, based on self-report, was assessed (mono-method bias). It is not clear
whether dissemination of the Report had any other consequences for other outcomes, such as
women's perception of care or resource use.
Reactivity to the experimental situation was recognised as a risk. The precise nature of the
survey was not stated in advance to prevent staff from making special efforts to consult the
Report before the interviews. Nevertheless, in responding to questions about clinical behaviour,
staff may have felt pressurised to report what they perceived to represent best practice. In
mitigation, the confidential nature of the survey and its aim to assess dissemination of the Report
rather than individual competence were explained to all participants.
Similarly, the interviewers possibly had expectations of what respondents, or subgroups of
respondents (e.g. more senior staff), knew about the Report recommendations (experimenter
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expectancies). Although efforts were made to standardise the interview schedule and enhance its
objectivity, it is feasible that interviewer expectancies led to an over-estimation (or under¬
estimation) of respondents' knowledge and compliance with the recommendations.
External validity. It is possible that staff who recalled more recommendations were more likely
to respond than those who declined to be interviewed. However, significant response bias was
unlikely given the response rate of 97% and quasi-random method of selecting participants.
Hence, the findings of this study are generalisable to obstetricians and senior midwives
throughout Scotland, and possibly elsewhere in the UK
This may not be the case when generalising more broadly. At face value, obstetricians and
midwives are likely to share many characteristics with other health professionals. However,
given the established history of conducting confidential enquiries in relation to obstetric events,
obstetricians and midwives might be more familiar with and receptive to Confidential Enquiry
reports than colleagues in other specialities. Similarly, these findings may not be generalisable to
other types of confidential enquiry.
Whether or not SPCERH can be categorised as a co-intervention, the context in which the Report
was published represented a potentially important mediator. Scotland contains a relatively close-
knit community of obstetricians and gynaecologists, formalised by the development of SPCERH
and other national professional bodies. Its prevailing professional culture could act as an effect
modifier - although there is no empirical evidence of such an effect.
Appropriateness ofstudy. This study was not designed to assess the effectiveness of national or
local dissemination activities. Despite the aforementioned pitfalls in ascertaining professional
awareness, the survey indicated which recommendations required reinforcement in future
dissemination activities. The survey represented a low cost, opportunistic project, consistent with
SPCERH's core audit and dissemination functions.
8.5.3 Survey of Scottish obstetricians to evaluate the impact of four national clinical
guidelines on self-reported practice
The survey of obstetricians to assess the impact of four national guidelines represented an
uncontrolled before-and-after study (Table 8.8). Observations comprised self-reported
behaviour, including responses to vignettes, made in one group of Scottish obstetricians before
and after dissemination of the guidelines.
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Table 8.8. Appraisal of the validity of the uncontrolled before-and-after study.
Study objective: To survey Scottish obstetricians to evaluate the impact of four national clinical
guidelines on self-reported practice (Chapter 4)
Relevant threats to validity Strengths Limitations
Statistical conclusion validity










History External local or national events
not controlled for
Maturation Independently occurring





scope for improved compliance







Mono-method bias Use of self-reports only
Reactivity to the experimental
situation
Participants may have given
socially desirable responses
External validity
Interaction of the causal
relationship with units
Low response rates limits
generalisability to all
obstetricians
Interaction of the causal
relationship over intervention
variations
Evidence that effect size varied
among four guidelines
Interaction of the causal
relationship with outcomes
Use of self-reports potentially
over-estimated compliance and
change in practice
Context-dependent mediation Potential effect modification of
SPCERH
Statistical conclusion validity. There was a risk of type I error because of multiple hypothesis
testing. At a significance level of 5%, at least one 'significant' change in practice would have
been anticipated in this study. Nevertheless, the overall trend was consistent with improved
knowledge and practice; the limited number of obstetricians available for the survey possibly
constrained the ability to detect further significant changes.
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Internal validity. The sequence of events is clearer with this design, with pre-intervention
observations acting as a control for the post-intervention observations. Many characteristics of
the study sample were similar when both measurements were taken, as only responses to those
replying to both surveys were analysed.
The main disadvantage was the lack of a non-intervention control group, which may have led to
an over-estimation of effect. Firstly, maturation effects can occur when the passage of time
brings about changes in the study participants independent of the intervention. The obstetricians
may have become more familiar with certain clinical practices over time independently of
knowledge of the guideline recommendations. Secondly, history bias may have occurred if other
local or national events contributed to any apparent improvement in awareness of
recommendations, e.g. publication ofCEMD reports.
The other threats to internal validity comprised regression and testing effects. For the follow-up
survey, those guideline recommendations with greatest scope for improvement in practice were
selected. Regression to the mean could have occurred if study recommendations selected on the
basis of their more extreme scores (low compliance with guideline recommendations) tended to
give subsequent scores closer to the average. Testing effects represented a threat because
changes in self-reported practice were assessed over time. Clinicians responding to the follow-up
questionnaire may have become sensitised to the most appropriate responses.
Construct validity. The constructs comprised the following:
• Participants: consultants and senior / specialist registrars in obstetrics
• Intervention: the launch of clinical guidelines at a national educational meeting supported by
feedback on self-reported performance and postal distribution of the guidelines, occurring
under the auspices of a national clinical effectiveness programme.
• Outcomes: self-reported practice, partly in relation to clinical vignettes
• Setting: secondary care in Scotland
Unlike the CEMD survey, participants completed vignettes designed - to a limited degree - to
represent realistic clinical scenarios. Hence, responses were (slightly) more likely to represent
actual practice. However, only self-reports were assessed (mono-method bias). Participants
could plausibly have reacted to the experimental situation by tailoring responses so as to be seen
to be complying with the guideline recommendations, hence inflating compliance. Despite the
confidential nature of the survey, some obstetricians may have felt under pressure to consult the
guidelines and find the 'correct' responses.
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External validity. The respondents were a self-selected group; 35% of the sample did not
respond and obstetricians unaware of. or not following, the guidelines may have been less likely
to respond to the survey. Therefore, the low response to both surveys limits the generalisability
of the findings to all obstetricians in Scotland.
In addition, there was limited evidence that the postulated causal relationship varied with the
nature of the intervention, i.e. the content of the guideline. There were significant improvements
in reported management relating to two guidelines, The Preparation of the Fetus for Preterm
Delivery and The Management of Pregnancy in Women with Epilepsy. However, reported
practice in relation to The Management of Mild, Non-proteinuric Hypertension in Pregnancy
improved little. This was perhaps because the guideline recommendations for this topic were
relatively complicated to understand and apply, and established patterns of practice more
resistant to change.
Only self-reports were assessed and these may over-estimate actual clinical performance (37). It
is possible that both the levels of compliance and changes in compliance observed in this study
would not be replicated in a study using outcomes based on actual patient data (129).
The guidelines were disseminated under the auspices of SPCERH and within the obstetric
community in Scotland. These factors may have acted as effect modifiers and thus may alter the
generalisability of the findings to other contexts.
Appropriateness of study. The primary objective was to audit reported practice following
dissemination of the guideline, demonstrating integration of guideline development,
dissemination and audit at a national level. This objective was inherited as part of SPCERH's
work programme. The time and expense of conducting this survey were low.
8.5.4 Simple interrupted time series analysis to evaluate the impact of a national
clinical guideline on the management of women with mild, non-proteinuric
hypertension
This evaluation comprised an interrupted time series analysis (Table 8.9). Multiple observations,
compliance with guideline recommendations assessed by a case note review, were taken before
and after an intervention: dissemination and implementation of the guideline. The objective was
to detect whether the intervention had an effect greater than any underlying trends in practice
(134).
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Table 8.9. Appraisal of the validity of the interrupted time series analysis
Study objective: To conduct an interrupted time series analysis to evaluate the impact of a national
clinical guideline on the management ofwomen with mild, non-proteinuric hypertension (Chapter 5)
Threats to validity Strengths Limitations
Statistical conclusion validity
Low statistical power Numbers of cases sampled per
time point and observations
decided on pragmatic grounds
Violated assumptions of
statistical tests
Logistic regression modelling adjusted
for clustering per time point
Fishing and the error rate Main outcomes determined prior to
problem analvsis




Restriction of range Outcomes modified (pre-analysis) to
enhance scope for detecting change
Heterogeneity of units Variable responses to
intervention among maternity
units may obscure causal effects
Interna! validity
Selection bias Same units assessed pre- and post-
intervention; no temporal change in
case mix
History External events judged unlikely to have
exerted any significant effects
Maturation Pre-intervention trends act as control
for post-intervention
Regression Analysis of trends allows estimation of
effects related to regression
Attrition Post-intervention data available for all
four units; 85% of case notes analysed
for appropriateness ofmanagement





limitations of patient follow-up data
Mono-operation bias Study evaluated one method of audit
and feedback
Mono-method bias Study outcomes consistent with survey Outcomes from case note
of obstetrician practice review, not (e.g.) patient views
Intervention sensitive
factorial structure








Unlikely given precedence of similar
interventions and low intensity of
intervention
External validity
Interaction of the causal Findings relevant to other obstetric and Limited generalisability to other
relationship with units midwifery staff professional groups
Interaction over Potential effect modification of
intervention variations guideline recommendations
Context-dependent Potential effect modification of
mediation SPCERH
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Statistical conclusion validity. The main outcomes for this study were determined in advance of
the analysis. However, the criteria for appropriate care were relaxed following the initial
estimations of compliance to deal with the threat of restricted range of the outcome measure.
This augmented the sensitivity of the outcome measures and the ability of the study to detect
changes in practice. The study was analysed appropriately using time series techniques,
employing logistic regression modelling adjusted for the clustering per time point.
Four factors probably impaired the ability of the analysis to detect significant changes in practice.
Firstly, and despite attempts to standardise data collection, the level of inter-observer variation
was unknown. Given the relative complexity of data extraction, it is likely that random error
reduced the precision of the effect estimates.
Secondly, it was envisaged that 40 cases would provide sufficiently reliable estimates for each
time point. A mean of 35 cases per month were available for the measurement of initial
diagnosis whilst a mean of 30 cases per month were available to measure the appropriateness of
subsequent clinical management. Given the wide error around each data point in the time series,
any small to moderate changes in practice may not have been detected. Visual examination of
the graph for appropriate diagnosis suggests a small increase in the intercept, raising the
possibility' of a type II error. There was little indication of any change in the intercept or gradient
for subsequent clinical management, suggesting that a larger study sample would have been
insufficient to detect a significant change.
Thirdly, the use of more post-intervention time points would have reduced ambiguity of the
diagnosis process trends. Following a non-significant post-intervention increase in the
appropriateness of diagnosis, there was evidence of a 1.2% decay in compliance per month.
Paradoxically, this decay could have caused an apparent intervention effect. Decreasing
compliance in the last five to six data points contributed to the negative slope of the fitted line,
hence increasing the level of effect at the intercept (start of the post-intervention period).
Hypothetically, had compliance subsequently risen again the negative slope of the fitted line
would have been reduced, thus diminishing the intervention effect. Without further data points
(beyond 12 months post-intervention) it was not possible to determine whether the increased
post-intervention compliance for the appropriateness of diagnosis was artefactual or real.
Fourthly, the four study units were heterogeneous, representing a range of self-reported practice,
locations and hospital types. These different units responded variably to the intervention.
Unadjusted for trends, the mean pre- to post-intervention change in the appropriateness of
diagnosis was 5.3% with a range of -0.4% to 12.0% among the four units. Similarly, the mean
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pre- to post-intervention change in the appropriateness ofmanagement was 3.7% with a range of
-2.3% to 10.2%. Although important for external validity, high levels of heterogeneity tend to
obscure causal relationships.
Internal validity. Simple (uncontrolled) interrupted time series analyses allow for secular
changes resulting from maturation or regression to the mean to be estimated. The main threats to
internal validity comprised selection, history, attrition and instrumentation effects.
Selection bias can be ruled out as the same units were assessed before and after the intervention.
Furthermore, there was no evidence of any change in case mix that could have altered the
outcomes following the intervention period.
History, other events occurring between the start of the intervention and post-intervention
observations, could have improved compliance in the absence of the intervention. Potentially
confounding local and national events were investigated and judged unlikely to have exerted any
significant effect on practice within the study units. As this identification was retrospective, and
in the absence of a control group, it remains possible that events exerting significant confounding
effects might not have been detected.
Attrition would have represented a threat had no data been available for one or more of the
maternity units post-intervention. However, although all 1263 case notes were assessed for
compliance with the diagnostic criteria, sufficient data was available on only 1081 (85%) for the
assessment of subsequent management. There was no indication of any trend in the proportion of
cases available for the assessment of management, suggesting that attrition over time did not
represent a major threat.
Instrumentation bias represents the final threat to internal validity, whereby the way in which
data were collected could have changed over the study period. A standard form was used to
collect objective data from case notes but data collectors were not explicitly blinded to the
hypothesis. The detection of key clinical events or processes in the case notes might have varied
according to the vigilance of data collectors. Hence, data collectors' awareness of the hypothesis
that clinical care was expected to improve following dissemination of the guideline could have
contributed to bias. Given the complexity of interpreting such data in the assessment of
compliance, any such effects were unlikely.
Construct validity. The constructs comprised the following:
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• Participants: consultant-led maternity units
• Intervention: the launch of a clinical guideline at a national educational meeting supported by
feedback on self-reported performance and postal distribution of the guidelines, occurring
under the auspices of a national clinical effectiveness programme.
• Outcomes: compliance with the clinical guideline assessed by a case note review
• Setting: secondary care in Scotland
The main outcomes consisted of compliance with criteria set out in the guideline
recommendations. Yet the guideline recommendations were relatively complex. In particular,
women could move between different levels of care over time, depending upon clinical findings
and the results of investigations. Subsequently, collecting data to capture all relevant events over
the complete course of a pregnancy would have been prohibitively time consuming and difficult
to analyse. The outcomes and data collection therefore focused on the diagnosis and
management of women during the first seven days following the initial detection of raised blood
pressure, proteinuria or both. The use of these narrower constructs may have prevented the
detection of changes in care occurring over longer follow-up periods for each woman.
For logistical reasons, the intervention comprised one of several methods of feeding back data on
performance. It is important that this particular operationalisation of audit and the negative
findings of the study are not generalised inappropriately to other ways of conducting audit
(mono-operation bias).
The method used to measure performance, the case note review, represents part of the outcome
construct. This aspect of the study was susceptible to mono-method bias as other outcomes were
not elicited, such as women's views on the quality and acceptability of care. Given the lack of
change detected with both the case note review and the obstetrician survey (8.5.3), any such other
effects seem unlikely.
Other aspects of the study design were unlikely to represent significant threats to construct
validity. The intervention could have affected the structure of the data available, independently
of the outcome measure (intervention sensitive factorial structure). The format of case notes may
have changed over time, possibly in response to the dissemination and implementation of the
guideline, allowing better recording of clinical details. The likelihood of such an effect was low
given the observed lack of significant change. The retrospective nature of the study protected
against participants' (clinical staff) reactivity to the experimental situation. Novelty and
disruption effects were unlikely given precedence of similar interventions (i.e. related national
standard setting and audit projects) and the low intensity of the intervention locally.
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External validity. The main strengths and weaknesses relating to external validity are similar to
those raised under sections 8.5.2 and 8.5.3. It is plausible that the four maternity units that
agreed to participate in this study were atypical. However, attempts were made to enhance the
representativeness of the units by sampling units from different geographical areas in Scotland,
comprising two teaching and two district general hospitals.
It is notable that, according to the obstetrician survey, there were no reported improvements in
practice in contrast to two other guidelines released simultaneously. Therefore, had the time
series analysis been conducted for one of the other topics instead, it is possible than a beneficial
effect could have been detected following what essentially represented the same intervention.
Appropriateness ofstudy. This study represented an opportunistic but more rigorous evaluation
of the guideline dissemination and implementation strategy than the uncontrolled before-and-
after survey of obstetrician practice. A randomised evaluation was not possible given that the
guideline had been disseminated throughout Scotland. The recruitment of external controls (i.e.
maternity units in Northern England) was considered outside the territory of the SPCERH
programme. Although less costly than a randomised evaluation, the time and expense of this
study were greater than anticipated because of data collection problems.
8.5.5 The identification of barriers to change and tailoring of a strategy to improve .....
induced abortion care
This critique focuses on the use of a cross-sectional survey, assessing the relationship between
unit compliance (measured by a case note review) with two guideline recommendations and
psychological measures in clinical staff from gynaecology units (Table 8.10). However,
reference will also be made to the supplementary use of open-ended survey questions and semi-
structured interviews with lead gynaecologists. Compliance was measured prior to a trial
intervention.
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Table 8.10. Appraisal of the validity of the cross-sectional study.
Study objective: To identify barriers to the implementation of a clinical guideline on women
requesting induced abortion and tailor a strategy to improve care (Chapter 6)




Modelling adjusting for cluster
effects










Unit compliance used as proxy
measure for individual
behaviour




Use of individual-level theory to
explain unit behaviour
Mono-method bias Combined use of TPB
questions, open-ended questions
and interviews
Reactivity to the experimental
situation
Use of psychometric testing
External validity
Interaction of the causal
relationship with units
Acceptable survey response rate
of 72%
No data on barriers available
from one gynaecology unit
Selection bias of survey
responders
TPB survey findings only apply
to staff directly involved in
abortion care





assessed in TPB survey
Statistical conclusion validity. Compliance data were analysed as a continuous rather than
categorical variable to enhance the ability to detect significant correlations with psychological
measures (226). Regression analysis accounted for hospital clustering effects (152).
Internal validity. Cross-sectional surveys can test the strength and direction of an association but
cannot provide direct evidence of causality because of ambiguous temporal precedence. In this
case staff attitudes may influence compliance with a guideline - but compliance levels may also
influence staff attitudes.
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Construct validity. The constructs comprised the following:
• Participants: gynaecology units
• Outcomes: association between (pre-intervention) unit compliance and individual
psychological measures
• Setting: secondary care in Scotland
It was not possible to obtain data on the performance of individual professionals. Unit
compliance was therefore used as a proxy measure for individual behaviour. Different results
might have been found if individual-level performance data had been available.
Construct confounding was a risk associated with the use of the survey. As a social cognitive
theory, TPB did not represent the most appropriate approach to identifying wider factors (i.e. the
full range of constructs) that influence behaviour, such as the organisation and wider
environment (235). The interviews with lead gynaecologists did provide such information. Yet
this complementary' approach was not based upon a theory-derived framework, thus limiting its
transferability.
Mono-method bias was avoided by the use of three approaches to identify barriers. The TPB
survey was complemented by the interviews with local lead gynaecologists, which tended to"
focus on organisational aspects, and more specific information about barriers and facilitators
given by the open-ended responses to the staff survey.
Reactivity to the experimental situation represents a problem with surveys, whereby respondents
may give what they perceive to be the correct responses. Compared with questions that ask
clinicians why they follow guidelines or not, psychometric methods may be more valid and
reliable in the identification of individually-mediated barriers and facilitators. The former
describe clinicians' reported reasons for their actions but these reasons are not necessarily the
same as the causes of their behaviour. For example, the TPB questionnaire findings indicated
that attitudinal factors were associated with unit compliance to offer an assessment appointment.
These factors were not identified from open-ended responses possibly because of a reluctance to
admit to negative attitudes.
External validity. The generalisability of the associations found to other gynaecology units was
limited in three respects. Firstly, no data were available for one gynaecology unit (unit C). Pre-
intervention compliance levels with the two guideline recommendations assessed in the TPB
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survey were in the lowest quartiles for this unit. The inclusion of this poorer performing unit
may have modified the associations found.
Secondly, the effective survey response rate was 72%, which generally suggests a representative
sample. However, there was an under-representation of junior medical staff sampled; a more
representative sample could have produced different results. For example, perceived behavioural
control (PBC) was lowest for the offer of an assessment appointment within five days of referral.
Had more junior medical staff responded, it is plausible that PBC would be even lower - as
junior medical staff tend to have less operational control within gynaecology units compared with
more senior staff. On regression analysis, there was weak evidence that PBC predicted unit pre-
intervention compliance (p=0.095); a stronger association might have been found had more
junior staff responded.
Thirdly, the survey findings are generalisable to clinical staff directly involved in the provision of
abortion care. The beliefs and intentions of staff in the wider organisation, which were not
ascertained, may differ and thus limit broader generalisation. Combining methods to identify
barriers partly circumvented this limitation.
The interaction of the associations also differed with respect to the two guideline
recommendations (or intervention variations) assessed by the TPB questionnaire. Individual
professionals' control over the offer of contraception supplies at discharge was notably greater
than that for the offer of an assessment appointment. This represented an important finding
rather than a weakness of the study design.
Appropriateness of study. This work contributed both to the tailoring of the ImpACT
intervention and understanding of its (lack of) effect. The combined approach to the
identification of barriers to and facilitators of guideline implementation was more resource-
intensive than anticipated.
8.5.6 Cluster randomised trial of a strategy, delivered within a national clinical
effectiveness programme, to improve implementation of a clinical guideline on
women requesting induced abortion
The evaluation of a strategy to support the implementation of the guideline, The Care ofWomen
Requesting Induced Abortion, represented a cluster randomised controlled trial (Table 8.11).
Groups of participants (gynaecology units), were randomly allocated to intervention and control
arms, and differences in the outcomes (compliance with key guideline recommendations),
attributed to the intervention.
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Table 8.11. Appraisal of the validity of the cluster randomised controlled trial
Study objective: To evaluate the effectiveness of a strategy to improve implementation of a clinical
guideline on women requesting induced abortion (Chapter 7)
Threats to validity Strengths Limitations
Statistical conclusion validity
Low statistical power Limited number of clusters,
failed matched randomisation,




Adjustment for clustering effects
Fishing and the error rate Main outcomes determined prior to
analysis
Unreliability ofmeasures Objective outcomes used for case note
review; Reliability of patient survey
questions previously established




Pragmatic study testing national rather





Selection, history, Protection by random allocation of
maturation & regression intervention
Attrition Completeness of sampling for case note
review; Similar characteristics of
respondents to patient survey in
intervention and control arms
Construct validity
Inadequate definition of Detailed definition of intervention
constructs constructs
Confounding constructs
with levels of constructs
Recognised low intensity of
mterventions to promote structured
case notes and patient information
Mono-method bias Combined outcome data from case
notes and patient survey
Intervention sensitive
factorial structure




Familiarity with audit and feedback,
and clinical effectiveness projects
Compensatory Prevented by cluster randomisation
equalisation
Compensatory rivalry Intervention units not explicitly
identified
Resentful demoralisation Unlikely given lack of intervention
effect
Intervention diffusion Minimised by cluster randomisation
(contamination)
External validity
Interaction of the causal
relationship with units
Generalisability to gynaecology units Generalisability to other specialties
Interaction of intervention
variations
Findings may vary if strategy or
choice of guideline changed
Context-dependent Potential effect modification of
mediation SPCERH
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Statistical conclusion validity. There were several strengths relating to statistical conclusion
validity. These included the determination of five key outcomes prior to data collection and the
use of appropriate statistical techniques to adjust for clustering effects. The outcome measures
were reliable: the case note review was based upon objective process data; and the reliability of
patient survey questions established by previous work (263).
The power of the study was limited by several factors: the limited number of clusters; the
unreliability of pre-intervention estimates of compliance and subsequent failure of matched
randomisation; ceiling effects related to several outcomes; and the limited follow up period. As
discussed in Chapter 7 (7.5.3.1), an exploration of trends in compliance and information on the
process of local implementation suggest that insufficient power is unlikely to explain the lack of
an intervention effect.
A range of gynaecology units was recruited and varied (for example) in size and teaching status.
The heterogeneity of the units and subsequent potential for variability in responses to the
intervention may have obscured causal effects. A crude sub-group analysis for one primary
outcome (Chapter 7.5.3.2) did at least suggest that gynaecology units with low pre-intervention
compliance were no more likely to respond to the intervention than controls.
The ImpACT intervention was delivered in a standardised manner to all of the intervention
gynaecology units. There was evidence that local implementation efforts varied substantially
(Chapter 7.4.4). However, the study was of a pragmatic nature and not designed to ensure
standardised local implementation.
Internal validity. Randomised trials counter many of the aforementioned threats to internal
validity, including selection, history and maturation effects. The principal remaining threat to
internal validity was attrition bias, if loss to follow-up of outcome measures in the intervention
and control arms had occurred systematically. Attrition bias was unlikely for the case note
review, given the similarity in the characteristics of the patients in each arm and the use of
complete groups or random samples of women undergoing induced abortion in the study units.
Attrition bias represented a more plausible threat to the comparison of compliance in the patient
survey; the overall response rate was 49%, and 7% lower in the intervention arm. However,
patient characteristics were similar in the two arms.
Construct validity. The constructs comprised the following:
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• Participants: Gynaecology units providing abortion care
• Intervention: A tailored package, deliverable by a national clinical effectiveness programme,
comprising audit and feedback, outreach educational meetings, dissemination of structured
case records, and promotion of a patient information booklet
• Outcomes: Compliance with guideline recommendations measured by a case note review and
patient survey
• Setting: Secondary care in Scotland
The intervention constructs were more complex than those in the aforementioned studies. Not
only was the intervention multi-faceted; each component of the package can be broken down into
a number of constituents. For example, the audit and feedback component comprised the
feedback of anonymised, comparative unit performance data six months following data collection
from a national clinical effectiveness programme to clinical staff in gynaecology units.
Furthermore, the interventions used were specifically set up within a research programme and
largely delivered by a researcher. Hence, this one component of the ImpACT strategy
represented a complex intervention in itself.
Confounding effects can occur in relation to different levels of constructs. In this case, the
promotion of structured case notes and patient information should not be confused with the actual
provision of these materials in the interpretation of the findings. As used within the trial, the
former represent relatively weaker interventions. Similarly, the intensity of other aspects of the
interventions delivered locally could have been greater, potentially leading to different effects.
Mono-method bias was avoided by use of a case note review and patient survey - with
reasonable consistency demonstrated for the majority of outcomes assessed by both methods. In
addition, the patient survey incorporated measures of patient satisfaction.
Treatment sensitive factorial structure represented a potential effect. The promotion of structured
case notes could have led to improved recording of clinical actions and hence improved
compliance in the intervention arm. This effect was unlikely because the process evaluation did
not suggest greater uptake of structured case notes in the intervention arm.
The implementation of the implementation strategy in the intervention units is likely to have
engendered little of a novelty effect; most participants were reasonably familiar with the main
constructs of the interventions (e.g. audit) and the content of the guideline. Although national
clinical effectiveness programmes represent a relatively new concept in Scotland, many units had
already participated in precursor national activities (e.g. GAPS). Awareness of participation in a
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research project might have generated greater efforts to improve practice in both intervention and
control groups. There was little evidence of this when overall median pre- and post-intervention
compliance was compared across several recommendations. The equal if not greater risk might
have been related to disruption caused by the interventions engendering negative reactions in a
small but significant minority of participants.
Compensatory equalisation constitutes a risk where an intervention provides additional desirable
support to intervention units, subsequently resisted by participants because of perceived
unfairness to controls. This effect is usually associated with trials randomising individual
patients rather than groups of professionals.
Compensatory rivalry represents a threat if those randomly allocated to control groups became
competitive, thereby making greater efforts to compensate and improve practice. The likelihood
of this was reduced within the trial by not publicly discussing the identity of gynaecology units
during feedback meetings - although it is feasible that knowledge of random allocation may have
diffused through informal professional networks. In contrast, resentful demoralisation seems
unlikely to have occurred among the control groups, given the absence of any differences in the
main outcomes or processes to support implementation of the guideline recommendations.
Intervention diffusion (contamination) was minimised by the use of a cluster randomised design.
Hence control group participants were unlikely to receive any aspect of the interventions.
External validity. The study findings apply to all Scottish gynaecology units. As described
above (8.5.2), the study intervention took place within the broader context of a clinical
effectiveness programme, which represents a potential effect modifier. Generalising from a
narrow to a broad spectrum, it is possible that causal effects may have been different in other
groups of professionals because of its novelty value, especially in those previously little exposed
to similar interventions or national collaborations.
The causal relationship could also vary according to modifications of the strategy (i.e. content
and intensity) or to changes in context (i.e. outwith SPCERH). A combined analysis of similar
intervention packages would be required to explore such variations.
Appropriateness of study. The trial tested an intervention package that could reasonably be
expected to be delivered by a national clinical effectiveness programme, such as SPCERH. The
trial was relatively costly and time-consuming to conduct. However, it addressed the core
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SPCERH objectives of supporting and evaluating guideline dissemination and implementation
activities.
8.6 Discussion
8.6.1 The utility of the framework
The framework enabled a systematic appraisal of individual studies, highlighting their relative
strengths and weaknesses. Earlier discussions of individual studies (in Chapters 2 to 7) tended to
focus on statistical conclusion validity and internal validity. The framework was useful in
prompting other considerations related to construct and external validity, issues integral to the
transferability of research findings.
There were two limitations to this exercise. Firstly, the framework was not necessarily applied
comprehensively in the appraisal of all studies. The intention was to focus on issues most
relevant to individual types of study, such as the greater internal validity associated with
randomised evaluations. Secondly, the categorisation of certain threats is disputable. For
example, in the uncontrolled before-and-after survey of obstetrician practice (8.5.3), the use of
self-reports can be seen as a threat to internal validity. It was categorised as a threat to external
validity because the changes in compliance observed might not have been reproduced had actual
patient data been used. According to the framework by Shadish et al, this represented a potential
interaction of the 'causal relationship' with the study outcomes (285).
The application of the framework in this chapter provides an opportunity to comment on the
validity and appropriateness of the overall programme ofwork contributing to the thesis.
8.6.2 Main strengths and weaknesses of the work programme
Statistical conclusion validity. Three issues arose consistently throughout the work programme:
multiple hypothesis testing, statistical power; and appropriateness of analyses.
In earlier studies, the uncontrolled after and the uncontrolled before-and-after surveys,
hypotheses were not specified in advance and their interpretation was thus prone to type 1 error.
However, the former was primarily intended as a descriptive study and the later as an audit. In
both the interrupted time series analysis and cluster randomised trial, the hypotheses and
outcomes were specified in advance.
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The main threat to the time series analysis and cluster randomised trial was low statistical power,
increasing the potential for type II error. In the time series analysis, power was mainly
compromised by the limited numbers of cases per time point and limited number of post-
intervention time points. In the randomised trial, power was limited by the number of
gynaecology units available, the failure ofmatched randomisation (largely because of imprecise
pre-intervention estimates of compliance) and high pre-intervention compliance for several
outcomes. Resources therefore largely limited the power of both studies. However, examination
of non-significant trends suggested that type II error was unlikely to explain the lack of
demonstrated effect in these studies.
The analyses of four studies appropriately adjusted for clustering effects, thereby reducing the
likelihood of type I errors, a problem with studies previously reported in this field (139).
Internal validity. In general, threats to internal validity were addressed to a greater degree by the
more rigorous intervention studies (the time series analysis and cluster randomised trial)
compared with the weaker evaluations of interventions (the uncontrolled after and the
uncontrolled before-and-after studies). The addition of controls enhanced internal validity,
countering the effects of history, maturation, regression and selection. The time series analysis
and its interpretation accounted for preceding trends in the same group of maternity units whilst
randomly allocated gynaecology units acted as controls in the cluster randomised trial. The main
limitation of the time series analysis was that its interpretation required making explicit but
potentially more fallible judgements about the extent of several threats to validity. In this
context, history and instrumentation were considered possible but not probable effects. This
judgement was made easier by the absence of any observed significant intervention effect -
although it is acknowledged that biases could have operated in other directions, i.e. against an
intervention effect.
Other threats meriting specific comment include ambiguous temporal precedence and regression
to the mean. Whilst ambiguous temporal precedence limited interpretation of the uncontrolled
after and the cross-sectional studies, four studies included pre- and post-intervention
observations. Regression to the mean remained a significant problem in the interpretation of the
uncontrolled before-and-after study. As mentioned above, regression effects were controlled for
the time series analysis and cluster randomised trial, whilst multi-level modelling was used in the
observational study (of recommendation attributes).
Construct validity. The explication of study constructs and recognition of confounding emerged
as key issues in the structured appraisal of construct validity. What initially appeared to be
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straightforward constructs often require further qualification on closer examination. For
example, the outcomes from the uncontrolled after survey of professional awareness of CEMD
recommendations were specific in that professionals answered questions without the usual
prompts of the clinical context.
In general, the study constructs became more complex with increasing sophistication of both
designs and interventions. Hence, each component (e.g. audit and feedback) of the ImpACT
strategy tested in the cluster randomised trial constituted a relatively complex intervention. In
isolation from a much wider body of research, there is a risk of interpreting the cluster
randomised trial findings as audit and feedback delivered within a multi-faceted strategy is
ineffective in changing professional practice. When the wider body of research is taken into
account, it emerges that audit and feedback is variably effective (197).
This, firstly, highlights the importance of systematic reviews in the synthesis of research
findings. Secondly, closer scrutiny of the constructs illustrates why two or more studies that
appear similar at a superficial level may produce contrasting results. There is a need for a
standard taxonomy to describe studies of complex interventions, including their content and
level, to help identify features consistently associated with greater effects (286).
External validity. The most distinctive feature of this work was its high generalisability to
secondary care professionals targeted by SPCERH activities. All of the studies (except the
uncontrolled before-and-after survey) involved assessments of patient care by teams of
obstetricians and gynaecologists, and midwifery and nursing staff or surveys of these
professionals. The findings of several studies may be generalisable to similar groups of
professionals elsewhere in the UK NHS. However, it is not known to what extent the context of
a national clinical effectiveness programme (SPCERH) or relevant precursor projects (e.g.
GAPS) influenced the outcomes, if at all.
Ironically, in the case of induced abortion care, the close knit nature of the Scottish
gynaecological community and presence of academic centres leading work on developing
methods of induced abortion may have contributed to the lack of effect demonstrated in the
ImpACT trial. Compared with England and Wales, services in Scotland generally appear to be
organised more coherently and follow recommendations from the RCOG guideline more
frequently (287). Therefore, there may have been greater scope for change and responsiveness to
the type of interventions used within ImpACT.
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It is also difficult to judge the generalisability of findings from the studies to other groups of
professionals in secondary or even primary care. The use of TPB did demonstrate variations in
practice associated with professional attitudes and beliefs. Wider testing of this theory among
other health care professionals may demonstrate that that certain attitudes and beliefs consistently
influence clinical behaviour.
However, the absence of any observed effects in the two main intervention studies, the time
series analysis and cluster randomised trial, does not necessarily mean that that none would be
observed elsewhere if the interventions or outcomes were varied. It is also possible that a
modification of the interventions (e.g. more intensive promotion of structured case notes within
ImpACT) would have produced different effects within the same setting. Such modifications
would probably need to be substantial to overcome some of the barriers identified, e.g. the
complexity of the hypertension guideline or the organisational obstacles faced in improving
abortion care.
Other findings from this work programme did suggest that modifying the content of clinical
guidelines could influence their subsequent uptake. Results from the observational study
indicated that attributes of recommendations were associated with variations in changes in
clinical practice. The uncontrolled before-and-after survey of obstetric guidelines provided less
direct evidence of variations in reported changes in practice among the four guidelines
disseminated.
Appropriateness. All studies met the needs of SPCERH's work programme, in particular: (1) the
development of clinical guidelines and monitoring standards through clinical audit; and (2) the
development of ways of implementing effective practice through research. Whilst the less
rigorous study designs were of limited validity, they did directly contribute to the stated needs of
the SPCERH work programme by highlighting gaps in knowledge about recommendations from
the CEMD Reports and auditing the dissemination of the four obstetric guidelines.
The range of study designs allowed different types of research questions to be addressed. Both of
the correlational studies contributed to knowledge of factors that modify the effectiveness of
interventions, i.e. the attributes of guideline recommendations and staff attitudes and beliefs.
In general, there was a trade-off between on one hand, higher statistical conclusion and internal
validity, and on the other, lower cost and complexity. Despite limitations in power, the time
series analysis and cluster randomised trial demonstrated the feasibility of conducting rigorous
evaluations of implementation strategies within a recognised network of clinicians. One
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challenge for the future lies in finding ways to improve the validity and impact of future
implementation studies within collaborations such as SPCERH.
8.7 Conclusion
The systematic appraisal of the validity of individual studies contributing to this programme of
work highlighted their relative strengths and weaknesses. The framework was particularly useful
in the detailed appraisal of construct and external validity, key determinants of the transferability
of research findings.
The main threat to statistical conclusion validity comprised low statistical power in the time
series analysis and cluster randomised trial, increasing the potential for type II error. In contrast,
multiple hypothesis testing in the uncontrolled before-and-after survey increased the likelihood of
type I error. The analyses of four studies appropriately adjusted for clustering effects, thereby
reducing the likelihood of type I errors.
Adding or improving control groups improved internal validity, countering the effects of history,
maturation, regression and selection. Although the cluster randomised trial emerged as with
highest internal validity, the interpretation of the time series analysis was only limited by the
possibility (but not probability) of history and instrumentation effects.
The explication of study constructs and recognition of confounding represented key issues in
determining construct validity. The study constructs became more complex with increasing
sophistication of both study designs and interventions. Yet, what initially appeared to be
straightforward constructs often required further qualification on closer scrutiny. The failure to
describe studies according to a common taxonomy contributes to confusion and uncertainty over
the effectiveness of interventions to improve professional practice.
The studies were of high generalisability to secondary care professionals targeted by SPCERH
activities. However, the absence of any observed effects in the time series analysis and cluster
randomised trial does not necessarily mean that that none would be observed in different settings
of if the interventions were to be varied.
The cost of the studies increased with growing complexity of design. All studies met the needs
of SPCERH's work programme, particularly the development of clinical guidelines and
monitoring standards through clinical audit, and the development of ways of implementing
effective practice through research.
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Chapter 9
Implications for SPCERH and implementation research
This chapter summarises implications for both SPCERH and implementation research on the
basis of the work contained within the thesis.
9.1 implications for SPCERH
The nature of clinical practice recommendations influences their subsequent ability to promote
changes in clinical policy and practice. The evaluation of the Gynaecology Audit Project in
Scotland (GAPS) recommendation attributes suggested that audit and feedback appeared to be
effective in promoting the implementation of recommendations judged to be less compatible with
clinician norms and values (Chapter 2). Feedback permitting comparisons among hospitals
during the audit programme may therefore have prompted action on recommendations previously
regarded as too disruptive or incompatible to implement. This finding may be specific to the
particular context of the GAPS project. Different attributes may have influenced change in
clinical behaviour following an intervention other than audit and feedback, e.g. interactive
educational programmes.
Less direct evidence about the influence of attributes of recommendations on implementation
comes from other work in this thesis. The strength of evidence underpinning recommendations
appeared relevant to two findings. Firstly, there were observed improvements in practice, albeit
self-reported, for recommendations supported by rigorous evidence from The Preparation of the
Fetus for Preterm Delivery guideline (Chapter 4). Secondly, historical data from GAPS
demonstrated low compliance with two Grade A recommendations (i.e. supported by rigorous
evidence) from the guideline, The Care ofWomen Requesting Induced Abortion. Both of these
recommendations (antibiotic prophylaxis or screening, and the use of misoprostol) were
subsequently selected as key outcome measures in ImpACT (Chapter 7). Within a ten year
period, compliance with both of these recommendations had reached near-optimal levels,
suggesting that networks of clinicians do respond to convincing evidence of effectiveness. The
problem that remains is how to ensure more rapid and equitable implementation of such
recommendations.
Other aspects of clinical practice recommendations appeared to be associated with poor
assimilation, as suggested by three studies. Firstly, several recommendations contained within
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the 1994-6 CEMD report that were new or contained public health messages were associated
with low levels of recall (Chapter 3). Secondly, the actual process of developing measures of
compliance with levels of care recommended by the guideline. The Management ofMild. Non-
proteinuric Hypertension in Pregnancy, highlighted the complexity of its key recommendations
(Chapter 5). Not surprisingly, lower levels of compliance were observed for the more complex
packages of care evaluated. In future, such recommendations may require further pre-testing to
assess their acceptability to and understanding by clinical staff. Thirdly, ImpACT indicated low
compliance with and major barriers to the implementation of recommendations requiring
organisational, and to some extent, cultural change (e.g. waiting times for initial assessment
appointment, Chapter 6).
When setting priorities, programmes such as SPCERH should attempt to anticipate both the
likely responsiveness of professionals and organisations to clinical practice recommendations and
(as covered below) what implementation strategy might be most appropriate for the
recommendations.
Combined approaches are useful in identifying local needs and potential barriers to
implementation. Work within ImpACT highlighted the importance of elucidating both individual
and organisational factors (Chapter 6). However, assessing barriers requires time and resources,
especially if involving a wide range of units and staff. Sufficient time needs to be incorporated
within project plans to allow reflection upon findings and to plan definitive interventions.
Interventions to promote the use of clinical guidelines should be appropriately targeted according
to identified needs and barriers. Work developing the ImpACT strategy suggested that a 'ceiling'
had been reached on motivating most staff involved in the delivery of abortion care to follow the
recommendations (Chapter 6). Therefore, components of the strategy that aimed to increase
compliance by influencing individual motivation were unlikely to work. Interventions targeting
wider aspects of the organisation might have been more appropriate and effective. However,
there is little empirical evidence to support many organisation-level interventions. Further
consideration should also be given to the greater use of interventions (such as prompts and
reminders) demonstrated to be of moderate effectiveness by systematic reviews. The structured
case record was only promoted within ImpACT in a relatively passive manner and scope exists to
strengthen this type of intervention.
There is a trade-off between the efficiency of nationally led activities and their potential
effectiveness. According to the time series analysis and ImpACT, two nationally led strategies of
different levels of intensity were ineffective (Chapters 6 & 7). Their lack of impact may have
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been attributable in part to effect modifiers, such as the nature of the guideline recommendations.
Arguably, the average cost per hospital unit was relatively low: £1695 per maternity unit for the
mild hypertension guideline; and £2067 per gynaecology unit for the induced abortion guideline.
The organisation of clinical effectiveness activities at a national level centralises costs and is
possibly less expensive compared with the organisation of similar activities locally. It is
speculative whether locally led and owned activities can be more effective in changing practice.
Nevertheless, future dissemination and implementation activities require further development to
enhance local involvement. Work is currently underway within SPCERH to evaluate the
acceptability of different approaches to feeding back audit data.
Future evaluations require an explicit recognition of the trade-off between rigour and cost. The
cost of the studies increased with growing complexity of design. A range of study designs can be
used to address different types of research questions. Surveys of professionals can identify
priorities for dissemination activities, although relatively little can be inferred on the
effectiveness of dissemination activities. Cross-sectional and observational studies can
contribute to knowledge of factors that modify the effectiveness of interventions, including
barriers associated with guideline recommendations, professionals and organisations. However,
questions about the effectiveness and efficiency of dissemination and implementation strategies
need to be addressed by rigorously designed intervention studies.
9.2 Implications for implementation research
Attributes of clinical practice recommendations appear to influence both compliance and
behaviour change and need to be considered when planning implementation activities. It is likely
that the effects of different implementation strategies may be modified by the attributes of
recommendations (Chapter 2). Consideration of the attributes of practice recommendations may
assist in the choice of implementation strategy. Further research is required to determine how
attributes of recommendations modify the effectiveness of different interventions in different
contexts. These studies should focus on behaviour change rather than compliance and use the
most robust estimates of behaviour change, preferably from randomised trials.
Assessing barriers requires time and resources, especially if involving a wide range of units and
staff. Further time needs to be integrated within project plans to allow sufficient reflection of
findings and planning of the definitive intervention(s). The frameworks used must be described
in sufficient detail to enhance their reproducibility in other contexts (Chapter 6).
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Behavioural theories can contribute to the development of interventions and provide a greater
understanding of the underlying barriers to change. Greater use of theory may help explain why
interventions work in some contexts but not others, by providing more generalisable evidence of
what factors may influence clinical behaviour (Chapter 6). Experience from developing the
ImpACT strategy highlights the need to extend behavioural research from individual
professionals towards team and organisational levels. The longer-term aim is develop
'diagnostic' tools that can provide an empirical basis for the selection of interventions, i.e.
whether individual, team or organisational levels should be targeted
Sufficient sample sizes are required to produce precise estimates of effect. Despite prior sample
size calculations, low statistical power represented an important threat to statistical conclusion
validity for both the interrupted time series analysis and cluster randomised trial (Chapters 6 &
7). The precision of the time series analysis would have been increased had more data per time
point sampled been collected. Similarly in the cluster randomised trial, collecting data from
larger pre-intervention samples might have enabled the use of a more powerful matched pairs
analysis.
Recruiting more clusters to randomised trials represents a more efficient means of improving
power than sampling more cases per cluster. However, the number of gynaecology units
available to participate in ImpACT was limited by the national boundary of the clinical
effectiveness programme.
Selecting clinical guidelines associated with more scope for improved performance represents
another means of increasing power. Paradoxically, such guidelines or their recommendations
may represent those that encounter greatest resistance to change, illustrated by the lack of success
in improving compliance with selected recommendations on induced abortion.
Opportunistic quasi-experiments can provide evidence of acceptable validity. Adding or
improving control groups to intervention studies improves internal validity, progressively
countering the effects of history, maturation, regression and selection. The cluster randomised
trial appeared to possess the highest internal validity of all the study designs used (Chapter 8).
However, the interpretation of the time series analysis was only limited by the possibility (but not
probability) of history and instrumentation effects. At a more practical level, gaining access to
archive data and developing satisfactory outcome measures based on the case note review
unexpectedly increased costs and time taken to complete the time series analysis (Chapter 5).
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Study constructs become more complex with the increasing sophistication of study design and
interventions. Implementation research requires the establishment of a common conceptual
framework within which to describe settings, individuals, targeted behaviours, and interventions
(Chapter 8). Hence, it should be possible to identify what features influence the likely
effectiveness of interventions. The studies in this thesis were ofmoderate to high generalisability
to secondary care professionals targeted by SPCERH activities. However, the absence of any
observed effects in the time series analysis and cluster randomised trial does not necessarily
mean that that none would be observed in different professional groups, by varying the
interventions or working outwith a clinical effectiveness programme.
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Gynaecology Audit Project in Scotland: Audit criteria, pre and post-
intervention compliance, and consensus panel rating of attributes
Topic: induced abortion






% change in compliance
1. All women
requesting abortion




48 (464/967) 56 (577/1037) +8
Attribute Final consensus panel
rating
Addresses common issue: concerned with a common clinical issue or a
decision important in daily care
9
Precisely described: provides a sufficiently detailed and predse guide to
clinical practice
9
Compatible: compatible with clinicians' current norms and values in practice 8
Key feature: essential to the whole set of recommendations and to the
ultimate goals
7
Based upon sound evidence: based upon sound scientific evidence
including, as appropriate, clinical trials or meta-analyses
5
Fits patient expectations: is likely to fit in with patient expectations 8
Observable: the benefits of using this practice or policy over existing
practices or policies can be seen quickly
8
Requires organisational change: requires changes in the way care is
organised or additional resources
8
Requires changed routines: requires changes to fixed routines or habits 8
High profile: has a high profile in educational programmes or the media 5
Complex: is complex and requires many steps to do or organise 7
Trialabie: can be tried out and discarded easily 2
Requires new knowledge or skills: requires the learning of new knowledge or
skills
1






% change in compliance
2. Abortion should be
undertaken within 7
days of the consultation
with the gynaecologist
81 (783/967) 80 (830/1037) -1
Attribute Final consensus panel
rating
Addresses common issue: concerned with a common clinical issue or a
decision important in daily care
8
Precisely described: provides a sufficiently detailed and precise guide to
clinical practice
9
Compatible: compatible with clinicians' current norms and values in practice 8
Key feature: essential to the whole set of recommendations and to the
ultimate goals
7
Based upon sound evidence: based upon sound scientific evidence
including, as appropriate, clinical trials or meta-analyses
6
Fits patient expectations: is likely to fit in with patient expectations 9
Observable: the benefits of using this practice or policy over existing
practices or policies can be seen quickly
7
Requires organisational change: requires changes in the way care is
organised or additional resources
7
Requires changed routines: requires changes to fixed routines or habits 6
High profile: has a high profile in educational programmes or the media 5
Complex: is complex and requires many steps to do or organise 2
Trialable: can be tried out and discarded easily 3










% change in compliance






managed as day cases.
72 (696/967) 83 (861/1037) +11
Attribute Final consensus panel
rating
Addresses common issue: concerned with a common clinical issue or a
decision important in daily care
9
Precisely described: provides a sufficiently detailed and precise guide to
clinical practice
9
Compatible: compatible with clinicians' current norms and values in practice 9
Key feature: essential to the whole set of recommendations and to the
ultimate goals
7
Based upon sound evidence: based upon sound scientific evidence
including, as appropriate, clinical trials or meta-analyses
9
Fits patient expectations: is likely to fit in with patient expectations 9
Observable: the benefits of using this practice or policy over existing
practices or policies can be seen quickly
8
Requires organisational change: requires changes in the way care is
organised or additional resources
2
Requires changed routines: requires changes to fixed routines or habits 2
High profile: has a high profile in educational programmes or the media 5
Complex: is complex and requires many steps to do or organise 3
Trialable: can be tried out and discarded easily 5










% change in compliance
4. Gestation need not
routinely be confirmed
by ultrasound scan.
The method of abortion
may often be decided
on the basis of clinical
estimation of uterine
size.
61 (590/967) 59 (612/1037) -2
Attribute Final consensus panel
rating
Addresses common issue: concerned with a common clinical issue or a
decision important in daily care
8
Precisely described: provides a sufficiently detailed and precise guide to
clinical practice
7
Compatible: compatible with clinicians' current norms and values in practice 9
Key feature: essential to the whole set of recommendations and to the
ultimate goals
3
Based upon sound evidence: based upon sound scientific evidence
including, as appropriate, clinical trials or meta-analyses
3
Fits patient expectations: is likely to fit in with patient expectations 6
Observable: the benefits of using this practice or policy over existing
practices or policies can be seen quickly
7
Requires organisational change: requires changes in the way care is
organised or additional resources
2
Requires changed routines: requires changes to fixed routines or habits 5
High profile: has a high profile in educational programmes or the media 2
Complex: is complex and requires many steps to do or organise 2
Trialable: can be tried out and discarded easily 7

















46 (445/967) 61 (633/1037) +15
Attribute Final consensus panel
rating
Addresses common issue: concerned with a common clinical issue or a
decision important in daily care
8
Precisely described: provides a sufficiently detailed and precise guide to
clinical practice
7
Compatible: compatible with clinicians' current norms and values in practice 7
Key feature: essential to the whole set of recommendations and to the
ultimate goals
1
Based upon sound evidence: based upon sound scientific evidence
including, as appropriate, clinical trials or meta-analyses
3
Fits patient expectations: is likely to fit in with patient expectations 5
Observable: the benefits of using this practice or policy over existing
practices or policies can be seen quickly
2
Requires organisational change: requires changes in the way care is
organised or additional resources
2
Requires changed routines: requires changes to fixed routines or habits 4
High profile: has a high profile in educational programmes or the media 5
Complex: is complex and requires many steps to do or organise 1
Trialable: can be tried out and discarded easily 2










% change in compliance






97 (938/967) 97 (1006/1037) 0
Attribute Final consensus panel
rating
Addresses common issue: concerned with a common clinical issue or a
decision important in daily care
9
Precisely described: provides a sufficiently detailed and precise guide to
clinical practice
9
Compatible: compatible with clinicians' current norms and values in practice 9
Key feature: essential to the whole set of recommendations and to the
ultimate goals
9
Based upon sound evidence: based upon sound scientific evidence
including, as appropriate, clinical trials or meta-analyses
9
Fits patient expectations: is likely to fit in with patient expectations 8
Observable: the benefits of using this practice or policy over existing
practices or policies can be seen quickly
5
Requires organisational change: requires changes in the way care is
organised or additional resources
1
Requires changed routines: requires changes to fixed routines or habits 1
High profile: has a high profile in educational programmes or the media 5
Complex: is complex and requires many steps to do or organise 1
Trialable: can be tried out and discarded easily 6










% change in compliance
7. Doctors managing
induced abortion should
have a policy for
identifying and treating
those women at risk of
gentiai tract infection
22 (213/967) 31 (321/1037) +9
Attribute Final consensus panel
rating
Addresses common issue: concerned with a common clinical issue or a
decision important in daily care
9
Precisely described: provides a sufficiently detailed and precise guide to
clinical practice
8
Compatible: compatible with clinicians' current norms and values in practice 7
Key feature: essential to the whole set of recommendations and to the
ultimate goals
7
Based upon sound evidence: based upon sound scientific evidence
including, as appropriate, clinical trials or meta-analyses
9
Fits patient expectations: is likely to fit in with patient expectations 3
Observable: the benefits of using this practice or policy over existing
practices or policies can be seen quickly
4
Requires organisational change: requires changes in the way care is
organised or additional resources
7
Requires changed routines: requires changes to fixed routines or habits 7
High profile: has a high profile in educational programmes or the media 6
Complex: is complex and requires many steps to do or organise 7
Trialable: can be tried out and discarded easily 6










% change in compliance
15. Before she is
discharged, the patient
should have aqreed on
a contraceptive Dlan
and should have been
given contraceptive
supplies.
92 (890/967) 86 (892/1037) -6
Attribute Final consensus panel
rating
Addresses common issue: concerned with a common clinical issue or a
decision important in daily care
9
Precisely described: provides a sufficiently detailed and precise guide to
clinical practice
9
Compatible: compatible with clinicians' current norms and values in practice 8
Key feature: essential to the whole set of recommendations and to the
ultimate goals
9
Based upon sound evidence: based upon sound scientific evidence
including, as appropriate, clinical trials or meta-analyses
7
Fits patient expectations: is likely to fit in with patient expectations 8
Observable: the benefits of using this practice or policy over existing
practices or policies can be seen quickly
2
Requires organisational change: requires changes in the way care is
organised or additional resources
2
Requires changed routines: requires changes to fixed routines or habits 2
High profile: has a high profile in educational programmes or the media 8
Complex: is complex and requires many steps to do or organise 5
Triaiable: can be tried out and discarded easily 3










% change in compliance
18. A follow-up
appointment, either at
the hospital, or with the
referring doctor, should
be given to every
patient.
54 (522/967) 69 (716/1037) +15
Attribute Final consensus panel
rating
Addresses common issue: concerned with a common clinical issue or a
decision important in daily care
9
Precisely described: provides a sufficiently detailed and precise guide to
clinical practice
6
Compatible: compatible with clinicians' current norms and values in practice 5
Key feature: essential to the whole set of recommendations and to the
ultimate goals
3
Based upon sound evidence: based upon sound scientific evidence
including, as appropriate, clinical trials or meta-analyses
6
Fits patient expectations: is likely to fit in with patient expectations 5
Observable: the benefits of using this practice or policy over existing
practices or policies can be seen quickly
2
Requires organisational change: requires changes in the way care is
organised or additional resources
7
Requires changed routines: requires changes to fixed routines or habits 5
High profile: has a high profile in educational programmes or the media 3
Complex: is complex and requires many steps to do or organise 3
Trialable: can be tried out and discarded easily 2










% change in compliance
19. The follow-up
appointment should be
within 14 days of the
abortion.
5 (48/967) 32 (332/1037) +27
Attribute Final consensus panel
rating
Addresses common issue: concerned with a common clinical issue or a
decision important in daily care
8
Precisely described: provides a sufficiently detailed and precise guide to
clinical practice
9
Compatible: compatible with clinicians' current norms and values in practice 2
Key feature: essential to the whole set of recommendations and to the
ultimate goals
3
Based upon sound evidence: based upon sound scientific evidence
including, as appropriate, clinical trials or meta-analyses
5
Fits patient expectations: is likely to fit in with patient expectations 3
Observable: the benefits of using this practice or policy over existing
practices or policies can be seen quickly
3
Requires organisational change: requires changes in the way care is
organised or additional resources
6
Requires changed routines: requires changes to fixed routines or habits 6
High profile: has a high profile in educational programmes or the media 2
Complex: is complex and requires many steps to do or organise 2
Trialable: can be tried out and discarded easily 2











% change in compliance
38. In almost all cases,
sterilisation should be
refused to women
under the age of 25 and
reversible methods of
contraception advised.
94 (928/988) 96 (1065/1115) +2
Attribute Final consensus panel
rating
Addresses common issue: concerned with a common clinical issue or a
decision important in daily care
9
Precisely described: provides a sufficiently detailed and precise guide to
clinical practice
9
Compatible: compatible with clinicians' current norms and values in practice 8
Key feature: essential to the whole set of recommendations and to the
ultimate goals
7
Based upon sound evidence: based upon sound scientific evidence
including, as appropriate, clinical trials or meta-analyses
8
Fits patient expectations: is likely to fit in with patient expectations 6
Observable: the benefits of using this practice or policy over existing
practices or policies can be seen quickly
2
Requires organisational change: requires changes in the way care is
organised or additional resources
2
Requires changed routines: requires changes to fixed routines or habits 5
High profile: has a high profile in educational programmes or the media 5
Complex: is complex and requires many steps to do or organise 2
Trialable: can be tried out and discarded easily 3










% change in compliance
39. Prior to sterilisation,
it should be verified, by
gynaecological history
taking and examination,
that a more radical
operation is not
indicated.
52 (513/990) 52 (592/1139) 0
Attribute Final consensus panel
rating
Addresses common issue: concerned with a common clinical issue or a
decision important in daily care
5
Precisely described: provides a sufficiently detailed and predse guide to
clinical practice
5
Compatible: compatible with clinicians' current norms and values in practice 3
Key feature: essential to the whole set of recommendations and to the
ultimate goals
5
Based upon sound evidence: based upon sound scientific evidence
including, as appropriate, clinical trials or meta-analyses
6
Fits patient expectations: is likely to fit in with patient expectations 6
Observable: the benefits of using this practice or policy over existing
practices or policies can be seen quickly
2
Requires organisational change: requires changes in the way care is
organised or additional resources
2
Requires changed routines: requires changes to fixed routines or habits 5
High profile: has a high profile in educational programmes or the media 3
Complex: is complex and requires many steps to do or organise 4
Trialable: can be tried out and discarded easily 2










% change in compliance
42. Pre-sterilisation
counselling should
include enquiry into any
disharmony within the
current relationship.
45 (445/988) 47 (538/1139) +2
Attribute Final consensus panel
rating
Addresses common issue: concerned with a common clinical issue or a
decision important in daily care
7
Precisely described: provides a sufficiently detailed and prease guide to
clinical practice
7
Compatible: compatible with clinicians' current norms and values in practice 6
Key feature: essential to the whole set of recommendations and to the
ultimate goals
6
Based upon sound evidence: based upon sound scientific evidence
including, as appropriate, clinical trials or meta-analyses
5
Fits patient expectations: is likely to fit in with patient expectations 6
Observable: the benefits of using this practice or policy over existing
practices or policies can be seen quickly
2
Requires organisational change: requires changes in the way care is
organised or additional resources
2
Requires changed routines: requires changes to fixed routines or habits 6
High profile: has a high profile in educational programmes or the media 3
Complex: is complex and requires many steps to do or organise 2
Trialable: can be tried out and discarded easily 2










% change in compliance






documented in the case
notes as well as
appearing on a printed
consent form.
87 (860/988) 90 (1026/1139) +3
Attribute Final consensus panel
rating
Addresses common issue: concerned with a common clinical issue or a
decision important in daily care
9
Precisely described: provides a sufficiently detailed and precise guide to
clinical practice
9
Compatible: compatible with clinicians' current norms and values in practice 8
Key feature: essential to the whole set of recommendations and to the
ultimate goals
9
Based upon sound evidence: based upon sound scientific evidence
including, as appropriate, clinical trials or meta-analyses
8
Fits patient expectations: is likely to fit in with patient expectations 6
Observable: the benefits of using this practice or policy over existing
practices or policies can be seen quickly
5
Requires organisational change: requires changes in the way care is
organised or additional resources
2
Requires changed routines: requires changes to fixed routines or habits 2
High profile: has a high profile in educational programmes or the media 7
Complex: is complex and requires many steps to do or organise 2
Trialable: can be tried out and discarded easily 2










% change in compliance
44. Prior to sterilisation,





7 (70/988) 8 (97/1139) +1
Attribute Final consensus panel
rating
Addresses common issue: concerned with a common clinical issue or a
decision important in daily care
8
Precisely described: provides a sufficiently detailed and precise guide to
clinical practice
8
Compatible: compatible with clinicians' current norms and values in practice 7
Key feature: essential to the whole set of recommendations and to the
ultimate goals
6
Based upon sound evidence: based upon sound scientific evidence
including, as appropriate, clinical trials or meta-analyses
7
Fits patient expectations: is likely to fit in with patient expectations 7
Observable: the benefits of using this practice or policy over existing
practices or policies can be seen quickly
5
Requires organisational change: requires changes in the way care is
organised or additional resources
5
Requires changed routines: requires changes to fixed routines or habits 2
High profile: has a high profile in educational programmes or the media 5
Complex: is complex and requires many steps to do or organise 2
Trialable: can be tried out and discarded easily 6










% change in compliance





with current users of
the contraceptive pill.
3 (10/339) 7 (34/423) +4
Attribute Final consensus panel
rating
Addresses common issue: concerned with a common clinical issue or a
decision important in daily care
8
Precisely described: provides a sufficiently detailed and precise guide to
clinical practice
8
Compatible: compatible with clinicians' current norms and values in practice 6
Key feature: essential to the whole set of recommendations and to the
ultimate goals
6
Based upon sound evidence: based upon sound scientific evidence
including, as appropriate, clinical trials or meta-analyses
7
Fits patient expectations: is likely to fit in with patient expectations 6
Observable: the benefits of using this practice or policy over existing
practices or policies can be seen quickly
3
Requires organisational change: requires changes in the way care is
organised or additional resources
2
Requires changed routines: requires changes to fixed routines or habits 5
High profile: has a high profile in educational programmes or the media 5
Complex: is complex and requires many steps to do or organise 2
Trialable: can be tried out and discarded easily 5















62 (619/998) 76 (866/1139) +14
Attribute Final consensus panel
rating
Addresses common issue: concerned with a common clinical issue or a
decision important in daily care
8
Precisely described: provides a sufficiently detailed and precise guide to
clinical practice
7
Compatible: compatible with clinicians' current norms and values in practice 6
Key feature: essential to the whole set of recommendations and to the
ultimate goals
5
Based upon sound evidence: based upon sound scientific evidence
including, as appropriate, clinical trials or meta-analyses
8
Fits patient expectations: is likely to fit in with patient expectations 5
Observable: the benefits of using this practice or policy over existing
practices or policies can be seen quickly
2
Requires organisational change: requires changes in the way care is
organised or additional resources
5
Requires changed routines: requires changes to fixed routines or habits 5
High profile: has a high profile in educational programmes or the media 3
Complex: is complex and requires many steps to do or organise 2
Trialable: can be tried out and discarded easily 2










% change in compliance
48. Except where there





performed as a day
case.
72 (719/998) 79 (900/1139) +7
Attribute Final consensus panel
rating
Addresses common issue: concerned with a common clinical issue or a
decision important in daily care
9
Precisely described: provides a sufficiently detailed and precise guide to
clinical practice
9
Compatible: compatible with clinicians' current norms and values in practice 9
Key feature: essential to the whole set of recommendations and to the
ultimate goals
7
Based upon sound evidence: based upon sound scientific evidence
including, as appropriate, clinical trials or meta-analyses
9
Fits patient expectations: is likely to fit in with patient expectations 8
Observable: the benefits of using this practice or policy over existing
practices or policies can be seen quickly
8
Requires organisational change: requires changes in the way care is
organised or additional resources
2
Requires changed routines: requires changes to fixed routines or habits 2
High profile: has a high profile in educational programmes or the media 7
Complex: is complex and requires many steps to do or organise 2
Trialable: can be tried out and discarded easily 2










% change in compliance
49. A post-MRCOG
gynaecologist should






88 (878/988) 80 (913/1139) -8
Attribute Final consensus panel
rating
Addresses common issue: concerned with a common clinical issue or a
decision important in daily care
8
Precisely described: provides a sufficiently detailed and precise guide to
clinical practice
9
Compatible: compatible with clinicians' current norms and values in practice 7
Key feature: essential to the whole set of recommendations and to the
ultimate goals
7
Based upon sound evidence: based upon sound scientific evidence
including, as appropriate, clinical trials or meta-analyses
7
Fits patient expectations: is likely to fit in with patient expectations 7
Observable: the benefits of using this practice or policy over existing
practices or policies can be seen quickly
5
Requires organisational change: requires changes in the way care is
organised or additional resources
6
Requires changed routines: requires changes to fixed routines or habits 6
High profile: has a high profile in educational programmes or the media 5
Complex: is complex and requires many steps to do or organise 2
Trialable: can be tried out and discarded easily 2

















rate at least three-fold.
This warning should be
documented in the case
notes.
29 (5/17) 50 (5/10) +21
Attribute Final consensus panel
rating
Addresses common issue: concerned with a common clinical issue or a
decision important in daily care
8
Precisely described: provides a sufficiently detailed and precise guide to
clinical practice
8
Compatible: compatible with clinicians' current norms and values in practice 7
Key feature: essential to the whole set of recommendations and to the
ultimate goals
7
Based upon sound evidence: based upon sound scientific evidence
including, as appropriate, clinical trials or meta-analyses
8
Fits patient expectations: is likely to fit in with patient expectations 5
Observable: the benefits of using this practice or policy over existing
practices or policies can be seen quickly
3
Requires organisational change: requires changes in the way care is
organised or additional resources
1
Requires changed routines: requires changes to fixed routines or habits 5
High profile: has a high profile in educational programmes or the media 3
Complex: is complex and requires many steps to do or organise 2
Trialable: can be tried out and discarded easily 5











% change in compliance
52. Women below the






need not have an
endometrial sample
taken.
77 (871/1133) 71 (799/1126) -6
Attribute Final consensus panel
rating
Addresses common issue: concerned with a common clinical issue or a
decision important in daily care
9
Precisely described: provides a sufficiently detailed and precise guide to
clinical practice
8
Compatible: compatible with clinicians' current norms and values in practice 8
Key feature: essential to the whole set of recommendations and to the
ultimate goals
8
Based upon sound evidence: based upon sound scientific evidence
including, as appropriate, clinical trials or meta-analyses
9
Fits patient expectations: is likely to fit in with patient expectations 7
Observable: the benefits of using this practice or policy over existing
practices or policies can be seen quickly
6
Requires organisational change: requires changes in the way care is
organised or additional resources
8
Requires changed routines: requires changes to fixed routines or habits 1
High profile: has a high profile in educational programmes or the media 5
Complex: is complex and requires many steps to do or organise 1
Trialable: can be tried out and discarded easily 2
















genital tract should be
performed.
84 (1010/1199) 82 (929/1126) -2
Attribute Final consensus panel
rating
Addresses common issue: concerned with a common clinical issue or a
decision important in daily care
8
Precisely described: provides a sufficiently detailed and precise guide to
clinical practice
8
Compatible: compatible with clinicians' current norms and values in practice 8
Key feature: essential to the whole set of recommendations and to the
ultimate goals
8
Based upon sound evidence: based upon sound scientific evidence
including, as appropriate, clinical trials or meta-analyses
8
Fits patient expectations: is likely to fit in with patient expectations 2
Observable: the benefits of using this practice or policy over existing
practices or policies can be seen quickly
6
Requires organisational change: requires changes in the way care is
organised or additional resources
1
Requires changed routines: requires changes to fixed routines or habits 1
High profile: has a high profile in educational programmes or the media 5
Complex: is complex and requires many steps to do or organise 1
Trialable: can be tried out and discarded easily 5










% change in compliance









32 (83/262) 33 (68/208) +1
Attribute Final consensus panel
rating
Addresses common issue: concerned with a common clinical issue or a
decision important in daily care
9
Precisely described: provides a sufficiently detailed and precise guide to
clinical practice
7
Compatible: compatible with clinicians' current norms and values in practice 7
Key feature: essential to the whole set of recommendations and to the
ultimate goals
5
Based upon sound evidence: based upon sound scientific evidence
including, as appropriate, clinical trials or meta-analyses
5
Fits patient expectations: is likely to fit in with patient expectations 5
Observable: the benefits of using this practice or policy over existing
practices or policies can be seen quickly
5
Requires organisational change: requires changes in the way care is
organised or additional resources
2
Requires changed routines: requires changes to fixed routines or habits 2
High profile: has a high profile in educational programmes or the media 4
Complex: is complex and requires many steps to do or organise 2
Trialable: can be tried out and discarded easily 2










% change in compliance
55. Endometrial biopsy
is the first line method




sample are by: Pipelle,
Karmen cannula or
Vabra aspiration).
44 (528/1199 41 (462/1126) -3
Attribute Final consensus panel
rating
Addresses common issue: concerned with a common clinical issue or a
decision important in daily care
9
Precisely described: provides a sufficiently detailed and prease guide to
clinical practice
9
Compatible: compatible with clinicians' current norms and values in practice 9
Key feature: essential to the whole set of recommendations and to the
ultimate goals
9
Based upon sound evidence: based upon sound scientific evidence
including, as appropriate, clinical trials or meta-analyses
9
Fits patient expectations: is likely to fit in with patient expectations 5
Observable: the benefits of using this practice or policy over existing
practices or policies can be seen quickly
5
Requires organisational change: requires changes in the way care is
organised or additional resources
1
Requires changed routines: requires changes to fixed routines or habits 2
High profile: has a high profile in educational programmes or the media 4
Complex: is complex and requires many steps to do or organise 2
Trialable: can be tried out and discarded easily 2














not the method of
choice, a hysteroscopy
plus or minus directed
biopsy represents the
method of choice.
4 (1/28) 7 (3/41) +3
Attribute Final consensus panel
rating
Addresses common issue: concerned with a common clinical issue or a
decision important in daily care
7
Precisely described: provides a sufficiently detailed and precise guide to
clinical practice
7
Compatible: compatible with clinicians' current norms and values in practice 5
Key feature: essential to the whole set of recommendations and to the
ultimate goals
7
Based upon sound evidence: based upon sound scientific evidence
including, as appropriate, clinical trials or meta-analyses
6
Fits patient expectations: is likely to fit in with patient expectations 7
Observable: the benefits of using this practice or policy over existing
practices or policies can be seen quickly
2
Requires organisational change: requires changes in the way care is
organised or additional resources
7
Requires changed routines: requires changes to fixed routines or habits 6
High profile: has a high profile in educational programmes or the media 5
Complex: is complex and requires many steps to do or organise 6
Trialable: can be tried out and discarded easily 2










% change in compliance
60. When a D&C is
performed, it should be





67 (402/600) 66 (380/571) -1
Attribute Final consensus panel
rating
Addresses common issue: concerned with a common clinical issue or a
decision important in daily care
9
Precisely described: provides a sufficiently detailed and precise guide to
clinical practice
9
Compatible: compatible with clinicians' current norms and values in practice 9
Key feature: essential to the whole set of recommendations and to the
ultimate goals
9
Based upon sound evidence: based upon sound scientific evidence
including, as appropriate, clinical trials or meta-analyses
9
Fits patient expectations: is likely to fit in with patient expectations 5
Observable: the benefits of using this practice or policy over existing
practices or policies can be seen quickly
7
Requires organisational change: requires changes in the way care is
organised or additional resources
1
Requires changed routines: requires changes to fixed routines or habits 1
High profile: has a high profile in educational programmes or the media 5
Complex: is complex and requires many steps to do or organise 1
Trialable: can be tried out and discarded easily 2




The management of infertility in a hospital setting






% change in compliance
61. The investigation of
infertility should involve
both partners from the
outset.
63 (951/1510) 74 (799/1080) +11
Attribute Final consensus panel
rating
Addresses common issue: concerned with a common clinical issue or a
decision important in daily care
8
Precisely described: provides a sufficiently detailed and precise guide to
clinical practice
9
Compatible: compatible with clinicians' current norms and values in practice 7
Key feature: essential to the whole set of recommendations and to the
ultimate goals
8
Based upon sound evidence: based upon sound scientific evidence
including, as appropriate, clinical trials or meta-analyses
8
Fits patient expectations: is likely to fit in with patient expectations 5
Observable: the benefits of using this practice or policy over existing
practices or policies can be seen quickly
6
Requires organisational change: requires changes in the way care is
organised or additional resources
2
Requires changed routines: requires changes to fixed routines or habits 3
High profile: has a high profile in educational programmes or the media 7
Complex: is complex and requires many steps to do or organise 2
Trialable: can be tried out and discarded easily 2














HSG, should be the
primary investigation of
the female genital tract.
85 (1284/1510) 79 (853/1080) -6
Attribute Final consensus panel
rating
Addresses common issue: concerned with a common clinical issue or a
decision important in daily care
8
Precisely described: provides a sufficiently detailed and precise guide to
clinical practice
9
Compatible: compatible with clinicians' current norms and values in practice 9
Key feature: essential to the whole set of recommendations and to the
ultimate goals
8
Based upon sound evidence: based upon sound scientific evidence
including, as appropriate, clinical trials or meta-analyses
7
Fits patient expectations: is likely to fit in with patient expectations 5
Observable: the benefits of using this practice or policy over existing
practices or policies can be seen quickly
5
Requires organisational change: requires changes in the way care is
organised or additional resources
2
Requires changed routines: requires changes to fixed routines or habits 3
High profile: has a high profile in educational programmes or the media 3
Complex: is complex and requires many steps to do or organise 2
Trialable: can be tried out and discarded easily 2














45 (680/1510) 57 (616/1080) +12
Attribute Final consensus panel
rating
Addresses common issue: concerned with a common clinical issue or a
decision important in daily care
9
Precisely described: provides a sufficiently detailed and precise guide to
clinical practice
9
Compatible: compatible with clinicians' current norms and values in practice 7
Key feature: essential to the whole set of recommendations and to the
ultimate goals
7
Based upon sound evidence: based upon sound scientific evidence
including, as appropriate, clinical trials or meta-analyses
8
Fits patient expectations: is likely to fit in with patient expectations 6
Observable: the benefits of using this practice or policy over existing
practices or policies can be seen quickly
1
Requires organisational change: requires changes in the way care is
organised or additional resources
2
Requires changed routines: requires changes to fixed routines or habits 7
High profile: has a high profile in educational programmes or the media 3
Complex: is complex and requires many steps to do or organise 2
Trialable: can be tried out and discarded easily 5










% change in compliance
65. A mid luteal plasma
progesterone level
should be checked in a
regularly menstruating
female as the basic test
of ovulation.
80 (798/992) 78 (548/704) -2
Attribute Final consensus panel
rating
Addresses common issue: concerned with a common clinical issue or a
decision important in daily care
9
Precisely described: provides a sufficiently detailed and precise guide to
clinical practice
9
Compatible: compatible with clinicians' current norms and values in practice 8
Key feature: essential to the whole set of recommendations and to the
ultimate goals
9
Based upon sound evidence: based upon sound scientific evidence
including, as appropriate, clinical trials or meta-analyses
9
Fits patient expectations: is likely to fit in with patient expectations 8
Observable: the benefits of using this practice or policy over existing
practices or policies can be seen quickly
7
Requires organisational change: requires changes in the way care is
organised or additional resources
2
Requires changed routines: requires changes to fixed routines or habits 2
High profile: has a high profile in educational programmes or the media 6
Complex: is complex and requires many steps to do or organise 2
Trialable: can be tried out and discarded easily 6










% change in compliance
66. A plan of
investigation with a
specific end-point
should be set down in
the notes and made
clear to the couple
concerned.
94 (1419/1510) 94 (1013/1080) 0
Attribute Final consensus panel
rating
Addresses common issue: concerned with a common clinical issue or a
decision important in daily care
8
Precisely described: provides a sufficiently detailed and precise guide to
clinical practice
8
Compatible: compatible with clinicians' current norms and values in practice 7
Key feature: essential to the whole set of recommendations and to the
ultimate goals
8
Based upon sound evidence: based upon sound scientific evidence
including, as appropriate, clinical trials or meta-analyses
8
Fits patient expectations: is likely to fit in with patient expectations 8
Observable: the benefits of using this practice or policy over existing
practices or policies can be seen quickly
6
Requires organisational change: requires changes in the way care is
organised or additional resources
2
Requires changed routines: requires changes to fixed routines or habits 6
High profile: has a high profile in educational programmes or the media 6
Complex: is complex and requires many steps to do or organise 4
Trialable: can be tried out and discarded easily 8










% change in compliance
67. The female partner






14 (211/1510) 43 (463/1080) +29
Attribute Final consensus panel
rating
Addresses common issue: concerned with a common clinical issue or a
decision important in daily care
9
Precisely described: provides a sufficiently detailed and precise guide to
clinical practice
9
Compatible: compatible with clinicians' current norms and values in practice 8
Key feature: essential to the whole set of recommendations and to the
ultimate goals
8
Based upon sound evidence: based upon sound scientific evidence
including, as appropriate, clinical trials or meta-analyses
9
Fits patient expectations: is likely to fit in with patient expectations 7
Observable: the benefits of using this practice or policy over existing
practices or policies can be seen quickly
4
Requires organisational change: requires changes in the way care is
organised or additional resources
1
Requires changed routines: requires changes to fixed routines or habits 2
High profile: has a high profile in educational programmes or the media 7
Complex: is complex and requires many steps to do or organise 1
Trialable: can be tried out and discarded easily 8















58 (1510) 71 (770/1080) +13
Attribute Final consensus panel
rating
Addresses common issue: concerned with a common clinical issue or a
decision important in daily care
9
Precisely described: provides a sufficiently detailed and precise guide to
clinical practice
9
Compatible: compatible with clinicians' current norms and values in practice 8
Key feature: essential to the whole set of recommendations and to the
ultimate goals
7
Based upon sound evidence: based upon sound scientific evidence
including, as appropriate, clinical trials or meta-analyses
5
Fits patient expectations: is likely to fit in with patient expectations 8
Observable: the benefits of using this practice or policy over existing
practices or policies can be seen quickly
2
Requires organisational change: requires changes in the way care is
organised or additional resources
1
Requires changed routines: requires changes to fixed routines or habits 2
High profile: has a high profile in educational programmes or the media 3
Complex: is complex and requires many steps to do or organise 1
Trialable: can be tried out and discarded easily 2










% change in compliance
69. Temperature charts




99 (1495/1510) 99 (1074/1080) 0
Attribute Final consensus panel
rating
Addresses common issue: concerned with a common clinical issue or a
decision important in daily care
8
Precisely described: provides a sufficiently detailed and precise guide to
clinical practice
9
Compatible: compatible with clinicians' current norms and values in practice 9
Key feature: essential to the whole set of recommendations and to the
ultimate goals
7
Based upon sound evidence: based upon sound scientific evidence
including, as appropriate, clinical trials or meta-analyses
6
Fits patient expectations: is likely to fit in with patient expectations 4
Observable: the benefits of using this practice or policy over existing
practices or policies can be seen quickly
7
Requires organisational change: requires changes in the way care is
organised or additional resources
1
Requires changed routines: requires changes to fixed routines or habits 1
High profile: has a high profile in educational programmes or the media 5
Complex: is complex and requires many steps to do or organise 2
Trialable: can be tried out and discarded easily 5















analyses at least one
month apart.
57 (869/1510) 60 (652/1080) +3
Attribute Final consensus panel
rating
Addresses common issue: concerned with a common clinical issue or a
decision important in daily care
8
Precisely described: provides a sufficiently detailed and prease guide to
clinical practice
9
Compatible: compatible with clinicians' current norms and values in practice 7
Key feature: essential to the whole set of recommendations and to the
ultimate goals
8
Based upon sound evidence: based upon sound scientific evidence
including, as appropriate, clinical trials or meta-analyses
8
Fits patient expectations: is likely to fit in with patient expectations 5
Observable: the benefits of using this practice or policy over existing
practices or policies can be seen quickly
6
Requires organisational change: requires changes in the way care is
organised or additional resources
2
Requires changed routines: requires changes to fixed routines or habits 2
High profile: has a high profile in educational programmes or the media 5
Complex: is complex and requires many steps to do or organise 2
Trialable: can be tried out and discarded easily 6










% change in compliance
72. Counselling by
trained counsellors
should be available to
all couples.
16 (241/1510) 37 (398/1080) +21
Attribute Final consensus panel
rating
Addresses common issue: concerned with a common clinical issue or a
decision important in daily care
8
Precisely described: provides a sufficiently detailed and precise guide to
clinical practice
7
Compatible: compatible with clinicians' current norms and values in practice 3
Key feature: essential to the whole set of recommendations and to the
ultimate goals
6
Based upon sound evidence: based upon sound scientific evidence
including, as appropriate, clinical trials or meta-analyses
7
Fits patient expectations: is likely to fit in with patient expectations 6
Observable: the benefits of using this practice or policy over existing
practices or policies can be seen quickly
2
Requires organisational change: requires changes in the way care is
organised or additional resources
9
Requires changed routines: requires changes to fixed routines or habits 9
High profile: has a high profile in educational programmes or the media 5
Complex: is complex and requires many steps to do or organise 8
Trialable: can be tried out and discarded easily 2










% change in compliance




should not be used.
96 (1454/1510) 99 (1065/1080) +3
Attribute Final consensus panel
rating
Addresses common issue: concerned with a common clinical issue or a
decision important in daily care
8
Precisely described: provides a sufficiently detailed and precise guide to
clinical practice
9
Compatible: compatible with clinicians' current norms and values in practice 8
Key feature: essential to the whole set of recommendations and to the
ultimate goals
8
Based upon sound evidence: based upon sound scientific evidence
including, as appropriate, clinical trials or meta-analyses
8
Fits patient expectations: is likely to fit in with patient expectations 3
Observable: the benefits of using this practice or policy over existing
practices or policies can be seen quickly
3
Requires organisational change: requires changes in the way care is
organised or additional resources
1
Requires changed routines: requires changes to fixed routines or habits 1
High profile: has a high profile in educational programmes or the media 5
Complex: is complex and requires many steps to do or organise 1
Trialable: can be tried out and discarded easily 2










% change in compliance
74. The post coital test
should not be used in
the routine investigation
of the infertile couple.
98 (1488/1510) 98 (1054/1080) 0
Attribute Final consensus panel
rating
Addresses common issue: concerned with a common clinical issue or a
decision important in daily care
8
Precisely described: provides a sufficiently detailed and precise guide to
clinical practice
9
Compatible: compatible with clinicians' current norms and values in practice 7
Key feature: essential to the whole set of recommendations and to the
ultimate goals
7
Based upon sound evidence: based upon sound scientific evidence
including, as appropriate, clinical trials or meta-analyses
8
Fits patient expectations: is likely to fit in with patient expectations 7
Observable: the benefits of using this practice or policy over existing
practices or policies can be seen quickly
2
Requires organisational change: requires changes in the way care is
organised or additional resources
1
Requires changed routines: requires changes to fixed routines or habits 1
High profile: has a high profile in educational programmes or the media 4
Complex: is complex and requires many steps to do or organise 1
Trialable: can be tried out and discarded easily £ 2











% change in compliance





until they have had 6
months of ovulatory
cycles in response to
clomiphene, except




56 (42/75) 51 (30/59) -5
Attribute Final consensus panel
rating
Addresses common issue: concerned with a common clinical issue or a
decision important in daily care
8
Precisely described: provides a sufficiently detailed and precise guide to
clinical practice
8
Compatible: compatible with clinicians' current norms and values in practice 8
Key feature: essential to the whole set of recommendations and to the
ultimate goals
8
Based upon sound evidence: based upon sound scientific evidence
including, as appropriate, clinical trials or meta-analyses
8
Fits patient expectations: is likely to fit in with patient expectations 5
Observable: the benefits of using this practice or policy over existing
practices or policies can be seen quickly
4
Requires organisational change: requires changes in the way care is
organised or additional resources
1
Requires changed routines: requires changes to fixed routines or habits 6
High profile: has a high profile in educational programmes or the media 5
Complex: is complex and requires many steps to do or organise 2
Triaiable: can be tried out and discarded easily 6










% change in compliance









56 (99/176) 66 (64/98) +10
Attribute Final consensus panel
rating
Addresses common issue: concerned with a common clinical issue or a
decision important in daily care
8
Precisely described: provides a sufficiently detailed and precise guide to
clinical practice
8
Compatible: compatible with clinicians' current norms and values in practice 8
Key feature: essential to the whole set of recommendations and to the
ultimate goals
8
Based upon sound evidence: based upon sound scientific evidence
including, as appropriate, clinical trials or meta-analyses
8
Fits patient expectations: is likely to fit in with patient expectations 3
Observable: the benefits of using this practice or policy over existing
practices or policies can be seen quickly
3
Requires organisational change: requires changes in the way care is
organised or additional resources
2
Requires changed routines: requires changes to fixed routines or habits 2
High profile: has a high profile in educational programmes or the media 6
Complex: is complex and requires many steps to do or organise 1
Trialable: can be tried out and discarded easily 2















25 (377/1510) 41 (441/1080) +16
Attribute Final consensus panel
rating
Addresses common issue: concerned with a common clinical issue or a
decision important in daily care
7
Precisely described: provides a sufficiently detailed and precise guide to
clinical practice
8
Compatible: compatible with clinicians' current norms and values in practice 3
Key feature: essential to the whole set of recommendations and to the
ultimate goals
5
Based upon sound evidence: based upon sound scientific evidence
including, as appropriate, clinical trials or meta-analyses
6
Fits patient expectations: is likely to fit in with patient expectations 5
Observable: the benefits of using this practice or policy over existing
practices or policies can be seen quickly
2
Requires organisational change: requires changes in the way care is
organised or additional resources
4
Requires changed routines: requires changes to fixed routines or habits 8
High profile: has a high profile in educational programmes or the media 3
Complex: is complex and requires many steps to do or organise 2
Trialable: can be tried out and discarded easily 2










% change in compliance
78. A genital
examination of the male
partner should be
performed.
23 (342/1510) 33 (361/1080) +10
Attribute Final consensus panel
rating
Addresses common issue: concerned with a common clinical issue or a
decision important in daily care
7
Precisely described: provides a sufficiently detailed and precise guide to
clinical practice
8
Compatible: compatible with clinicians' current norms and values in practice 2
Key feature: essential to the whole set of recommendations and to the
ultimate goals
4
Based upon sound evidence: based upon sound scientific evidence
including, as appropriate, clinical trials or meta-analyses
6
Fits patient expectations: is likely to fit in with patient expectations 4
Observable: the benefits of using this practice or policy over existing
practices or policies can be seen quickly
1
Requires organisational change: requires changes in the way care is
organised or additional resources
6
Requires changed routines: requires changes to fixed routines or habits 9
High profile: has a high profile in educational programmes or the media 2
Complex: is complex and requires many steps to do or organise 2
Trialable: can be tried out and discarded easily 3





Telephone questionnaire to doctors and midwives on knowledge of
CEMD Report recommendations
1. Identity number allocated
2. Hospital







Senior house officer (years 1-2)
Senior house officer (year 3 or above)
Midwifery sister (labour ward)
Staff midwife (labour ward)
Midwifery sister (ANC)
Staff midwife (ANC)
I am conducting a telephone survey on behalf of the Scottish Programme for Clinical
Effectiveness in Reproductive Health. The survey involves taking a random sample of
on-call obstetricians and duty midwives from across Scotland. We are specifically
interested in the Confidential Enquiry into Maternal Deaths and how much staff 'on the
frontline' actually know about its key recommendations.
Using a telephone questionnaire because if we used a postal survey, being good
professionals, staff would read up on the best answers to the questions before replying.
This survey will take no longer than 5-10 minutes, does NOT test individual competence
and is in complete CONFIDENCE
Therefore, the most honest answers which reflect everyday practice are the most helpful
We can call back at a more convenient time if appropriate
6. Agrees to respond Yes [ ] No [ ]
Count those who say 'no' as non-responders. If unable to respond at time of first
contact, note follow up arrangements
S/he will call us back later
Date: Time:
We can call her/him back later
Date: Time: Bleep: Tel:
7. Are you aware of the latest Report on Confidential Enquiries into Maternal Deaths in the
UK 1994-6? (entitled Why Mothers Die)?
Yes [ ] No [ ]
8. Have you received a copy of the...
a. Full report? Yes [ ] No [ ]
b. Executive summary? Yes [ 3 No [ ]
9. Have you read a copy of the...
a. Full report? Yes, all or most [ ] Yes, some [ ] No [ 3
b. Executive summary? Yes, all or most [ ] Yes, some [ ] No [ 3
10. The next question is probably the most difficult and is about how easily you can
remember recommendations from the last report. As a general reminder the report covers in
detail:
• Certain conditions which place mothers at higher risk of death
• Factors which contribute to sub-optimal care
• Recommendations about individual patient care
• Recommendations about the way local obstetric care is organised
Move to next page now
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Without any prompting, can you recall any three key or more recommendations from the
report?
Tick boxes against issues raised by the respondent (and according to how precise or vague
their response is)
Direct HIT Near MISS
a. Recognition of main direct causes of death [ ] [ ]
b. Importance of prompt diagnosis or referral of suspected [] []
serious disease
c. Identification of women at risk of postnatal mental illness [] []
or self harm during antenatal care
d. Enquiry about domestic violence [ ] [ ]
e. Education of women about the use of seatbelts [ ] [ ]
f. Education of women about symptoms associated with pre-eclampsia [ ] [ ]
g. Education of women about first aid of epileptic fits [] []
h. Early attention to chest or leg symptoms to exclude presence [ ] [ ]
of thromboembolism
i. Management of eclampsia or pre-eclampsia by a single [] []
senior clinician
j. Pregnancy testing considered in any woman with unexplained [ ] [ ]
abdominal pain
k. Prompt management of suspected ectopic pregnancy [ ] [ ]
I. Assessment of risk factors in considering prophylaxis against [ ] [ ]
thromboembolism in all women undergoing caesarean section
m. Use of prophylactic antibiotics in caesarean section [ ] [ ]
n. Awareness of puerperal sepsis [ ] [ ]
o. Participation in confidential enquiries [ ] [ ]
p. Consultant attendance or appropriate delegation in emergencies [ ] [ ]
q. Need for units to have protocols for massive haemorrhage [ ] [ ]
or pulmonary embolism
r. Unit "fire drills" for emergencies [ ] [ ]
s. Other recommendations not mentioned above (please specify): [ ] [ ]
If in doubt whether response fits with any of the above, make a note and we will make
a formal decision later.
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The following two questions are concerned with the most common causes of maternal death.
11. In the report, direct deaths are those directly due to pregnancy. Can you name the three
most common causes of maternal death (starting with the most common)?
(Interviewer to write order in which causes are cited in boxes, e.g. if
thromboembolism mentioned as the most common, mark "1"; and "2" for the next
most common, etc.)
a. Thromboembolism
b. Pregnancy induced hypertension
c. Amniotic fluid embolus
d. Early pregnancy problems (e.g. ectopic pregnancy)
e. Sepsis (or infection)
f. Haemorrhage
g. Uterine rupture
h. Fatty liver of pregnancy
i. Anaesthesia
j. Others named:
12. In the report, indirect deaths are those due to pre-existing illness aggravated by
pregnancy. Can you name the three most common causes of maternal death (starting with
the most common)?
(interviewer to write order in which causes are cited in boxes, e.g. if cardiac disease







13. The following questions are concerned with antenatal care. Are you usually involved in
providing antenatal care?
Yes [ ] No f ]
If no, miss this section and go to question 17.
14. Do you usually enquire about or check any of the following at booking clinics?
Usually If indicated Not usually
a. Previous psychiatric disorders [ ] [ ] [ ]
b. Episodes of self-harm [ ] [ ] [ ]
c. Domestic violence [ ] [ ] [ ]
d. Substance abuse [ ] [ ] [ ]
e. Alcohol intake [ ] [ ] [ ]
15. Do you discuss any of the following issues at clinics (or antenatal classes)?
Usually If indicated Not usually
a. Correct use of seatbelts in pregnancy [ ] [ ] [ ]
b. Advice on recognising symptoms of [ ] [ ] [ ]
pre-eclampsia in early pregnancy
c. Advice on safety to women with [ ] [ ] [ ]
with epilepsy
16. What advice about personal safety, if any, would you offer to women with epilepsy in
pregnancy?
Allow respondent to volunteer advice usually given and tick relevant box.
a. Not bathing alone, or taking a shower instead [ ]
b. That relatives or friends know what to do in case of a fit [ ]
(Do not accept 'not being alone' or 'not sleeping alone' etc.)
17. Which of the following investigations are safe to conduct in pregnancy?
a. VQ scans in women with symptoms or signs suggestive of DVT or pulmonary embolism
Yes [ ] No [ ] Don't know [ ]
b. Chest x-ray in pregnant women with chest pain
Yes [ ] No [ ] Don't know [ ]
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18. The following questions are concerned with guidelines and policies in your maternity unit.
Are you aware of local policies on the following topics? And, if yes, have you received a
copy or are they readily available (e.g. in labour rooms)?
Yes - readily Yes - but No (or
available or have NOT don't know)
have seen seen
a. Management of pre-eclampsia / eclampsia [ ] [ ] [ ]
b. Management of obstetric haemorrhage [ ] [ ] [ ]
c. Use of thromboprophylaxis [ ] [ ] [ ]
d. Antibiotic cover for caesarean sections [ ] [ ] [ ]
e. Management of women who decline [ ] [ ] [ ]
blood products, e.g. Jehovah's Witnesses
f. Investigation and management of [ ] [ ] [ ]
ectopic pregnancy
19. Are you aware of the following having taken place in the past 6 months in your
department? (Tease out how interactive any educational session attended was.)
Yes: attended Yes: attended Yes: unable No
locally elsewhere to attend
(Didactic) lecture on the CEMD [ ] [ ] [ ] [ ]
or any important clinical aspect
of the CEMD
Interactive group tutorial on [ ] [ ] [ ] [ ]
the CEMD or any important clinical
aspect of the CEMD
"Fire drills" to test emergency protocols [ ] [ ] [ ] [ ]
Thank you for your time. Are there any questions we can answer about the survey?
Please refrain from mentioning the exact subject of this survey to your colleagues in
the near future as we wish to interview staff in the course of their usual practice.
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Appendix 4A
Questionnaire used in postal survey
Scottish Obstetric Guidelines and Audit Project
Questionnaire for Obstetricians in Scotland
Clinical Practice Guidelines for four important obstetric topics as aids to patient care in
Scotland were launched nationally over 1997 and 1998. These guidelines were developed
by groups of obstetricians, clinical colleagues and patient representatives.
As part of the audit element of the SOGAP project, we are now trying to obtain a picture of
how much practice has changed in relation to the four guideline topics since the 'pre-
guideline' survey was conducted two years ago. We would much appreciate you completing
the enclosed questionnaire which has sections relating to each of the four topics. Your
responses will help us obtain a representative picture of 'post-guideline' practice.
Results from this survey will be presented later in 1999.
Please return your completed questionnaire in the SAE provided within two weeks:
General questions about the guidelines
Q.1 Do you recall receiving any guidelines from SOGAP on the following topics?
Yes No
a) The preparation of the fetus for pre-term delivery
b) The management of mild, non-proteinuric hypertension in pregnancy
c) The management of pregnancy in women with epilepsy
d) The management of post-partum haemorrhage
Q.2 Where are these guidelines now?
a) On my shelf for future reference
b) Uncertain
c) Thrown away a, b or c
Q.3 How relevant to your clinical practice did you find the guidelines?
a) Relevant and prompted me to change some aspects of my practice
b) Relevant and prompted me to reconsider some aspects of my practice
c) Of some general interest
d) Of no real interest to me
e) A waste of paper
a - e
The preparation of the fetus for pre-term delivery
The management of mild, non-proteinuric hypertension in pregnancy
The management of pregnancy in women with epilepsy
The management of post-partum haemorrhage
Q.4 Did you adopt or adapt any of the guidelines for use in your department?
Yes No
The preparation of the fetus for pre-term delivery
The management of mild, non-proteinuric hypertension in pregnancy
The management of pregnancy in women with epilepsy
The management of post-partum haemorrhage
Q.5 Has there been any clinical audit related to any aspect of the guidelines within your
department?
Yes No
The preparation of the fetus for pre-term delivery
The management of mild, non-proteinuric hypertension in pregnancy
The management of pregnancy in women with epilepsy
The management of post-partum haemorrhage
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Section I - Preparation of the Fetus for Pre-term Delivery
Q.1 In the course of your clinical practice, are you involved in the




(If No, please proceed to Section II on page 5)
Q.2
box only








Q.2 If you ever prescribe antenatal steroids,
what is the lowest gestation at which you would
consider doing so?
Enter No. of Weeks
eg: 2 0
completed weeks completed weeks
Q.3 If Yes, what is the highest gestation at which you would
consider prescribing ante-natal steroids?
eg: 8
Enter No. of weeks




Q 4 In what circumstances would you use tocolysis? Tick one
box only
a) Never
b) In rare circumstances (eg to permit intra-uterine
transfer to a tertiary centre or to allow a course
of steroids to be administered) and for a maximum
period of <48 hours
c) More liberally and for periods of >48 hours
d) Other, please specify
Q.5 Do you use prophylactic antibiotics in the routine
management of women presenting with pre-term, pre-labour
rupture of the membranes (PPROM)? Tick one box only
a) no, I only give antibiotics if there are clinical signs
of chorio-amnionitis
b) yes, I use routine, prophylactic antibiotics
c) I am participating in the ORACLE trial and would
usually recruit women with PPROM into this trial
d) other policy, please specify
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Q.6 A 25 year old primigravida with insulin-dependent diabetes
(IDDM) and a twin pregnancy presents with regular, painful
contractions at 28 weeks gestation. Following a clinical
assessment, you decide that she is at risk of delivery within
the next 7 days.
ii) Would you initiate ante-natal steroid therapy?
Tick one box only
a) Yes
b) No, because I would not prescribe steroids for any
patient at 28 weeks
c) No, because I feel steroids are contra-indicated
in IDDM.
iii) If you would initiate steroid therapy, would you:
Tick one box only
a) initiate steroid therapy according to my usual dosage schedule
b) initiate steroid therapy using a higher dose of steroids than
my usual schedule
c) other, please describe
iv) Assuming that contractions are regular and painful, and that vaginal
examination has indicated that the cervix is 50% effaced and 3cm
dilated, would you commence tocolytic therapy in an attempt to
delay delivery to allow steroid therapy to have an optimal effect? Tick one box only
a) Yes
b) No
c) Other, (please specify
v) If you would use tocolysis, which drug would you use in this case?Tick one box only




e) other, please specify
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Q.7 A 28 year old primigravida with no relevant medical
or obstetric history presents at 35 weeks gestation with
PPROM.
i) Would you initiate steroid therapy? Tick one box only
a) Yes
b) No
ii) Would you initiate prophylactic antibiotic therapy? Tick one box only
a) Yes
b) No
c) i would enter her into the ORACLE Study
d) other, please specify
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Section II - Management of mild, non-proteinuric hypertension in
pregnancy
Q.1 In the course of your clinical practice, are you involved in
providing ante-natal care? Tick one box only
a) Yes
b) No
(If No, please proceed to Section III on page 12)
□
□
Q.2 The established, UK classification of hypertensive disorders
of pregnancy (ISSHP Classification of Davey and MacGillivray,
1988) requires that a diastolic BP of >90mmHg be sustained for
at least 4 hours before "hypertension" is diagnosed
If a patient attends you for routine ante-natal care and is found
to have a "spot" diastolic BP of 95mmHg, but no proteinuria,
how would you usually proceed? Tick one box only
a) Recheck the BP over a short period (perhaps 20
minutes) and if diastolic remains elevated,
arrange further investigations including blood tests.
b) Recheck the BP within a short period and, if diastolic
remains elevated, make arrangements (eg repeat
attendance at surgery, home visit by community
midwife, attendance at hospital day care facility)
for a further BP check at least 4 hours later before
initiating further investigations.
c) Other course of action. Please specify
Q.3. Mrs AB is a 20 year old primigravida. At 34 weeks gestation
she develops gestational hypertension (diastolic BP
consistently 95mmHg) but no proteinuria. At this stage Tick one box only
would you initiate antihypertensive drug treatment?
a) Yes, I would be likely to do so.
b) No, I would be unlikely to do so.
c) I would not initiate such treatment myself but would
refer her to a colleague for advice.
d) Other, please specify
□
297
Q.4. If a similar clinical picture arose at 31 weeks gestation
would you initiate anti-hypertensive therapy? Tick one box only
a) Yes, I would be likely to do so.
b) No, I would be unlikely to do so




Q.5. In circumstances where you do initiate antihypertensive drug
treatment for women with gestational hypertension, which














In the case of Mrs AB (a 20 year old primigravida with a
diastolic BP of 95mmHg, but no proteinuria, at 34 weeks
gestation), how often would you wish her to be seen for
BP check and urine testing?
Enter no. of days: eg every
days
I would not arrange for her to be seen on an






Q.7. Which investigations would you employ for the
intermittent assessment of a woman such as
Mrs AB (with mild gestational hypertension, but no Tick all that apply
proteinuria, remote from term)?
a) full blood count
b) platelet count
c) platelet volume
d) proteinuria assessed by 'dipsticks'
e) proteinuria assessed by 24hr collections
f) urea and electrolytes
g) 24 hr urine collection for creatinine clearance
h) liver function tests
I) serum urate
j) ultrasound assessment fetal size
k) serial ultrasound assessment fetal growth
I) ultrasound assessment liquor volume
m) CTG recording :x:
n) umbilical artery Doppler ultrasound
o) others (please list)
Q.8 In measuring diastolic BP, do you use Korotkoff phase IV




Section III - Pregnancy in Women with Epilepsy
Q.1 In the course of your clinical practice, are you ever involved




(If No, please proceed to Section IV on page 12)
Q.2 In relation to periconceptual folic acid supplements for Tick one box only
women with epilepsy, do you:
a) advise folic acid supplements at the 0.4mg-0.65mg/day
level, as for most other women
b) advise folic acid supplements at the 4-5mg/day level,
as for women with a previous history of neural tube defect
c) although I advise most women to take periconceptual
folic acid, I exclude women with epilepsy as I believe
folic acid worsens seizure control
d) I do not advise periconceptual folic acid supplements
for any woman
e) other, please specify
Q.3 In relation to the use of Vitamin K for the prevention of
haemorrhagic disease of the newborn, do you: Tick one box only
a) ensure that the babies of mothers with epilepsy receive
Vitamin K 1mg at birth
b) as above, but in addition treat the mother with Vitamin K
20mg orally daily from 36 weeks gestation until delivery
c) Give Vitamin K to neither the mother nor the baby
d) Other strategy, please specify
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Q 4 In relation to breast feeding and the mother with Tick one box only
epilepsy, do you:
a) encourage and support breast feeding as for any
other mother
b) discourage breast feeding in women on sedative
anticonvulsants
c) discourage breast feeding in any mother with epilepsy
d) other policy - please specify
Q.5 In providing advice on combined oral contraception
(COC) for women with epilepsy, do you: Tick all that apply
a) indicate that COC is unsuitable for any woman with epilepsy
and advise non-hormonal methods
b) indicate that COC is unsuitable for women on enzyme-
inducing anticonvulsants (carbamazepine, phenytoin,
primidone, phenobarbitone) and advise non-hormonal methods
c) include COC among the contraceptive options offered
to women on enzyme-inducers but encourage the use
of non-hormonal methods
d) when COC is chosen by a woman on an enzyme-inducing
agent, advise a 50pg pill (eg Ovran) as the first-line pill
e) when COC is chosen by a woman on an enzyme-inducing
agent, use two lower dose pills (eg 2 x Marvelon) as first-line
f) when COC is chosen by a woman on an enzyme inducer,
routinely advise a regimen involving taking three or more
packs of pills in succession without a pill-free interval






Section IV - Obstetric Haemorrhage
Q.1 In the course of your clinical practice, are you involved in
the care of women in the labour ward? Tick one box only
a) Yes
b) No
(If No, please return the questionnaire in the SAE provided, NOW)
Q.2 The 1988-1990 Report on Confidential Enquiries into Maternal
Deaths provided guidelines for the management of massive
obstetric haemorrhage. In your recollection, which of the Tick all that accord
following recommendations are included in the guidelines: with the Confidential
Enquiry Guidelines
a) Alert all of the following: anaesthetist, haematologist, —
blood transfusion, porters.
b) A minimum of 2 units of blood should be ordered.
c) Dextrans are recommended for resuscitation until blood arrives.
d) At least two intravenous lines should be set up using cannulae
of not less than 14 gauge.
e) Blood warming equipment is unnecessary.
f) Central venous pressure monitoring should immediately be set
up to help ensure that therapy is safely controlled.
Thank you for your time and effort. Please return your questionnaire in the SAE
provided NOW. If you have any further comments about the questionnaire, or about
the SOGAP project, please add them below:
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Appendix 5A. Members of Steering Group for the interrupted













Professor, Department of Obstetrics and Gynaecology, University
of Glasgow, and Consultant Obstetrician and Gynaecologist,
Glasgow Royal Infirmary
MRC / CSO training fellow in health services research, Scottish
Programme for Clinical Effectiveness in Reproductive Health
(SPCERH), University of Edinburgh
National Coordinator, SPCERH, Aberdeen Maternity Hospital,
and Clinical Senior Lecturer in Obstetrics and Gynaecology,
University of Edinburgh
Director of the Clinical Epidemiology Programme Ottawa Health
Research Institute and Director of the and Centre for Best
Practices, Institute of Population Health, University of Ottawa
(Formerly: Programme Director, Health Services Research Unit
(HSRU), University of Aberdeen)
Senior Statistician, Health Services Research Unit, University of
Aberdeen
Research Fellow (health economics), Health Services Research
Unit, University of Aberdeen
Lecturer, Department of Obstetrics and Gynaecology, University
of Glasgow, and Consultant Obstetrician and Gynaecologist,
Royal Alexandra Hospital, Paisley
Consultant Obstetrician and Gynaecologist, Aberdeen Maternity
Hospital
Consultant Obstetrician and Gynaecologist, Edinburgh Royal
Infirmary
Midwife, Ayrshire Central Hospital, Irvine
Consultant Obstetrician and Gynaecologist, Ayrshire Central
Hospital, Irvine
Tahir Mahmood Consultant Obstetrician and Gynaecologist, Forth Park Hospital,
Kirkcaldy
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Management of mild, non-proteinuric
hypertension in pregnancy
Research data collection form
Scottish Programme for Clinical Effectiveness












4 Date of first antenatal visit (day/month/year) / / 4
5 Gestation at first visit weeks 5
6 Age at first visit years 6
7 Parity (completed pregnancies) 7
8 Parity (miscarriages and terminations of pregnancy) 8
During the period from 20 weeks gestation to the onset of labour ONLY, which of the following problems
occurred?
9 Episode of diastolic BP = or > 90 mmHg No = 0
Yes = 1
9
10 If yes, state gestation this first occurred at Weeks 10
11 Episode of proteinuria + or greater No = 0
Yes = 1
11
12 If yes, state gestation this first occurred at Weeks 12
13 Which problem occurred earliest? High diastolic BP = 1
Proteinuria = 2
13
For questions 14 to 40, only collect data for the 7 days including and following
the first episode.
Blood pressure readings
14 Diastolic BP at time of initial clinical problem (first episode of raised
blood pressure or proteinuria)
MmHg 14
15 If the diastolic 90 mmHg or greater,
was it re-checked?
YES, 4 to 24 hrs later = 1
YES, <4 hrs later = 2
Yes, timing not recorded = 3
NO or re-checked > 24 hrs = 4
15
16 If re-checked, what was the re-checked diastolic BP reading? (Use




17 What was the reading on urine
dipstix at the time of this first clinical
problem?
Normal or trace = 0 (Go to Q24)
+ = 1 (Goto Q18)
++ = 2 (Go to Q20)
+++ = 3 (Go to Q24)
Not recorded = 4 (Go to Q24)
17
18 If proteinuria of + was recorded,
was the urine specific gravity (SG)
measured?
No or not recorded = 0
Yes = 1
18
19 If urine specific gravity recorded,
was it under 1.03 AND the pH less
than 8?
No or not recorded = 0
Yes = 1
19
20 If proteinuria + or ++, was an MSU
taken?
No or not recorded = 0
Yes = 1
20
21 If proteinuria + or ++, was a urinary
tract infection (UTI) diagnosed?
Diagnosis can be based on clinical
picture AND/OR microbiology. (If
MSU is negative but patient has
received antibiotics, this counts as
a UTI)




22 If proteinuria of ++ was recorded,
was it re-checked within 24 hours?
No or not recorded = 0
Yes = 1
22
23 If proteinuria of ++ was re-checked,
what was the second reading?





Clinical findings and management within week of first episode (excluding findings after
the onset of labour)
24 Highest diastolic BP recorded within
following 6 days
None recorded = 0
Less than 90 = 1
90- 100 = 2
101 - 110 = 3
Greater than 110 = 4
24
25 Highest urinary protein measurement
within following 6 days




Over 300mg/ 24hr = 4
None recorded = 5
25
26 Including first contact above, total number of clinical contacts of any
type during that week
Count each attendance at antenatal clinic, day case, community clinic
or home visit, or admission as one contact.
26
27 Admission as an in-patient No (go to Q31) = 0
Yes, including for hypertension = 1
Yes, for labour = 2
Yes, other reason or reason not
stated = 3
27
28 Date of admission / / 28
29 Number of nights spent in hospital during that week (but only up until
the onset of labour)
29
30 Is there any record of a hospital
obstetrician (any grade) seeing the











31 Fundal height Over or less than 3cm of
week of gestation
31
32 Enquiry into fetal movements Reduced or absent 32
33 Serum urate (or uric acid) Outwith local reference
range
33





35 Platelet count Outwith local reference
range
35
36 Liver function tests (Protein, albumin,









38 Doppler ultrasound Any abnormality
recorded in notes
38
39 Antenatal CTG Any abnormality
recorded in notes
39
40 24 hour urine collection for protein
estimation
If over 300 mg / 24 hrs 40
Q41 onwards concern the antenatal period from 20 weeks onwards to delivery
Anti-hypertensive therapy
Please indicate whether any of the following anti¬








46 If another drug was prescribed, please write name of drug 46
47 If treated with any of the above drugs, did hypertension (or




48 First recorded diastolic BP reading in this pregnancy (including any recorded at
booking or on GP referral letter)
mmHg 48




50 Total number of nights spent in hospital for any reason from 20 weeks
gestation until date of delivery
50
51 Date of delivery / / 51
52 Gestational age at delivery Weeks 52
53 Induction of labour No = 0
Yes, including for hypertension = 1
Yes, other indication = 2
53
54 Caesarean section No = 0
Yes, including for hypertension = 1
Yes, other reason = 2
54




Appendix 5D. Resource use and unit costs, expressed in 2001
values
Component Resources used Unit cost (£)
Guideline development
Development group meetings Four meetings lasting 4 hours
each, attended by:










Travel Nine guideline development
group members to 4 meetings
£30 per person per meeting
Writing up Twelve weeks of clinical
research fellow time (40
hours per week)
£37.11 per hour









Planning Clinical research fellow time
for 40 hours
£37.11 per hour ~
Catering Lunch for 87 participants £7 per person



























Feedback Clinical research fellow time
for 40 hours





Printing Printing of 7,700 guidelines £0.67 per guideline




Appendix 5E. Categorisation of outcomes
1 Descriptive data
Purpose of analysis
• To assess how many cases per unit and per month we have available for analysis
• To describe any trends and variations in demography and casemix over time and among
the four hospitals
• To help assess generalisability of findings
All of the following will therefore be described by hospital and by month of year
Descriptive data Analysis Comments
Number of cases for each
month
Frequency of deliveries per
month by year (first two items
on database)
Number of cases for each
month by hospital
Frequency of deliveries per
month by year and 2(hospital)
Age at first visit 6(age)




Gestation at delivery 52(gestational age)
Recorded episodes of raised
diastolic BP = or > 90 mmHg
9(diastolic over 90) Data collectors extracted data
on up to 10 cases per month.
This will tend to under-estimate
number of cases in months
where more cases were found.
More data available from case
identification sheets held by
local data collectors
Recorded episodes of
proteinuria + or greater
11 (proteinuria) Ditto
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2 Compliance with guideline recommendations
2.1 Appropriate diagnosis of mild, non-proteinuric hypertension
Two criteria to be met:
• Confirmation of mild hypertension by checking two BP measurements 4-24 hours apart;




hypertension by checking two
BP measurements 4-24 hours
apart
Proportion of cases with raised
BP with documented,
appropriate re-checking
A. Mild or spot hypertension
Denominator:
9(diastolic over 90) = 1 and
13(earliest problem) = 1 or 0
and 14(diastolic BP) <110
Numerator:




9(diastoiic over 90) = 1 and
13(earliest problem) = 1 or 0
and 14(diastolic BP) > or = 110
Numerator:
15(re-checked BP) = 0, 1, 2, 3
or 4
(i.e. severe hypertension does
not need to be re-checked)
ADD BOTH SUBSETS TOGETHER
FOR FINAL PROPORTION
The criterion of documenting
re-checking over 4-24 hours
later might be too strict, i.e.
many women will have their
BPs re-checked within 4 hours,
including assessment in day
care. Therefore, we have
allowed ANY check as
appropriate for the numerator,
i.e.
15(re-checked) = 1, 2 or 3
Investigation of'+' proteinuria
by checking urine specific
gravity and investigating for
infection (STRICT
INTERPRETATION)
Proportion of cases with
proteinuria + and SG checked
Denominator:
11 (proteinuria) = 1 and
13 (earliest problem) = 2 or 0
Numerator:
Proteinuria +
17(first urine dipstix) = 1
and
18(SG measured) = 1
Insisting upon checking of SG
is likely to result in no women
with proteinuria being
categorised as appropriately
diagnosed (since SG was
measured so infrequently)
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Investigation of'+' proteinuria Proportion of cases with + or Relaxed interpretation
by checking urine specific greater proteinuria appropriately justifiable as (to the best of our




11 (proteinuria) = 1 and of proteinuria +++ not specified.
13 (earliest problem) = 2 or 0
Numerators:
Proteinuria +
17(first urine dipstix) = 1
and
20(MSU taken) = 1 or
21(UTI) = 1
Proteinuria ++
17(first urine dipstix) = 2 and
22(re-check proteinuria) = 1
Proteinuria +++
17(first urine dipstix) = 3
Then add up numerators and
divide by denominator
Comment
• For the majority of cases, these should be mutually exclusive, i.e. women will have been
assessed for a raised DBP or proteinuria. To assess compliance with the guideline, we
simply need to add together the numerators and denominators.
• For a subset of cases, raised BP and proteinuria may have occurred at the same time -
probably detected in database by:
10 (gestation of DBP) = 12(gestation of proteinuria)
• For these cases, the numerator will require compliance for investigation of both
hypertension and proteinuria as defined above.
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2.2 Management of women with a confirmed diagnosis of mild, non-proteinuric
hypertension
2.2.1 The denominator
The analysis of appropriate management begins by categorising cases for the denominator
according to the diagnostic groups (or levels of care) defined by the guideline.
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Diagnostic group and




And no significant proteinuria
(< or = +)
Analysis
9(diastolic over 90) = 1 and
13(earliest problem)= 1 or 0 and
16(re-checked BP) < 90
OR
11 (proteinuria) = 1 and
13(earliest problem) = 2 or 0 and
16(re-checked BP) < 90
and either of
17(first urine dipstix) = 0 or 1
or
17(first urine dipstix) = 2 and
21 (UTI diagnosed) = 1 or
23(rechecked reading) = 0 or 1
Comments
This does not include strict
criterion for re-checking
DBP 4-24 hours later
The final section of this
algorithm is complex






with no (significant) proteinuria
and no abnormal findings on
investigation
16(re-checked BP) between 90 and
100 inclusive
AND either of
17(first urine diptix) = 0 or 1
or
17(first urine diptix) = 2 and
21 (UTI diagnosed) = 1 or
23(rechecked reading) = 0 or 1
AND
24(highest DBP) = 0, 1 or 2
AND
25(highest protein) = 0, 1 or 5
AND








49(highest DBP) minus 48 (first DBP)
< 25
This does not include strict
criterion for re-checking
DBP 4-24 hours later
Risk of relying upon
normal findings on
investigation is risk of
spurious false positives -
leading to too many
women being categorised
under basic surveillance.
This might be a risk for
U&E results. If this
appears to be a frequent
problem, we could take
one or two variables out.
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Enhanced surveillance
Diastolic BP sustained at over
100mmHg or with mild
hypertension and an
incremental rise more than 25
mmHg since booking, clinical
suspicion of poor fetal or
maternal well-being or abnormal
results on basic surveillance
blood tests
Any one of
• 16(re-checked DBP) between
101 and 110 inclusive or
• 24(highest DBP) = 3 or
• 16(re-checked DBP) between 90
and 110 and 49(highest DBP)
minus 48 (first DBP) > or = 25 or
• Any abnormality on investigation;







17(first urine diptix) = 0 or 1
or
17(first urine diptix) = 2 and
21(UTI diagnosed) = 1 or
23(rechecked reading) = 0 or 1
AND






potential false positives on
investigation (e.g. for
U&Es)
Specialist care Any one of
• 14(diastolic BP) > or = 110
• 16(re-checked BP) > or = 110
• 24(highest DBP) =4
• 17(first urine diptix) =2 and
21 (UTI diagnosed) =0 or 23(re-
checked reading) =2 or 3
• 17(first urine diptix) =3
• 16(re-checked DBP) between 90
and 109 and any abnormal test;













Not specified - but implicitly
absence of unnecessary visits
and investigations
Analysis
For compliance, 2 OUT OF 3
criteria for contacts, admissions
and investigations must be met.
VISITS: Absence of
unnecessary visits, i.e. either
26(total contacts) = 1 or 2
ADMISSIONS: avoidance of
admissions, i.e.
27(IP admission) = 0 or 2
INVESTIGATIONS: avoidance
of investigations
All of following = 0
33a(serum urate)
34a(U&Es)






For some women, the visits to
ANC and day care for re-
checking of BP on the same
day were counted as 'two
contacts' during data collection.
Allowing two contacts may be
appropriate but could over¬
estimate compliance.
Is there a risk that platelets
might be measured as part of




For similar reasons, ultrasound,
Doppler and CTGs could be






BP recording and urine 'dipstix'
twice weekly; clinical appraisal
of fetal size and well-being;
single estimate of serum urate,
urea and electrolytes, full blood
count, platelets
For compliance, 3 OUT OF 4
criteria for contacts, admissions,
investigations and treatment
must be met.
CONTACTS: Twice weekly BP
recording and urine dipstix
26(total contacts) = 2 or 3
ADMISSIONS: avoidance of
admissions, i.e.
27(IP admission) = 0 or 2
INVESTIGATIONS: appropriate
tests all as follows
31a(fundal height) = 1, 2, 3 or 4
32a(fetal movements)=1,2,3or 4









treatment unless arising before
32 weeks gestation or diastolic
BP over 100, and appropriate




47(HT before 32 weeks) = 1 and
either 41 (methyldopa) or
42(labetolol) = 1
OR
49(highest DBP) > 100
Need to consider ultrasound,










BP recording and urine dipstix
at least 3 times per week;
weekly serum urate, U&Es,
FBC, platelets, LFTs; scan
assessment of fetal size and
liquor volume; CTG
assessment of fetal well-being
For compliance, 3 OUT OF 4
criteria for contacts, admissions,
investigations and treatment
must be met.
CONTACTS: Thrice weeklv BP
recording and urine dipstix
26(total contacts) = 3 or 4
ADMISSIONS: avoidance of
admissions, i.e.
27(IP admission) = 0 or 2
INVESTIGATIONS: weeklv
blood tests, i.e. all of






and CTG (or other assessment
of fetal well-being), i.e. either
38a(Doppler) = 1 or





41 (methyldopa) = 1, or
42(labetolol) = 1
Similar adjustments to above
Presumably, Doppler counts as






30(s/b obstetrician) = 1 Being seen by an obstetrician is
a (weak) proxy marker of an
appropriate referral.
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Appendix 5F. Tables describing characteristics of patients by
hospital and month
NB. For the following tables, maternity unit A = AM; B = AC; C = SM; and D = FP.
Table E1. Number of patients per hospital per month
Time (months) * HOSPITAL Crosstabulation
Count
HOSPITAL
TotalAC AM FP SM
Time 1 8 6 9 3 26
(months) 2 9 10 9 10 38
3 10 10 10 9 39
4 6 6 10 9 31
5 7 9 10 5 31
6 9 10 10 6 35
7 8 10 9 9 36
8 10 10 4 6 30
9 8 10 10 8 36
10 9 9 7 9 34
11 10 6 10 9 35
12 8 8 9 10 35
13 9 6 9 8 32
14 9 10 10 10 39
15 4 10 10 10 34
16 8 10 8 10 36
17 5 10 10 6 31
18 6 10 10 5 31
19 10 10 9 5 34
20 10 7 10 7 34
21 9 10 10 8 37
22 9 10 10 6 35
23 10 10 9 9 38
24 10 10 7 9 36
25 7 10 10 7 34
26 10 10 10 5 35
27 10 10 10 9 39
28 10 10 10 9 39
29 9 10 10 9 38
30 10 9 10 7 36
31 10 10 10 8 38
32 9 10 10 10 39
33 10 9 11 3 33
34 6 10 10 10 36
35 6 10 10 9 35
36 10 9 10 9 38
Total 308 334 340 281 1263
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Table E2. Mean age of women at first visit









MeanMean Mean Mean Mean
Time 1.00 29.13 26.00 24.00 31.67 26.92
(months) 2.00 24.78 23.30 24.67 30.30 25.82
3.00 26.80 27.70 27.60 31.44 28.31
4.00 25.33 25.67 27.80 27.56 26.84
5.00 29.14 29.11 26.70 30.60 28.58
6.00 28.00 28.30 28.70 31.33 28.86
7.00 21.63 26.70 26.78 29.67 26.33
8.00 25.20 28.20 21.00 30.00 26.60
9.00 27.13 26.50 29.60 32.25 28.78
10.00 26.00 28.89 27.43 28.33 27.68
11.00 26.70 21.50 27.20 29.00 26.54
12.00 24.00 27.63 25.67 27.20 26.17
13.00 26.89 28.17 28.56 25.25 27.19
14.00 27.44 28.70 22.00 29.40 26.87
15.00 28.75 29.30 26.20 30.00 28.53
16.00 28.13 25.30 29.38 28.50 27.72
17.00 31.00 26.50 28.80 30.67 28.77
18.00 25.83 23.80 29.40 30.00 27.00
19.00 26.90 28.44 25.78 29.60 27.42
20.00 23.90 29.86 25.80 30.86 27.12
21.00 27.22 23.40 25.60 30.00 26.35
22.00 28.00 22.90 26.50 28.33 26.17
23.00 24.60 27.30 24.89 26.22 25.76
24.00 32.10 27.70 26.43 27.33 28.58
25.00 26.43 29.10 29.70 29.71 28.85
26.00 29.30 26.40 28.80 29.20 28.31
27.00 27.00 29.50 24.80 31.89 28.21
28.00 25.00 31.40 27.30 29.89 28.36
29.00 26.00 29.30 27.10 29.44 27.97
30.00 25.80 28.78 27.20 25.43 26.86
31.00 28.30 25.20 26.80 29.13 27.26
32.00 27.00 25.70 27.20 27.90 26.95
33.00 26.50 24.33 27.55 28.00 26.39
34.00 26.67 26.20 25.60 32.60 27.89
35.00 25.00 26.50 27.10 28.00 26.80
36.00 29.40 26.11 26.80 29.78 28.03
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Table E3. Mean completed parity













MeanMean Mean Mean Mean
Time 1.00 1.13 .50 .33 .00 .58
(months) 2.00 .78 .40 .56 .50 .55
3.00 .70 1.40 1.30 .33 .95
4.00 .33 .67 .90 .44 .61
5.00 .86 .67 .50 .80 .68
6.00 .89 .80 1.70 1.00 1.11
7.00 .50 .20 .56 1.33 .64
8.00 .60 .80 .50 .17 .57
9.00 1.38 .40 1.20 1.25 1.03
10.00 .67 1.00 .43 .22 .59
11.00 .90 .00 1.00 .56 .69
12.00 .63 .88 .33 .30 .51
13.00 1.00 1.00 .89 .88 .94
14.00 .89 .40 1.10 .30 .67
15.00 .75 1.30 .70 .40 .79
16.00 1.00 .70 .63 .80 .78
17.00 1.80 .80 1.00 .50 .97
18.00 1.33 .80 1.00 .60 .94
19.00 .90 .22 .78 .40 .61
20.00 .90 1.00 .40 1.29 .85
21.00 .44 .10 .60 .75 .46
22.00 .56 .50 .40 .50 .49
23.00 .40 .50 .44 .22 .39
24.00 .70 .20 .29 .44 .42
25.00 .86 .50 .90 .86 .76
26.00 .60 .20 .90 2.20 .80
27.00 .80 .60 1.00 .67 .77
28.00 .10 .50 .50 .11 .31
29.00 .78 .30 .50 .89 .61
30.00 .40 .56 .50 .29 .44
31.00 .40 .10 .70 .00 .32
32.00 .56 .30 .60 .70 .54
33.00 1.00 .33 .91 .67 .76
34.00 .83 .80 .20 1.30 .78
35.00 1.17 .30 .60 .33 .54
36.00 .80 .33 .80 .33 .58
Table E4. Mean parity (uncompleted pregnancies)
AC AM FP SM Total
Parity not Parity not Parity not Parity not
MeanMean Mean Mean Mean
Time 1.00 .38 .33 .11 1.33 .38
(months) 2.00 .67 .30 .22 .50 .42
3.00 1.20 .80 .30 .22 .64
4.00 1.00 .33 .60 .00 .45
5.00 .57 .22 .30 1.40 .52
6.00 .11 .80 .30 .17 .37
7.00 .38 .30 .11 .33 .28
8.00 .40 .60 .00 .33 .40
9.00 .25 .30 .40 .13 .28
10.00 .44 .33 .00 .44 .32
11.00 .60 .17 .20 .44 .37
12.00 .00 .50 .11 .50 .29
13.00 .22 .50 .33 .00 .25
14.00 .11 .60 .40 .40 .38
15.00 .50 .40 .40 .10 .32
16.00 .25 .70 .38 .00 .33
17.00 1.20 .10 .40 .17 .39
18.00 1.00 .20 .20 .40 .39
19.00 .50 .67 .56 .00 .48
20.00 .60 .86 .20 .71 .56
21.00 .33 .00 .60 .13 .27
22.00 .78 .50 .30 .50 .51
23.00 .40 .30 .44 .11 .32
24.00 .30 .90 .14 .44 .47
25.00 .00 .20 .40 .71 .32
26.00 .00 .20 .30 .60 .23
27.00 .50 .40 .90 .33 .54
28.00 .10 .40 .20 .78 .36
29.00 .56 .30 .10 .22 .29
30.00 .00 .78 .10 .71 .36
31.00 .40 .70 .20 .13 .37
32.00 .44 .30 .00 .40 .28
33.00 .80 .56 .45 .67 .61
34.00 1.33 .20 .30 .70 .56
35.00 .33 .20 .10 .44 .26
36.00 1.30 .22 .40 .44 .61
Table E5. Mean gestation at delivery
AC AM FP SM Total
Gestation Gestation Gestation Gestation
al age at al age at al age at al age at
delivery delivery delivery delivery
Mean Mean Mean Mean Mean
Time 1.00 39.63 39.17 40.11 37.00 39.38
(months) 2.00 39.78 39.40 39.56 38.30 39.24
3.00 38.70 37.70 39.60 39.22 38.79
4.00 39.50 39.17 40.10 38.22 39.26
5.00 38.14 39.00 39.60 37.20 38.71
6.00 39.67 39.80 38.90 40.50 39.63
7.00 39.63 39.30 39.89 39.56 39.58
8.00 39.50 38.90 39.75 39.50 39.33
9.00 37.25 39.10 40.00 39.75 39.08
10.00 39.00 38.44 39.14 38.89 38.85
11.00 38.80 40.00 39.50 39.22 39.31
12.00 40.25 39.50 38.78 38.90 39.31
13.00 39.78 39.67 39.22 38.88 39.38
14.00 38.78 40.10 38.80 38.30 39.00
15.00 38.50 39.00 39.60 39.70 39.32
16.00 38.88 40.10 38.75 39.40 39.33
17.00 39.20 39.70 39.80 39.33 39.58
18.00 38.33 38.80 38.50 40.00 38.81
19.00 39.30 39.00 39.33 39.20 39.21
20.00 39.40 40.14 39.20 39.14 39.44
21.00 39.67 39.10 39.60 39.50 39.46
22.00 39.00 39.90 40.60 39.50 39.80
23.00 39.80 39.50 39.56 37.44 39.11
24.00 39.30 39.30 40.43 38.22 39.25
25.00 38.86 39.10 39.70 37.43 38.88
26.00 40.30 39.30 39.60 38.80 39.60
27.00 39.50 38.30 39.20 37.89 38.74
28.00 40.20 39.10 38.70 39.89 39.46
29.00 39.11 39.60 38.90 38.78 39.11
30.00 39.00 38.78 39.30 39.43 39.11
31.00 39.70 39.70 38.80 38.88 39.29
32.00 39.11 38.40 39.10 39.50 39.03
33.00 40.10 39.33 38.91 38.67 39.36
34.00 38.67 40.20 38.90 39.10 39.28
35.00 39.67 38.70 35.70 39.44 38.20
36.00 38.60 38.89 39.90 38.67 39.03
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Table E6. Proportion of patients with raised DBP
AC AM FP SM Total
Mean Mean Mean Mean Mean
Time 1.00 Diastolic over 90 .63 .67 .67 1.00 .69
(months) 2.00 Diastolic over 90 .56 .90 .44 .70 .66
3.00 Diastolic over 90 .60 .80 .60 .78 .69
4.00 Diastolic over 90 .33 .50 .70 .78 .61
5.00 Diastolic over 90 .43 .67 .30 .60 .48
6.00 Diastolic over 90 .78 .90 .40 .50 .66
7.00 Diastolic over 90 .50 .60 .56 .78 .61
8.00 Diastolic over 90 .70 .80 .75 .83 .77
9.00 Diastolic over 90 .75 .90 .50 .00 .56
10.00 Diastolic over 90 .67 1.00 .57 .56 .71
11.00 Diastolic over 90 .70 .83 .80 .56 .71
12.00 Diastolic over 90 .63 .50 .89 .60 .66
13.00 Diastolic over 90 .44 .67 .67 .75 .63
14.00 Diastolic over 90 .78 .60 .40 1.00 .69
15.00 Diastolic over 90 .50 .60 .80 .70 .68
16.00 Diastolic over 90 .75 .60 .13 .50 .50
17.00 Diastolic over 90 .20 .30 .60 .83 .48
18.00 Diastolic over 90 .50 .70 .90 .20 .65
19.00 Diastolic over 90 .60 .80 .67 .60 .68
20.00 Diastolic over 90 .60 .43 .70 .71 .62
21.00 Diastolic over 90 .56 .50 .70 .25 .51
22.00 Diastolic over 90 .33 .60 .40 .83 .51
23.00 Diastolic over 90 .50 .70 .67 .67 .63
24.00 Diastolic over 90 .60 .50 .71 .56 .58
25.00 Diastolic over 90 .43 .70 .90 .71 .71
26.00 Diastolic over 90 .60 .70 .40 .80 .60
27.00 Diastolic over 90 .40 .70 .50 .56 .54
28.00 Diastolic over 90 .40 .50 .80 .67 .59
29.00 Diastolic over 90 .33 .60 .70 .44 .53
30.00 Diastolic over 90 .60 .44 .50 .43 .50
31.00 Diastolic over 90 .30 .80 .70 .75 .63
32.00 Diastolic over 90 .22 .60 .70 .60 .54
33.00 Diastolic over 90 .30 1.00 .64 1.00 .67
34.00 Diastolic over 90 .83 .70 .80 .60 .72
35.00 Diastolic over 90 .33 .60 .60 .44 .51
36.00 Diastolic over 90 .90 .56 .60 .78 .71
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Table E7. Proportion of cases with suspected proteinuric episode
AC AM FP SM Total
Mean Mean Mean Mean Mean
Time 1.00 Proteinuria .50 .83 .56 .00 .54
(months) 2.00 Proteinuria .67 .40 .78 .70 .63
3.00 Proteinuria .60 .60 .50 .33 .51
4.00 Proteinuria .83 .67 .70 .67 .71
5.00 Proteinuria .71 .44 .70 .60 .61
6.00 Proteinuria .33 .20 .80 .50 .46
7.00 Proteinuria .88 .40 .56 .78 .64
8.00 Proteinuria .80 .50 .25 .50 .57
9.00 Proteinuria .63 .50 .70 1.00 .69
10.00 Proteinuria .56 .33 .43 .44 .44
11.00 Proteinuria .70 .83 .40 .78 .66
12.00 Proteinuria .88 .75 .11 .60 .57
13.00 Proteinuria .67 .33 .33 .88 .56
14.00 Proteinuria .44 .60 .90 .40 .59
15.00 Proteinuria .50 .70 .50 .40 .53
16.00 Proteinuria .50 .60 .88 .70 .67
17.00 Proteinuria .80 .80 .60 .17 .61
18.00 Proteinuria .67 .40 .40 .80 .52
19.00 Proteinuria .60 .50 .44 .40 .50
20.00 Proteinuria .70 .71 .50 .43 .59
21.00 Proteinuria .56 .70 .50 .75 .62
22.00 Proteinuria .78 .70 .80 .50 .71
23.00 Proteinuria .90 .60 .78 .56 .71
24.00 Proteinuria .80 .80 .71 .78 .78
25.00 Proteinuria .86 .60 .30 .57 .56
26.00 Proteinuria .70 .60 .80 .40 .66
27.00 Proteinuria .80 .60 .70 .78 .72
28.00 Proteinuria .80 .80 .80 .78 .79
29.00 Proteinuria .67 .60 .60 .89 .68
30.00 Proteinuria .70 .78 .90 1.00 .83
31.00 Proteinuria .90 .50 .50 .50 .61
32.00 Proteinuria .89 .80 .60 .60 .72
33.00 Proteinuria .80 .44 .45 1.00 .61
34.00 Proteinuria .67 .60 .30 .80 .58
35.00 Proteinuria .67 .70 .80 .67 .71
36.00 Proteinuria .40 .67 .50 .44 .50
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4 Date of meeting
Purpose of meeting
(5-10 min)
5 Objectives of meeting
• Identification of factors that might
help or hinder implementation of key
guideline recommendations
• Identification of clinical staff for the
(TPB) questionnaire survey and
targeting of the intervention
• Local development of the intervention
6 Questions asked about IMPACT
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Factors that help or hinder implementation of the guideline
recommendations
(5 min per recommendation; total time 30 min)
7 Guideline
recommendation
Unit baseline compliance %
Offer of appointment
with a gynaecologist
within five days of
referral











B Individual factors Women seeking abortion seen
as high priority
1 Women seeking abortion seen
as low priority
1
2 Lack of feedback on waiting
times
2
3 Doubt over potential benefits 3









1 Delay mainly caused by referrer 1
Unit guidance or targets
available
2 Insufficient resources to improve
referral system / not
organisational priority
2
3 Coping with fluctuations in
demand or supply (e.g.
colleagues on leave)
3
4 No unit guidance or targets 4










Help implementation Hinder implementation
A Recommendation-
specific factors
High priority given to cervical
screening





2 Little point in asking if unable or




B Individual factors 1 Accidental omission 1
2 Low outcome expectancy 2





Expected norm 1 Not expected norm 1
Unit guidance available 2 No unit guidance 2
3 Insufficient time 3







Unit baseline compliance %
Antibiotic prophylaxis
or screening for lower
genital tract
organisms
Help implementation Hinder implementation
A Recommendation-
specific factors
Convincing evidence base 1 Uncertainty over supporting
evidence
1





B Individual factors 1 Low outcome expectancy
(perceived because infection is
uncommon or high number
needed to treat)
1
2 (Some) patients not perceived
as high risk
2




Unit guidance available 1 No unit guidance 1
Expected local norm 2 Not expected norm 2













Help implementation Hinder implementation
A Recommendation-
specific factors




Fewer side effects 3 3
Ease of storage 4 4
B Individual factors Cost-effectiveness seen as
priority
1 Individual clinical autonomy (and
antipathy to cost-containment)
1







Unit guidance available 1 No unit guidance 1
Expected local norm 2 Not expected local norm 2
Routine part of care (e.g. written






Unit baseline compliance %
Offer of contraceptive
supplies if required
Help implementation Hinder implementation
A Recommendation-
specific factors






B Individual factors High priority for gynaecologist 1 Low outcome expectancy 1
2 Accidental omission 2




Availability of one or more
methods
1 Unavailability of choice of
methods at discharge
1
High priority for unit 2 Delays in obtaining supplies
from pharmacy
2
Unit guidance available 3 Low priority for unit 3
4 Lack of shared protocol or
communication with referrer
4
5 No unit guidance 5





Unit baseline compliance %






















Number / location Names (if known)
A Consultants












Component Interest or planned uptake
14 Feedback of baseline audit data
15 Educational meeting (including
refreshments)
A Presentation including
• A brief outline of the IMPACT study
• Feedback of baseline audit
• The rationale behind the RCOG induced
abortion guideline
• The evidence supporting key
recommendations
B Discussion of barriers and potential solutions
• Feedback of barriers identified from TPB
staff survey, literature review and
interviews with lead gynaecologists
• Breakout groups to address specific
issues
C Alternative: More focused discussion with
whole group agreeing and focusing on most
important areas for improvement
D Formulation and agreement of action plan,
including local target setting
E Production of a short local newsletter (with
practical and financial support)





16 Review of structured case records
Structured case record available?
17 Promotion of patient leaflet
18 Other comments or suggestions
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Appendix 6B. ImpACT survey of clinical staff
ImpACT (Improving Abortion Care Trial) is testing the effectiveness of a strategy to improve
clinical practice in line with recommendations from the RCOG guideline, The care of women
requesting induced abortion.
A wide range of barriers exists to the provision of optimal care, e.g. related to resources, skills
or attitudes. In designing a strategy to help overcome at least some of these barriers, we will
take account of previous research on how and why people change behaviour.
We therefore hope to find out about the views of medical and nursing staff involved in
abortion care about two guideline recommendations using a postal questionnaire.
The questionnaire is designed to measure four things for each of the two guideline
recommendations:
• People's intentions to follow the recommendation,
• Their attitude towards it,
• How much social pressure they feel to follow the recommendation,
• Whether they are actually able to follow the recommendation in their current clinical
environment.
There are between three and five questions for each of these measures. Some questions
may therefore appear repetitive. This is necessary because previous research has found that
people respond differently to slightly different wording of the questions.
We also appreciate that you may have no direct control over whether you can actually follow
all recommendations in practice. There might be a clinical action you wish to take but cannot,
for example because of unit policy or because you delegate this to somebody else. This
questionnaire explores this sort of issue.
This questionnaire should take no longer than 10 minutes to complete. Thank you for your
time.
All responses to this survey will be treated in confidence and all results will be presented
anonymously. Therefore individual staff and units will not be identified.
We have coded each questionnaire to help identify individual respondents and
hospitals. This information will both help the analysis and ensure that we do not
bother staff who have already completed the survey with further reminder letters.
Questionniare code
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The following questions refer to this scenario: Next week, a woman is referred to
your clinical team by her GP requesting abortion.
We recognise that you may or may not have much control over how soon this woman
can be offered an assessment appointment. Furthermore, some units use a
centralised referral system whereby GPs or family planning doctors can arrange
assessment appointments for patients by telephone.
Please circle relevant response
1. Are patients referred to your unit for an assessment appointment via a centralised referral
system?
Yes No Not sure
Attitudes
2. Overall, I think that offering this woman an assessment appointment within 5 days of referral
would be:
Bad practice 1 2 3 4 5 6 7 Good practice
Harmful to her 1 2 3 4 5 6 7 Beneficial to her
The wrong
thing to do
1 2 3 4 5 6 7 The right thing
to do





3. I intend to offer this woman an assessment appointment within 5 days of referral
Definitely do not 1 2 3 4 5 6 7 Definitely do
4. I want to offer this woman an assessment appointment within 5 days of referral
Definitely do not 1 2 3 4 5 6 7 Definitely do
5. I plan to offer this woman an assessment appointment within 5 days of referral
Definitely do not 1 2 3 4 5 6 7 Definitely do
Social pressure
6. Most professional colleagues would offer this woman an assessment appointment within
5 days of referral
Definitely no 1 2 3 4 5 6 7 Definitely yes
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7. People who are important to me think that I ...
Definitely should 1 2 3 4 5 6 7 Definitely
not should
... offer this woman an assessment appointment within 5 days of referral
8. My professional body (RCOG, RCM or RCN) would ...
Definitely 1 2 3 4 5 6 7 Definitely
disapprove approve
... of my offering this woman an assessment appointment within 5 days of referral
Ability
9. Offering this woman an assessment appointment within 5 days of referral is:
Difficult 1 2 3 4 5 6 7 Easy
10. What is the likelihood that you will be able to offer this woman an assessment
appointment within 5 days of referral?
Very unlikely 1 2 3 4 5 6 7 Very likely
11. I am confident that I could offer an assessment appointment within 5 days of referral to this
woman if I wanted to.
Strongly disagree 1 2 3 4 5 6 7 Strongly agree
12. There are factors outside my control that prevent me from offering this woman an
assessment appointment within 5 days of referral
Strongly disagree 1 2 3 4 5 6 7 Strongly
agree
13. How much control do you have over whether or not to offer an assessment appointment
within 5 days of referral?
No control 1 2 3 4 5 6 7 Complete
control
14. Please add any comments on what factors make it difficult or easy to offer an assessment
appointment within 5 days of referral
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The following questions refer to this scenario: Next week, a woman is being
discharged from your unit following suction termination ofpregnancy. She
has indicated her wish to use the oral contraceptive pill but has not already
been given supplies from any source.
We recognise that in some units nursing staff are responsible for providing
contraception on discharge - if it is required.
Please circle relevant response
15. Who provides contraception at discharge on your unit?
Mainly nursing Mainly medical A combination Contraception not Not sure
staff staff of clinical staff routinely provided
at discharge
Attitudes
16. Overall, I think that providing contraceptive supplies to this woman prior to discharge
would be:
17.
Bad practice 1 2 3 4 5 6 7 Good
practice
Harmful 1 2 3 4 5 6 7 Beneficial
A waste of time 1 2 3 4 5 6 7 A good use
of time
The wrong 1 2 3 4 5 6 7 The right
thing to do thing to do
Intentions
18. I intend to provide contraceptive supplies for this woman prior to discharge
Definitely do not 1 2 3 4 5 6 7 Definitely do
19. I want to provide this woman with contraceptive supplies prior to discharge
Definitely do not 1 2 3 4 5 6 7 Definitely do
20. I plan to provide this woman with contraceptive supplies prior to discharge
Definitely do not 1 2 3 4 5 6 7 Definitely do
Social pressure
21. Most professional colleagues would provide this woman with contraceptive supplies prior
to discharge
Definitely no 1234567 Definitely yes
22. People who are important to me think that I ...
Definitely should 1 2 3 4 5 6 7 Definitely
not should
... provide this woman with contraceptive supplies prior to discharge
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23. My professional body (RCOG, RCM or RCN) would ...
Definitely 1 2 3 4 5 6 7 Definitely
disapprove approve
... of my providing this woman with contraceptive supplies prior to discharge
Ability
24. Providing this woman with contraceptive supplies prior to discharge would be:
Difficult 1 2 3 4 5 6 7 Easy
25. What is the likelihood that you will be able to provide this woman with contraceptive
supplies prior to discharge?
Very unlikely 1 2 3 4 5 6 7 Very likely
26. I am confident that I could provide this woman with contraceptive supplies prior to
discharge if I wanted to.
Strongly disagree 1 2 3 4 5 6 7 Strongly
agree
27. There are factors outside my control that prevent me from providing this woman with
contraceptive supplies prior to discharge
Strongly disagree 1 2 3 4 5 6 7 Strongly
agree
28. How much control do you have over whether or not to provide contraceptive supplies
prior to discharge?
Complete control 1 234567 No control
29. Please add any comments on what factors make it difficult or easy to provide
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Background. Induced abortion is one of the most commonly performed gynaecological
procedures, with over 12,000 undertaken annually in Scotland. In March 2000, the Royal
College of Obstetricians and Gynaecologists published a clinical guideline, The care of
women requesting induced abortion. Despite continuing improvements, standards of care still
vary within and among hospitals in Scotland. The guideline aims to improve the following key
aspects of care: access to care; information for women; assessment for abortion procedures;
choice of procedures; and after care.
The Scottish Programme for Clinical Effectiveness in Reproductive Health (SPCERH).
This professionally-led programme brings together a wide range of educational, audit and
research activities that share the common aim of promoting evidence-based practice among
reproductive healthcare professionals.
One of the programmes' core activities is to develop and disseminate clinical guidelines.
Previous research suggests that the distribution of a clinical guideline is unlikely to change
clinical practice by itself. It is therefore important to test new ways of providing support to
local units to put clinical guidelines into practice.
This baseline audit represents part of a national study to improve induced abortion care. All
twenty-six gynaecology units in Scotland are participating in this study. Its findings will inform
SPCERH's methods of disseminating clinical guidelines in the future.
Confidentiality. Audit results relating to individual gynaecology units will remain confidential.
Results on the performance of individual units are therefore presented in this report in
anonymised form. Each hospital has been allocated a letter and the lead gynaecologist at
each 'intervention' hospital has been informed of the letter allocated to his/her unit. Thus,
staff at each gynaecology unit can view their own performance against the range of
performance achieved by others.
Data collection. For the baseline audit, all women admitted for an induced abortion from 1st
September to 30th November 2000 were identified locally via ward admission books or referral
records. Induced abortions for fetal anomaly were excluded. Data collection was performed
by local clinical or clerical staff following a standard training session.
The case note review assessed adherence to 27 out of the 57 graded recommendations
made in the guideline.
A random sample of 50 cases was identified in each gynaecology unit and case notes were
reviewed using a structured data collection form. All case notes were reviewed in units
admitting 50 or fewer cases over this period.
A follow up case note review is scheduled to take place over a similar period in 2001. Where
available, 75 case notes will be reviewed in each unit. A patient survey is provisionally
scheduled to take place during September 2001.
Purposes and interpretation of feedback. This feedback aims to stimulate local discussion
and help staff in individual units identify good clinical practice as well as any potential to
improve care.
There are two general limitations to the baseline audit data. Firstly, fifty represents a
relatively small sample size for audit purposes. Therefore, some of the variation between
gynaecology units may be due to chance. Secondly, case note reviews may under-estimate
adherence to guideline recommendations when patients receive care which is not recorded in
case notes. However, for the majority of these guideline recommendations, clear recording in
case notes is important, least of all for medico-legal purposes.
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Local coordinators and data collectors
Hospital Coordinator Data coliector(s)
Aberdeen Royal Infirmary Dr Gillian Flett Ms Frances Findlay
Ayrshire Central Hospital Dr Nivison Russell Sister Jackie McCallum
Borders General Hospital Dr Roddy Campbell Ms Marion McKenzie
Caithness General Hospital Dr Adam Gordon Ms Rona McLeod
Dr Gray's Hospital Dr David Evans Ms Jane Gray
Dumfries & Galloway Royal Infirmary Dr Michael Geals Sister Joanne Bradley
Falkirk & District Royal Infirmary Dr Ken Grant Ms Carol Davies
Forth Park Hospital Dr Tahir Mahmood Ms Morag Telfer
Glasgow Royal Infirmary Dr Mary Rodger Sister Anne Kerr
Hairmyres Hospital Dr Keith Spowart Staff Elizabeth Flanagan
Inverclyde Royal Hospital Dr Jim Robins Sister Shirley Roche
Law Hospital Dr Chris Lennox Sister Margaret Morgan
Monklands Hospital Dr T Dow Sister Anne Lawrie
Ninewells Hospital Dr Maggie Thomson Sister Jackie Dunlop
Perth Royal Infirmary DrW Phillips Ms Fionna Clark
Ms Rena McDonald
Raigmore Hospital Dr Lucy Caird Ms Margaret Cameron
Ms Jackie Campbell
Ms MargaretWilliamson
Royal Alexandra Hospital Dr Ken Muir Ms Sandra Crawford
Edinburgh Royal Infirmary Professor Hilary
Critchley
Ms Lorraine Adamson
Southern General Hospital Dr Bill Naismith Sister Nicky Harvey




Stirling Royal Infirmary DrWendy McMullen Ms Alana Horsburgh
Stobhill NHS Trust Dr Colin Forrest Ms Margaret Burke
Ms Anne Coyle
Vale of Leven Hospital Dr Mike Haxton Staff Elsie McKechnie
Victoria Infirmary NHS Trust Dr Douglas Mack Sister Victoria Morrison
Western Infirmary NHS Trust Dr Judith Roberts Ms Fiona McLeod





The guideline recommendations were graded as follows:
A Requires at least one randomised controlled trial as part of a body of literature of overall
good quality and consistency addressing the specific recommendation.
B Requires the availability of well conducted clinical studies, but no randomised clinical
trials on the topic of the recommendation.
C Requires evidence obtained from expert committee reports or opinions and/or clinical
experience of respected authorities. Indicates an absence of directly applicable clinical
studies of good quality.
Good practice points. Recommended best practice based on the clinical experience of the
Guideline Development Group
Rationale A brief summary of the rationale or supporting evidence for each recommendation.
Method of
assessment
How case note data were used to measure adherence to recommendation.
Number of cases relevant to recommendation. For certain recommendations, several
gynaecology units had no relevant cases. Therefore, their identifying letter does not appear
in subsequent bar charts or tables. No data were available for unit Z at the time of writing.
Bar chart The horizontal axis represents each gynaecology unit in Scotland, each identified
by a letter. The vertical axis represents the percentage compliance with the
recommendation in the guideline. Therefore, 100% is perfect compliance with the
guideline and 0% is zero compliance with the guideline.
The horizontal lines on the graph represent the median compliance (solid line) and the 25th
and 75th percentiles (dashed lines). The median compliance is the point at which 50% of
the hospitals are above this value and 50% are below this value. The 75th percentile is the
point at which 25% of the hospitals lie above this value, and the 25th percentile represents
the point at which 25% of the hospitals lie below this value.
The overall number of relevant cases assessed was small for several
recommendations. Feedback for these recommendations is therefore presented in
tabular or text format as bar charts might give a misleading impression.
Comments Commentary on overall pattern, including average compliance and variations among
gynaecology units. For five recommendations, interviews with lead gynaecologists from




Service arrangements should be such that:
• Ideally, all women requesting abortion are offered an assessment
appointment within five days of referral
• As a minimum standard, all women requesting abortion are offered
an assessment appointment within two weeks of referral
(Grade C)
Rationale • The earlier in pregnancy an abortion is performed, the lower the risk
of complications
• Five days suggested as an appropriate target between referral and
assessment by Birth Control Trust




Proportion of patients with 5 or fewer days between date of referral
(usually on general practitioner letter) and date of first gynaecology
outpatient assessment appointment (Figure 1).
Proportion meeting minimum standard (i.e. within 14 days) calculated
similarly (Figure 2).
Data available for total of 1041 cases.
Comments Median compliance with the first recommendation was 53%, with
substantial variation among gynaecology units. Most notably units C, D,
J, 0, V and X had problems providing assessment appointments within 5
days. In calculating adherence, no allowance was made for non-working
days nor for the possibility that some women may have not have
attended the first appointment offered. At least 90% of women were
seen within 14 days in 15 units.
Factors suggested that help meeting this recommendation:
• Women seeking abortion seen as high priority
• Existing telephone referral system
• Regular reminders to GPs about need for prompt referral and to
make use of telephone referral system
• One person coordinates appointments or clinic
• No limits on clinic appointments
Factors suggested that hinder meeting this recommendation:
• Insufficient resources to improve referral system / not
organisational priority
• Women seeking abortion seen as low priority (usually by some
or minority of clinicians)
• Limited number of consultants or juniors perform abortions
• Coping with fluctuations in demand or supply (e.g. colleagues on
leave, limited spaces on theatre lists)
• Lack of facilities, e.g. clinic rooms, day or gynaecology beds,
theatre capacity




Figure 1. Percentage of women attending assessment appointment within 5 days of referral
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Figure 2. Percentage of women attending assessment appointment within 14 days of referral
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Recommendation Service arrangements should be such that:
• Ideally, all women can undergo the abortion within seven days of the
decision to proceed being agreed.
• As a minimum standard, all women can undergo the abortion within
two weeks of the decision to proceed being agreed.
• As a minimum standard, no individual woman need wait longer than
three weeks from her initial referral to the time of her abortion
(Grade C)
Rationale • The earlier in pregnancy an abortion is performed, the lower the risk of
complications
• Seven days as an appropriate target between assessment and
procedure suggested by Birth Control Trust




Proportion of patients with 7 or fewer days between date of assessment
appointment and date of abortion, including administration of mifepristone
(Figure 3)
Proportion meeting minimum standard (i.e. within 14 days) calculated
similarly (Figure 4).
Proportion meeting minimum standard of not waiting longer than three
weeks from initial referral to time of procedure (Figure 5).
Data available for total of 1054 cases.
Comments In relation to the interval between the assessment appointment and
procedure, median compliance was 87% for the ideal target and 98% for
meeting the minimum standard.
No allowance was made for non-working days. Nor was it possible to
assess when the actual decision to proceed with abortion was made.
Hence, compliance with recommendation may be under-estimated for
some cases.
Ensuring that no woman needs to wait longer than 3 weeks between initial
referral and the induced abortion procedure may represent the most
important minimum standard. Units A, G, P and U met this standard for





Figure 3. Percentage of induced abortions occurring within 7 days of clinic assessment
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Figure 5. Percentage of induced abortions occurring within three weeks of initial referral.
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Recommendation In the absence of specific medical, social or geographical contra¬
indications, induced abortion may be managed on a day-case basis.
(Good practice point)
Rationale • Day care recognised as cost effective model of service provision
• Minimisation of disruption to lives of women and their families
• Need for inpatient care for some women, e.g. because of geographical
factors, medical problems requiring assessment prior to anaesthetic or
the lack of an adult companion at home
Method of
assessment
Proportion of cases discharged on same day as admission, including day
of administration of misoprostol for medical abortions (Figure 6).
Data available for total of 1064 cases.
Comments Median compliance was 96%. The four units (A, F, L and N) with lower
proportions managed as day cases all serve rural or semi-rural
populations.
Hospital
Figure 6. Percentage of induced abortions performed as day cases.
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Pre-abortion management
Recommendation Pre-abortion assessment should include:
• Measurement of haemoglobin concentration
• Determination of ABO and Rhesus blood groups with screening for red
cell antibodies
(Grade C)
Rationale • Possibility of excessive blood loss associated with surgical abortion




Proportion of patients having BOTH haemoglobin and blood group status
checked (Figure 7).
Data available for total of 1073 cases
Comments Compliance with this standard was low in four units: A, E, G and P. In unit














Figure 7. Percentage of women having appropriate blood tests.
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Recommendation It is not cost-effective routinely to cross-match women undergoing
termination of pregnancy. (Grade B)
Rationale • Rarity of requirement for blood transfusion following abortion




Proportion of patients where cross matching was not performed (Figure 8).
Data available for total of 1073 cases.
Comments Most units met or were close to this standard, except for unit G. It is
possible that for several cases, cross-matching was undertaken following
complications with the abortion procedure. However, only 3 cases of high
intra-operative blood loss and 2 case of actual or suspected uterine














Figure 8. Percentage of women not cross-matched.
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Recommendation Assessment prior to induced abortion may be viewed as an opportunity to
ascertain each woman's cervical cytology history. (Good practice point)
Rationale Attendance for abortion care represents opportunity to review broader
aspects of reproductive health care
Method of
assessment
Proportion of patients 20 years or over with written evidence of smear
enquiry in case notes (Figure 9). This may under-estimate true extent of
ascertainment if enquiry made but not recorded
Data available for total of 776 cases
Comments There was marked variation between units. In four units (D, H, R and U)
over 90% of women had cervical screening status recorded. In three units
(B, C and K) less than 10% of women had their status recorded. Overall,
there appears to be major scope for improvement in meeting this
recommendation across in Scotland.
Factors suggested that help meeting this recommendation:
• High priority given to cervical screening
• Fits in with routines, e.g. doing vaginal examinations in clinic
• Expected norm
• Structured case notes available
Factors suggested that hinder meeting this recommendation:
• Low priority of cervical screening in abortion care
• Incompatible with local routines, e.g. do not do VEs at clinics
• Little point in asking if unable or not planning smear at clinic
• Less need for smears because of increased uptake of screening
• Local advice against doing smears during pregnancy - even if due






Figure 9. Percentage of women 20 years or over with record of enquiry into cervical smear
status.
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Recommendation Women who have not had a smear within the interval recommended in





Proportion of women 20 years or over with an enquiry into cervical
cytology history who had
• No smear taken within previous 3 years and had a smear taken at
gynaecological assessment, and
• Smear taken within previous 3 years and no smear taken at
gynaecological assessment.
(Figure 10)
Data available for total of 413 cases.
Comments Median compliance with this recommendation was 75% when a history of















Figure 10. Percentage of patients with appropriate cervical smear history and action.
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Recommendation Ultrasound scanning is not considered to be an essential prerequisite of
abortion in all cases. However, all units must have access to scanning as it
can be a necessary part of pre-abortion assessment, particularly where
gestation is in doubt or where extrauterine pregnancy is suspected.
(Grade C)
Rationale • Lack of randomised trials supporting ultrasonography in this context
• Observational studies suggest use of ultrasonography alters estimated




Figure 11 shows the percentage of all women having scanning performed.
Figure 12 shows the proportion of women either (a) not being scanned or
(b) being scanned because the gestation was in doubt or extrauterine
pregnancy was suspected. This does not account for women in whom
scanning was indicated but not performed. It is also likely that the majority
of ultrasounds were performed to check gestation but that this indication
was not recorded
Data available for total of 1073 cases.
Comments The evidence supporting the routine use of ultrasound is arguably
equivocal. However, accepting that many gynaecologists believe it has a
valid role in pre-abortion assessment, scanning should be performed in an
















Figure 11. Percentage of women having ultrasonography performed.
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Figure 12. Percentage of women not having an ultrasound or having a recorded indication
when ultrasound was performed.
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Recommendation Abortion care should encompass a strategy for minimising the risk of post
abortion infective morbidity. Appropriate strategies include:
• Antibiotic prophylaxis (Grade A), or
• Screening for lower genital tract organisms with treatment of
positive cases (Grade B).
Rationale • Genital tract infection is recognised complication of abortion, possibly
occurring in up to 10% of women not receiving antibiotic prophylaxis
• Risk of long term sequelae: tubal infertility and ectopic pregnancy
• Three main options exist:
1. Screening and treating positive cases
2. Universal antibiotic prophylaxis
3. Universal prophylaxis combined with screening
• Universal antibiotic prophylaxis halves risk of infective morbidity and,
by itself, is most cost-effective strategy for minimising short term
infective sequelae of abortion




Proportion of women either (a) given antibiotic prophylaxis or (b) tested
with documented treatment if positive (Figure 13).
Data available for total of 1073 cases.
Comments Compliance with this recommendation was generally high - and
represents a substantial improvement since the 1992-3 national audit of
abortion care (Gynaecology Audit Project in Scotland). The
recommendation was not applied to any cases in unit C, and inconsistently
applied in units X and Y.
Factors suggested that help meeting this recommendation:
• Convincing evidence base
• Guideline produced by professional body (RCOG) - or covered by
recent SIGN guideline
• Prevalence of chlamydial infection
• Unit guidance available
• Expected local norm
Factors suggested that hinder meeting this recommendation:
• Negative attitudes, e.g. concern over acceptability to patients,





Figure 13. Percentage of women either given antibiotic prophylaxis or tested with
documented treatment if positive.
Procedures
Recommendation Medical abortion, using mifepristone plus prostaglandin, is an appropriate
method at gestations of <7 weeks. (Grade B)
Conventional suction termination should be avoided at gestations of <7
weeks. (Grade B)
Rationale • Suction terminations performed at less than seven weeks gestation
are three times more likely to fail to remove the gestation sac than
those performed between 7-12 weeks.
• For mifepristone / prostaglandin regimens used in early medical
abortion the complete abortion rate falls as gestation advances
• Medical abortion is at its most effective at earliest stages of pregnancy
Method of
assessment
Proportion of women with gestation less than 7 weeks undergoing medical
abortion (Figure 14).
Data available for total of 132 cases. No relevant cases were available for
units C, L and Y.
Comments The bar chart requires cautious interpretation as it is based upon a
relatively small number of cases per unit (range 1 to 18). However, units
(B, E, I and W) with relatively higher numbers of women eligible for early
medical abortion, between 10 and 20 cases each, generally performed
better
Compliance with this recommendation was 50% or less for six units (D, M,
0, U, V and X). No relevant cases may have been identified in units C, L
and Y because either no women were referred sufficiently early or this
service is not available locally.
Suction termination can be effective if conducted according to a rigorous
published protocol. Compliance might therefore be underestimated if
women categorised as having surgical abortions underwent procedures in
accordance with such a protocol. It seems unlikely that this would apply to
all cases and units performing relatively few early medical abortions may
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Figure 14. Percentage of women at less than 7 weeks gestation undergoing medical
abortion.
361
Recommendation For early medical abortion, a dose of 200mg of mifepristone, in
combination with a prostaglandin is adequate. (Grade A)
Rationale A dose of 200 mg mifepristone prior to prostaglandin administration for
early medical abortion is as effective as the 600 mg dose (recommended
in the manufacturer's data sheet)
Method of
assessment
Proportion of women with pregnancies up to 9 weeks gestation undergoing
early medical abortion prescribed 200 mg mifepristone (Figure 15).
Data available for total of 354 cases. No relevant cases were available for
units C, L, U, V and X.
Comments All units providing medical abortion up to 9 weeks routinely used
mifepristone 200 mg except unit Y.
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Hospital
Figure 15. Percentage of women with pregnancies up to 9 weeks gestation undergoing early
medical abortion prescribed 200 mg mifepristone.
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Recommendation Misoprostol (a prostaglandin E1 analogue), given vaginally is a cost-
effective alternative for all abortion procedures for which the E1 analogue,
gemeprost is conventionally used (early medical abortion, cervical priming,
mid-trimester medical abortion). (Grade A)
Rationale • Misoprostol less expensive and as effective as gemeprost at
gestations of up to 7 weeks
• At gestations of 7-9 weeks, the continuing pregnancy rate may be
higher when misoprostol is used
• Use of misoprostol by vaginal route constitutes an unlicensed
indication and an unlicensed route of administration. However, the EC
Pharmaceutical Directive 65/65/EEC specifically permits doctors to
use 'licensed medicines for indications or in doses or by routes of
administration outside the recommendations given in the license'.
Patients should be properly informed before a drug is prescribed for an
unlicensed indication. Drugs prescribed by doctors outside licence




Proportion of women in whom misoprostol is used for early medical
abortion, cervical priming and mid-trimester abortion (Figure 16).
Data available for total of 1069 cases
Comments Most units appeared to operate uniform policies of using either misoprostol
or gemeprost. One unit (G) that used gemeprost at the time of data
collection has now changed its policy. Other units (S, T, U and X) may
wish to review their local policies.
Factors suggested that help meeting this recommendation:
• Convincing evidence base
• Fewer side effects
• Cost-effectiveness
• Expected local norm
• Routine part of care (e.g. written up at assessment clinic)
Factors suggested that hinder meeting this recommendation:
• Need further convincing of benefit
• Not licensed / objections from colleagues or pharmacy
• Greater familiarity with gemeprost
• Delays caused by administration, e.g. unsuitable for cervical
priming associated with 'fast track' abortion care
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Figure 16. Percentage of women undergoing early medical abortion, cervical priming and
mid-trimester abortion in whom misoprostol was used.
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Recommendation Use of conventional suction termination at gestations of 7-15 weeks if
appropriate or preferred
Rationale • Suction termination of pregnancy is currently the standard method at
gestations of 9-12 weeks in the UK
• Either suction termination or medical abortion are appropriate at
gestations of 13 to 15 weeks
Method of
assessment
Proportion of women at 7-15 weeks gestation inclusive undergoing
surgical abortion (Figure 17).
Data available for 918 cases.
Comments There were wide variations in the proportions of women undergoing
suction termination. This was the main or only method used in units C, L,
0, U, V and X. These units may wish to review their ability to offer women
medical as well as surgical terminations in the future.
Hospital
Figure 17. Percentage of women at 7-15 weeks gestation inclusive undergoing surgical
abortion.
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Recommendation For women presenting between 7-15 weeks' gestation, suction
termination may be safer under local anaesthesia than under general
anaesthesia. Consideration should be given to making this option
available. (Grade B)
Rationale Lower complication rates and reduced time between admission and
evacuation associated with local anaesthesia
Method of
assessment
Proportion of women at 7-15 weeks gestation inclusive undergoing
surgical abortion under local anaesthesia.
Data available for total of 587 cases
Comments No graph is provided as only 2 abortions were performed under local
anaesthesia (one each in unit S and U). All units may wish to review the
feasibility and acceptability of providing this option.
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Recommendation Cervical preparation is beneficial prior to suction termination and should
be routine if the woman is aged under 18 years or at a gestation of >10
weeks. (Grade B)
Rationale • Young patient age is a risk factor for cervical damage
• Increasing gestation is associated with increasing risk of uterine
perforation
• Use of cervical priming reduces rates of both of these complications
Method of
assessment
Proportion of all women undergoing surgical abortion receiving cervical
priming (Figure 18).
Data available for total of 604 cases
Proportion of higher risk women (aged less than 18 years or over 10
weeks gestation) undergoing surgical abortion receiving cervical priming
(Figure 19).
Data available for total of 164 cases
Comments Nearly all women in the higher risk category underwent cervical priming
prior to surgical abortion, indicating a major improvement in practice since




Figure 18. Percentage of all women undergoing surgical abortion receiving cervical priming.
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Figure 19. Percentage of higher risk women (aged less than 18 years or over 10 weeks
gestation) undergoing surgical abortion receiving cervical priming.
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Recommendation For mid-trimester medical abortion, a dose of 200mg of mifepristone is
adequate. (Grade A)




Proportion of women with pregnancies between 13 and 24 weeks
(inclusive) gestation undergoing medical abortion prescribed 200 mg
mifepristone.
Data available for total of 65 cases. No relevant cases were available for
units A, C, D, H, V and X.
Comments Table 1 shows that there was 100% adherence to this recommendation
where units provided this option.
Table 1. Number of women undergoing mid-trimester medical abortion prescribed 200 mg
mifepristone.
Gynaecology unit Number of women prescribed
200mg mifepristone






















Recommendation Surgical evacuation of the uterus is not required routinely following mid-
trimester medical abortion. It should only be undertaken if there is clinical
evidence that the abortion is incomplete. (Grade B)
Rationale Less than 10% of patients undergoing mid-trimester medical abortion
subsequently require surgical evacuation
Method of
assessment
Proportion of women having mid-trimester medical abortions (13 to 24
weeks inclusive) either (a) not undergoing surgical evacuation or (b)
undergoing surgical evacuation indicated for incomplete abortion.
Data available for total of 65 cases. No relevant cases were available for
units A, C, D, H, V and X.
Comments Table 2 shows an overall adherence of 95% to this recommendation.
Table 2. Number of women having mid-trimester medical abortions either (a) not undergoing
surgical evacuation or (b) undergoing surgical evacuation indicated for incomplete abortion
Gynaecology unit Number of women managed
appropriately






















Recommendation Mid-trimester abortion by dilatation & evacuation (D&E), preceded by
cervical preparation, is safe and effective when undertaken by specialist
practitioners with access to the necessary instruments and who have a
sufficiently large case-load to maintain their skills. (Grade A)
Rationale • Contemporary methods of mid-trimester medical abortion have not
been compared with D&E
• D&E is safer than older, instillation methods of mid-trimester medical
abortion
• Use of real time ultrasound scanning during D&E can further reduce
the uterine perforation rate
Method of
assessment
Proportion of women undergoing surgical abortion (greater than 15 weeks
gestation) which is preceded by cervical priming and where a consultant
or staff grade doctor is the most senior operator present.
No cases were identified.
Comments This procedure is not or seldom performed in Scotland.
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Recommendation For women presenting at greater than 15 weeks' gestation, as an
alternative to D & E, services may prefer to offer medical abortion. (Grade
B)
Rationale For gynaecologists lacking the necessary expertise and case-load and




Proportion of women with pregnancies greater than 15 weeks gestation
undergoing medical abortion
Data available for total of 30 cases. No relevant cases were available for
units A, C, D, H, I, L, M, 0, R, T, V and X.
Comments Table 3 shows that there was 100% adherence to this recommendation.
Table 3. Number of women with pregnancies greater than 15 weeks gestation undergoing
medical abortion.
Gynaecology unit Number undergoing medical
abortion

















Recommendation Oxytocics are effective in reducing intra-operative blood loss (Good
practice point)
Rationale Significant in immediate blood loss shown by randomised trials assessing
role of oxytocics during surgical abortion.
Method of
assessment
Proportion of women undergoing surgical abortion with an estimated
blood loss of over 500 ml who receive oxytocics.
Data available for total of 3 cases.
Comments This complication occurred in only 3 cases following surgical abortion.
One case occurring in unit H did not receive oxytocics. One out of 2
cases occurring in unit J did not receive oxytocics.
Recommendation In cases of suspected uterine perforation laparoscopy is the investigation
of choice (Good practice point)
Rationale • Case series indicate low rate of serious sequelae as a result of
uterine perforation
• Laparoscopy of use in deciding whether laparotomy is required
Method of
assessment
Proportion of women with suspected uterine perforation undergoing
laparoscopy.
Data available for total of 2 cases
Comments Both cases underwent laparoscopy: one in unit L; and 1 in unit S.
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After care
Recommendation Anti-D IgG should be given to all non-sensitised RhD negative women
following abortion, whether by surgical or medical methods and
reqardless of gestational age. (Grade B)
Rationale Prevention of RhD sensitisation
Method of
assessment
Proportion of RhD negative women receiving anti-D (Figure 20).
Data available for total of 194 cases
Comments Across Scotland, a total of 12 out of 194 eligible women had no record of
receiving anti-D prophylaxis. This may be related to poor documentation
or accidental omission, possibly because of faster throughput. However,
some units may wish to review discharge procedures In particular, there
was no record of prophylaxis for 2 out of 9 eligible women in unit X, and 3














Figure 20. Percentage of RhD negative women receiving anti-D.
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Recommendation A follow-up appointment (either within the abortion service or with the
referring clinician) within two weeks of the procedure should be offered to
each patient following abortion. (Grade C)
Rationale Follow up within two weeks required for early medical abortion (although
optional if complete abortion is confirmed on day of procedure).
Method of
assessment
Proportion of women with any documented follow-up appointment with
abortion service or referring clinician (Figure 21).
Figure 22 shows percentage of women with documented follow-up
appointment within two weeks of discharge with abortion service or
referring clinician.
Data available for total of 1073 cases.
Comments In 14 units, at least 75% of women had some documented offer of follow
up, even if this only included advice to visit the referring doctor. Such an
offer or advice was recorded much less frequently in units C, J and Y.
Fewer units had any documented offer of follow up within 2 weeks. All

















Figure 21. Percentage of women with any documented follow-up appointment with abortion
service or referring clinician.
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Figure 22. Percentage of women with documented follow-up appointment with abortion
service or referring clinician made within two weeks of discharge.
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Recommendation Before she is discharged following abortion, future contraception should
have been discussed with each patient and contraceptive supplies should
have been offered if required. The chosen method of contraception
should be initiated immediately following abortion. (Grade B)




Proportion of women with documentation of discussion regarding future
contraception (Figure 23).
Proportion of women with documented supply of contraception from
either referring clinician or gynaecology unit (Figure 24).
Data available for total of 1073 cases.
Comments The majority of women had some discussion of future contraception
needs documented in most units. Documentation was poorer in units A,
C, T and V.
The assessment of provision of contraception at discharge
underestimates compliance with the original recommendation, which
concerned offering contraception. Less than half of women had
documented provision in units A, C, F, P, T and X.
It is also worth noting that this responsibility is often shared between
primary and secondary care. However, units may wish to review
procedures for checking whether the referring doctor has provided
contraceptive supplies.
Factors suggested that help the provision of contraceptive supplies:
• High priority for gynaecologist and unit
• Unit guidance available or reinforced within integrated care
pathway form
• Availability of family planning trained nursing staff
• Availability of one or more methods
Factors suggested that hinder the provision of contraceptive supplies:
• Belief in 'patient choice' and responsibility during counselling
• Uncertain impact on subsequent unwanted pregnancy rates
• Provision is responsibility of others, e.g. GP / FPC responsibility
• Lack of family planning trained nurses
• Variable quality of family planning advice
• Unavailability of choice of methods at discharge




























Figure 24. Percentage of women with documented supply of contraception from either
referring clinician or gynaecology unit.
379
Recommendation Sterilisation can safely be performed at the time of induced abortion.
However combined procedures are associated with higher rates of failure
and of regret on the part of the woman. (Grade B)
Rationale • Comment by RCOG Medico-Legal Committee: 'In view of the
increased failure rate of sterilisation procedures on those currently
pregnant, it is questionable whether such operations should be
carried out at all. Apart from the potential increased risk of failure, the
possibility of feelings of regret has been voiced as a reason for
performing sterilisation as an interval procedure.'
• In one study, women requesting sterilisation at time of abortion were
randomised to sterilisation in combination with abortion or an interval




Proportion of women having abortions who underwent sterilisation at time
of abortion procedure (Figure 25).
Data available for 1073 cases. No relevant cases identified for unit A.
Comments Only 16 women in total underwent sterilisation at the time of the abortion
procedure. Ideally, this should be avoided. Anticipated difficulties with
follow up following abortion (e.g. because of geographical factors) may
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Figure 25. Percentage of all women undergoing abortion sterilised at time of abortion
procedure.
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Recommendation It is safe and effective to insert an IUCD for contraceptive use
immediately following induced abortion. (Grade A)
Rationale Randomised studies demonstrating IUCD insertion following induced
abortion is safe form of contraception, with no increase in post abortion
infection rates and good toleration of devices
Method of
assessment
Proportion of all women receiving contraception from hospital who had
IUCD inserted at time of abortion procedure (Figure 26).
Data available for 1073 cases.
Comments The provision of lUCDs varies among units. Ideally, a range of
contraceptive methods should be available immediately following
contraception. Low proportions of usage in some units may be a chance











Figure 26. Percentage of ali women receiving contraception from hospital who had IUCD
inserted at time of abortion procedure.
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Improving Abortion Care Trial (ImpACT)
ImpACT is a randomised trial to test the impact of additional support for the implementation of
the guideline, The Care of Women Requesting Induced Abortion. All fellows and members of
the RCOG have received identical printed guideline summaries. Half of the gynaecology
units in Scotland have been randomised to the intervention group whilst the other half act as
controls. The intervention 'package' comprises:
• Feedback of baseline audit data (including this document)
• An educational meeting
• A review of structured case records
• Promotion of a patient leaflet
The main outcome measure will be appropriateness of care, based upon adherence to with
key recommendations from the clinical guideline. Adherence to the guideline
recommendations will be assessed by a case note review and survey of women undergoing
induced abortion. An economic analysis will also assess the efficiency of the intervention.
ImpACT is jointly run between the Scottish Programme for Clinical Effectiveness in
Reproductive Health and the Health Service Research Unit (at Aberdeen University). In
addition, gynaecologists from Glasgow, Edinburgh and Aberdeen are acting as clinical
advisors to ImpACT.
The trial steering group members are:
Dr Robbie Foy (lead investigator) MRC / CSO training fellow in health services research,
Department of Reproductive and Developmental
Sciences, University of Edinburgh
Dr Gillian Penney National Coordinator, SPCERH, Dugald Baird Centre
for Research in Women's Health, Aberdeen Maternity
Hospital
Prof Jeremy Grimshaw Programme Director, HSRU, University of Aberdeen
Dr Anna Glasier Consultant / director, Family Planning and Well Women
Services, Lothian Primary Care NHS Trust
Dr Alison Bigrigg Consultant / director, Family Planning and Well Women
Services, Greater Glasgow Primary Care NHS Trust
Prof Andrew Calder Department of Reproductive and Developmental
Sciences, University of Edinburgh (and Chairman of the
RCOG Scottish Executive)
Dr Craig Ramsay Senior statistician, HSRU, University of Aberdeen
Dr Anne Walker Senior behavioural scientist, HSRU, University of
Aberdeen
Dr Jim Chalmers Consultant in public health medicine, Information and
Statistics Division, NHS in Scotland
Dr Sally Stearns Senior research fellow, Health Economics Research
Unit, University of Aberdeen
The trial secretary is Ms Lorraine Adamson, based at the SPCERH office, Department of
Reproductive and Developmental Sciences, University of Edinburgh.
IMPACT is funded by the Health Services Research Committee of the Chief Scientist's Office.
The study has been approved by the multi-centre research ethics committee for Scotland and
by all local research ethics committees.
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Appendix 6D. Barriers identified from semfstructured
interviews with lead gynaecologists
1 Guideline
recommendation
Mean baseline compliance %
Offer of appointment
with a gynaecologist
within five days of
referral
Help implementation (and number
of units raising or discussing each
point)
Hinder implementation (and number






1 Lack of evidence supporting
recommendation
Emailing or faxing of referrals
hindered by need for
accompanying green form
1
B Individual factors Women seeking abortion seen
as high priority (usually by lead
gynaecologist)
6 Women seeking abortion seen
as low priority (usually by
some or minority of clinicians)
5
Flexibility of nursing staff, e.g.
can do early medical abortions
at weekends
1 Lack of feedback on waiting
times
Doubt over potential benefits
Unfamiliarity with guideline or
recommendation
Limited number of consultants
perform abortions
2
Junior doctors disagree with or







9 Delay mainly caused by
referrer, e.g. postage of
referrals
1
Unit guidance or targets
available
2 Insufficient resources to
improve referral system / not
organisational priority
3
No limits on clinic
appointments; or sufficient
capacity
4 Coping with fluctuations in
demand or supply (e.g.
colleagues on leave, limited
spaces on theatre lists)
9
One secretary or person in
charge coordinates
appointments or clinic
5 No unit guidance or targets
Availability of day beds for
'fast-tracking'
1 Lack of facilities, e.g. clinic
rooms, day or gynaecology
beds, theatre capacity
6
Reminders for GPs who
refer by letter
2 Lack of medical staffing for
clinic
2
Staff available to provide care,
e.g. nurses
1 External threats, e.g. risk of
reduced capacity if move to
surgical day care, under
pressure to drop protected
spaces for STOPs from lists
2
All GPs and FPCs circulated 1 Limit numbers to allow for
adequate counselling
2
Dedicated clinic or list 2 Delays caused by out-of-
district or other routes of
referrals to consultants
1








Help implementation (and number
of units raising or discussing each
point)
Hinder implementation (and number




High priority given to cervical
screening
2 Low priority of cervical




Little point in asking if unable
or not planning smear at clinic
1
Fits in with routines, e.g. doing
vaginal examinations anyway
in clinic
2 Incompatible with local
routines, e.g. do not do VEs at
clinics
1
Many patients under 20 years
and ineligible for screening
3
Local consensus / guidance /
advice against doing smears
during pregnancy - even if
due; GP task
3
Low outcome expectancy, i.e.
less need for smears because
of increased uptake of
screening
2





Omissions more likely if
delegated to junior staff
1
Workload at clinic 2
C Organisational or
environmental factors
Expected norm 4 Not expected norm 2





mention need for smears
1 Women don't expect smear at
clinic
1
Staff become responsible for
dealing with subsequent






Mean baseline compliance %
Antibiotic prophylaxis
or screening for lower
genital tract
organisms
Help implementation (and number
of units raising or discussing each
point)
Hinder implementation (and number




Convincing evidence base 3 Uncertainty over supporting
evidence
Reduction of complications 2 Lack of local consensus 1
Guideline produced by
professional body (RCOG) -
or covered by recent SIGN
guideline
3




B Individual factors Low outcome expectancy
(perceived because infection is
uncommon or high number
needed to treat)




concern over acceptability to
patients, some nursing staff
consider speculum exam and





Unit guidance available 7 No unit guidance
Expected local norm 10 Not expected norm















Help implementation (and number
of units raising or discussing each
point)
Hinder implementation (and number








3 Not licensed / objections from
colleagues or pharmacy
4
Fewer side effects 3 Need further convincing of
benefit, e.g. by conduct of
local audit
1
Ease of storage 2
Familiarity with misoprostol 1
B individual factors Cost-effectiveness seen as
priority
10 Individual clinical autonomy







Unit guidance available 3 No unit guidance
Expected local norm 5 Not expected local norm
Routine part of care (e.g.
written up at assessment
clinic)
2 Delays caused by
administration, e.g. unsuitable
for cervical priming associated








Mean baseline compliance %
Offer of contraceptive
supplies if required
Help implementation (and number
of units raising or discussing each
point)
Hinder implementation (and number











Concern regarding quality of
follow up by GPs
1





Low priority for gynaecologist,
e.g. versus GP / FPC
responsibility
1






Availability of one or more
methods
7 Unavailability of choice of
methods at discharge, e.g.
Mirena
4
High priority for unit 4 Delays in obtaining supplies
from pharmacy - or supplies
not on ward
2
Unit guidance available 5 Low priority for unit
Covered in local staff training 2 Lack of shared protocol or
communication with referrer
Availability of FP trained
nursing staff
4 No unit guidance 1
No pharmacy delays;
pharmacy and day surgery
next to one another
2 Need for FP trained nurses 2
Repeated on integrated care
pathway form
1 Variable quality of FP advice 1
Patients discharged prior to




Appendix 6E. Interim analysis of staff survey
Table E1. Response rates to staff survey by discipline and grade (preliminary analysis).







Consultants 43 33 77
Staff Grades 5 4 80
Specialist Registrars 31 17 55
SHOs 45 16 36
Nursing and midwifery sisters 23 15 65
Staff midwives and nurses 58 27 46
Total 205 112 55
*Excludes four responses where grade unknown
Table E2. Response rates to staff survey by gynaecology unit (preliminary analysis).
Gynaecology unit Number of Number Response rate
recipients completing (%)
questionnaires*
A 6 5 69
B 18 11 61
C - -
D 15 9 60
E 8 8 100
F 31 16 51
G 22 12 54
H 14 10 71
I 14 9 64
J 18 10 56
K 23 10 43
L 8 4 50
M 28 10 36
Total 205 114 56
*Excludes two responses where unit unknown
Table E3. Pre-intervention compliance with assessment appointment within 5 days of referral
(preliminary analysis).
Compliance Units Respondents
Lower (< 19.5%) 3 18
Moderate (19.5-46%) 7 64
Higher (>46%) 3 28
Table E4. Pre-intervention compliance with offer of contraceptive supplies at discharge
(preliminary analysis).
Compliance Units Respondents
Lower (< 49%) 3 20
Moderate (49-94%) 7 66
Higher (>94%) 3 25
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Table E5. Raw data on assessment of appointment within 5 days of referral (preliminary
analysis).
Reliability Mean SD Median Minimum Maximum
Behavioural intention 0.89 6.14 1.19 6.67 1.00 7.00
Attitude 0.81 6.41 0.97 7.00 2.50 7.00
Subjective norm 0.43 5.83 0.97 6.00 3.00 7.00
Perceived control 0.80 3.94 1.37 4.00 1.00 7.00
Table E6. Raw data on offer of contraceptive supplies at discharge (preliminary analysis).
Reliability Mean SD Median Minimum Maximum
Behavioural intention 0.95 6.69 0.90 7.00 2.00 7.00
Attitude 0.84 6.76 0.78 7.00 2.50 7.00
Subjective norm 0.59 6.48 0.69 6.67 3.33 7.00
Perceived control 0.82 6.09 1.17 6.60 1.00 7.00
Table E7. Scores on psychological measures [mean (SD)] according to pre-intervention
compliance for assessment appointment within 5 days of referral (preliminary analysis).
Pre-intervention compliance F P
Low Medium High
Behavioural intention 5.78 (1.31) 6.18 (1.19) 6.25 (1.13) 0.96 0.38
Attitude 6.82 (0.47) 6.27 (1.02) 6.43 (1.06) 2.28 0.11
Subjective norm 5.76 (0.89) 5.75 (0.94) 6.01 (1.09) 0.69 0.50
Perceived control 2.82 (1.50) 3.87 (1.30) 4.77 (0.95) 12.31 <0.001
Table E8. Scores on psychological measures [mean (SD)] according to pre-intervention
compliance for offer of contraceptive supplies at discharge (preliminary analysis).
Pre-intervention compliance F P
Low Medium High
Behavioural intention 6.5 (1.16) 6.70 (0.79) 6.76 (1.01) 0.51 0.60
Attitude 6.61 (0.63) 6.81 (0.72) 6.70 (1.06) 0.59 0.56
Subjective norm 6.12 (0.84) 6.53 (0.56) 6.58 (0.81) 3.38 0.04
Perceived control 5.43 (1.15) 6.12 (1.25) 6.49 (0.73) 4.97 0.009
Table E9. Correlations (Pearson's r) between psychological measures for assessment
appointment within 5 days of referral (preliminary analysis).
Behavioural intention Attitude Social pressure
Behavioural intention -
Attitude 0.32** -
Subjective norm 0.52** 0.46** -
Perceived control 0.26** 0.13 0.24**
"""Correlation significant at the 0.01 level (2-tailed).
389
Table E10. Linear regression of behavioural intentions onto psychological measures








Attitude 0.13 0.10 -0.11, 0.37 0.26
Subjective norm 0.54 0.43 0.30, 0.77 <0.001
Perceived control 0.12 0.14 -0.03, 0.27 0.11
Table E11. Correlations (Pearson's r) between psychological measures for offer of
contraceptive supplies at discharge (preliminary analysis).
Behavioural intention Attitude Social pressure
Behavioural intention -
Attitude 0.47** -
Subjective norm 0.46** 0.52** -
Perceived control 0.29** 0.07 0.32**
**Correlation significant at the 0.01 level (2-tailed).
Table E12. Linear regression of behavioural intentions onto psychological measures








Attitude 0.39 0.34 0.18, 0.61 <0.001
Subjective norm 0.28 0.21 0.02, 0.53 0.03
Perceived control 0.16 0.20 0.03, 0.28 0.02
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Appendix 6F. Model structured case record
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Initial assessment





















Reason for request of induced abortion





Date of last smear:
Result: Smear taken?
□ FBC
□ Group & save
□ Chlamydia
□ Need for further counselling?
□ Certificate A




Explanation of procedures and risks
□ Procedure explained
□ Around 1 in 1000 for:
Haemorrhage
Uterine perforation (surgical)
Failed surgical or medical abortion
□ Around 1 in 100 for cervical trauma
□ Around 1 in 10 for infection
□ Uncomplicated procedure no effect on future
reproductive outcomes
(infertility or preterm delivery)
Method of abortion and arrangements
1st trimester MTOP
Date attending for mifepristone / /
Date returning for admission / /
2na trimester MTOP
Date attending for mifepristone / /
Date returning for admission / /
STOP + misoprostol
Admission date / /
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Admission for procedure





□ Phone ward only if vomited within 2 hours
□ Paracetamol based analgesia only for pain
□ Sanitary towels only for bleeding
□ 1 % risk of miscarriage - contact GP / ward
□ Avoid alcohol and / or smoking
□ Admission letter
Medical abortion: second visit
1st trimester
Date / /
Misoprostol 800 micrograms (4 X 200 microgram
tabs) vaginally
□ Products of conception seen?
If not, arrange follow up within 2 weeks
2na trimester
Date / /
Misoprostol 800 micrograms (4 X 200 microgram
tabs) vaginally, then misoprostol 400 micrograms
orally every hours to a maximum of 4 oral doses
□ Fetus seen? □ Placenta seen?
Surgical abortion
□ Consent
□ Cervical preparation: Misoprostol
400 micrograms vaginally, 3 hours prior to
surgery (or Mifepristone)
Other prescriptions written up (surgical or
medical)
□ Antibiotic prophylaxis (Azithromycin 1G or






□ Required? □ Given?
Contraception
Method
Immediate supply Subsequent provision
□ Hospital □ FPC
□ FPC □ GP
□ GP □ Other
Discharge advice













The above patient was admitted to on under the care of and
underwent medical termination of pregnancy.
□ The products of conception were complete
□ The products were not seen / incomplete and she has been given an appointment to
attend for follow-up on She is aware of the importance of follow up.
□ An evacuation of uterus was performed under GA
Chlamydia result
□ Negative
□ Positive, antibiotics were administered prior to discharge, and we have recommended
that she attend GUM for follow up and contact tracing.
□ Equivocal - action taken
□ Not known - Action taken
Contraception
Chosen method
Immediate supply: hospital / FPC / GP
Subsequent provision: FPC / GP / Other
Blood group Anti-D Next cervical smear due
We have recommended that the patient attend for follow up with her general practitioner /
family planning clinic (delete as appropriate) within weeks. This is to check that
the abortion is complete, the use of contraception, the appropriate treatment of infection,





The above patient was admitted to on under the care of and
underwent surgical termination of pregnancy
Chlamydia result
□ Negative
□ Positive, antibiotics were administered prior to discharge, and we have recommended
that she attend GUM for follow up and contact tracing.
□ Equivocal - action taken
□ Not known - Action taken
Contraception
Chosen method:
Immediate supply: hospital / FPC / GP
Subsequent provision: FPC / GP / Other
Blood group Anti-D Next cervical smear due
We have recommended that the patient attend for follow up with her general practitioner/
family planning clinic (delete as appropriate) within weeks. This is to check that
the abortion is complete, the use of contraception, the appropriate treatment of infection,




Appendix 6G. Frequently asked questions
The clinical guideline, The care of women requesting induced abortion, was launched in
March 2000. Subsequently, a national audit of abortion care was initiated by the Scottish
Programme for Clinical Effectiveness in Reproductive Health (SPCERH) at the end of 2000.
The audit results were fed back to participating gynaecology units at local meetings between
June and July 2001.
The rationale behind or feasibility of several guideline recommendations were questioned
during feedback. Not all of these issues could be addressed in full during the meetings. This
paper responds further to some of the questions raised. However, it is recognised that many
clinicians or units may have legitimate reasons for not following certain recommendations in
part or in full.
What are the benefits of offering an assessment appointment within five days of
referral? The earlier in pregnancy an abortion is performed, the lower the risk of
complications. The absolute risk of complications at the time of abortion is low (0.7%) (1). The
risk of serious complications increases 1.4 times for every 2 week increment in gestation
beyond 12 weeks (2).
It has also been suggested that efforts to minimise the time between initial referral and the
abortion procedure may pressurise some women to reach a decision (to have an abortion)
quickly. Studies on the psychological aspects of induced abortion indicate that the majority of
women decide early to have an abortion (3-6).
Setting a target of 5 days from referral to appointment is not feasible for units running weekly
clinics. Yet, 38% of women in Scotland need to wait longer than 7 days for an assessment
appointment. In 1992, a survey of Scottish gynaecologists (92% response rate), 81% agreed
that a 'referral to assessment appointment' interval of 5 days represented an appropriate
criterion for good quality care (7).
What some units have done or intend to do
• Eight out of thirteen units that received audit data have reorganised or are reviewing the
organisation of their clinics.
• Some delays may be related to the failure of some practices and locum GPs to use the
telephone referral service. As well as reminding GPs about quicker methods of referral, it
might also be appropriate to direct reminders at practice managers (and perhaps practice
secretaries as well).
Why enquire into cervical smear status? Three arguments were put forward against
enquiring into cervical screening status during the pre-abortion assessment. First, women
having abortions are generally younger and therefore at lower risk of cervical cancer than
older age groups. Second, smears are more difficult to interpret during pregnancy. Third,
taking smears may interfere with the primary care screening programme, especially if
secondary care settings lack appropriate mechanisms for follow up of results.
The guideline does not suggest taking 'opportunistic' smears that would disrupt the screening
programme; rather, that a smear should be considered and taken only if it is overdue.
Abortion care should be part of a holistic approach to sexual health services. Checking
cervical smear status offers an opportunity to discuss the value of screening and explore any
concerns with women whose smears are overdue. Women requiring a smear can be
reminded to attend their own general practices following the abortion. A sub-group of women
attending for abortion care may make poor use of preventative services and subsequently
represent a high risk group for cervical cancer.
What some units have done or intend to do
• The commonest reasons suggested for low compliance with this recommendation were
either accidental omission or not recording even if smear status had been checked.
• Nine out of thirteen units fed back audit data are now considering amending or
introducing structured case sheets that would include a question on smear status.
What are the benefits of ensuring contraception provision at discharge? In 1999, 24%
of 12,167 women undergoing induced abortion in Scotland had experienced at least previous
one abortion [ISD data]. The offer or provision of contraception is an essential component of
preventive care following abortion. Whilst few gynaecologists would disagree with this
statement, 30% of women having abortions in Scotland were discharged without a
contraception supply or device (from either hospital or primary care). Some units reported
organisational barriers to the provision of contraception at discharge. However, our survey of
units indicated that low provision of contraception was associated with doubts regarding the
value or effectiveness of contraception provision at discharge.
On 'average' across Scotland, 500 women attend each gynaecology unit for abortion care per
year. The box below outlines scenarios considering the potential benefits of increasing
provision at discharge. Considered in the context of other 'numbers needed to treat' (e.g. use
of antenatal steroids), provision of contraception at discharge may be highly effective.
Individual gynaecologists might prefer to calculate the potential benefits using a different set
of more optimistic or pessimistic assumptions.
Best case scenario Worst case scenario
If an additional 20% of women received
contraception at discharge, 10% might still be using
it by one year. Assuming that actually using
contraception might prevent an unwanted
pregnancy in one half of these women (compared
with nothing), then a further unwanted pregnancy
will be prevented in 5% of women who originally
attended for abortion.
This would translate roughly into 25 unwanted
pregnancies prevented each year by each
gynaecology unit (or 600 across Scotland).
If an additional 10% of women received
contraception at discharge, 2% might still be using
it by one year. Assuming that actually using
contraception might prevent an unwanted
pregnancy in one half of these women (compared
with nothing), then a further unwanted pregnancy
will be prevented in 1% of women who originally
attended for abortion.
This would translate roughly into 5 unwanted
pregnancies prevented each year by each
gynaecology unit (or 120 across Scotland).
Why offer a foliow-up appointment within 2 weeks of discharge? The guideline suggests
that women are offered a follow up appointment with either the abortion service or referring
doctor. Doubts were expressed over both the value of providing routine follow up and the
appropriateness of the suggested timing (2 weeks). Reasons for offering follow up include:
• Provision of counselling and reinforcement relating to contraceptive use - especially for
women experiencing early problems when starting a new method of contraception;
• Detection of post-abortion infection;
• Exclusion of on-going pregnancy - for either medical or a smaller proportion of surgical
cases.
The main rationale behind suggesting an interval of 2 weeks is that attendance rates for
follow-up are likely to decline over longer periods of time. The costs of offering follow-up
need to be balanced against those of not detecting failed procedures. Incomplete and failed
procedures account for approximately half of complaints related to induced abortions (8). In a
previous survey of women undergoing abortion in Scotland, 83% felt that a follow-up
appointment was worthwhile (9).
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General practitioners or family planning doctors can provide follow up care as required. If so,
gynaecology units should consider incorporating an explicit statement in discharge letters
concerning who is providing and the rationale for follow up.
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Improving Abortion Care Trial
Data collection form
Scottish Programme for Clinical Effectiveness
in Reproductive Health (SPCERH)
Where appropriate, please mark boxes with a cross.
X
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Referral and initial assessment
3 Date of referral on GP's letter or of self-referral to family planning clinic
d d m m y y
4 Who referred the patient for the gynaecological assessment appointment
(where the procedure was arranged)?
General practitioner = 1
Family planning clinic = 2
Self = 3
Other = 4
Other specified source of referral
(Cross appropriate box)
Venue where gynaecological assessment appointment took place (i.e. where
procedure was arranged)
Hospital outpatient clinic = 1
Family planning clinic = 2
6 Date patient attended for above appointment (Q5)
7 Patient age at time of referral (years)
8 Number of live and still births
9 Number of miscarriages and previous induced abortions
10 Date of LMP (Place an 'XX' in the box if any figure is unknown)
11
d d m m y y
d d m m y y
11 Best estimate of gestation at date of assessment appointment at
gynaecology outpatients OR family planning clinic (completed weeks; use








13 Blood group (ABO) checked?
14 Cross matching performed?
15 Rhesus (Rh) status checked?
(Cross appropriate box)
16 Enquiry about date of last cervical smear?
acceptable as a response.)
18 Cervical smear taken at the clinic?
19 Ultrasound scan undertaken?





Rh +ve = 1
Rh -ve = 2





3f 'smear up to date'
Yes = 1
No = 2







Stated as gestation in doubt = 1
Suspected extra-uterine pregnancy = 2
Routine OR not recorded = 3
(Cross appropriate box)
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21 Screening for lower genital tract organisms and/or antibiotic prophylaxis*
Genital tract screening AND antibiotics
given
= 1
Genital tract screening ONLY = 2
Antibiotics given ONLY
(go to question 23)
= 3
Not recorded
(go to question 23)
= 4
'Screening includes either taking a genital tract swab for culture OR sending urine for Ligase Chain Reaction (LCR).
Antibiotic treatment may be recorded in case notes, the day case form, or drug kardex.)
22 Results of screening
Positive test or significant growth* AND
given antibiotics
= 1
Positive test or significant growth BUT
NOT given antibiotics
= 2
Other or no significant growth = 3
Result not found nor recorded = 4
*Significant or positive test results are for one or more of: Chlamydia trachomatis, Neisseria Gonorrhoea or bacterial
vaginosis.
The abortion procedure
(Information on drugs prescribed may be found in the case notes, day case form, or drug kardex.)
23 Date termination procedure commenced (surgical or mifepristone component
of medical abortion)
d d m m Y y
24 Date of admission for abortion (surgical or Gemeprost / misoprostol
component)
d d m m y y
25 Estimated gestation at date of termination (completed weeks)
26 Date of discharge
d d m m y y









28 Use of surgical evacuation following medical abortion
Yes - record of incomplete abortion = 1
Yes - no record of incomplete abortion = 2
No = 3
29 Medical abortion: Dose of mifepristone
200 mg = 1
400 mg = 2
600 mg = 3
30 Medical abortion: Prostaglandin used
Misoprostol = 1
Gemeprost 0.5 g = 2
Gemeprost 1 g = 3
Now go to question 35
Surgical abortions
31 Type of anaesthetic recorded
General anaesthetic = 1
Local anaesthetic = 2





Not recorded = 5
33 Most senior grade of operator present (as written on operation note)
Consultant = 1







34 Grade of any other operator present
Consultant = 1









35 If Rhesus negative, was anti-D given?
Yes = 1
Not recorded = 2
Not required = 3
36 Immediate post or peri-operative complications documented
Suspected or actual uterine perforation
(go to question 37)
= 1
Haemorrhage (more than 500 ml recorded)
(go to question 38)
= 2
Cervical trauma requiring suture
(go to question 39)
= 3
None of the above
(go to question 39)
= 4












39 Contraceptive plan documented by time of discharge
Yes (including any plan recorded at
assessment appointment)
= 1
Not recorded = 2
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41 If yes, state type of contraceptive supplied
Oral contraceptive = 1
Condoms = 2
Other (specify) = 3
Other specified treatment
42 If no, were contraceptive supplies documented as being provided by the
hospital before or at the time Of discharge? (i.e. exclude later return appointments for
sterilisation or insertion of lUCDs, etc.)
Yes = 1
No = 2
43 If yes, type of contraceptive supplied (cross all that apply)














Other (specify) = 9
Other specified treatment
44 Documented follow-up arrangements as stated in the case notes or discharge
letter (cross all that apply)
Hospital = 1
Referring doctor = 2
GUM clinic = 3
None recorded = 4
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45 What was the suggested interval to follow up?
1 week = 1
2 weeks = 2
3 weeks = 3
4 weeks = 4
6 weeks = 5
None or none stated = 6
Other (please specify) = 7
Other specified
Initials of data collector: Date:
Thank you. Please return in batches of 5 - 10 to:
Robbie Foy
SPCERH






































Appendix 7D. Patient questionnaire
Scottish survey of abortion care
Name of Unit
PATIENT QUESTIONNAIRE
Please read the 'Information for patients' before looking at this questionnaire. This
questionnaire asks about your experience of having an abortion. All information
collected about you will be kept anonymous and strictly confidential. Therefore you
cannot be identified from this questionnaire. You may decline to answer any
question in the questionnaire without giving a reason. If you decide to help us by
filling in this questionnaire, please do so now or shortly after leaving the hospital.
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THE FOLLOWING QUESTIONS CONCERN ARRANGEMENTS MADE FOR YOUR
ABORTION
1 Most women having an abortion first
see their general practitioner or family
planning doctor before being referred
to a hospital clinic or a specialist
within the family planning centre.
Did this happen to you?
Please circle response that best fits your
experience
Yes





2 After seeing your general practitioner
or family planning doctor, how long
did you wait to attend your first
hospital or specialist appointment?
Approximately davs
3 After this assessment appointment
with the gynaecologist or family
planning doctor, how long did you wait
to attend the hospital for your abortion
procedure?
If you had a medical (drug) abortion
only (no operation and general
anaesthetic), this refers to how long
you waited until the day you received
your first drug treatment.
Approximately davs
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THE FOLLOWING QUESTIONS CONCERN HOW SATISFIED YOU ARE WITH
ANY COUNSELLING YOU RECEIVED




Neither agree or disagree 3
Disagree 4
Strongly disagree 5
5 There was too much medical talk Strongly agree 1
Agree 2
Neither agree or disagree 3
Disagree 4
Strongly disagree 5
6 The staff asked too many questions Strongly agree 1
Agree 2
Neither agree or disagree 3
Disagree 4
Strongly disagree 5
7 During your clinic appointments, did Yes 1
you have enough time and help in
Noreaching your decision to have an 2
abortion?
8 Do you feel now that your decision Yes 1
was right for you?
No 2
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THE FOLLOWING QUESTIONS CONCERN HOW SATISFIED YOU ARE WITH
THE CARE YOU RECEIVED




Neither agree or disagree 3
Disagree 4
Strongly disagree 5
10 My confidentiality was protected Strongly agree 1
Agree 2
Neither agree or disagree 3
Disagree 4
Strongly disagree 5
11 The staff treated me with respect Strongly agree 1
Agree 2
Neither agree or disagree ; -;3
Disagree 4
Strongly disagree 5
12 The staff were professional and Strongly agree 1
thorough
Agree 2
Neither agree or disagree 3
Disagree 4
Strongly disagree 5
13 The staff treated me as a whole Strongly agree 1
person
Agree 2




14 The staff weren't afraid to discuss
emotional issues (about how you felt).
Strongly agree
Agree








15 There are some things about the












16 Some women having an abortion may
be suitable for either medical (drug
treatment only) or surgical (requiring
general anaesthetic) abortion
methods.















THE FOLLOWING QUESTIONS CONCERN INFORMATION GIVEN TO YOU.
18 Were you given a leaflet about








19 Did the doctors or nurses talk to you








Major complications are rare following
abortion.
Were any of the following possible
complications mentioned to you?








21 Damage to the uterus, or womb,
requiring a more major operation
(uterine perforation; this is only
relevant to surgical abortions)
Yes
No
Can't recall / not sure






22 Failure of the abortion method (and
need for another abortion procedure)
Yes
No




23 Pelvic infection Yes
No




24 While you were at hospital, were you
given a leaflet or letter describing any
symptoms you may experience after
the abortion, including those that









THE FOLLOWING QUESTIONS CONCERN ARRANGEMENTS MADE
FOLLOWING THE ABORTION.
25 Has a follow up appointment been No, not offered 1
arranged for you?
No, I was offered but did not want a 2
further appointment
Yes, at the hospital 3
Yes, at the family planning clinic 4
Yes, with my GP 5
26 If yes, how many weeks after the
abortion has an appointment been
arranged for? Aooroximatelv weeks
27 While you were at hospital, did Yes 1
anyone discuss your future plans for
Nocontraception with you? 2
Can't recall / not sure 3
28 While you were at hospital, did Yes 1
anyone offer to provide you with a
Nomethod of contraception before going 2
home?
No need. I already have 3
contraception through my GP or
family planning clinic
Can't recall / not sure 4
29 What are you going to do about I am on the contraceptive pill 1
contraception from now?
I have had a contraceptive injection 2
or implant
I have an IUD fitted (also known as 3
the coil)
We / my partner uses condoms 4
I have been sterilised 5
My partner has been sterilised 6
I use a cap / diaphragm 7
Nothing, but I plan to start soon 8
Nothing, I don't need contraception 9
now
I use another method (please 10
describe below)
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THE FINAL QUESTIONS ARE ABOUT YOU
30 What is your age?
Years
31 How many weeks pregnant were you
at the time of your abortion? Weeks
32 We wish to make general
comparisons between women
participating in this survey and all
women in Scotland having an
abortion. This can be done without
revealing your address or identity if
you are able to provide your postcode
WITHOUT THE LAST 2 LETTERS.
For example
If your postcode has SIX numbers and
letters, miss out the last two letters,
EH3 9ER becomes EH3 9
If your postcode has SEVEN numbers
and letters, miss out the last 2 letters:
EH13 9ER becomes EH13 9
My postcode without the last
2 letters is
Or, tick this box if you do not
know your postcode [ j
PLEASE CHECK THAT YOU HAVE ANSWERED ALL OF THE QUESTIONS AND
RETURN THE QUESTIONNAIRE IN THE STAMPED ADDRESSED ENVELOPE.
Thank you for your help
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Appendix 7E. Action list following outreach educational
meetings
1 Name of unit
Educational meeting
2 Length
3 Attendance (separate sheet for



































1. Organisation of clinic appointments during May to November 2001 ? YES / NO
If yes, what changes occurred in the
structure or process of abortion
care itself? (Probe for details on
time and resource implications.)
CHANGE in clinic, ward or theatre time
CHANGE in staff time and composition
Training and education




How much time was spent
negotiating the change, e.g.
meetings, paperwork?
Activity Staff type and grade Time (hrs)
Were there any costs or benefits to
other services as a result of these
processes or changes?
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2. Recording of cervical smear status during May to November 2001 ? YES / NO
If yes, what changes occurred in the
structure or process of abortion
care itself? (Probe for details on
time and resource implications.)
CHANGE in clinic, ward or theatre time
CHANGE in staff time and composition
Training and education




How much time was spent
negotiating the change, e.g.
meetings, paperwork?
Activity Staff type and grade Time (hrs)
Were there any costs or benefits to
other services as a result of these
processes or changes?
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3. Strategies to minimise risk of post-abortion infection (antibiotic prophylaxis or
screening) during May to November 2001? YES / NO
If yes, what changes occurred in the
structure or process of abortion
care itself? (Probe for details on
time and resource implications.)
CHANGE in clinic, ward or theatre time
CHANGE in staff time and composition
Training and education




How much time was spent
negotiating the change, e.g.
meetings, paperwork?
Activity Staff type and grade Time (hrs)
Were there any costs or benefits to
other services as a result of these
processes or changes?
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4. Use of misoprostol in place of gemeprost during May to November 2001? YES / NO
If yes, what changes occurred in the
structure or process of abortion
care itself? (Probe for details on
time and resource implications.)
CHANGE in clinic, ward or theatre time
CHANGE in staff time and composition
Training and education




How much time was spent
negotiating the change, e.g.
meetings, paperwork?
Activity Staff type and grade Time (hrs)
Were there any costs or benefits to
other services as a result of these
processes or changes?
423
5. Provision of contraception at discharge during May to November 2001? YES / NO
If yes, what changes occurred in the
structure or process of abortion
care itself? (Probe for details on
time and resource implications.)
CHANGE in clinic, ward or theatre time
CHANGE in staff time and composition
Training and education




How much time was spent
negotiating the change, e.g.
meetings, paperwork?
Activity Staff type and grade Time (hrs)
Were there any costs or benefits to
other services as a result of these
processes or changes?
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6. Offer of follow-up at discharge during May to November 2001? YES / NO
If yes, what changes occurred in the
structure or process of abortion
care itself? (Probe for details on
time and resource implications.)
CHANGE in clinic, ward or theatre time
CHANGE in staff time and composition
Training and education





How much time was spent
negotiating the change, e.g.
meetings, paperwork?
Activity Staff type and grade Time (hrs)
Were there any costs or benefits to
other services as a result of these
processes or changes?
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7. Can you recall ANY OTHER changes to the way abortion care is provided in your unit
within the past 6 months?
If yes, please list main changes (one box or page for each change)
Change made. (Probe for details on
time and resource implications.)
CHANGE in clinic, ward or theatre time
CHANGE in staff time and composition
Training and education




How much time was spent
negotiating the change, e.g.
meetings, paperwork?
Activity Staff type and grade Time (hrs)
Were there any costs or benefits to
other services as a result of these
processes or changes?
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8. Can you recall ANY OTHER changes to the way abortion care is provided in your unit
within the past 6 months?
Change made. (Probe for details on
time and resource implications.)
(Unplanned) greater input to abortion care from current batch of
SHOs
CHANGE in clinic, ward or theatre time
CHANGE in staff time and composition
Training and education




How much time was spent
negotiating the change, e.g.
meetings, paperwork?
Activity Staff type and grade Time (hrs)
Were there any costs or benefits to
other services as a result of these
processes or changes?
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Offer of appointment with a gynaecologist
within five days of referral (ideal; primary
outcome)
Denominator = all women
Numerator = 6 (date assessment) minus 3
(referral date)
Should equal 5 days or less for compliance
Offer of appointment with a gynaecologist
within 14 days of referral (acceptable)
Denominator = all women
Numerator =
6 (date assessment) minus 3 (referral date)
Should equal 14 days or less for minimum
standard
Abortion within seven days of the decision to
proceed being agreed (ideal)
Denominator = all women
Numerator =
23 (date termination) minus 6 (date
assessment)
Should equal 7 days or less for compliance
Abortion within 14 days of the decision to
proceed being agreed (acceptable)
Denominator = all women
Numerator =
23 (date termination) minus 6 (date
assessment)
Should equal 14 days or less for minimum
standard
As a minimum standard, no individual woman
need wait longer than three weeks from her
initial referral to the time of her abortion.
Denominator = all women
Numerator =
23 (date termination) minus 3 (referral date) =
LESS than 21 days
Management of induced abortion as day case
unless contra-indicated
Denominator = all women
Numerator = 26 (date discharge) minus 24
(date admission)




Appropriate blood tests performed Denominator = all women
Numerator =
Compliance if ALL of the following met:
12 (haemoglobin) = 1
AND
13 (blood group) = 1
AND
15 (rhesus) = 1 OR 2
Avoidance of routine cross-matching Denominator = all women
Numerator =
14 (cross matching) = 2
Ascertainment of cervical cytology history
(primary outcome)
Denominator =
7 (age) > 19 years
Numerator =
16 (smear enquiry) = 1
Offer of cervical smear if indicated and
appropriate follow up action
Denominator (women 20 years or over who
have had a smear enquiry) =
7 (age) > 19 years AND
16 (smear enquiry) = 1
Numerator (it is appropriate for women who
have NOT had a smear in the previous 3
years to have a smear taken. It is also
appropriate for women who have had a
smear taken in previous 3 years NOT to have
a smear taken) =
17 (smear <3 years) = 1 AND
18 (smear taken) = 2
OR
17 (smear <3 years) = 2 AND
18 (smear taken) = 1
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Avoidance of ultrasound scanning unless
indicated (gestation in doubt or suspected
extra-uterine pregnancy)
Proportion of women not having ultrasound
OR having a recorded indication
Denominator = all women
Numerator =
EITHER
19 (ultrasound) = 2
OR
19 (ultrasound) = 1 AND
20 (reason) = 1 OR 2
Antibiotic prophylaxis or screening for Denominator = all women
lower genital tract organisms (primary
outcome) Numerator =
21 (GU screening) = 1 OR 3
OR
21 (GU screening) = 2 AND




Preferential use of medical abortion at Denominator (all women with gestation less
gestations < 7 (and up to 9) weeks than 7 weeks) =
25 (estimated gestation at abortion) < 7
weeks
Numerator =
27 (method of abortion) = 2
For early medical abortion, a dose of 200mg Denominator (all women having an early
of mifepristone, in combination with a medical abortion) =
prostaglandin is adequate
25 (estimated gestation at abortion) <10
weeks AND
27 (method abortion) = 2
Numerator =
29 (dose mifepristone) = 1
Misoprostol cost-effective alternative to For medical abortions
gemeprost (in early medical abortion,
cervical priming and mid-trimester Denominator is all women who have had a
medical abortion) (primary outcome) medical abortion up to 24 weeks, i.e.
25 (estimated gestation at abortion) < 25
weeks AND
27 (Method abortion) = 2
Numerator is:
30 (Prostaglandin) = 1
For surgical abortions
Denominator is surgical abortions where
priming was used, i.e.
27 (Method abortion) = 1 AND
32 (Cervical preparation) = 1, 2, 3, or 4
Numerator is:
32 (Cervical preparation) = 2
Then add both of these sums together for
composite measure of compliance
431
Use of conventional suction termination at
gestations of 7-15 weeks if appropriate or
preferred
Denominator (all women between 7 and 15
weeks gestation inclusive) =
25 (estimated gestation at abortion) 7 to 15
weeks inclusive
Numerator is:
27 (Method abortion) = 1
Availability of local rather than general
anaesthesia for suction termination
Denominator is
27 (method abortion) = 1 AND
25 (Gestation) = 7 to 15 weeks inclusive
Numerator:
31 (type of anaesthetic) = 2
Routine use of cervical priming for women
aged under 18 or > 10 weeks gestation
Denominator (all women having surgical
abortions aged under 18 or at over 10 weeks
gestation), ie.
27 (method abortion) = 1
AND at least one of
1 (Age) LESS THAN 18 years
OR
25 (Gestation) GREATER THAN 10 weeks
Numerator (use of cervical priming) =
32 (Cervical preparation) = 1, 2, 3 or 4
200mg of mifepristone plus prostaglandin in
mid-trimester medical abortion
Denominator =
25 (estimated gestation at abortion) 13 to 24
weeks inclusive AND
27 (method abortion) = 2
Numerator =
29 (dose mifepristone) = 1
Avoidance of routine surgical evacuation of
uterus following mid-trimester medical
abortion unless indicated
Denominator is
27 (method of abortion) = 2 AND
25 (estimated gestation at abortion) 13 to 24
weeks inclusive
Numerator is
28 (use of surgical evac) must = 1 OR 3
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Mid-trimester abortion using D&E by
specialist practitioners with access to
necessary instruments and sufficiently large
caseload
Denominator:
25 (gestation at abortion) > 15 weeks AND
27 (method of abortion) = 1,
Numerator:
32 (Cervical preparation) = 1, 2, 3 or 4 (for
surgical abortions) AND
33 (most senior operator) = 1 or 2
Alternative use of medical abortion at > 15
weeks gestation
Denominator is
25 (gestation at abortion) > 15 weeks,
Numerator is:
27 (method of abortion) = 2
Managing complications
Recommendation Database analysis
Oxytocics are effective in reducing intra¬
operative blood loss
Denominator is
27 (method of abortion) = 1 AND
36(complications) = 2
Numerator is
38 (initial treatment) = 1
In cases of suspected uterine perforation
laparoscopy is the investigation of choice
Denominator is
27 (method of abortion) = 1 AND
36(complications) = 1
Numerator is




Administration of Anti-D IgG to all non-
sensitised RhD negative women following
abortion
Denominator =
15 (rhesus) = 2
Numerator =
35 (anti-D) = 1
Offer of follow-up appointment (with service
or referrer) within 2 weeks of abortion
Denominator = all women
Numerator =
44 (FU venue) = NOT 4, AND
45 (Suggested interval) = 1 or 2
Discussion of future contraception prior to
discharge
Denominator is all women
Numerator =
39 (contraceptive plan) = 1
Offer of contraceptive supplies if required
prior to discharge (primary outcome)
Denominator = all women
Numerator =
40 (Referrer supply) = 1
OR
42 (Hospital supply) = 1
OR
Both of above
Sterilisation can safely be performed at time
of induced abortion (with higher rates of
failure and regret)
Denominator = all women
Numerator =
43 (type supplied) = NOT 6
Inverse of baseline analysis to demonstrate
compliance rather than non-compliance
Safety and effectiveness of IUCD insertion
immediately following induced abortion
Denominator = all women
Numerator =
43 (type supplied) = 3
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Offer of appointment with a gynaecologist
within five days of referral (ideal; primary
outcome)
Denominator:
1 (referring doctor) = 1
Numerator:
2 (first appointment) = 5 or less
Offer of appointment with a gynaecologist
within 14 days of referral (acceptable)
Denominator:
1 (referring doctor) = 1
Numerator:
2 (first appointment) = 14 or less
Abortion within seven days of the decision to
proceed being agreed (ideal)
Denominator: All cases
Numerator:
3 (date procedure) = 7 or less
Abortion within 14 days of the decision to
proceed being agreed (acceptable)
Denominator: All cases
Numerator:
3 (date procedure) = 14 or less
As a minimum standard, no individual woman
need wait longer than three weeks from her
initial referral to the time of her abortion.
Denominator:
1 (referring doctor) = 1
Numerator:
The sum of [2 (first appointment) AND 3 (date
procedure)] = 21 or less
Information for women
Recommendation Database analysis
Verbal advice must be supported by
accurate, impartial printed information which
the woman considering abortion can




18 (leaflet) = 1
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Information for women and professionals
should emphasise the duty of confidentiality
by which, as for any form of health care, all




10 (confidentiality) = 1 or 2
Professionals providing abortion services
should possess accurate knowledge about
possible complications and sequelae of
abortion. This will permit them to provide
women with the information they need in
order to give genuinely informed consent
Denominator: all women
Numerator:
19 (possible problems) = 1




20 (haemorrhage) = 1
Possible complications mentioned during
counselling: uterine perforation
Denominator:
17 (type of abortion) = 1
Numerator:
21 (uterine perforation) = 1
Possible complications mentioned during
counselling: failure
Denominator: all women
22 (failure) = 1
Possible complications mentioned during
counselling: pelvic infection
Denominator: all women
23 (pelvic infection) = 1
436
Composite score for patient information For surgical cases
• Based on meeting 5/5 of above criteria Denominator:
for surgical cases
• Based on meeting 4/4 of above criteria 17 (type of abortion) = 1
(not Q21) for medical cases








17 (type of abortion) = 2





Then add both together for overall
score
Pre-abortion management
No items covered on patient questionnaire
Procedures
Recommendation Database analysis
Ideally, abortion services must be able to Denominator:
offer a choice of recommended procedures
for relevant gestation bands 31 (gestation) between 7 and 9 inclusive or
13 and 24 weeks inclusive
Numerator:
16 (choice) = 1
Managing complications




After an abortion, women must be given a
written account of the symptoms they may
experience and a list of those that would
make an urgent medical consultation
necessary. They should be given a 24 hour
help-line telephone number to use if they feel
worried about pain, bleeding or high
temperature
Denominator: all women
24 (leaflet) = 1
A follow-up appointment (either within the
abortion service or with the referring clinician)
within two weeks of the procedure should be
offered to each patient following abortion
Denominator: all women
Numerator:
25 (follow up appointment) = 3, 4 or 5
AND 26 (weeks) = 1 or 2
Before she is discharged following abortion,
future contraception should have been
discussed with each patient
Denominator: all women
Numerator:
27 (contraceptive plan) = 1
Contraceptive supplies should have been
offered if required. The chosen method of
contraception should be initiated




28 (contraception method) = 1 or 3
Sterilisation can safely be performed at the
time of induced abortion. However combined
procedures are associated with higher rates
of failure and of regret
Denominator: all women
Numerator:
29 (contraception now) = NOT 5
It is safe and effective to insert an IUCD for




29 (contraception now) = 3
Counselling process
Recommendation Database analysis
There was too much emotional talk 4 (emotional) = mean response
There was too much medical talk 5 (medical) = mean response
The staff asked too many questions 6 (questions) = mean response
Summary score (used by Zapka et al) Summary mean of above items for each case
Other questions about counselling
Recommendation Database analysis
During your clinic appointments, did you have
enough time and help in reaching your
decision to have an abortion?
Denominator: all women
Numerator: 7 (time) = 1
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Do you feel now that your decision was right
for you?
Denominator: all women
Numerator: 8 (right decision) = 1
Staff competency
Recommendation Database analysis
The clinical care 1 received was excellent 9 (clinical care) = mean
My confidentiality was protected (Duplicates
earlier question about recommendation)
10 (confidentiality) = mean
The staff treated me with respect 11 (respect) = mean
The staff were professional and thorough 12 (professional) = mean
Summary score Summary mean of above items for each case
Staff sensitivity
Recommendation Database analysis
The staff treated me as a whole person 13 (whole person) = mean
The staff weren't afraid to discuss emotional
issues (about how you felt).
14 (emotional) = mean
Summary score Summary mean of above items for each case
Global rating of satisfaction
Recommendation Database analysis
There are some things about the medical
care 1 received that could be better
15 (could be better) = mean
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Appendix 71. Costing of ImpACT intervention
Audit and feedback
Component or step Resources Cost per
hour (£)
Total (£)
Planning of design and data
collection
80 hours @ clinical research fellow (grade
AM2)
25.40 2031.74
8 hours @ clinical senior lecturer (non-
consultant scale)
36.35 290.83
Liaison with 13 intervention
units, e.g. to recruit data
collectors
8 hours @ grade CN3 secretarial support 8.95 71.62
40 hours @ clinical research fellow (grade
AM2)
25.40 1015.85
1 hour each for 13 local lead consultants 48.75 633.81
Training of data collectors:
training day in Edinburgh
8 hours @ clinical research fellow (grade
AM2)
25.40 203.17
8 hours @ clinical senior lecturer (non-
consultant scale)
36.35 290.83
4 hours @ grade CN3 secretarial support 8.95 35.81
8 hours of data collectors' time
(intervention units only)
3 nursing sisters 18.86 452.62
3 staff nurses 13.75 330.06
5 medical secretaries 8.95 358.08
4 hours of above data collectors' travel
(estimated time of round trip)
142.59 570.37
Travel expenses claimed for 11 data
collectors @ £20 each
220.00
Catering 100.00
Outreach training (for data
collectors unable to attend
training day)
2 visits @ 4 hours each of clinical research
fellow (grade AM2)
25.40 203.17
Estimated total of 15 hours travel time @
clinical research fellow (grade AM2)
25.40 380.95
2 hours each of data collectors' time 142.59 285.19
Catering 50.00
Printing and postage of data
collection forms
1000 forms printed for intervention units 75.00
Postage @ £5 per pack 65.00
Data collection Average of 41 cases per unit @ £6 paid
per form returned
3198.00
Case note retrieval @ £1 per case note 533.00
Data entry 4 hours @ clinical research fellow (grade
AM2)
25.40 101.59
20 hours @ grade CN3 secretarial support 8.95 179.04
Data analysis 32 hours @ clinical research fellow (grade
AM2)
25.40 812.80
8 hours of statistician time 14.30 114.40
Preparation and dissemination
of baseline audit reports
32 hours @ clinical research fellow (grade
AM2)
25.40 812.80
8 hours @ grade CN3 secretarial support 8.95 71.62
4 hours @ clinical senior lecturer (non-
consultant scale)
36.35 145.41
Photocopying = 3p per sheet
1 report (45 pages) = £1.35
Postage £5
For 10 reports per unit
240.50
Total intervention cost 13341.00
Average cost per unit 1026.23
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Identification of barriers
Component or step Resources Cost per
hour (£)
Total (£)
Outreach meetings with clinical
directors
13 meetings, 1 hour per meeting @ clinical
research fellow (grade AM2)
25.40 330.16
Travel to 13 meetings, 2 hours per trip @
clinical research fellow (grade AM2)
25.40 660.32
1 hour each for 13 local lead consultants 48.75 633.81
8 hours analysis of findings @ clinical
research fellow (grade AM2)
25.40 203.17
Staff survey preparation of
questionnaire and survey
32 hours @ clinical research fellow (grade
AM2)
25.40 609.52
4 hours @ clinical senior lecturer (non-
consultant scale)
36.35 145.41
4 hours by behavioural scientist 21.68 86.73
Production and postage of 200
questionnaires
Photocopying = 5 sheets @ 3p each; £30
total
Postage = 27p each; £54 total
84.00
Completion of questionnaires 147 questionnaires @ 20 minutes each
38 Consultants 48.73 617.31
5 Staff Grades 31.74 52.91
21 Specialist Registrars 26.78 187.46
23 SHOs 23.62 181.09
17 Nursing and midwifery sisters 18.86 106.87
43 Staff midwives and nurses 13.75 197.12
Data entry 12 hours @ grade CN3 secretarial support 8.95 107.42
Data analysis 8 hours by behavioural scientist 21.68 173.45
8 hours @ clinical research fellow (grade
AM2)
25.40 203.17
Total intervention cost 4579.92
Average cost per unit 352.30
Educational meetings
Component or step Resources Cost per
hour (£)
Total (£)
Preparation 13 meetings, 1 hour per meeting @
clinical research fellow (grade AM2)
25.40 330.16
Travel 13 meetings, 3 hours travel per meeting @
clinical research fellow (grade AM2)
25.40 990.48
Direct travel costs @ £20 per meeting 260.00
Catering £50 per meeting 650.00
Attendance atmeetings 13 meetings, 1 hour per meeting @
clinical research fellow (grade AM2)
25.40 330.16
1 hour attendance by clinical staff 4228.16
Costs of room £50 per room for 13 meetings 650.00
Action planning meetings 13 meetings, 20 minutes per meeting @
clinical research fellow (grade AM2)
25.40 110.05
20 minutes per meeting clinical staff 289.27
Preparation of FAQ sheet 8 hours @ clinical research fellow (grade
AM2)
25.40 203.17
Total intervention cost 8041.45
Average cost per unit 618.57
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Review of structured case records
Component or step Resources Cost per
hour (£)
Total (£)
Collation of existing records Liaison with all Scottish gynaecology units
8 hours @ grade CN3 secretarial support
8.95 71.62
Planning 8 hours @ clinical research
fellow (grade AM2)
25.40 101.62
Preparation and revision 24 hours @ clinical research fellow (grade
AM2)
25.40 609.52
20 minutes each pre-testing on 3
consultants
48.75 48.75
20 minutes each pre-testing on 3 staff
nurses
13.75 13.75
Dissemination 4 hours @ grade CN3 secretarial support 8.95 35.81
Total intervention cost 881.04
Average cost per unit 67.77
Promotion of patient information booklet





10 per unit @ 3p per page and 8 pages
per copy
31.20
Promotion Conducted during outreach meetings
Total intervention cost 31.20
Average cost per unit
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Appendix 7J. Local coordinators, data collectors, and
contacts for patient survey
Hospital | Coordinator Data Collectors Patient survey contacts
Aberdeen Royal
Infirmary
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Abstract
Aims to provide a framework for identifying barriers to
the implementation of a clinical guideline by examining a
clinical effectiveness programme and a review of relevant
literature. A total of 41 types of barrier were identified
and categorised according to characteristics of the
guideline to be introduced, the individuals who need to
change behaviour and the organisation or environment in
which the change is to occur. Several groups have the
potential to overcome such barriers, ranging from
individual clinicians to national policy makers. Multi-level
as well as multi-faceted strategies may be required to
overcome barriers to the effective implementation of
clinical guidelines.
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Introduction
There is a widely acknowledged gap between
the evidence base and the delivery of health
care (Haines and Donald, 1998). The
importance of reducing this gap and
inappropriate variations in health care has
been acknowledged in recent NHS policy
initiatives in the UK, including clinical
governance. Such initiatives are more likely to
work, if, amongst other factors, they
incorporate proven means of promoting best
clinical practice (Bero et al., 2000).
The Scottish Programme for Clinical
Effectiveness in Reproductive Health
(SPCERH) was established in 1997 and
represents the first of a series of multi-
professional programmes funded by the
Clinical Resource and Audit Group (CRAG)
of the Scottish Executive Department of
Health. SPCERH attempts to bring together
a wide range of educational, audit and
research activities, which aim to promote
evidence-based practice and policy in
reproductive health care.
Clinical guidelines represent one of the
principal means of disseminating best practice
(Walker et al., 2000) and form an integral
component of the national quality-enhancing
initiatives. However, it is recognised that
passive methods, such as the simple
distribution of guidelines, are relatively
ineffective at improving clinical practice
(NHS Centre for Reviews and Dissemination,
1999a). Practice may improve, but in a
piecemeal fashion or at a slower rate than
anticipated (Firth-Cozens, 1997). This has
led to increased interest in more active
implementation strategies. A growing body of
evidence suggests that such strategies should
be designed following the prior assessment of
barriers to adoption (Davis et al., 1995).
This article aims to provide a framework to
help in the identification of barriers to the
implementation of clinical guidelines.
Methods
We reviewed the scope and nature of barriers
to the adoption of evidence-based care,
encountered first, within SPCERH's own
work and, second, by other initiatives
concerned with the implementation of clinical
guidelines or guidance. We identified further
barriers via recent systematic reviews (Cabana
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et al., 1999; Wensing e: al., 1999; Pagliari and
Kahan, 1999) and other articles describing
barriers to effective health care. However, it
should be emphasised that our aim was not to
undertake a further systematic review, but
rather, by combining these sources, to provide
an overview of reported barriers to the
adoption of clinical guidelines.
Identified barriers were divided into three
broad categories according to whether they
related primarily to:
(1) characteristics of the guideline to
be introduced;
(2) characteristics of the individuals who
need to change; or
(3) characteristics of the organisation or
environment in which the change is
to occur.
We sought examples to illustrate each type of
barrier either from existing literature or from
SPCERH's own work. Although most
examples relate to experiences within
Scotland and to reproductive health care,
their message is relevant to a wider audience.
We also attempted to identify which
professional group(s) might have the greatest
potential to overcome each barrier.
Professional groups considered included:
national policy makers, guideline developers,
local health service managers, trainers,
clinicians and researchers.
Findings and implications for policy and
practice
A total of 41 different types of barrier were
identified. Ten relate primarily to
characteristics of the guideline itself (Table I).
These included its perceived validity and
relevance as well as the practical aspects of
implementation in a particular setting.
Guideline developers or clinical effectiveness
staff within NHS Trusts could address the
majority of these barriers.
A total of 16 of the identified barriers relate
primarily to characteristics of the individuals
who need to change (Table II). These barriers
fell into the broad categories of knowledge,
beliefs and attitudes and skills or abilities.
These are more likely to require interventions
involving education, persuasion or training.
However, some could be addressed by
changes to the way in which services are
delivered, or by introducing reminders. The
British Journal of Clinical Governance
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potential to address these lies predominantly
with trainers and clinicians themselves, either
at local or national levels - through
professional organisations, for example.
A total of 15 identified barriers relate
mainly to characteristics of the organisation or
environment (Table III). These included
established procedures and processes, the
culture of the organisation, resources and
means of evaluation. Managers and policy
makers have more power to address most of
these barriers than do clinicians or guideline
developers.
Patients can play an important role in
improving practice. To date, the knowledge
and expectations of patients have been
identified in the research literature as a barrier
to guideline implementation. However, this
may not always be the case. Informed patients
may facilitate rather than impede guideline
implementation in some circumstances.
Patient characteristics do not fit easily into the
framework that we have described here and
the 41st identified barrier has been termed
"patient factors." However, the groups we
have identified do have the potential to
address both patient information needs and
the abilities of clinicians to negotiate
treatment decisions with their patients or to
handle conflict. For example, guideline
developers could consider producing
materials for patients alongside those for
clinicians; local tutors could introduce
training in negotiation skills.
Some of the distinctions among barriers
appear arbitrary. However, the framework
that we describe here is not presented as a
theoretical taxonomy, but as a checklist to
guide those concerned with changing clinical
practice. There may be further barriers that
have not yet been identified through research
studies or practical experience.
A number of interventions have been shown
to be consistently effective at promoting
behavioural change among health
professionals, including the use of clinical
prompts and reminders, interactive
educational meetings and (in more limited
circumstances) educational outreach visits
(Bero et al., 1998). Multifaceted (or
combined) interventions tend to be more
effective, because more than one barrier
usually exists for each desired behavioural
change (Cabana et al., 1999). There is still a
need for a greater theoretical understanding
of how successful interventions work and for
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1. Invalidity of guideline
recommendations, i.e. when followed
they fail to lead to the health gains and
cost benefits predicted for them
(Institute of Medicine, 1992; Eastwood
and Sheldon, 1996)
2. Insufficient quality control in
guideline development process
Poorer quality studies assessing diagnostic
tests may over-estimate their accuracy by
up to three fold (Lijmer et al., 1999)
Failure to make explicit link between
recommendations and supporting evidence
in 18 per cent of medical society guidelines






3. Limited applicability of
recommendations to clinical practice
because of differences in population
characteristics or availability of
intervention (Mant, 1999)
4. Uncertainty about the durability (or
"shelf-life") of new research (Oswald
and Bateman, 2000)
5. Unavailability of direct evidence to
answer clinically important questions
6. Applying data from studies to
individual patients with different levels
of baseline risk (Mant, 1999)
Wider use of hysterosalpingography (HSG)
as first line in the investigation of infertility
- as recommended by clinical guidelines
(Royal College of Obstetricians and
Gynaecologists, 2000a) - limited by
availability of appropriately trained
radiologists
Variation in the use of agents to prevent or
delay active pre-term labour because of
evolving evidence about optimal choice of
agent and regimen and selection of women
most likely to benefit.
Lack of data indicating likelihood of
myocardial infarction for young, low-risk
women using combined oral contraception
(Hannaford and Owen-Smith, 1998)
Use of magnesium sulphate to prevent fits
in pre-eclampsia despite lack of clear











7. Imprecise or ambiguous wording of
recommendations (Grol et al., 1998)
8. Disruption to routine practice (Grol et
al., 1998)
9. Low awareness of information sources
or unavailability of evidence at point of
need (McColl et al., 1998)
10. Attainment of "ceiling effects,"
beyond which it is more difficult to
change practice further
Ambiguity of recommendations to
investigate "post-menopausal bleeding"
because of varying criteria to diagnose
menopause
Introduction of new interventions, e.g.
medical, as opposed to surgical, abortion





Reviews (Iqbal et al., 1998; Paterson-Brown Clinicians
etal., 1993)
Lack of improvement in compliance with
selected recommendations from Cochrane
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Table II Barriers related to characteristics of the individuals who need to change
Barrier Example
Groups with potential to
overcome
Knowledge
11. Lack of awareness that clinical
practice may be inappropriate
12. Over-estimation of self-reported
performance, (Ecdes et al., 1999) or
perceived irrelevance of
recommendations (Dunning et al.,
1998)
Attitudes and beliefs
13. General hostility to guidelines
(Cabana et al., 1999)
14. Previous adverse experience of
changing practice (Armstrong
et al., 1996)
15. Doubts over credibility of
source or
change agent (Oliver et al., 1996;
Humphrey and Berrow, 2000; Kitson
et al., 1998)
16. Hostility to challenges to
established practices, including
those where research
has been outpaced by development
(Grimes, 1993)
17. Low outcome expectation, i.e.
belief that following
recommendation will not lead to
expected outcome (Cabana
et al., 1999)
18. Avoidance of recommendations
because of perceived increased
susceptibility to litigation
19. Not sharing information with
patients because of perceived
resistance or demands (McColl et
al., 1998) or concern about raising
anxiety levels
Skills and abilities
20. Lack of skills and time to
undertake
brief targeted searches for clinical
evidence or guidelines
21. Lack of skills in critical
appraisal (of clinical guidelines as
well as original research) (McColl et
al., 1998; Oswald and Bateman,
2000)
Prescribing of ineffective drug therapy for
endometriosis-related infertility (Penney and
Templeton, 1995)
Over-estimatio n of actual use of
corticosteroids to prevent complications
following pre-term labour (Iqbal et al., 1998)
Fears that introduction of guidelines
increases susceptibility to litigation or
reduces scope for using clinical judgement
(Dye et al., 2000)
Experience of foetal death following use of
external cephalic version in management of
term breech (Burr et al., 1999)
Rejection of patient information leaflet by
midwives and ultrasonographers because of
disagreement with its assessment of costs
and benefits of routine ultrasound screening
(Oliver et al., 1996)
Routine use of intra-partum cardiotocography
(CTG) despite doubts over the evidence base
(Thacker and Stroup, 2000)
Perceived low "returns" on preventive
measures such as encouraging smoking
cessation in pregnancy
Over-investigation and management of
women with mild hypertension in pregnancy
because of concerns relating to the
development of more severe hypertension
(Scottish Obstetric Guideline and Audit
Project, 1997)
Ultrasonographers' "protection" of women
from information about the potential harms
of antenatal ultrasound, e.g. abnormal scan
result leading to abortion of normal fetus
(Oliver et al., 1996)
Undertaking apparently simple but time-
consuming Medline searches
Over-estimation of benefits or risks from
interventions when relative risk reduction
is used (Bucher et al., 1994), e.g. "risk of
transfusion at time of abortion doubles for






















Barriers to clinical guidelines: the need for concerted action British Journal of Clinical Governance
Robbie Foy, Anne Walker and Gillian Penney Volume 6 ■ Number 3 • 2001 • 166-174
Table II
Groups with potential to
Barrier Example overcome
22. Over-reliance on trusted or
convenient sources of information
(Slawson and Shaughnessy, 1997)
23. Lack of familiarity or self-
efficacy,
i.e. clinician belief that he cannot
perform the task (Cabana et al.,
1999)
24. Managing the complexity of
adopting desired practice (Grol et
al., 1998; Kitson et al., 1998)
Behaviour
25. Limited ability of professionals
to process all relevant information
in clinical practice, especially
during high pressure situations
(McDonald, 1976)
26. Lack of protected time and
resources to plan changes in
practice (Dunning
et al., 1998; Grol and Wensing,
1995; Cabana et al., 1999)
(Royal College of Obstetricians and
Gynaecologists, 2000b), fails to convey
absolute risk of only 2/1,000 and the fact
that abortion is a very safe procedure
Seeking advice from colleagues or specialists
without querying evidence base
(Olatunbosun eta/., 1998)
Infrequent enquiry during antenatal
consultations by midwives or obstetricians
about domestic violence (Foy et al., 2000)
Organisation of multi-disciplinary care and
follow-up for women with gynaecological
cancer (NHS Centre for Reviews and
Dissemination, 1999b)





Continuing use of intensive schedules of
antenatal care despite evidence that reduced-
visit schedules do not compromise safety







Table III Barriers related to characteristics of the organisation or environment
Barrier Example
Groups with potential to
overcome
Established practices and decision¬
making processes
27. Over-reliance on passive
methods of dissemination
(Freemantle et al., 1999; Davis et
al., 1995)
28. Poor targeting of guidelines
29. Guideline "adopted" without
consensus or adaptation to local
circumstances (Grimshaw and
Russell, 1993)
30. Failure to prioritise
implementation (Dawson, 1997)
Passive dissemination of Report of
Confidential Enquiries into Maternal Deaths
and resulting lack of awareness of key
recommendations among obstetricians and
midwives (Foy et al., 2000)
Inability of professionals and organisations
to cope with proliferating quantities of
clinical guidelines (Hibble et al., 1998;
Firth-Cozens, 1997)
Imposition of national guidance without
consultation - such as the requirements for
"approval of independent sector places for
the termination of pregnancy" by the
Secretary of State for Health (Royal College
of Obstetricians and Gynaecologists, 2000b)
Coping with multiple external and internal
priorities; the need to ensure that sufficient
resources are provided for implementation
relative to the production of evidence (e.g.
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Table III
Groups with potential to
Barrier Example overcome
31. Inertia of larger organisations
or networks
Culture
32. Little or no history of multi-
disciplinary working (Dunning
et al., 1998)
33. Negative attitudes from
colleagues or other professionals
towards challenging existing
practices or reinforcing new
effective practices (McColl et al„
1998; Armstrong et al., 1996)
Resources
34. Opportunity costs of evaluating
and changing performance
35. Diluted or non-implementation
of proven interventions because of
limited resources (Foy et al., 1999)
Knowledge and assessment of
organisational performance
36. Promotion of non-evidence
based standards (Sheldon, 1998)
37. Negative attitudes to clinical
audit by clinicians and managers
38. Absence or poor quality of
clinical audit (Kitson et al., 1998)
39. Difficulty in measuring or
interpreting outcomes (Dunning
et al., 1999)
40. Short-term outlook rather than
appreciation of long-term nature of
achieving and sustaining change
(Dunning et al., 1998)
Patient factors
41. Conflicting patient knowledge,
expectations and preference over
choices in clinical management
(Oliver et al., 1996)
Continuing use of intensive schedules of
antenatal care, with duplications of care by
obstetricians, GPs and midwives, despite
evidence that reduced-visit schedules do
not compromise safety and that many
women can be cared for by GPs and
midwives alone (Hall et al., 1980; Tucker
et al., 1996)
Resistance to an expanded role for
gynaecology nurses has slowed the
introduction of medical abortion.
Resistance to adoption of routine antibiotic
prophylaxis at Caesarean section despite
Cochrane Review demonstrating efficacy






Establishment of guideline initiatives without Managers
link to audit
Rationing of in vitro fertilisation (Smith and Policy makers
Plomer, 1996) Managers
Failure of 82 per cent of published
professionally-developed guidelines to
explicitly link recommendations to strength
of evidence (Grilli et al., 2000)
Concerns over perceived threats to
professionals, restriction of clinical freedom
and increased workload (Johnston et al.,
2000), resulting in marginalisation of audit
activities (Donaldson and Muir Gray, 1998)
Insufficient resources to support audit and
lack of expertise in conducting audit
(Johnston et al., 2000)
Unreliability of in vitro fertilisation league
tables in assessment of units' performance
because of year-on-year random variation
and biases in presentation of results
(Marshall and Spiegelhalter, 1998;
Winston, 1998)
Traditional short-term project funding of
audit and guideline exercises (until recently)
by CRAG National Projects Committee
Demand for Caesarean section in the
absence of medical indications
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more evidence on the cost-effectiveness of
tailoring interventions specifically to
identified barriers. Furthermore, although we
have identified "barriers", it is important to
note that such factors may facilitate improved
practice if they operate the other way around
(Kitson et al., 1998). For example, previous
positive experiences of change or availability
of special skills become strengths to be
considered in the design of any local
implementation strategy.
Those with the greatest potential to address
barriers range from individual clinicians to
national policy makers - but it is seldom
possible to identify a single group capable of
effectively tackling a barrier in isolation. For
example, developing clinical skills in order to
follow guideline recommendations requires
support from both local tutors and
management to provide protected time and
resources for training. Ultimately, the priority
given to such training is determined by
national policy-makers, for example, in
establishing frameworks such as clinical
governance to ensure that these needs are
identified and met. Therefore, strategies to
tackle barriers to change need to be multi¬
level as well as multi-faceted. A critical test of
clinical governance and managed clinical
networks will be the extent to which they can
help prioritise and unite action across
organisational and professional boundaries.
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How can we improve the quality
of primary care?
Clinical research continually produces new findings
that can contribute to effective and efficient patient care.
However, such research cannot change patient outcomes
unless health services and health care professionals
adopt them in practice. Uneven uptake of research
findings—and thus inappropriate care—occurs across
different health care settings, countries and specialities,
as demonstrated by two papers on implementing
evidence-based medicine published in this issue of
Family PracticeH
In primary care, the detection and management of risks
related to hypertension3 or hyperlipidaemia are highly
variable.4 The impact of secondary prevention, including
the administration of secondary prophylactic drugs to
patients surviving a myocardial infarction, is reduced by
similar disparities.5-7 Much of this variation is not
attributable to either patient or resource factors.
There aremounting expectations to deliver high quality
primary care from governments impatient for results.
Legitimate challenges to improve the quality of care8
must be informed by research that can offer clinicians
and managers effective and efficient means to enhance
service delivery.9 Implementation research (the scientific
study of methods to promote the uptake of research
findings, and hence to reduce inappropriate care) aims to
inform policy decisions about how best to use resources
to improve the uptake of research findings by testing
approaches to change professional and organizational
behaviour.
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What is known?
As with clinical care, systematic reviews of rigorous
studies have contributed greatly to our knowledge about
what works in changing professional and organizational
behaviour. A recent overview of systematic reviews10
suggested that it was possible to identify strategies that
were more, or less, effective. Strategies such as postal
distribution of guidelines or didactic educational sessions
were suggested to be largely ineffective. Local consensus
conferences, the use of opinion leaders or audit and
feedback were of variable effectiveness, and strategies
such as interactive educational workshops, reminder
systems, educational outreach and multifaceted inter¬
ventions were suggested as largely effective. This sounds
very promising but, as is ever the case, the devil is in the
detail.
Limitations of the evidence
On closer scrutiny, the evidence for effective inter¬
ventions may not stand up to the real world of local
implementation because of limited or unpredictable
transferability. Our understanding of what makes
professionals and organizations change (or not) is based
upon superficial and, sometimes, hopeful interpretation
of the processes. 'Academic detailing' (or educational
outreach) involves the use of a trained person providing
information, including feedback on performance, to pro¬
fessionals in their practice settings with the intent of
changing behaviour. This appears to be effective when
combined with 'social marketing' approaches that help
identify and overcome barriers to change—but demon¬
strated benefits have been largely confined to prescrib¬
ing in North America.11 We need to understand in greater
detail which factors influence the effectiveness of
interventions in other circumstances, such as different
settings, types of professional or targeted behaviours.
Attempts to generalize research findings to primary
care (or any other setting) encounter three main prob¬
lems. First, we are unsure of what factors are important
in the relative success or failure of reported strategies
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because of the lack of an established theoretical frame¬
work. Secondly, studies do not measure or report
potential effect modifiers, e.g. the influence of different
attributes of targeted behaviours on outcomes.12 Thirdly,
interventions are often poorly described—thus posing a
problem for aggregation within systematic reviews and
for subsequent interpretation in order to reproduce
successful interventions. These problems are analogous
to those of applying clinical research findings from
secondary to primary care settings without considering
population characteristics or available resources and
skills.13
Systematic reviews of more rigorous evaluations
(including randomized trials) indicate variable effective¬
ness within the same interventions, such as audit and
feedback or use of local opinion leaders (people identi¬
fied by their peers as being educationally influential.
These variations might be attributable to the modifying
effects of context and content. For example, it might be
more feasible to identify and use local opinion leaders in
secondary care settings than in primary care. Inconsis¬
tent findings might also be explained by variations in the
intensity or quality of the interventions tested. Although
prompts and reminders appear to be consistently
effective, their frequency and proximity to the point of
clinical decision making may influence the size of their
impact.
Evidence on the effectiveness of certain strategies is
sparse. For total quality management (TQM), uncon¬
trolled evaluations have suggested benefit not borne out
by randomized controlled trials.14 Existing evidence may
not be trustworthy or may be difficult to interpret because
of methodological weaknesses, such as randomizing
and analysing organization-wide interventions on an
individual rather than group basis.15
Where effectiveness is consistently demonstrated, it
is difficult to judge whether benefits are outweighed
by costs. Few studies have assessed the direct costs of
changing clinical behaviour, not to mention the indirect
effects on health services following implementation
strategies.16 Resources are limited and any implementa¬
tion strategies that exhaust these limited resources will
not be sustainable in the long term. Those responsible
for local implementation need to know as much about
the cost-effectiveness of behavioural interventions as
they do about that of clinical interventions.
What is needed?
Implementation research has to tackle a number of
issues in order to improve the transferability of its find¬
ings. Studies require a conceptual framework within
which to describe common elements of settings, indi¬
viduals, targeted behaviours and interventions. Hence, it
should be possible to identify what features influence the
likely effectiveness of interventions.
Behavioural models that attempt to explain change
require further development and testing in health care
settings. We need to assess, for instance, how far changes
in beliefs about research findings translate into changed
practice.17 Beyond explaining change, greater use should
be made of theoretical models in the design of interven¬
tions.18 Ultimately, the aim is to develop an empirical
basis for selecting interventions given specific barriers
and circumstances.
Better designed trials, more usually based upon
cluster rather than individual randomization, will
produce more valid (trustworthy) results.19 Randomized
trials of head to head comparisons are required to
establish the relative effectiveness of interventions in the
same setting.19 Further work is needed to optimize
the evaluation of evolving systems, such as computer
support for clinical decision making and managed
care pathways. Such evaluations should incorporate
some assessment of the economic consequences of
change strategies.
This research agenda demands stronger collaborations
not only between different research teams and dis¬
ciplines, but also among researchers, policy makers
and those clinicians and managers responsible for local
implementation.
Conclusion
Scope exists to improve the effectiveness of strategies to
change behaviour. However, the current evidence base
is limited. If efforts to improve the quality of primary
care are to achieve their potential, we will need a new
generation of theoretically derived, tailored, efficiency-
based trials that will move us towards "evidence based
medicine being complemented by evidence based
implementation".20
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Abstract
The object of this study was to determine which attributes of clinical practice recommendations influence changes in clinical practice following
audit and feedback. This was an observational study using multilevel modeling to examine the relationship between attributes of clinical practice rec¬
ommendations and compliance with the recommendations before and after audit and feedback. Sixteen hospital gynecology units in Scotland partic¬
ipated in a national audit project. Clinical practice recommendations covering selected gynecological topics were developed and data collected to as¬
sess baseline (preintervention) compliance. Summaries of performance were fed back to consultant gynecologists in each hospital and follow-up
(postintervention) data were collected. Trained audit assistants used standardized forms to abstract data from case notes. Compliance data were
available at baseline and follow-up for a total of 42 clinical practice recommendations. Altogether, 4,664 case notes contributed to baseline data and
4,382 to follow-up data. Thirteen attributes describing clinical practice recommendations were developed, based upon previous work, and pretested.
A panel of seven consultant gynecologists rated the extent to which each of the 42 recommendations possessed each of the 13 attributes. The main
outcome measures were the association of each attribute with compliance and with changes in clinical practice. Recommendations compatible with
clinician values and not requiring changes to fixed routines were independently associated with greater compliance at baseline and follow-up. How¬
ever, recommendations incompatible with clinician values were independently associated with greater change in practice following audit and feed¬
back. Attributes of recommendations may influence the effectiveness of audit and feedback in secondary care. Recommendations seen as incompat¬
ible with clinician values are associated with lower compliance but greater behavioral change following audit and feedback. © 2002 Elsevier Science
Inc. All rights reserved.
Keywords: Audit and feedback; Clinical practice guidelines; Professional practice; Behavior
1. Introduction
The implementation of valid clinical guidelines can im¬
prove the quality of health care [1], Passive dissemination
of a guideline is unlikely to lead to changes in clinical prac¬
tice [2]. Combining more active interventions, such as re¬
minders or interactive education, with guideline dissemi¬
nation and implementation is more likely to change
professional and organizational practice.
Various factors, or effect modifiers, can influence the ef¬
fectiveness of such interventions [3], Until recently, most
research has focused on characteristics of clinicians or
health care organizations, such as local attitudes or pre¬
paredness to change. However, the characteristics of clini¬
* Corresponding author. Tel.: +44 13 1 229 2575; fax: +44 0131 229
2408.
E-mail address: R.Foy@ed.ac.uk (R. Foy).
cal practice recommendations themselves may also influ¬
ence their rate of adoption [4],
Grilli and Lomas first assessed the association between
such characteristics and compliance with clinical guideline
recommendations [5]. They reviewed published studies re¬
porting compliance rates with 143 different recommendations
developed or endorsed by official organizations. Compliance
was higher for recommendations displaying "trialability"
(which could be tried out temporarily and discarded if found
wanting) and lower for complex recommendations. The "ob¬
servability" of recommendations (how readily their benefits
could be seen to be achieved) had no impact.
Grol et al. [6] assessed the extent to which Dutch general
practitioners' compliance with 47 guideline recommenda¬
tions was influenced by 12 characteristics (or attributes) of
the recommendations. The guidelines were disseminated via
journals and continuing medical education programs. Com¬
pliance was lower if recommendations were vaguely
worded, incompatible with clinician norms and values, and
disruptive to routine practice.
0895^1356/02/$ - see front matter © 2002 Elsevier Science Inc. All rights reserved.
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Table I
Summary of study methods
Context. Following a multicenter audit of gynaecological practice across 16
hospitals in Scotland, case note data on compliance at baseline and
follow-up were available for a total of 42 clinical practice
recommendations
Step 1. Development and pretesting of 13 attributes describing clincal
practice recommendations
Step 2. Panel of seven gynaecologists, using a modified RAND consensual
process, rates the extent to which each of the 42 recommendations
displays each of the 13 attributes
Step 3. Regression analysis to examine the influence of each attribute on
compliance and change in practice with the 42 recommendations.
Multilevel modeling incorporated to account for potential clustering
effects of hospital data
This previous work focused on the effects of various at¬
tributes on compliance with recommendations (i.e., a one-
off measure of performance). However, clinical guidelines
are produced to promote change in behavior (i.e., hereafter
referring to a decrease or increase in compliance), which
may be influenced by attributes different from those associ¬
ated with compliance. We investigated whether various at¬
tributes of clinical practice recommendations influenced
both compliance and change in clinical behavior among
specialists participating in a national audit program.
2. Methods
Table 1 summarizes the context and main steps of this
study, now described in detail.
2.1. Context: the Gynecology Audit Project in
Scotland (GAPS)
This study assessed change in clinical practice within the
context of a national audit and feedback program. Audit and
feedback is defined as: any summary of clinical perfor¬
mance of health care over a specified period of time, which
may include recommendations for clinical action [7], Crite¬
ria for good quality care covering selected gynecological
topics were developed and disseminated across Scotland be¬
tween 1992 and 1997 [8-11], The criteria were developed
using an approach similar to that advocated for formal clini¬
cal guideline recommendations and are hereafter referred to
as "clinical practice recommendations" [12]. Their develop¬
ment was based on reviews of available evidence, panel dis¬
cussions, and questionnaire surveys of gynecologists and
structured peer review.
Baseline compliance with the clinical practice recom¬
mendations was audited using data collected from case note
reviews. Trained audit assistants used standardized forms to
abstract data from case notes in 16 hospitals across Scot¬
land.
Following the baseline audit period for each topic, a
feedback report summarizing the agreed clinical practice
recommendations, the results of the audit exercise, and sug¬
gestions for change in practice was circulated to all consult-
Table 2
Number (percentage) of the 42 clinical practice recommendations judged




Addresses common issue: concerned with a
common clinical issue or a decision important
in daily care
Precisely described: provides a sufficiently detailed
and precise guide to clinical practice
Compatible: compatible with clinicians' current
norms and values in practice
Key feature: Essential to the whole set of
recommendations and to the ultimate goals
Based upon sound evidence: based upon sound
scientific evidence including, as appropriate,
clinical trials or metaanalyses
Fits patient expectations: is likely to fit in with
patient expectations
Observable: the benefits of using this practice or
policy over existing practices or policies can be
seen quickly
Requires organizational change: requires changes
in the way care is organized or additional
resources
Requires changed routines: requires changes to
fixed routines or habits
High profile: has a high profile in educational
programs or the media
Complex: is complex and requires many steps to do
or organize
Trialable: can be tried out and discarded easily
Requires new knowledge or skills: requires the














ant gynecologists in Scotland. Gynecologists working in
units contributing to data collection also received an indi¬
vidualized covering letter providing information to allow
their unit to be identified, and highlighting the strengths and
weaknesses of the local results. The circulation of the re¬
ports was complemented by presentations of the audit re¬
sults at postgraduate meetings in individual hospitals and at
national meetings. Follow-up data were then collected to
help assess whether clinical behavior had changed in line
with the recommendations. The cycle of audit and feedback
lasted approximately 18 months for each topic.
2.1.1. Available clinical practice data
Baseline (hereafter referred to as "preintervention") and
follow up ("postintervention") data were available from
case note audits for a total of 42 clinical practice recommen¬
dations relating to four topics: induced abortion, endome¬
trial sampling, laparoscopic sterilization, and infertility. Al¬
together, 4,664 case notes contributed to preintervention
data and 4,382 to postintervention data.
2.1.2. Step 1: selection ofattributes
Thirteen attributes of recommendations (e.g., whether
the recommendation was based on sound evidence, whether
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Table 3
Illustrative examples of clinical practice recommendations, compliance and ranges of compliance among hospitals
Preintervention compliance and















Laparascopic sterlization: prior to 7 (0-68)
sterilization, women should be given
an information leaflet summarizing
the various factors covered in the
counseling
Induced abortion: the follow-up 5 (0-18)
appointment should be within 14 days
of the abortion
Management of infertility: drug 45 (0-100)
treatments for endometriosis in
women with this condition and
infertility do not improve conception
rates and should not be prescribed for
this purpose
Induced abortion: the woman's 97 (86-100)
rhesus status should be ascertained,
and rhesus prophylaxis given























it was compatible with clinician norms) were developed,
based upon previous work [5,6], and modified following
pretesting on a convenience sample of four consultant gyne¬
cologists (see Table 2 for list and Table 3 for illustrative ex¬
amples.)
2.1.3. Step 2: rating of recommendations
A purposive sample of seven consultant gynecologists
was recruited to form a consensus panel. Attempts were
made to balance clinician age and their hospital characteris¬
tics (teaching and nonteaching; urban and rural).
Using a modified RAND process [13], the panel rated
the extent to which each of the 42 gynecology recommenda¬
tions displayed each of the 13 attributes. Initially, each pan¬
ellist rated the recommendations independently using an or¬
dinal 1-9 scale. The median scores and levels of agreement
from this first round of rating were fed back at a panel meet¬
ing. Structured discussion centred on the recommendation
attributes over which there was maximal discordance (de¬
fined as at least three panellists scoring 1-3 and at least
three scoring 7-9). Much discussion concerned clarifying
definitions of attributes or recommendations and the degree
to which certain recommendations displayed certain at¬
tributes. Immediately after this discussion, panellists again
independently rated the extent to which each recommenda¬
tion possessed each attribute. A median score of 7 or more
was used as the cutoff point for categorizing recommenda¬
tions as possessing an attribute.
2.1.4. Step 3: regression analysis
Regression analyses were undertaken to assess the
strength of associations between adherence to the recom¬
mendations and the extent to which each recommendation
displayed each of the 13 attributes (as measured by the mef
dian panel rating). Initially the influences on compliance
and behavior change were assessed for each attribute indi¬
vidually (univariate analyses). Subsequently, a multivariate
analysis was undertaken to assess which attributes had the
most significant independent effect on compliance and be¬
havior change.
Analyses were performed relating to (a) preintervention
compliance, (b) postintervention compliance, and (c)
change in compliance. The effect of each attribute on
change in compliance is presented as an interaction term, as
recommended by Cook and Campbell [14].
There was marked variation in compliance among hospi¬
tals. Multilevel regression modeling was, therefore, adopted
for all analyses. Multilevel modeling is designed for the
analysis of hierarchical data, and thus allowed us to model
patient outcomes while adjusting for the different hospital
effects, for example, hospitals might differ according to
whether or not they were teaching hospitals [15], A two-
level hierarchical linear model was adopted for all the anal¬
yses (patients within hospitals in this case), and a Normal
error structure assumed. The multilevel regression modeling
was undertaken using the statistical package MLWin. The
subclustering of patients within clinicians was not incorpo¬
rated in the model, as it was assumed that clustering would
be most likely at the level of the hospital, as local manage¬
ment protocols, if any, would be instituted at the organiza¬
tional level rather than at the level of the individual clini¬
cian. In addition, the intervention feedback was aggregated
at the hospital level rather than the level of the individual
clinician.
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The number of cases available for the assessment of
compliance with each of the 42 recommendations varied
widely (from 10 cases to 1,510 cases). To avoid the possi¬
bility of spurious correlation arising from analysis based
upon rate ratios (in this case percentage compliance), the
outcome variable in all regression analyses was the actual
number of compliant cases, with subsequent adjustment for
the total number of cases in the regression model [16].
3. Results
3.1. Panel rating ofGAPS recommendations
The number of clinical recommendations displaying
each attribute varied widely (Table 2). For example, 40
(95%) of the 42 recommendations were judged to precisely
describe recommended clinical practice, and 41 (98%) as
addressing a common clinical issue. None were judged as re¬
quiring new knowledge or skills, and only 3 (7%) each as
trialable or as complex.
The five attributes (precisely described, addresses com¬
mon issue, requires new knowledge or skills, complex and
trialable) displayed by over 90%, or under 10%, of recom¬
mendations were not included in further analysis, because
of their lack of variation. Thus, the modifying effects of
eight attributes on compliance and change were studied.
3.2. Influence ofattributes on compliance
Overall mean compliance with the 42 recommendations
was 58% preintervention and 61% postintervention, al¬
though there were marked variations in compliance among
hospitals (illustrated in Table 3). (A full list of recommen¬
dations and panel ratings is available from the authors.)
When considered separately, all eight attributes were signif¬
icantly associated with compliance both before and after
feedback (Table 4). The regression coefficients were
smaller for the postintervention compliance—primarily a
reflection of the narrower range generally seen in compli¬
ance scores postintervention. As such, there was less poten¬
tial for the attributes of the recommendation to influence
compliance in the postintervention phase. The following six
attributes had positive effects on compliance both pre- and
postintervention: based upon sound evidence; key feature;
compatibility; fits patient expectations; high profile; and
observable. Negative effects were associated with two attri¬
butes: requires organizational change; and requires changed
routines.
When the impact of all attributes were considered to¬
gether on multivariate analysis, only two attributes were
found to be significantly and independently associated with
compliance at both pre- and postintervention (Table 5).
Compatibility was positively associated with compliance,
i.e., the more the recommendation was compatible with cli¬
nician values, the higher the compliance. Requires changed
routines was negatively associated with compliance, i.e., the
more the recommendation required changes to routines, the
lower the compliance. Compatibility was significantly cor¬
related with the other seven remaining attributes in the
model, and might represent a general marker for a range of
attributes that influence practice.
3.3. Influence ofattributes on behavior change
Considered separately, four attributes were significantly
associated with behavior change. However, the directions of
these associations were reversed in comparison with those
obtained for compliance. The attributes positively associ¬
ated with compliance (compatibility and key feature) were
negatively associated with behavior change, and those nega¬
tively associated with compliance (requires organizational
change and requires changed routines) were positively asso¬
ciated with behavior change (Table 4).
When the impact of all attributes were considered to¬
gether on multivariate analysis, only compatibility was
found to be significantly and independently associated with
change in compliance. The more compatible the recommen¬
dation with clinician norms and values, the smaller the be¬
havior change pre- to postintervention (Table 5).
4. Discussion
4.1. Principal findings
Certain attributes of clinical practice recommendations
were associated with variations in compliance and behavior
Table 4
Univariate analyses of the association between eight attributes and complicance with recommendations
Attribute Regression coefficient (95% Cls)
Preintervention compliance Postintervention compliance Change pre- to postintervention"1
Compatible
Key feature
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Table 5
Results of multivariate regression analysis of the association between the
attributes and compliance with recommendations
Regression coeffcient Significance
Variable (95% CI) of regression
Preintervention compliance
Compatible 6.76 (4.73, 8.88) <.001
Requires changed -2.52 (-4.10, -0.95)
routines
Postintervention compliance
Compatible 4.26 (2.44, 6.08) <.001
Requires changed -1.77 (-3.19, -0.35)
routines
Change in compliance pre- to post- intervention
Compatible -3.34 (-5.37, -1.31)'" <.001
Coefficient of interaction term.
change before and after an audit and feedback program in
secondary care. Consistent with previous work [6], recom¬
mendations compatible with clinician norms and values and
not requiring changed routines were independently associ¬
ated with higher compliance. However, clinical practice
recommendations are intended to change behavior, and a
different picture emerged when changes in compliance fol¬
lowing audit and feedback were examined. Recommenda¬
tions less compatible with clinician norms and values were
associated with greater improvements in clinical practice,
probably because of a greater potential for change due to
low baseline compliance. Those recommendations more
compatible with clinician norms and values thus may have
been associated with potential ceiling effects, with limited
scope for further improvements in practice.
4.2. Strengths and weaknesses of the study
To our knowledge, this is the first study to investigate
whether attributes of recommendations independently influ¬
ence change in clinical behavior as opposed to compliance.
Much implementation research is still based upon a "black
box" approach but it is important to explore the potential
impact of a range of effect modifiers (such as attributes of
clinical practice recommendations) to improve our under¬
standing of why interventions may or may not succeed in
changing professional behavior.
We used a more rigorous consensus process than previ¬
ous research to define the attributes of clinical practice rec¬
ommendations, based upon the perceptions of our targeted
clinicians. Given the retrospective design of this study, it is
possible that panel ratings were biased by the gynecolo¬
gists' knowledge of how widely certain recommendations
were actually adopted in practice. The use of multilevel
modeling, incorporating individual hospital effects, was jus¬
tified given the marked variation in practice observed
among different hospitals. Analyses based on patient level
data, which did not account for "clustering" effects, might
have overemphasized the significance of any results [15].
Case notes may not contain all relevant information to
assess whether recommendations are followed in clinical
practice. Although several clinical practice recommenda¬
tions were concerned with adequate recording of actions in
the case notes, it is possible that the use of such data might
underestimate actual adherence to some recommendations.
However, assuming such a bias applies equally to the pre-
and postintervention data, it is unlikely to underestimate
changes in behavior.
4.3. Meaning of the study (possible mechanisms and
implicationsfor clinicians or policy makers)
A range of interventions exists to improve clinical prac¬
tice. Systematic reviews of rigorous evaluations suggest that
some of these interventions are largely ineffective (e.g.,
postal distribution of guidelines alone) while others work
more consistently (e.g., use of clinical prompts and remind¬
ers) [17]. However, it is often difficult to predict which in¬
terventions are best suited to particular circumstances. Au¬
dit and feedback is variably effective [18]; this may be
related to factors such as the method of feeding back perfor¬
mance data to clinicians or the actual content of the recom¬
mendations.
In this study, audit and feedback appeared to be effective
in promoting the implementation of recommendations
judged to be less compatible with clinician norms and val¬
ues. For example, in the care of women undergoing induced
abortion, preintervention compliance was low (5%) for one
such recommendation, "The follow-up appointment should
be within 14 days of the abortion." Following audit and
feedback, compliance increased moderately by 27% (to
32%). Feedback permitting comparisons among hospitals
during the audit programme may therefore have prompted
action on recommendations previously regarded as too dis¬
ruptive or incompatible to implement. In contrast, preinter¬
vention was compliance was high (97%) for a recommenda¬
tion rated as compatible with clinician norms and values,
"The woman's rhesus status should be ascertained, and
rhesus prophylaxis given following abortion, if indicated."
Subsequently, there was little scope for improvement in
compliance with this recommendation following audit and
feedback.
Different attributes may have influenced change in clini¬
cal behavior following an intervention other than audit and
feedback (e.g., interactive educational programs). For ex¬
ample, recent experience regarding the dissemination of
four clinical guidelines within the context of a national clin¬
ical effectiveness program suggests that adherence to one
guideline (albeit clinician reported) did not improve be¬
cause of the relatively complex nature of its recommenda¬
tions [19].
Implementation strategies, based upon a "diagnostic
analysis"—identification of potential needs and barriers—
are more likely to be effective [20]. Attributes of individual
recommendations appear to influence both compliance and
behavior change, and need to be considered when planning
implementation activities. It is likely that the effects of dif¬
ferent implementation strategies may be modified by the at-
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tributes of recommendations. At present, there is only lim¬
ited information about how such attributes modify the
effects of implementation strategies; however, as further ev¬
idence becomes available consideration of the attributes of
practice recommendations may assist in the choice of im¬
plementation strategy.
4.4. Unanswered questions andfuture research
Further research is required to determine how attributes
of recommendations modify the effectiveness of different
interventions in different contexts. These studies should fo¬
cus on behavior change rather than compliance, and use the
most robust estimates of behavior change, preferably from
randomized trials.
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Objective To evaluate the impact of disseminating the Report on Confidential Enquiries into Maternal
Deaths 1994-1996.
Design Telephone survey.
Setting Twenty-three consultant-led maternity units in Scotland.
Participants Obstetricians and senior midwives.
Main outcome measures Awareness of key recommendations from the report and participation in
implementation activities.
Results Two hundred and one of 208 staff (97%) agreed to participate. One hundred and thirty-one (65%)
stated they had read at least some of the report. A median of three of 18 key recommendations were
recalled, with recall of newer issues being poorer. Although reported access to key clinical guidelines was
high, other dissemination and implementation activities were used inconsistently, if at all.
Conclusion Publication of future confidential enquiry reports should be accompanied by active
dissemination strategies, possibly emphasising newer or more important recommendations.
Keywords: clinical audit, maternity care, survey
Introduction
The series of reports dealing with confidential
enquiries into maternal deaths (CEMD) aims to
draw generalisable lessons for maternity care by
scrutinising events preceding maternal deaths in the
United Kingdom. Participation in these enquiries
Robbie Foy is an MRC training fellowwith the Scottish Programme
for Clinical Effectivenss in Reproductive Health (SPCERH); Fiona
Nelson is a specialist registrar; and Gillian Penney is programme
coordinator for SPCERH.
Correspondence to; Dr R. Foy. Tel: 0131 229 2575; fax; 0131 229
2408; e-mail: R.Foy@ed.ac.uk
and implementation of subsequent recommenda¬
tions represent core functions within clinical govern¬
ance.1 The last report, for the years 1994-1996, sub¬
titled Why Mothers Die, also highlighted wider public
health issues.2 Many of the maternal deaths are
associated with episodes of sub-standard care, but
instances of such care related to mortality may
represent only the 'tip of the iceberg', with a large
proportion of 'near miss' events likely. Although
maternal mortality lias continued to fall, similar
errors in clinical care tend to recur. The implementa¬
tion of the report's recommendations therefore
continues to represen' a major challenge for
maternity services, especially in the light of the
professional time and interest invested in the conduct
© 2000 Radcliffe Medical Press Journal of Clinical Excellence 2 (2000)
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of the enquiries and production of the reports.
Copies of the report are sent to all consultant
obstetricians and heads of midwifery in Scotland.
Given the multidisciplinary nature ofmaternity care,
it is important that key clinical recommendations are
disseminated widely. The 1994-1996 report was
supplemented by an executive summary, listing key
recommendations, intended for wider distribution
among all staff involved in maternity care.
Effective dissemination represents a critical first
step in implementation. This study aimed to assess
awareness among obstetricians and midwives in
Scotland of the key recommendations from the
1994—1996 report, and to determine their participa¬
tion in local dissemination activities.
Methods
The sample consisted of duty obstetric (senior house
officers, specialist registrars and consultants) and
midwifery (midwives in charge of labour wards and
antenatal clinics) staff from all 23 consultant-led
maternity units in Scotland. Most units were sampled
twice with five staff members being approached on
each occasion, but in the three smallest units, only
three staff members were approached. In one larger
unit, only four staff members were eligible on the
second occasion. Thus, 208 staffwere approached for
interview.
An interview schedule for a telephone survey was
developed and pre-tested to include:
• awareness of key recommendations from the
report and the main causes ofmaternal mortality,
• reported clinical practice,
• access to clinical guidelines,
• participation in educational activities relevant to
the report.
Enquiry was made into recall of key recommenda¬
tions, with minimal prompting by the interviewers.
For the purposes of this study, mention ofat least one
aspect of a recommendation was counted as a
positive response.
Where possible, the precise topic of the survey was
not revealed prior to the interviews. The confidential
nature of this survey and the fact that it was to assess
dissemination of the report rather than individual
competence were explained to all potential partici¬
pants. The interviews took place 6 months after the
report was published.
Data were entered into an Access database
(Microsoft Access, 1997, INSO Corporation) and
analysed using SPSS for Windows (version 8, 1997,
SPSS Inc.). Median recall scores were compared using
the Mann-Whitney U test with two-sided P values.
Results
Two hundred and one of 208 staff agreed to be
interviewed (a response rate of 97%). Three refused
to be interviewed and four could not be contacted
after at least six attempts. Responders were evenly
distributed by grade and discipline according to the
sampling frame.
One hundred and eighty-five (92%) were aware of
the latest'report (Table 1) and 131 (65%) reported
having read at least some of the full report or
executive summary. Fewer had participated in
educational meetings or tests of emergency protocols
('fire drills'). Reported access to clinical guidelines
was high except for the management of women who
declined blood products and the management of
ectopic pregnancy. (The latter were mentioned as
being more frequently located in gynaecological
units.)
Each responder recalled a median of three out of
18 key recommendations. At least a third of
responders recalled issues relating to the manage¬
ment of eclampsia and pre-eclampsia, protocols for
emergencies, consultants' attendance and delega¬
tion, and prophylaxis for thromboembolism (Table
2). However, recall of certain preventive issues such
as seatbelt use, domestic violence, antibiotic pro¬
phylaxis in caesarean section and awareness of
puerperal sepsis was much lower. Forty-seven
respondents (33%) were unable to recall any
recommendations.
Asked about direct causes of maternal mortality,
most respondents ranked thromboembolism and
pregnancy induced hypertension within the top three
but omitted amniotic fluid embolism (Table 3).
Respondents were also less aware that epilepsy and
psychiatric illness represented major indirect causes
ofmaternal death. In response to a separate question
about epilepsy, 120 of 163 staff involved in antenatal
care (74%) could recall neither of the specific
recommendations pertaining to personal safety (not
bathing unsupervised and that friends or relatives
know what to do in the event of a fit).
Respondents who reported having read at least
some of either report recalled a median of three
recommendations compared with 0.5 for those who
had not (Z— 6.73, 2P< 0.001). Respondents who had
attended any educational meeting recalled a median
of four recommendations compared with two for
those who had not (Z = 4.59, 2P < 0.001).
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Table 1. Number and per cent of interviewees reporting participation in or access to dissemination
activities
Activity Number (%)
Recognition, receipt and reading
Awareness of the Report 185 (92)
Received or seen a copy of the Full Report 119 (59)
Received or seen a copy of the Executive Summary 79 (39)
Read at least some of the Full Report 104 (52)
Read at least some of the Executive Summary 67 (33)
Training activities
Lecture specifically on the most recent Report (didactic style) 19 (9)
Group tutorial specifically on the most recent Report (interactive style) 40 (20)
Tests of emergency obstetric protocols ('fire drills') in preceding 6 months 49 (24)
Access to local guidelines or policies
Management of pre-eclampsia and eclampsia 195 (97)
Management of obstetric haemorrhage 186 (93)
Use of thromboprophylaxis 179 (89)
Antibiotic cover for caesarean sections 169 (84)
Management ofwomen who decline blood products 102 (51)
Investigation and management of ectopic pregnancy 106 (53)
A total of 201 staffwere interviewed.
Discussion
Overall awareness of the report's content was low,
especially of those recommendations included for the
first time in the current report. Although most staff
reported access to major clinical guidelines, other
educational efforts to disseminate key CEMD
recommendations were used inconsistently, if at all.
The high response rate and quasi-random method
of selecting participants improved the likelihood that
the sample was representative of obstetricians and
senior midwives in Scotland. Attempts were also
made to minimise biases which might over-estimate
awareness of the report's content. It is likely that the
pressure of participating in telephone interviews led
to an under-estimate of respondents' actual know¬
ledge. However, responses to a postal questionnaire
might have over-estimated awareness of recommen¬
dations, because some respondents might have been
prompted to read the report as they answered
questions. Furthermore, information on the relative
levels of recall and recognition of recommendations
indicates which recommendations appeared less
important to clinical staff or require reinforcement
in future dissemination activities.
This study was not designed to assess the effect of
dissemination activities. Confounding may explain
much of the apparent association between higher
recall of recommendations and reading of the reports
or attendance at educational meetings. For example,
staff who received or read the reports may already
have been more interested in the issues raised and so
recalled more recommendations.
Knowledge of newer issues (e.g. the contribution
of amniotic fluid embolism) appeared low compared
with those mentioned in previous reports (e.g.
consultants' attendance). The report incorporated a
revised method for diagnosing deaths from amniotic
fluid embolism, where the clinical picture alone may
fulfil diagnostic criteria without pathological evid¬
ence. It is possible that the perceived contribution of
post-partum haemorrhage to maternal deaths was
Journal ofClinical Excellence 2 (2000)
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Table 2. Number and per cent of respondents recalling key recommendations from the report
Recommendation Number (%)
Recognition of main direct causes of death 53 (26)
Importance of prompt diagnosis or referral of suspected serious disease 49 (24)
Identification of women at risk of post-natal mental illness or self-harm during 15 (7)
antenatal care
Enquiry about domestic violence 8 (4)
Education of women about the use of seatbelts 4 (2)
Education ofwomen about symptoms associated with pre-eclampsia 11 (5)
Education of women about first aid of epileptic fits 12 (6)
Early attention to chest or leg symptoms to exclude presence of thromboembolism 62 (31)
Management of eclampsia or pre-eclampsia by a single senior clinician 88 (44)
Pregnancy testing considered in any woman with unexplained abdominal pain 11 (5)
Prompt management of suspected ectopic pregnancy 33 (16)
Assessment of risk factors in considering prophylaxis against thromboembolism in all 66 (33)
women undergoing caesarean section
Use of prophylactic antibiotics in caesarean section 9 (4)
Awareness of puerperal sepsis 6 (3)
Participation in confidential enquiries 6 (3)
Consultant attendance or appropriate delegation in emergencies 77 (38)
Need for units to have protocols for massive haemorrhage or pulmonary embolism 88 (44)
Unit 'fire drills' for emergencies 7 (3)
A total of 201 staff were interviewed.
raised following the recent dissemination of a guide¬
line on this topic in Scotland.3
The report's public health messages appear to have
been poorly assimilated, particularly those pertaining
to the correct use of seatbelts and domestic violence.
Such recommendations may have been given lower
priority or seen as more problematic to implement.
Several midwifery respondents mentioned that they
were currently exploring acceptable ways to identify
victims of domestic violence.
A re-audit of the implementation of the 1991-1993
report found improvements in the organisation of
maternity services and availability of guidelines.4
However, the simple distribution of printed educa¬
tional material is relatively ineffective for improving
clinical practice.5 It is of concern that awareness of
key recommendations was so low, especially given the
high profile of the confidential enquiry into maternal
deaths. Newer recommendations, such as the enquiry
about domestic violence, may require greater em¬
phasis in future reports and additional support to
implement at a local level.
Conclusions
Participation in these confidential enquiries repre¬
sents a core task in clinical governance. However, the
time and effort expended in producing the reports
need to be matched by appropriate dissemination
activities. Among obstetric and midwifery staff in
Scotland, knowledge of key recommendations from
the last report (1994-1996) was poor. Educational
efforts to disseminate recommendations were used
inconsistently, if at all, at a local level. Publication of
future reports should be accompanied by active
dissemination and implementation strategies.
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Table 3. Respondents' knowledge ofmain causes of direct and indirect maternal deaths
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Psychiatric illness (including suicide) 20 (10)
A total of 201 staf were interviewed.
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Abstract
Objective: To audit reported clinical practice in
relation to four national obstetric guidelines on The
Preparation of the Foetus for Preterm Delivery, The
Management of Mild, Non-proteinuric
Hypertension in Pregnancy, The Management of
Pregnancy in Women with Epilepsy and The
Management of Postpartum Haemorrhage.
Design: Questionnaire surveys before and after
dissemination of the guidelines.
Subjects: One hundred and sixty one consultants and
senior specialist registrars in Scotland.
Results: The response rates to the baseline and
follow-up surveys were 85% and 74% respectively.
Over 90% of the obstetricians kept the guidelines for
reference and 85% had been prompted to change or
reconsider their practice. Reported compliance
improved significantly for six out of twenty nine
recommendations covering: the use of tocolysis in
women at risk of pre-term labour; the use of
prophylactic antibiotics or entry to a clinical trial for
pre-term, pre-labour rupture of the membranes; the
initiation of steroid therapy in women with insulin-
dependent diabetes mellitus; and the prescribing of
periconceptual folic acid and vitamin K to women
with epilepsy. There were no significant
improvements in relation to mild, non-proteinuric
hypertension or post-partum haemorrhage.
Conclusions: There were significant improvements
in the reported management of women at risk of
preterm labour and those with epilepsy. However,
reported practice in relation to mild,
non-proteinuric hypertension and post-partum
haemorrhage has improved little. This is possibly
because the guidelines for these topics were
relatively complicated to understand and apply, and
established patterns of practice more resistant to
change.
Keywords: clinical governance; clinical guidelines;
survey; maternity care.
Background
Clinical guidelines and clinical audit represent two
fundamental components of the NHS clinical
effectiveness1 and clinical governance2 initiatives.
These represent national efforts to promote more
uniform standards of high quality, evidence-based care.
Within these recent, quality-promoting initiatives,
attempts have been made to bring together guideline,
audit and related activities. Previously, audit3 and
guidelines*1 had been promoted as separate activities and
were often undertaken in isolation.5
In Scotland, a national body, the Scottish Intercollegiate
Guidelines Network (SIGN) has developed a rigorous
methodology for the selection of topics for. and
development of, clinical practice guidelines. Between
1995 and 1997, four obstetric guidelines (The
Preparation of the Foetus for Preterm Delivery, The
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Management ofMild, Non-proteinuric Hypertension in
Pregnancy, The Management ofPregnancy in Women
with Epilepsy and The Management of Postpartum
Haemorrhage) were developed by multidisciplinary
groups in accordance with this methodology.7
Individual recommendations within the guidelines were
graded as follows:7
Grade A: at least one randomised controlled trial as
part of the body of literature of overall good quality
and consistency addressing the specific
recommendation;
Grade B: availability of well-conducted clinical
studies but no randomised clinical trials on the topic
of the recommendation;
• Grade C: evidence from expert committee reports
or opinions and/or clinical experience of respected
authorities.
The guidelines were disseminated by means of a
national meeting attended by medical and midwifery
representatives from all Scottish maternity units and by
postal circulation to relevant medical and midwifery
staff. Publication and dissemination were undertaken
under the auspices of the Scottish Programme for
Clinical Effectiveness in Reproductive Health
(SPCERH), a national programme endorsed by the
Scottish Branches of both the Royal College of
Obstetricians and Gynaecologists and the Royal
College ofMidwives. National strategies for promoting
clinical effectiveness have evolved from stand-alone
projects towards integrated, multidisciplinary
programmes. SPCERH represents such an initiative,
bringing together educational, audit and research
activities which relate to reproductive healthcare.
However, the value of such programmes in improving
healthcare and health outcomes requires evaluation.
In the spirit of an integrated clinical effectiveness
programme, the development and dissemination of
these four guidelines was complemented by an audit
exercise which aimed to assess obstetricians' baseline
compliance with the guideline recommendations and to
assess any changes in practice subsequent to
dissemination. The findings of this audit of self-reported
practice are reported here.
Methods
A questionnaire enquiring into aspects of practice
related to the guidelines, including brief case vignettes,
was developed. It was sent to 161 senior obstetricians
in 1997. comprising all consultants and all identifiable
senior registrar/ year four and five specialist registrars
in Scotland. The findings of the baseline audit
questionnaire were disseminated at the time of
distribution of the guidelines. A shorter questionnaire
was posted to the same obstetricians two years later,
containing a subset of the original questions which
mainly addressed those recommendations where there
was some potential for change in clinical practice. All
initial non-responders to both questionnaires received
one reminder.
Responses were entered into an Access database8 and
analysed using SPSS." Responses were categorised as
'appropriate' if they were consistent with
recommendations in the guidelines and included in the
analysis only when matched questions from both the
baseline and follow-up questionnaires had been
answered. The exact matched pairs test was performed
using Arcus10" and two sided P values were used. To
allow simpler presentation of results, the overall
proportion and direction of change in practice is
presented in addition to baseline compliance. As this
way of presenting results could mask substantial shifts
in opinion from compliant to non-compliant responses,
large shifts (20% or more of respondents) in this
direction were highlighted. One way analysis of
variance (ANOVA) was used in the comparison of
multiple means.
Results
During the period between the two surveys, 19 of the
original 161 obstetricians retired from obstetric practice
or moved outwith Scotland. Of the 142 obstetricians
available for survey at both time points, 121 (85%)
returned the baseline questionnaire and 105 (74%) the
follow-up questionnaire. Ninety-two of these 142
obstetricians (65%) completed both questionnaires and
results are subsequently based upon this group.
Eighty-four (91%) obstetricians reported that they had
kept the guidelines for future reference whilst the others
were uncertain of their location or had thrown them
away. Seventy-eight (85%) reported that they had
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Table 1. Receipt, adoption and audit of the guidelines (n=92)
The preparation of the foetus for pre-term delivery
The management of mild, non-proteinuric hypertension
The management of pregnancy in women with epilepsy
The management of postpartum haemorrhage
changed or reconsidered aspects of their practice in
response to the guidelines. Of these, 30 (33%) found the
guidelines sufficiently relevant to prompt changes in
some aspects of practice, whilst 48 (52%) were
prompted to reconsider their practice. The remainder
found them of general interest (12, 13%) of no real
interest and (1, 1%). Approximately half of all
respondents reported adopting the guidelines locally but
fewer reported using them in local audit. Of the four
guidelines, that on mild, non-proteinuric hypertension
was least often adopted or used for audit locally.
Regarding preparation for preterm delivery, there were
significant reported increases in both appropriate use of
tocolysis and in consideration of prophylactic antibiotic
therapy or entry to the MRC Preterm Antibiotic
Uncertainty Study (ORACLE) in preterm pre-labour
rupture of the membranes (PPROM). Compared with
seven respondents who (appropriately) changed
response to the avoidance of steroid therapy in a 28 year
old primigravida presenting at 35 weeks gestation with
PPROM, 17 changed response to prescribing steroids.
Despite positive trends, there were no significant
improvements in the management of mild,
non-proteinuric hypertension from a mixed baseline
compliance. There was no change in the proportion of
obstetricians reporting performing at least four out of
the five basic investigations recommended in
monitoring mild, non-proteinuric hypertension (50,
59% at baseline and 45. 53% at follow-up; P = 0.46).
Improvements were more pronounced in the reported
care of pregnant women with epilepsy, with significant
increases in the use of a higher dose of folic acid and
combined administration of vitamin K. However,
compared with nine respondents who changed
(appropriately) to including combined oral
Recall Adopted Used in local
receipt (%) locally (%) audit (%)
79(86) 46(50) 18 (20)
85(92) 40(43) 6 (7)
86 (93) 53(58) 13 (14)
78 (85) 47 (51) 23 (25)
contraception in options offered to women on enzyme
inducers, 20 now would not.
Knowledge of recommendations for major obstetric
haemorrhage from the 1991-3 Report on the
Confidential Enquiry into Maternal Deaths (CEMD) did
not consistently improve, although baseline knowledge
was already high for four out of the six
recommendations.12 Compared with ten respondents
who changed (appropriately) to setting up central
venous pressure (CVP) monitoring. 21 would no longer
do so.
Differences in reported mean compliance at follow-up
was assessed according to whether recommendations
were graded A. B or C. No significant differences were
found (F = 1.53; DF=2; NS).
Discussion
Feedback of results from a baseline audit and
dissemination of guidelines under the auspices of a
national programme were followed by improvements in
knowledge and self-reported obstetric practice. Overall,
reported adherence to the guidelines increased
significantly for six out of 29 recommendations.
This project represented one of the first attempts to
complement national clinical guideline development
with a related audit exercise. However, these results
should be interpreted with appropriate caution as
compliance with the guideline recommendations may
have been overestimated for two reasons. First, 35% of
the sample did not respond and obstetricians unaware
of, or not following, the guidelines may have been less
likely to respond to the survey. Second, self-reported
practice may over-estimate actual clinical
performance.13
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Table 2. Guideline recommendations on the management of women at risk of preterm delivery, grade of
recommendation and reported adherence
Baseline Overall p
number (%) change from
baseline (%)
Prescription of ante-natal steroids for women at risk of pre- 83 (100) 0(0) 1
term delivery (n=83) Grade A
Lowest gestation at which steroids would be considered 69(82) 4(5)** 0.39
(above 24 inconsistent with guideline, n=84) A
Highest gestation at which steroids would be considered (34 67 (80) 5 (6) 0.42
to 36 weeks consistent with guideline, n=84) C
Use of tocolysis (Acceptable: rarely to permit intra-uterine 67(81) 12(14) 0.004
transfer to a tertiary centre or to allow a course of steroids to
be administered and for a maximum period of 48 hours,
n=83) A
Use of prophylactic antibiotics or entry to ORACLE trial in the 52(62) 20(24) <0.0001
management of women presenting with preterm, pre-labour
rupture of the membranes (PPROM) (n=84) A
A 25 year old primigravida with insulin-dependent diabetes
(IDDM) and a twin pregnancy at 28 weeks gestation at risk of
delivery in the next 7 days.
Initiation of steroid therapy (n=83) C 77(93) 6(7) 0.03
Usual dosage if initiating steroid therapy (n=78) A 72(92) 3(4) 0.45
Use of tocolytic therapy to allow steroid therapy to have an 55(65) 10(12) 0.07
optimal effect, assuming that contractions are regular and
painful, and that vaginal examination has indicated the cervix
is 50% effaced and 3 cm dilated (n=84) A
Indomethacin as preferred drug for tocolysis in IDDM (n=67) B 27(40) 4(6) 0.06
A 2Syr old primigravida with no relevant medical or obstetric
history presenting at 35 weeks gestation with PPROM
Avoidance of steroid therapy (n=83) C 62(75) -10 (-12) 0.06
Use of prophylactic antibiotic therapy or entry to ORACLE 44(52) 23 (28) <0-001
(n=84)A
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Table 3. Guideline recommendations on the management of mild, non-proteinuric hypertension in




Use of Korotkoff phase IV (muffling of sounds) in measuring 58(69) 6(7) 0.21
diastolic BP (n=84) Grade C
A patient attending for routine antenatal care is found to have 55 (64) 9(10) 0.09
a "spot" diastolic BP of 95 mmHg but no proteinuria. (Re-
checking of BP within a short period and, if diastolic remains
elevated, make arrangements for a further check in the
hospital or community at least 4 hours later before initiating
further investigations, n=86) C
Avoidance of anti-hypertensive treatment (or referral to a
colleague for advice) for a 20 year old primigravida at 34
weeks gestation developing gestational hypertension (diastolic
BP consistently 95 mmHg) but no proteinuria (n=86) A
Consideration of anti-hypertensive treatment (or referral to
colleague for advice) for a 20 year old primigravida at 31
weeks gestation developing gestational hypertension (diastolic
BP consistently 95 mmHg) but no proteinuria. (n=85) A
Methyldopa as preferred first line agent for treatment, where
appropriate, of gestational hypertension (n=85) B
Twice weekly (every 3-4 days) follow up for BP check and
urine testing for a 20 year old primigravida with a diastolic BP
of 95 mmHg but no proteinuria at 34 wks gestation (n=85) C
73 (86) 4 (4) 0.42
21 (25) 3 (3) 0.63
13(15) 5(6) 0.23
40 (47) 5 (6) 0.49
Selection of investigations for intermittent assessment of the 16(19) 1(1) 1
above woman (no more than two deviations from a list of 14
appropriate and inappropriate investigations. Appropriate
tests are full blood count, platelet count, 'dipstick' testing for
proteinuria, urea and electrolytes, and serum urate, n=85)
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Table 4. Guideline recommendations on the management of pregnancy in women with epilepsy, grade of
recommendation and reported adherence
Periconceptual folic acid supplements at 4-5 mg/day (as for
women with a previous history of neural tube defects) for
women with epilepsy (n=78) Grade C
Use of vitamin K 1 mg at birth for babies and treatment of
mother with 20 mg orally daily from 36 weeks gestation for the
prevention of haemorrhagic disease of the newborn (n=74) B
Encouragement and support of breast feeding as for any
other mother (n=76) B
Inclusion of combined oral contraception (COC) among the
contraceptive options offered to women on enzyme inducers
whilst encouraging the use of non-hormonal methods (n=79). B
Use of regimens containing higher doses of oestrogen as a
first line when COC is chosen by a woman on an enzyme
inducing anticonvulsant. (Any of: 50 ug pill, combination of
two lower dose pills or taking three or more packs of pills in
succession without a pill-free interval, n=79) B
At a significance level of five per cent at least one
'significant" change in practice will occur by chance
following the multiple statistical tests performed in this
study. Nevertheless, the overall trend was consistent
with improved knowledge and practice and the limited
number of obstetricians available for the survey may
have constrained our ability to detect further significant
changes. Whilst improvements in practice cannot be
directly attributed to the methods of audit and guideline
dissemination, they are consistent in direction and
magnitude with those observed in a previous national
audit programme.16
Our experience highlights lessons for similar initiatives
to improve clinical practice. Several factors may
explain why some guideline recommendations were
apparently adopted more successfully than others.
Reported practice improved across most aspects of the
management of anticipated preterm labour, notably in





13 (18) 42 (58) <0.0001
67 (88) 6 (8) 0.07
42 (53) -11 (A4) 0.06
58(73) 6(8) 0.38
prophylactic antibiotics in PPROM. Significant
improvements occurred despite high baseline
compliance. This may reflect obstetricians' growing
acceptance of a reliable evidence base15 and, perhaps,
synergistic effects of educational activities undertaken
by the ORACLE study group around this time to
promote the trial. Similarly, the trends towards reported
improved practice in women with epilepsy were
encouraging.
However, considerable uncertainty persists regarding
the optimal management of women with mild,
non-proteinuric hypertension. There were wide
variations in the reported frequency of follow up.
selected investigations and therapeutic choices. Some
choices of investigation (such as the use of ultrasound)
may have been influenced more by availability and
women's preferences than by guideline
recommendations. Furthermore, once established, such
clinical practices are difficult to alter.
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Table 5. Guideline recommendations on the management of postpartum haemorrhage, grade of
recommendation and reported adherence
Baseline Overall p
number (%) change from
baseline (%)
Correct recall of recommendations made in the 1988-1990
Report on Confidential Enquiries into Maternal Deaths
providing guidelines for the management ofmassive obstetric
haemorrhage (n=86)
Alert all of the following: anaesthetist, haematologist, blood
transfusion and porters (true) Grade C
A minimum of 2 units blood should be ordered (true) C
Dextrans are recommended for transfusion until blood arrives
(false) C
At least two intravenous lines should be set up using
cannulae of not less than 14 gauge (true) C
Blood warming equipment is unnecessary (false) C
Central venous pressure monitoring should immediately be
set up to ensure that therapy is safely controlled (true) C
The latest CEMD Report demonstrates that pregnancy
induced hypertension is the second most common cause
of maternal mortality." Clinicians appear to be
managing women with mild hypertension in pregnancy
too aggressively and this probably reflects anxiety in
missing or under-managing more serious disease. The
guideline set out to support obstetricians in minimising
clinical risk by offering a more structured, as well as
efficient, approach to management. It is notable that 40
respondents (47% of 85) did not report the use of at least
four out of the five basic investigations recommended
in monitoring mild, non-proteinuric hypertension. This
guideline possibly represents the most complex of the
four to follow.
Approximately half of respondents did not correctly
recall the CEMD Report recommendations that a
minimum of two units of blood should be ordered and




86(100) -3 (-3) 0.58
75 (87) -6 (-7) 0.29
57(66) -11 (-13) 0.07
employed in the management of massive obstetric
haemorrhage. However, responses to the baseline
survey indicated that all Scottish maternity units now
have appropriate protocols in place. Rapid access to
such protocols during clinical emergencies may be more
important in improving standards of care than relying
upon the limitations of memory."
Compliance at follow up was unrelated to the grade of
recommendations. Other characteristics of guideline
recommendations may influence compliance, such as
their compatibility with clinician norms and values, or
disruption to routine practice. "The recommendations to
use combined vitamin K regimens and the higher dose
of folic acid supplement in pregnant women with
epilepsy were graded B and C respectively. The precise
nature of these recommendations may have contributed
to the observed significant changes in reported practice.
The instances where sizeable proportions of clinicians
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shifted from compliant to non-compliant responses may
be attributable to more ambiguous or complex
recommendations (inclusion of COC as option for
women receiving enzyme inducers) or inconsistency
with overall management trends (avoidance of steroid
therapy at 35 weeks gestation in PPROM). However, the
trend away from CVP monitoring in massive
haemorrhage seems more difficult to explain in this
context.
It is acknowledged that the distribution of guidelines by
itself is unlikely to change practice." However, the
dissemination and audit of clinical guidelines under a
recognised national clinical effectiveness programme
may contribute to consistent improvements in reported
clinical practice. It is also important to learn why certain
recommendations appear less acceptable to
obstetricians. Those responsible for future guideline
development and dissemination need to be able to
anticipate barriers to implementation and design means
of overcoming them. Whilst self-reported practice is not
the most rigorous outcome measure, this survey has
highlighted aspects of the guideline project requiring
further evaluation. We are currently evaluating the
impact of one of these guidelines by assessing both the
effect upon actual clinical practice and the costs and
benefits of the dissemination programme.
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